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Abstract 
 
 
 
 Chapter 1. We have developed a single-vessel catalytic protocol for double protoboryl 
additions to terminal alkynes with B2(pin)2 promoted by Cu complex derived from chiral 
N-heterocyclic carbene (NHC), to achieve enantiomerically enriched versatile vicinal 
diborons. Since an alkenyl(pinacolato)boron, which was in situ generated by the first 
protoboration of a terminal alkyne, can serve as an effective substrate for the second 
protoboration (alkenylboron can allow delocalization of π electrons of olefin to a partially 
vacant p orbital on boron), single-vessel catalytic process with 2 equiv. of B2(pin)2 in the 
presence of sulfonate-bearing chiral NHC–Cu complex, affords enantiomerically 
enriched 1,2-diborons in up to 93% yield and 97.5:2.5 enantiomeric ratio (e.r.). Site-
selective Pd-catalyzed cross-coupling with alkenyl bromide shows the versatility of the 
resulting diboron compounds, which delivers the coupling product efficiently. 
 
 
Interestingly, only the less hindered, primary C–B bond on vicinal diboron compound 
participates in the cross coupling. 
 
 
 Chapter 2. Cu-catalyzed protocol for selective formation of α-alkenylborons has been 
demonstrated. With achiral NHC–Cu complex, readily prepared from commercially 
available imidazolinium salt, various terminal alkynes are converted to internal 
alkenylborons in up to 93% yield with high to exclusive α selectivity. Propargyl ethers, 
amides and aryl alkynes are proved to be suitable substrates. Utility of α-alkenylborons is 
demonstrated by conversion to methyl ketone and synthesis of cyclic alkenylboron 
compound. In addition, when Cu complex bearing a stronger electron-donating NHC is 
used, the site selectivity of protoboration reaction becomes reversed, which delivers the 
alternative isomer, β-alkenylboron efficiently. By altering the steric and electronic nature 
of NHC, site selectivity is dramatically changed. Mechanistic basis for site selectivity is 
presented. 
 
 
 
 
 Chapter 3. Efficient and selective protocol for synthesis of enantiomerically enriched 
silylborons is described. In the presence of achiral NHC–Cu complex, site- and 
stereoselective protosilyl additions to terminal alkynes afford a wide range of alkyl- and 
aryl-substituted (E)-β-alkenylsilanes. Chiral monodentate NHC−Cu complex promotes 
enantioselective protoboration of alkyl- or alkenyl-bearing alkenylsilanes, delivering 
vicinal borosilanes with up to 96.5:3.5 e.r. When an alkene bearing both silyl and aryl 
groups is utilized, on the other hand, geminal silylboron is obtained with high enantio- 
(93:7–98.5:1.5 e.r.) and site selectivity (up to >98% geminal). In this case, we have 
reasoned that the electronic attribute of aryl unit is more dominant than the silyl group to 
control site selectivity. 
To demonstrate the utility of the Cu-catalyzed transformation, we have illustrated 
the formal synthesis of bruguierol A, natural product active against Gram-positive and 
also Gram-negative bacteria. The key intermediate geminal borosilane is provided by 
sequential NHC–Cu-catalyzed protosilylation and protoboration of terminal alkyne in 77% 
overall yield with 97.5:2.5 e.r. and 97% site selectivity. Additionally, stereochemical 
models to account for levels and trends in site- and enantioselectivity are proposed. 
 
 
 
 
 Chapter 4. New methods for enantioselective protonation of 2-B(pin)-bearing 
allylcopper, which is in situ generated by site-selective Cu–B addition to 1,1-
disubstituted allene, are presented. Transformations are promoted by a chiral NHC–Cu 
complex, affording an alkenylboron containing α-carbon stereogenic center. 
Enantiomerically enriched aryl-, heteroaryl- and silyl-bearing alkenylborons are 
generated in high yield (up to 98%) and selectivities (up to >98% site selectivity and 
96.5:3.5 e.r.). To explore the utility of enantiomerically enriched alkenylborons, we have 
developed Cu-catalyzed enantioselective allylic alkenyl addition to allylic phosphate. A 
chiral NHC–Cu complex promotes the allylic substitution of enantiomerically enriched 
alkenylboronic acid with ally phosphate to deliver 1,4-diene in 62% yield with 96:4 d.r. 
(>98% stereoselectivity). 
 
 
 Chapter 5. We have developed a single-vessel, multicomponent process to synthesize 
N-bearing quaternary carbon stereogenic centers with exceptional diastereo- (>98:2 d.r. 
for all cases) and high enantioselectivity (88:12 to >99:1 e.r. except one case). Especially, 
protecting group-free ketoimine (“N–H” ketoimine), which can be prepared by alkylation 
of a readily available nitrile, has been utilized for the study. The transformation of “N–H” 
ketoimine is very useful because the obtained amine has no protecting group, which 
allows us to avoid the deprotection step as well as to be able to choose appropriate 
 
 
protecting group for subsequent chemical reactions. By oxidation of α-tertiary carbamine 
with NaBO3, β-amino ketones (Mannich reaction product) are obtained in up to 83% 
yield. A stereochemical model to account for the level of diastereo- and enantioselectivity 
are presented using DFT calculations. To show the utility of the present method, we have 
synthesized a medicinally active compound, which was studied for Alzheimer’s disease. 
The Cu-catalyzed protocol delivers the core structure of the target molecule with 
exclusive diastereo- and enantioselectivity (>98:2 d.r. and 99.5:0.5 e.r.). 
 
  
 
 
Index of Imidazolinium Salts 
 
 
 
Acknowledgements 
 
 I would like to express my sincere appreciation to my advisor Prof. Amir H. 
Hoveyda for all of his supports, advices, and encouragements. I was very lucky to join his 
group. He is passionate about thinking of, talking about, and teaching all kinds of 
chemistry. He has been leading me to be a better chemist and group members. In addition, 
he has given great advices for my future career. I’ll keep in mind them all the time. I 
would also thank Prof. Mark L. Snapper and Prof. Masayuki Wasa for kindly accepting 
to serve as members of my doctoral committee, spending time to read this document, and 
giving me valuable suggestions. 
 
During my Ph. D. work, I have had excellent coworkers. I want to thank my 
mentor, Dr. Yunmi Lee, for leading me to a successful graduate student. Because of her 
guidance and helps, I could become a member of Hoveyda group and also learn how to 
manage the projects. I am also grateful for Dr. Adil R. Zhugralin, Dr. Fanke Meng, Dr. 
Byunghyuck Jung, Dr. Sebastian Torker, and Dr. Filippo Romiti for their insights and 
valuable suggestions. I really enjoyed working with them and learned a lot from them. 
 
 I also want to thank all Korean friends in BC chemistry department. Dr. Kang-
sang Lee was the first person I met on my first day in Boston. He helped me to start my 
life as a graduate student at Boston College. I also had lots of good memories wirh Dr. 
Yeon-ju Lee, Dr. Hee Yeon Cho, Dr. Youn Hee Nam, and Hyelee Lee. Additionally, it 
has been great time to work with KyungA (Stella) Lee and Jaehee Lee in Hoveyda group. 
 
 
I spent a lot of time with them to talk about chemistry, a life in BC, and so on. I’ll not 
forget the days with all my Korean friends and wish the best luck on their future. 
 
I have been a member of Boron subgroup and also one of allylation subgroup. I’d 
like to acknowledge all past and present members of those subgroups; Dr. Rosa Corberan, 
Dr. Aiko Guzman-Martinez, Dr. Hao Wu, Suttipol "Benz" Radomkit, Nick Mszar, Dr. 
Hiroshi Miyamoto, Dr. Dan Silverio, Farid van der Mei, Dr. Changming Qin, Shaochen 
Zhang, Ryan Morrison, and Diana Fager. They are all talented chemists and kind 
colleagues. I got a lot of advices and solutions from them in subgroup meetings. 
Fortunately, I have had great people in Boston College Chemistry Department. Deborah 
Lynch and Jodi Silton kept helping me and encouraging me. I would like to give a great 
appreciation to all the staff members in Chemistry Department including them.  
 
 Finally, I would like to acknowledge my family’s contribution to the completion 
of my Ph. D. degree. The endless love and supports from my parents has encouraged me 
to get over difficulties. I know they always think of me, believe me, and pray for me. I’d 
like to thank my brother, Hwanjun, his wife, and their two kids for their supports. And 
also I’d like to express my appreciation to my parents-in-law, brother-in-law and his 
family for their thoughts and wishes for me. Lastly, my wife AHyun deserves the most 
sincere appreciation for all of what she has done for me always. I could not finish my 
doctoral study without her encouragements and love. 
 
i 
 
Table of Contents 
 
Chapter 1. Tandem Site- and Enantioselective NHC–Cu-Catalyzed Double 
Protoboryl Additions to Terminal Alkynes to Generate Enantiomerically 
Enriched Vicinal Diboron 
1.1. Introduction………………………………………………………………………….1 
1.2. Background………………………………………………………………………….3 
     1.2.1. Metal-Catalyzed Enantioselective Hydroboration of Alkenylborons…………...4 
     1.2.2. Metal-Catalyzed Diboration with Chiral Diboron Reagents……………………4 
     1.2.3. Metal-Catalyzed Enantioselective Diboration of Alkenes………………………5 
     1.2.4. Metal-Catalyzed Enantioselective Hydrogenation of Alkenylborons…………..8 
1.3. NHC–Cu-Catalyzed Enantioselective Double Protoborations of Terminal 
Alkynes………………………………………………………………………………..…10 
     1.3.1. Initial Observations…………………….………………………………………10 
     1.3.2. Examination of Various Chiral NHC–Cu Complexes…………………………11 
     1.3.3. Substrate Scope of NHC–Cu-Catalyzed Enantioselective Double Protoborations 
of Terminal Alkynes…………………..…………………………………………………13 
     1.3.4. Functionalization of Enantiomerically Enriched Vicinal Diborons and Utility in 
Chemical Synthesis………………………………………………………………………18 
1.4. Conclusions…………………………………………………………………………19 
1.5. Experimentals………………………………………………………………………21 
 
Chapter 2. Site-Selective NHC–Cu-Catalyzed Protoboryl Addition to 
Terminal Alkynes for Synthesis of Internal (α-) or Terminal (β-) 
Alkenylborons. Utility in Chemical Synthesis and Mechanistic Basis for Site 
Selectivity 
2.1. Introduction…………………….…………………………………………………52 
2.2. Background……………………...…………………………………………………55 
2.3. NHC–Cu-Catalyzed α-Selective Protoborations of Terminal Alkynes…………58 
     2.3.1. Examination of Various NHC–Cu Complexes……………………………...…58 
ii 
 
     2.3.2. α-Selective Protoborations of Propargyl Alcohols, Amines and Derivatives….59 
     2.3.3. α-Selective Protoborations of Aryl- and Heteroaryl-Substituted Terminal 
Alkynes……………………………………………..……………………………………61 
     2.3.4. The Utility of Cu-Catalyzed α-Selective Protoboration of Terminal Alkyne….64 
2.4. NHC–Cu-Catalyzed β-Selective Protoborations of Terminal Alkynes…………67 
2.5. Mechanistic Basis for Site Selectivity in NHC–Cu-Catalyzed Protoboration of 
Terminal Alkynes…………………………….…………………………………………69 
2.6. Conclusions…………………………………………………………………………73 
2.7. Experimentals………………………………………………………………………75 
 
Chapter 3. (E)- and β-Selective NHC–Cu-Catalyzed Protosilyl Addition to 
Terminal Alkynes and Site- and Enantioselective Protoboryl Addition to the 
Resulting Alkenylsilanes: Synthesis of Enantiomerically Enriched Vicinal and 
Geminal Borosilanes 
3.1. Introduction………………………….……………………………………………130 
3.2. Background…………………………………….…………………………………134 
     3.2.1. Metal-Catalyzed Silaborations of Terminal Alkenes………………………....134 
     3.2.2. Base-Mediated Selective Silaboration of Aryl Alkenes………...……………136 
     3.2.3. Cu-Catalyzed Selective Synthesis of Cyclic Vicinal Borosilanes……………137 
     3.2.4. Non-Catalytic Synthesis of Enantiomerically Enriched Geminal Borosilanes.139 
3.3. Site- and Stereoselective Synthesis of alkenylsilanes by NHC–Cu-Catalyzed 
Protosilylation of Terminal Alkynes…………………………………………………140 
3.4. Site- and Enantioselective NHC–Cu-Catalyzed Protoboration of Alkenylsilanes 
…………………………………………………………………………………………..142 
     3.4.1. Examination of Various Chiral NHC–Cu Complexes………..………………142 
     3.4.2. NHC–Cu-Catalyzed Enantioselective Protoborations of Alkyl- and Alkenyl-
Substituted Alkenylsilanes…………………………………………………..…………146 
     3.4.3. NHC–Cu-Catalyzed Enantioselective Protoborations of Aryl-Substituted 
Alkenylsilanes……………………………………………..……………………………147 
     3.4.4. Functionalization and Utility in Chemical Synthesis…..…………………….149 
iii 
 
     3.4.5. Stereochemical Models to Account for Levels and Trends in Site - and 
Enantioselectivity……………………………….………………………………………152 
3.5. Conclusions…………………………………………..……………………………157 
3.6. Experimentals………………………………………..……………………………158 
 
Chapter 4. Site- and Enantioselective NHC–Cu-Catalyzed Protoboryl 
Additions to Disubstituted Allenes: Access to Enantiomerically Enriched 
Alkenylborons 
4.1. Introduction……………………………….………………………………………221 
4.2. Background……………………………………….………………………………224 
     4.2.1. Catalytic Enantioselective Synthesis of α-Stereogenic Center-bearing Ketones 
…………………………………………………………………………………………..224 
     4.2.2. Preparation of α-Stereogenic Center-containing Alkenyl Bromides…………227 
     4.2.3. Catalytic Enantioselective Allylic Substitutions with Alkenylboron Reagent.228 
4.3. Practical Method for Preparation of 1,1-Disubstituted Allenes….……………233 
4.4. Catalytic Enantioselective Protoboration of 1,1-Disubstituted Allenes….……234 
     4.4.1. Evaluation of Chiral NHC–Cu and Bisphosphine–Cu Complexes…….……..234 
     4.4.2. Cu-Catalyzed Enantioselective Protoboration of 1,1-Disubstituted Allenes…238 
     4.4.3. Stereochemical Models to Account for Enantioselectivity…..……………….241 
     4.4.4. Representative Functionalizations……………………………………………242 
     4.4.5. Catalytic Allylic Substitutions with Enantiomerically Enriched Alkenylboron 
…………………………………………………………………………………………..245 
4.5. Conclusions…………………………………………..……………………………247 
4.6. Experimentals………………………………..……………………………………249 
 
Chapter 5. NHC–Cu-Catalyzed Chemoselective Boron–Copper Addition to 
Monosubstituted Allenes followed by Diastereo- and Enantioselective 
Additions to Protecting Group-Free Ketoimines: Three-Component, Single-
Vessel Catalytic Protocol for 2-B(pin)-Substituted Homoallylic Tertiary 
Carbamines 
iv 
 
5.1. Introduction……………………………….………………………………………338 
5.2. Background……………………………….………………………………………341 
5.3. Diastereoselective Additions of 2-B(pin)-Substituted Allyl Groups to 
Unprotected Ketoimines………………………………………………………………345 
     5.3.1. Search for Optimal Conditions……….………………………………………345 
     5.3.2. Substrate Scope of Diastereoselective Cu–B Addition/Allyl Addition to 
Unprotected Ketoimines………………………………………………………………..346 
     5.3.3. Stereochemical Models to Account for Levels in Diastereoselectivity………349 
5.4. Diastereo- and Enantioselective Additions of 2-B(pin)-Substituted Allyl Groups 
to Unprotected Ketoimines……………………………………………………………350 
     5.4.1. Study of Chiral Cu Complexes………………………………………….……350 
     5.4.2. Substrate Scope of Diastereo- and Enantioselective Cu–B Addition/Allyl 
Addition to Unprotected Ketoimines……………………………………………..…….352 
     5.4.3. Stereochemical Models to Account for Levels in Enantioselectivity…..……355 
     5.4.4. Functionalization and Utility in Chemical Synthesis…………………..…….356 
5.5. Conclusions…………………………………………………………………..……362 
5.6. Experimentals………………………………………………………………..……364 
 
 
Chapter 1, Page 1 
 
 
Chapter One 
Tandem Site- and Enantioselective 
NHC–Cu-Catalyzed Double Protoboryl Additions 
to Terminal Alkynes to Generate 
Enantiomerically Enriched Vicinal Diborons 
 
1.1. Introduction 
 Organoboron compounds are one of the most useful intermediates in the field of 
organic synthetic chemistry due to the versatility of the carbon–boron bond. 1 
Stereoselective metal-catalyzed hydroboration has been widely studied for the synthesis 
of organoboron compounds.
2
 There are, however, still a number of challenges that remain 
to be addressed. In most of previous examples, precious metals such as Rh, Ir, or Pd have 
been utilized. In 2009, our group reported first enantioselective NHC–Cu-catalyzed 
protoboryl addition to styrenes (site-selective boron–copper addition to aryl alkene 
followed by protonation of in situ generated carbon–copper bond by MeOH).3 It was 
                                                 
(1) For reviews on functionalizations of organoboron compounds, see: (a) Brown, H. C.; Singaram, B. Pure 
& Appl. Chem. 1987, 59, 879–894. (b) Brown, H. C.; Singaram, B. Acc. Chem. Rec. 1988, 21, 287–293. (c) 
Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–2483. (d) Miyaura, N. Bull. Chem. Soc. Jpn. 2008, 81, 
1535–1553. 
(2) For reviews on metal-catalyzed hydroborations, see: (a) Burgess, K.; Ohlmeyer, M. J. Chem. Rev. 1991, 
91, 1179–1191. (b) Beletskaya, I.; Pelter, A. Tetrahedron 1997, 53, 4957–5026. For reviews on 
enantioselective hydroboration of olefins, see: (c) Crudden, C. M.; Edwards, D. Eur. J. Org. Chem. 2003, 
4695–4712. (d) Carroll, A. -M.; O’Sullivan, T. P.; Guiry, P. J. Adv. Synth. Catal. 2005, 347, 609–631. (e) 
Thomas, S. P.; Aggarwal, V. K. Angew. Chem., Int. Ed. 2009, 48, 1896–1898. 
(3) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160–3161. 
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shown that aryl group is required to achieve high efficiency since it lowers the olefin’s 
LUMO energy, which promotes olefin–Cu coordination. We reasoned that if 
alkenylborons, which contain boron, allowing delocalization of π electrons of olefin to a 
partially vacant p orbital on boron, can be induced to undergo site-selective 
protoborations, an efficient Cu-catalyzed protocol for enantioselective synthesis of the 
highly versatile vicinal diboron compounds would be accomplished. Since alkenylborons 
can be prepared by another protoboryl addition to terminal alkynes, we examined a 
single-vessel Cu-catalyzed process for double protoborations of terminal alkynes to 
achieve enantiomerically enriched versatile vicinal diborons (eq 1.1). 
 
Vicinal diborons are versatile building blocks for organic syntheses. A lot of 
efforts have been made to develop efficient procedure for preparation of 1,2-diboron 
compounds, the majority of which is metal-catalyzed diboration of alkenes.
4
 A number of 
metal-catalyzed protocols for diboration of alkenes,
5
 alkynes,
6
 enones,
7
 and allenes
8
 have 
                                                 
(4) For reviews on metal-catalyzed diboration, see: (a) Marder, T. B.; Norman, N. C. Top. Catal. 1998, 5, 
63–73. (b) Ishiyama, T.; Miyaura, N. J. Organomet. Chem. 2000, 611, 392–402. (c) Ishiyama, T.; Miyaura, 
N. Chem. Rec. 2004, 3, 271–280. (d) Beletskaya, I.; Moberg, C. Chem. Rev. 2006, 106, 2320–2354. (e) 
Burks, H. E.; Morken, J. P. Chem. Commun. 2007, 4717–4725. (f) Ramirez, J.; Lillo, V.; Segarra, A. M.; 
Fernandez, E. Comp. Rend. Chim. 2007, 10, 138–151.  
(5) For selected recent reports regarding catalytic enantioselective diboration of terminal alkenes, see: Rh-
catalyzed: (a) Morgan, J. B.; Miller, S. P.; Morken, J. P. J. Am. Chem. Soc. 2003, 125, 8702–8703. (b) 
Trudeau, S.; Morgan, J. B.; Shrestha, M.; Morken, J. P. J. Org. Chem. 2005, 70, 9538–9544. Pt-catalyzed: 
(c) Kliman, L. T.; Mlynarski, S. N.; Morken, J. P. J. Am. Chem. Soc. 2009, 131, 13210–13211. 
(6) (a) Ishiyama, T.; Matsuda, N.; Miyaura, N.; Suzuki, A. J. Am. Chem. Soc. 1993, 115, 11018–11019. (b) 
Ishiyama, T.; Matsuda, N.; Murata, M.; Ozawa, F.; Suzuki, A.; Miyaura, N. Organometallics 1996, 15, 
713–720. 
(7) (a) Ito, H.; Yamanaka, H.; Tateiwa, J.; Hosomi, A. Tetrahedron Lett. 2000, 41, 6821–6825. (b) Mun, S.; 
Lee, J.-E.; Yun, J. Org. Lett. 2006, 8, 4887–4889. 
(8) (a) Ishiyama, T.; Kitano, T.; Miyaura, N. Tetrahedron Lett. 1998, 39, 2357–2360. (b) Pelz, N. F.; 
Woodward, A. R.; Burks, H. E.; Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2004, 126, 16328–16329. 
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been extensively reported through the use of Rh, Ir, Pt, Pd or Au catalysts, however, few 
of which demonstrate dihydroboration of alkynes to generate 1,2-diborated compounds 
and enantioselectivities reported for dihydroboration are low (65:35–67.5:32.5 e.r.).9 
Moreover, the more practical Cu-catalyzed variant of these reactions has been 
underdeveloped. Thus, an efficient and enantioselective Cu-catalyzed double 
protoborations of alkynes would thus constitute an important contribution. Herein, we 
have disclosed tandem site- and enantioselective NHC–Cu-catalyzed double protoboryl 
additions to terminal alkynes to achieve enantiomerically enriched vicinal diboron 
compounds. 
 
1.2. Background 
 Enantiomerically enriched vicinal diboron compounds are key intermediates in 
chemical synthesis since two C–B bonds can be converted to synthetically useful C–O, 
C–N, C–C or C–H bonds independently. Therefore, efficient and selective protocols for 
preparing this class of molecules have been developed. In this section, we will summarize 
the advances regarding catalytic synthesis of enantiomerically enriched 1,2-diboron 
compounds, which includes (1) metal-catalyzed enantioselective hydroboration of 
alkenylboron compounds, (2) metal-catalyzed diboration with chiral diboron reagents, (3) 
metal-catalyzed enantioselective diboration of olefins, and (4) metal-catalyzed 
enantioselective hydrogenation of alkenyldiborons. 
 
 
                                                 
(9) Nguyen, P.; Coapes, R. B.; Woodward, A. D.; Taylor, N. J.; Burke, J. M.; Howard, J. A. K.; Marder, T. 
B. J. Organomet. Chem. 2002, 652, 77-85. Ramirez, J.; Segarra, A. M.; Fernandez, E. Tetrahedron: 
Asymmetry 2005, 16, 1289–1294. 
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1.2.1. Metal-Catalyzed Enantioselective Hydroboration of Alkenylborons 
 In 1996, Weissensteiner and coworkers reported that enantioselective 
hydroboration of (E)-alkenylboronic ester 1.1 in the presence of 2 mol % of (S)-binap–Rh 
complex with catecolborane affords 1,2-diol 1.2 in 49% yield and 86:14 e.r. after 
oxidation (Scheme 1.1).
10
 Several bisphosphine–rhodium complexes were investigated, 
and they obtained the highest efficiency and enantioselectivity with (S)-binap–Rh 
complex. Substrate scope is, however, extremely limited; they only showed one example 
of the desired diol product 1.2. 
 
 
1.2.2. Metal-Catalyzed Diboration with Chiral Diboron Reagents 
 An alternative strategy for optically active vicinal diboron compounds is 
diboration of terminal alkenes. Norman and coworkers developed Pt-catalyzed diboration 
of terminal olefins with chiral diboron reagent (Scheme 1.2).
11
 With 5 mol % of Pt(dba)2, 
diboration of styrenyl olefin 1.3 in the presence of chiral diboron reagent 1.4 affords 
vicinal diboron compound 1.5 in 80% yield and 80:20 d.r. There are several limitations 
for the aforementioned transformation. The reaction requires stoichiometric amounts of 
expensive chiral diboron 1.4, and also a long reaction time (3 days) to achieve high 
                                                 
(10) Wiesauer, C.; Weissensteiner, W. Tetrahedron: Asymmetry 1996, 7, 5–8. 
(11) Marder, T. B.; Norman, N. C.; Rice, C. R. Tetrahedron Lett. 1998, 39, 155–158. 
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efficiency. In addition, they only demonstrated three substrates, which are all styrenyl 
olefins, showed moderate selectivities (55:45–80:20 d.r.). 
 
 
1.2.3. Metal-Catalyzed Enantioselective Diboration of Alkenes 
The first catalytic enantioselective diboration of olefins with chiral ligand was 
disclosed by Morken and coworkers in 2003.
12
 The authors utilized commercially 
available B2(cat)2 reagent. As illustrated in Scheme 1.3, reaction of various alkenes is 
promoted by 5 mol % of rhodium salt and chiral bisphosphine (S)-quinap.  When they use 
(E)-disubstituted olefin 1.6, after oxidation with H2O2, desired diol 1.7 is obtained with 
high efficiency (71% yield) and enantioselectivity (96.5:3.5 e.r.). Transformation of 
symmetric disubstituted olefin is highly selective to deliver the corresponding diol 1.8 in 
76% yield and 99:1 e.r. (S)-Quinap–Rh-catalyzed diboration of (Z)-disubstituted alkene, 
however, is significantly less enantioselective, providing diol 1.9 in 74.5:25.5 e.r. 
(96.5:3.5 e.r. for 1.7 from (E)-alkene). Additionally, enantioselective diboration of 
terminal or 1,1-disubstituted olefin does not proceed with high levels of selectivity 
(66.5:33.5 e.r. for ent-1.2 and 73:27 e.r. for 1.10).  
                                                 
(12) Morgan, J. B.; Miller, S. P.; Morken, J. P. J. Am. Chem. Soc. 2003, 125, 8702–8703. 
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 In subsequent studies, Morken and coworkers demonstrated that Rh-catalyzed 
enantioselective diboration of a broad range of alkenes is efficient and selective (Scheme 
1.4).
13
 Reaction of desymmetrized dialkyl-substituted olefin shows high selectivity (99:1 
e.r. for 1.11). Several alkyl-substituted terminal alkenes were investigated; sterically 
demanding t-butyl-bearing 1.12 was obtained with high enantioselectivity, but moderate 
yield (97:3 e.r. and 47% yield). On the other hand, when n-octyl-alkene was utilized, diol 
1.13 was isolated with higher efficiency, but reduced selectivity (82% yield and 81:19 
e.r.). Reaction of 1,1-dialkyl-olefin provides diol 1.14 in 58% yield and 62.5:37.5 e.r. 
Even though the authors illustrated that phosphine–Rh-catalyzed diboration reaction can 
be applied to wide range of simple alkenes, there are still unsolved limitations including 
low selectivities for terminal and 1,1-disubstituted olefins. 
 
                                                 
(13) (a) Miller, S. P.; Morgan, J. B.; Nepveux, F. J.; Morken, J. P. Org. Lett. 2004, 6, 131–133. (b) 
Trudeau, S.; Morgan, J. B.; Shrestha, M.; Morken, J. P. J. Org. Chem. 2005, 70, 9538–9544. 
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 Fernández and coworkers studied chiral phosphine–Rh- or NHC–Ag-catalyzed 
complex to promote transformations of styrene to diboryl compound.
14
 They observed, 
however, minimal enantioselectivities. 
 Recently, Morken and coworkers reported Pt-catalyzed enantioselective 
diboration of terminal olefins (Scheme 1.5).
15
 In this report, the low selectivity issue for 
terminal olefins was addressed. At the same time, they also introduced less expensive and 
more robust reagent, B2(pin)2 for their enantioselective diboration reaction. They found 
that taddol-derived phosphonite–Pt complex promotes diboration of various 
monosubstituted olefins with B2(pin)2 to generate corresponding vicinal diols after 
oxidation. Reaction of 1-octene 1.15 with B2(pin)2 in the presence of 5 mol % of chiral 
(R,R)-1.16−Pt complex affords 1,2-diol 1.17 in 83% yield and 96:4 e.r. In their previous 
Rh-catalyzed protocol, transformation of n-alkyl-olefin showed moderate selectivity 
(81:19 e.r. for 1.13 in Scheme 1.4). In addition, Pt-catalyzed diboration of styrene 
delivers vicinal diol 1.2 more efficiently with much higher enantioselectivity compared to 
Rh-catalyzed protocol (84% yield and 93:7 e.r. vs 68% yield and 66.5:33.5 e.r. in Scheme 
1.3). Cyclohexyl- and t-butyl-bearing olefins are utilized as substrates for Pt-catalyzed 
diboration, and both are converted to vicinal diols efficiently and enantioselectively (87% 
yield, 97:3 e.r. for 1.18 and 46% yield, 95:5 e.r. for ent-1.12). Additionally, catalytic 
transformation tolerates silyl ether moiety in 1.19 (92% yield and 95:5 e.r.). 
                                                 
(14) (a) Ramírez, J.; Segarra, A. M.; Fernández, E. Tetrahedron: Asymmetry 2005, 16, 1289–1294. (b) 
Corberán, R.; Ramírez, J.; Poyatos, M.; Peris, E.; Fernández, E. Tetrahedron: Asymmetry 2006, 17, 1759–
1762. 
(15) Kliman, L. T.; Mlynarski, S. N.; Morken, J. P. J. Am. Chem. Soc. 2009, 131, 13210–13211. 
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1.2.4. Metal-catalyzed Enantioselective Hydrogenation of Alkenyldiborons 
 In 2004, Morken and coworkers reported another approach to reach 
enantiomerically enriched 1,2-diborons through Rh-catalyzed hydrogenation of 
alkenyldiborons (Scheme 1.6).
16
 In the presence of walphos 1.21–Rh complex, 
hydrogenation of alkenyl bis(boronates) proceed efficiently with high enantioselectivity. 
Aryl-bearing olefins are converted to diols after oxidative work-up with up to 96.5:3.5 
e.r. (1.2 and 1.22). Alkyl-substituted vicinal diols are also successfully obtained 
efficiently with similar levels of selectivity (92.5:7.5 e.r. for 1.23 and 94.5:5.5 e.r. for 
1.18). 
                                                 
(16) Morgan, J. B.; Morken, J. P. J. Am. Chem. Soc. 2004, 126, 15338–15339. 
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 In a related report, Andersson and coworkers developed enantioselective 
hydrogenation of bis(boryl)alkenes catalyzed by chiral ligand–Ir complex (Scheme 1.7).17 
The Ir complex derived from Ir salt and chiral N,P ligand 1.24 promotes the 
hydrogenation of aryl-bearing alkenyldiborons to afford corresponding 1,2-diols with 
high enantioselectivities (91:9–98:2 e.r. for 1.2, 1.25 and 1.26). When the authors used 
alkyl-substituted olefin, however, the selectivity of reaction was reduced (74:26 e.r. for 
1.27).  
 
                                                 
(17) Paptchikhine, A.; Cheruku, P.; Engman, M.; Andersson, P. G. Chem. Commun. 2009, 5996–5998. 
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 Herein, we have disclosed efficient and selective protocol for enantiomerically 
enriched vicinal diboron compounds through tandem NHC–Cu-catalyzed protoborations 
to readily accessible terminal alkynes. 
 
1.3. NHC–Cu-Catalyzed Enantioselective Double Protoborations of Terminal 
Alkynes 
1.3.1. Initial Obervations 
 We began by examining the efficiency and site selectivity of protoboration of 
alkenylboronic pinacol ester under the identical conditions that are optimal for the 
previously disclosed styrene protoboration reactions.
3
 We investigated the Cu-catalyzed 
protoboryl addition to alkenylboron 1.28 in the presence of 5 mol % of NHC–Cu 
complex 1.29, NaOt-Bu, and MeOH (eq 1.2). After 5 h, we obtained the desired vicinal 
diboron 1.30 in 97% yield and exclusive site selectivity (<2% geminal diboron). 
 
Alkenylborons might be prepared by Cu-catalyzed protoboration of terminal 
alkynes. Thus, we explored to utilize an NHC–Cu complex 1.29 for double 
protoborations, which could deliver 1,2-diboron compound from the corresponding 
alkyne in a single-vessel process. As illustrated in Scheme 1.8, we examined Cu-
catalyzed protoboration of 1-hexyne 1.31 with 0.9 equiv. of B2(pin)2 in the presence of 1 
mol % of NHC–Cu complex 1.29 and NaOt-Bu to obtain alkenylboron compound. After 
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30 min, a 90:10 mixture of terminal (1.32) and internal (1.33) alkenylboron isomers are 
obtained with complete conversion. Then, we tested to realize the above strategy; with 
2.1 equiv. of B2(pin)2 and 3 equiv. of MeOH, 1-hexyne 1.31 was completely converted to 
vicinal diboron compound 1.34 with exclusive site selectivity (<2% geminal), which can 
be isolated by silica gel column chromatography in 98% yield. It is worth mentioning that 
isolated diboron compounds have been reported scarcely due to the instability of 
organoboron species with catechol. 
 
 
1.3.2. Examination of Various Chiral NHC–Cu Complexes 
Since we succeeded to obtain vicinal diboron compound selectively with achiral 
NHC–Cu complex 1.29, we investigated chiral NHCs our laboratory developed18  for 
efficient and enantioselective double protoborations of terminal alkynes under conditions 
that might be optimal for the second enantioselective process (–15 °C, thf).3 As shown in 
                                                 
(18) (a) Larsen, A. O.; Liu, W.; Nieto-Oberhuber, C.; Campbell, J. E.; Hoveyda, A. H. J. Am. Chem. Soc. 
2004, 126, 11130–11131. (b) Van Veldhuizen, J. J.; Campbell, J. E.; Giudici, R. E.; Hoveyda, A. H. J. Am. 
Chem. Soc. 2005, 127, 6877–6882. (c) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. 
Chem., Int. Ed. 2007, 46, 1097–1100. 
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Scheme 1.9, reaction of 5-chloropentyne 1.35 was examined in the presence of 5 mol % 
chiral imidazolinium salt, CuCl and 20 mol % NaOt-Bu. Initially, three types of NHCs 
derived from A.1–A.3 were investigated. Monodentate NHC from A.1 provides 1,2-
diboron 1.36 in only 27% conversion and 58:42 e.r., which leads us to rule out this type 
of NHC for further investigation. With phenoxy-bearing A.2, reaction of 1.35 proceeds 
much more efficiently and selectively (94% conv and 85.5:14.5 e.r.). When NHC–Cu 
complex generated from sulfonate-containing A.3 is used, we observed a similar level of 
selectivity (85.5:14.5 e.r.). Based on these preliminary observations, we decided to 
examine more chiral Cu complexes bearing these types of NHCs (bidentate phenoxy- or 
sulfonate-containing). With sterically more demanding, triisopropylphenyl-bearing A.4, 
however, we could not improve enantioselectivity (83:17 e.r.). Interestingly, in the case 
with sulfonate-containing bidentate NHCs, as the size of substituents on N-Ar is 
increased, enantioselectivity is also enhanced (85.5:14.5 e.r. with A.3, 90:10 e.r. with 
A.5, and 95:5 e.r. with A.6) without deterioration of the efficiency (90% conv with A.6). 
Double protoborations of 1.35 with a chiral imidazolinium salt A.7 containing a 
monophenyl backbone delivers diboron 1.36 with a similar level of enantioselectivity to 
the result with corresponding diphenyl backbone bearing A.3 (86:14 e.r. with A.7 vs 
85.5:14.5 e.r. with A.3). To improve the enantioselectivity further, we prepared 
structurally modified imidazolinium salts A.8 and A.9 bearing o-phenyl substituent on N-
aryl group, which might make more severe sterically demanding environment around Cu 
center. With 5 mol % of Cu complex with A.8, reaction becomes sluggish (21% conv) 
without improved enantioselectivity (83:17 e.r.) mainly due to the severe sterics on o-
position (2-phenyl and 6-methyl) interrupting the association of Cu with substrate. When 
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we moved one of the o-substituent to m-position (6-methyl to 5-tert-butyl; A.9), complete 
conversion was achieved with moderate selectivity (80.5:19.5 e.r.). Based on the chiral 
NHC screening results, we chose the chiral imidazolinium salt A.6, which contains a 
sulfonate group on N-Ar and triisopropyl substituents on the other N-Ar unit at the same 
time as an optimal NHC precursor. 
 
 
1.3.3. Substrate Scope of NHC–Cu-Catalyzed Enantioselective Double Protoborations 
of Terminal Alkynes 
 As summarized in Scheme 1.10, a wide range of terminal alkynes are examined 
for enantioselective double protoborations with 2.1 equiv. of B2(pin)2 and 3 equiv. of 
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MeOH in the presence of 5 mol % of NHC–Cu complex generated from chiral 
imidazolinium salt A.6, CuCl and NaOt-Bu. An alkyne 1.31, bearing n-alkyl unit, which 
was originally examined for achiral reaction in the presence of NHC–Cu complex 1.29 
(Scheme 1.8) undergo diprotoboration to provide vicinal diboron 1.34 in 84% yield and 
95.5:4.5 e.r. at –15 °C in 48 h. Since we elongate the reaction time to 48 h (vs 24 h in 
Scheme 1.9) to achieve optimal efficiency, chlorine-containing diboron 1.36 is isolated in 
93% yield. Terminal alkynes bearing functional group such as amide, ester, or ether have 
been utilized, affording corresponding 1,2-diborons efficiently and selectively (72% yield 
and 93.5:6.5 e.r. for 1.37; 83% yield and 96:4 e.r. for 1.38; 74% yield and 96.5:3.5 e.r. for 
1.39). In addition, β-branched chain-bearing vicinal diboron compounds 1.40 and 1.41 
are obtained through Cu-catalyzed transformation in 60−78% yield and 96.5:3.5 e.r. For 
these alkynes, 7.5 mol % of A.6 and CuCl are required for high conversion due to the 
sterics of β-branched chain. On the other hand, when α-branched chain-bearing alkynes 
are used, we obtain similar level of efficiency with only 5 mol % of NHC−Cu complex 
(61–76% yield for 1.42 and 1.43). Reaction of terminal alkynes bearing aryl group 
proceed more enantioselectively, but less efficiently (61% yield and 97.5:2.5 e.r. for 1.43; 
59% yield and 97:3 e.r. for 1.44). Electronics on aryl group might play an important role 
in diprotoboration reaction. p-MeO-containing phenylacetylene undergo transformation 
in the presence of 7.5 mol % Cu–NHC derived from A.6 to afford the desired product 
1.44 in 59% yield. Comparison of this data with that in 1.43 (product from 
phenylacetylene; 61% yield with 5 mol % A.6) indicates that transformation of alkynes 
containing an electron-donating group proceed slower. 
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Additionally, two interesting terminal alkynes 1.45 and 1.47 bearing a propargylic 
heteroatom are examined. The Cu-catalyzed double protoborations presented in eqs 1.3 
and 1.4 demonstrate that the reaction can be carried out with these types of terminal 
alkynes, affording 1.46 and 1.48 in 71% and 82% yield and 97:3 and 95:5 e.r., 
respectively. This type of vicinal diboron compounds is not easy to be prepared through 
metal-catalyzed diboration of alkene because when transition metal adds to α-carbon to 
the propargylic heteroatom, facile elimination reaction becomes competitive. Therefore, 
Cu-catalyzed protocol is exceptionally useful reaction for propargylic heteroatom-
containing compounds. 
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During this study, we found a critical attribute of the sulfonate group-containing 
NHC−Cu complex derived from A.6: high site selectivity in alkyne protoboration. As 
illustrated in Scheme 1.11, Protoboryl addition to propargyl ether 1.45 with 0.9 equiv. of 
B2(pin)2 and 1 equiv. of MeOH in the presence of 1 mol % achiral NHC−Cu complex 
1.29 (condition a) proceeds to internal alkenylboron isomer 1.50 predominantly 
(1.49:1.50 = 17:83). In contrast, when 1 mol % of imidazolinium salt A.6 is utilized for 
an NHC precursor (condition b), terminal alkenylboron 1.49 is provided selectively 
(1.49:1.50 = 89:11).
19
 Control experiments indicate that protoboration of internal 
alkenylborons (e.g., 1.50) catalyzed by NHC–Cu complex derived from A.6 delivers 
vicinal diborons with substantially lower enantiomeric purity. For example, after isolation 
of a pure sample of 1.50, we carry out transformation of 1.50 under the identical 
condition as previously described. The reaction is sluggish and much less selective (13% 
conversion to 1.46, and 55:45 e.r.). Thus, high level of enantioselectivity we achieved 
with chiral NHC–Cu complex from A.6 is mainly due to its ability to control the site 
selectivity of the first stage protoboration of terminal alkyne for generation of the 
terminal alkenylboron isomer selectively (e.g., 1.49). In addition, propargyl amide 1.47 is 
                                                 
(19) For a study regarding variations in the site selectivity of boron–copper additions to terminal alkynes 
(not catalytic), see: Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Organomet. Chem. 2001, 625, 47–53. 
Chapter 1, Page 17 
 
 
also investigated, affording internal alkenylboron 1.52 as a major isomer with the achiral 
NHC–Cu complex 1.29 (1.51:1.52 = 10:90; condition a), and delivering terminal isomer 
1.51 with 89:11 selectivity with A.6 (condition b), which is consistent with the above 
findings with propargyl ether 1.45. 
 
Furthermore, our own Cu-catalyzed protoboration has another essential property: 
high chemoselectivity. When we use a molecule containing both terminal alkyne and 
terminal alkene 1.53 for catalytic enantioselective double protoborations in the presence 
of 7.5 mol % NHC–Cu derived from A.6, reaction proceeds to afford olefin-bearing 
diboron compound 1.54 in 69% yield and 94.5:5.5 e.r. (eq 1.5), which means that Cu–B 
addition to alkene is not favored (<2% conversion to alkene). The Cu-catalyzed reaction, 
thus, allows for chemoselective diprotoboration of an alkyne in the presence of an olefin. 
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1.3.4. Functionalization of Enantiomerically Enriched Vicinal Diborons and Utility in 
Chemical Synthesis 
 The enantiomerically enriched vicinal diborons obtained through the present 
method are versatile, providing access to other useful molecules since functionalization 
of C–B bonds is already well developed. 1,2-Diboron compound has two distinctive C–B 
bonds (primary and secondary), which can be independently functionalized. Pd-catalyzed 
selective cross-coupling of in situ generated diboron catechol ester with aryl halides was 
reported by Morken and coworkers.
13a
 In their work, they obtained sterically less 
hindered, primary C–B bond coupled only product selectively. They only showed, 
however, aryl halides as a cross partner, and alkenyl halides have not been studied. Thus, 
we investigate the development of site selective cross coupling of vicinal diboron 
compound with alkenyl halides. As demonstrated in eq 1.6, with 10 mol % of 
Pd(dppf)Cl2 and 3 equiv. of Cs2CO3, cross-coupling reaction of enantiomerically 
enriched vicinal diboron 1.46 (96.5:3.5 e.r.) and commercially available alkenyl bromide 
1.55 is performed, generating desired primary C–B bond only coupled product 1.56 in 
72% yield after oxidative work-up without loss of enantiomeric purity (96.5:3.5 e.r. for 
1.56). 
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 Moreover, the utility of NHC–Cu-catalyzed enantioselective double 
protoborations of terminal alkyne has been demonstrated by one of colleagues in our 
group.
20
 Z-Alkenyl ether-bearing 1,2-diol 1.58 is obtained in 64% overall yield and 98:2 
e.r. after oxidation (<2% reaction of alkene) through Cu-catalyzed diprotoboration of 
corresponding terminal alkyne containing Z-olefin 1.57 in the presence of 2.5 mol % of 
NHC−Cu complex derived from A.6 without loss of olefin stereochemistry (high 
chemoselectivity; eq 1.7). Optically active diol 1.58 has been used further for the 
stereoselective synthesis of an anti-oxidant plasmalogen phospholipid C18 (plasm)-16:0 
(PC). 
 
 
1.4. Conclusions 
 We have developed an efficient and enantioselective NHC–Cu-catalyzed double 
protoboryl addition to various terminal alkynes with readily accessible B2(pin)2 and 
MeOH to afford vicinal diboron compounds in up to 93% yield with high 
enantioselectivity (93.5:6.5–97.5:2.5 e.r.). In a single-vessel, two reactions occurred; (1) a 
                                                 
(20) Meek, S. J.; O'Brien, R. V.; Llaveria, J.; Schrock, R. R.; Hoveyda, A. H. Nature 2011, 471, 461–466. 
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site-selective protoboration of terminal alkynes to afford alkenylboron, (2) a site- and 
enantioselective protoboration of the derived alkenylboron to generate enantiomerically 
enriched vicinal diboron compound. Various functional group-bearing alkynes are 
investigated, delivering desired vicinal diborons with high efficiency and selectivity. 
 The site selectivity for the first protoboration is reversed by altering the NHC–Cu 
complexes. With N-mesityl-bearing NHC–Cu complex, unusual α-selectivity is observed, 
which forms internal alkenylboron preferentially. In addition, catalytic process of the 
molecule containing both alkene and alkyne generates 1,2-diboron compound with 
exceptional site selectivity (<2% alkene addition) and high enantioselecitvity (94.5:5.5 
e.r.). Moreover, selective functionalization of primary C–B bond of vicinal diboron is 
illustrated; Pd-catalyzed cross-coupling with alkenyl bromide followed by oxidation 
generates the primary C–B bond coupled only product in 72% yield without diminution 
of enantiomeric enrichment. 
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1.5. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, max in cm
−1
. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 
1
H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet app = apparent), and coupling 
constants (Hz). 
13
C NMR spectra were recorded on a Varian Unity INOVA 400 (100 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in 
ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a Micromass LCT 
ESI-MS (positive mode) at the Mass Spectrometry Facility, Boston College. Elemental 
microanalyses were performed at Robertson Microlit Laboratories (Madison, NJ). 
Enantiomeric ratios were determined by high-performance liquid chromatography 
(HPLC) with a Shimadzu chromatograph (Chiral Technologies Chiralcel OD (4.6 x 250 
mm), Chiral Technologies Chiralcel OB-H (4.6 x 250 mm), Chiral Technologies 
Chiralcel OJ-H (4.6 x 250 mm), or Chiral Technologies Chiralpak AS (4.6 x 250 mm)) in 
comparison with authentic racemic materials. Optical rotations were measured on a 
Rudolph Research Analytical Autopol IV Polarimeter. Unless otherwise noted, all 
reactions were carried out with distilled and degassed solvents under an atmosphere of 
dry N2 in oven- (135 °C) or flame-dried glassware with standard dry box or vacuum-line 
techniques. Dichloromethane (Fisher Scientific, Inc.) was purified by being passed 
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through two alumina columns under a positive pressure of dry argon by a modified 
Innovative Technologies purification system. Tetrahydrofuran (Aldrich Chemical Co.) 
was purified by distillation from sodium benzophenone ketyl immediately prior to use 
unless otherwise specified. Methanol (Aldrich Chemical Co.) was distilled over CaH2. 
All work-up and purification procedures were carried out with reagent grade solvents 
(purchased from Doe & Ingalls) under air. 
 
1.5.1. Reagents and Ligands 
Benzoyl Chloride: purchased from Aldrich Chemical Co. and used as received. 
Bis(pinacolato)diboron: purchased from Frontier Scientific, Inc. and recrystallized from 
pentane. 
N-Boc-propargylamine (1.47): purchased from Aldrich Chemical Co. and purified by 
flash silica gel chromatography (hexanes:EtOAc = 10:1). 
3-Bromo-5,5-dimethylcyclohex-2-enone (1.55): prepared according to previously 
reported procedures.
21
 
6-tert-Butoxyhex-1-yne: prepared according to a previously reported procedure.
22
 
3-tert-Butoxyprop-1-yne (1.45): prepared according to a previously reported 
procedure.
23
 
tert-Butyl allyl(but-3-ynyl)carbamate (1.53): prepared according to previously reported 
procedures.
24
 
                                                 
(21) Mewshaw, R. E. Tetrahedron Lett. 1989, 30, 3753‒3756. 
(22) Mansurova, M.; Klusák, V.; Nešněrová, P.; Muck, A.; Doubský, J.; Svatoš, A. Tetrahedron 2009, 65, 
1069‒1076. 
(23) Alexakis, A.; Gardette, M.; Colin, S. Tetrahedron Lett. 1988, 29, 2951‒2954. 
(24) Becker, D. P.; Flynn, D. L. Tetrahedron 1993, 49, 5047‒5054. 
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tert-Butyl pent-4-ynylcarbamate: prepared according to a previously reported 
procedure.
25
 
Cesium carbonate: purchased from Aldrich Chemical Co. and used as received. 
5-Chloro-1-pentyne (1.35): purchased from Aldrich Chemical Co. and purified by 
distillation over CaCl2. 
Copper (I) chloride: purchased from Aldrich Chemical Co. and used as received. 
Cu−NHC complex (1.29): prepared according to previously reported procedures.26 
Cyclohexylacetylene: purchased from Aldrich Chemical Co. and purified by distillation 
over CaH2 under reduced pressure. 
3-Cyclopentyl-1-propyne: purchased from Aldrich Chemical Co. and purified by 
distillation over CaH2. 
Dichloro 1,1’-bis(diphenylphosphino)ferrocene palladium (II) dichloromethane 
adduct: purchased from Strem Chemicals Inc. and used as received. 
1-Hexyne: purchased from Aldrich Chemical Co. and purified by distillation over CaH2. 
Hydrogen peroxide (35 wt. % solution in water): purchased from Aldrich Chemical 
Co. and used as received. 
Imidazolinium salt (A.1): prepared according to previously reported procedures.
27
 
Imidazolinium salt (A.6): prepared according to previously reported procedures.
28
 
                                                 
(25) Saito, Y.; Matsumoto, K.; Bag, S. S.; Ogasawara, S.; Fujimoto, K.; Hanawa, K.; Saito, I. Tetrahedron 
2008, 64, 3578‒3588. 
(26) Díez-González, S.; Kaur, H.; Zinn, F. K.; Stevens, E. D.; Nolan, S. P. J. Org. Chem. 2005, 70, 4784‒
4796. 
(27) (a) Chaulagain, M. R.; Sormunen, G. J.; Montgomery, J. J. Am. Chem. Soc. 2007, 129, 9568‒9569. (b) 
Lillo, V.; Prieto, A.; Bonet, A.; Díaz-Requejo, M. M.; Ramírez, J.; Pérez, P. J.; Fernández, E. 
Organometallics, 2009, 28, 659‒662. (c) Lee, K-s.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455‒4462. 
(28) (a) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 1097‒
1100. (b) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7468‒7472. 
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Phenylacetylene: purchased from Aldrich Chemical Co. and purified by distillation and 
passed through activated neutral alumina prior to use. 
3-Phenyl-1-propyne: purchased from Aldrich Chemical Co. and purified by distillation 
over CaH2 under reduced pressure. 
Pyridine (anhydrous): purchased from Aldrich Chemical Co. and used as received. 
Sodium tert-butoxide (98%): purchased from Strem Chemicals Inc. and used as received. 
Sodium perborate tetrahydrate: purchased from Aldrich Chemical Co. and used as 
received. 
 
1.5.2. Experimental Procedure and Characterization Data 
 Representative Experimental Procedure for Enantioselective Cu-Catalyzed 
Double Protoborations of 6-tert-Butoxyhex-1-yne: In a N2-filled glovebox, an oven-
dried vial (4 mL, 17 x 38 mm) with magnetic stir bar was charged with imidazolinium 
salt A.6 (5.80 mg, 0.0100 mmol, 5.0 mol %), CuCl (1.00 mg, 0.0100 mmol, 5.0 mol %), 
NaOt-Bu (3.80 mg, 0.0400 mmol, 20 mol %)
29
 and thf (0.5 mL). The mixture was sealed 
with a cap (phenolic open top cap with red PTFE/white silicone) and allowed to stir for 
30 min. Bis(pinacolato)diboron (107 mg, 0.420 mmol, 2.1 equiv.) was added to the 
solution. The color of the solution immediately turned dark brown. The vial was resealed 
with a cap (phenolic open top cap with red PTFE/white silicone) and removed from the 
glovebox. After 30 min, the mixture was allowed to cool to ‒78 °C (dry ice/acetone bath) 
under N2 atm. A solution of 6-tert-butoxyhex-1-yne (30.8 mg, 0.200 mmol, 1.0 equiv.) in 
thf (0.3 mL) and MeOH (24.0 μL, 0.600 mmol, 3.0 equiv.) were added by syringes. The 
                                                 
(29) Since NaOt-Bu does not promote protoboration, four equivalents of NaOt-Bu per CuCl are used for 
reproducible conversions to afford the desired diborons. 
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vial was transferred to a ‒30 °C cryocool. After 48 h, the solution was allowed to cool to 
‒78 °C and quenched by passing through a short plug of celite and silica gel and washed 
with Et2O (3 x 2 mL). The filtrate was concentrated in vacuo to provide dark brown oil, 
which was purified by silica gel column chromatography (hexanes:EtOAc=10:1) to 
afford the desired product 1.39 as a colorless oil (60.5 mg, 0.147 mmol, 74% yield). 
 
 Representative Experimental Procedure for Oxidation30 /Monobenzoylation of 
Diboron 1.42 to Determine the Enantiomeric Purity: 
1-Cyclohexylethane-1,2-diol. To a solution of 1.42 (163 mg, 0.447 mmol) in thf (1 mL) 
at 0 °C (ice bath) were added H2O2 (217 μL, 2.23 mmol) and 2 N NaOH (1.12 mL, 2.23 
mmol). The resulting solution was allowed to stir for 20 min. After this time, the mixture 
was diluted with water (2 mL), washed with EtOAc (3 x 1 mL), and filtered through a 
plug of MgSO4. The filtrate was concentrated in vacuo to provide colorless oil, which 
was purified by silica gel chromatography (hexanes:EtOAc=1:2) to afford the derived 
diol as a colorless oil (62.1 mg, 0.430 mmol, 96% yield). (This compound has been 
previously reported and spectra data match those described).
31
 
1
H NMR (400 MHz, 
CDCl3): δ 3.65 (1H, m), 3.47 (1H, m), 3.39 (1H, t, J = 7.2 Hz), 2.95 (2H, s), 1.86‒1.80 
(1H, m), 1.74‒1.67 (2H, m), 1.64‒1.58 (2H, m), 1.40‒1.31 (1H, m), 1.25‒0.95 (5H, m); 
13
C NMR (100 MHz, CDCl3): δ 76.6, 64.8, 40.8, 29.0, 28.7, 26.4, 26.1, 26.1. 
2-Cyclohexyl-2-hydroxyethyl benzoate. To a solution of diol (24 mg, 
0.17 mmol) in CH2Cl2 (1 mL) were added pyridine (27 μL, 0.33 mmol) 
                                                 
(30) Oxidation of diborons could be carried out in the presence of NaBO3•4H2O. See: Lee, J.-E.; Yun, J. 
Angew. Chem., Int. Ed. 2008, 47, 145‒147. 
(31) Miller, S. P.; Morgan, J. B.; Nepveux V, F. J.; Morken, J. P. Org. Lett. 2004, 6, 131‒133. 
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and benzoyl chloride (25 μL, 0.21 mmol). The resulting mixture was allowed to stir at 22 
°C for 1 hour. After this time, the mixture was quenched through the addition of a 
saturated aqueous solution of NH4Cl (2 mL), washed with CH2Cl2 (3 x 1 mL), and 
filtered through a plug of MgSO4. The filtrate was concentrated in vacuo to provide a 
colorless oil, which was purified by silica gel chromatography (hexanes:Et2O=3:1) to 
afford the monobenzoyl alcohol as a white solid (28 mg, 0.11 mmol, 68% yield). mp: 65 
°C; IR (neat): 3480 (br), 2923 (m), 2851 (w), 1717 (m), 1701 (m), 1449 (m), 1268 (s), 
1176 (w), 1115 (m), 1096 (m), 1068 (m), 1025 (m), 708 (s) cm
‒1
; 
1
H NMR (CDCl3, 400 
MHz): δ 8.06‒8.03 (2H, m), 7.59‒7.54 (1H, m), 7.46‒7.41 (2H, m), 4.46 (1H, dd, J = 
11.6, 3.2 Hz), 4.29 (1H, dd, J = 11.6, 7.6 Hz), 3.76‒3.71 (1H, m), 2.26 (1H, br s), 1.93‒
1.90 (1H, m), 1.80‒1.66 (4H, m), 1.58‒1.49 (1H, m), 1.32‒1.07 (5H, m); 13C NMR 
(CDCl3, 100 MHz): δ 166.9, 133.2, 130.0, 129.7, 128.5, 74.3, 67.9, 41.1, 29.0, 28.3, 26.4, 
26.2, 26.1; HRMS (ESI
+
): Calcd for C15H21O3  [M+H]
+
: 249.14907, Found: 249.14860. 
(R)-2,2'-(Hexane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (1.34). IR 
(neat): 2977 (w), 2925 (w), 2858 (w), 1369 (s), 1309 (s), 1271 (w), 1249 (w), 1229 (w), 
1139 (s), 967 (m), 845 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 1.45‒1.36 (1H, m), 
1.33‒1.23 (5H, m), 1.21 (6H, s), 1.21 (6H, s), 1.20 (6H, s), 1.20 (6H, s), 1.12‒1.04 (1H, 
m), 0.85 (1H, dd, J = 15.6, 9.6 Hz), 0.84 (3H, t, J = 6.8 Hz), 0.77 (1H, dd, J = 15.6, 6.0 
Hz); 
13
C NMR (CDCl3, 100 MHz): δ 82.8, 82.8, 33.6, 31.2, 25.0, 24.9, 24.8, 24.8, 23.0, 
18.5, 14.2, 12.8; HRMS (ESI
+
): Calcd for C18H37B2O4 [M+H]
+
: 339.28779, Found: 
339.28856. Elemental Analysis: Calcd for C18H36B2O4: C, 63.94; H, 10.73; Found: C, 
64.21; H, 11.00. Specific Rotation: [α]D
20
 +0.47 (c 2.38, CHCl3) for an enantiomerically 
enriched sample of 95.5:4.5 e.r. 
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(S)-Hexane-1,2-diol (Oxidation of 1.34, This compound has been 
previously reported and spectra data match those described).
32
 
1
H 
NMR (400 MHz, CDCl3): δ 3.69‒3.63 (1H, m), 3.60 (1H, dd, J = 11.2, 2.8 Hz), 3.39 (1H, 
dd, J = 11.2, 8.0 Hz), 3.24 (2H, s), 1.44‒1.24 (6H, m), 0.88 (3H, t, J = 7.2 Hz); 13C NMR 
(100 MHz, CDCl3): δ 72.4, 66.8, 32.9, 27.8, 22.8, 14.1. Specific Rotation: [α]D
20
 ‒9.21 (c 
0.73, EtOH) for an enantiomerically enriched sample of 95.5:4.5 e.r. 
Proof of Stereochemistry: Literature value ([α]D
20
 ‒22.1 (c 1.00, EtOH), >99:1 e.r.) is 
assigned to the (S) enantiomer.
32a 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralpak AS column, 
99/1 hexanes/i-PrOH, 1.0 mL/min, 220 nm). 
 
(R)-2,2'-(5-Chloropentane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(1.36). IR (neat): 2977 (w), 2929 (w), 1459 (w), 1369 (s), 1310 (s), 1267 (m), 1139 (s), 
967 (m), 860 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 3.47 (2H, dt, J = 6.8, 1.6 Hz), 
                                                 
(32) (a) Hasegawa, J.; Ogura, M.; Tsuda, S.; Maemoto, S.; Kutsuki, H.; Ohashi, T. Agric. Biol. Chem. 1990, 
54, 1819. (b) Brown, S. P.; Brochu, M. P.; Sinz, C. J.; MacMillan, D. W. J. Am. Chem. Soc. 2003, 125, 
10808‒10809. 
Chapter 1, Page 28 
 
 
1.79‒1.72 (2H, m), 1.57‒1.49 (1H, m), 1.48‒1.35 (1H, m), 1.20 (6H, s), 1.20 (6H, s), 
1.20 (6H, s), 1.19 (6H, s), 1.12‒1.04 (1H, m), 0.89‒0.79 (2H, m); 13C NMR (CDCl3, 100 
MHz): δ 83.0, 45.4, 32.1, 31.0, 24.9, 24.9, 24.8, 24.8, 17.8, 12.8; HRMS (ESI+): Calcd 
for C17H34B2Cl1O4 [M+H]
+
: 359.23317, Found: 359.23455. Elemental Analysis: Calcd 
for C17H33B2Cl1O4: C, 56.95; H, 9.28; Found: C, 57.22; H, 9.54. Specific Rotation: [α]D
20
 
‒1.45 (c 3.30, CHCl3) for an enantiomerically enriched sample of 94.5:5.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralcel OJ-H 
column, 92:8 hexanes/i-PrOH, 0.5 mL/min, 220 nm). 
 
 
(R)-tert-Butyl 4,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentylcarbamate 
(1.37). IR (neat): 3370 (br), 2977 (m), 2929 (w), 1703 (m), 1512 (m), 1366 (s), 1311 (s), 
1270 (m), 1248 (m), 1215 (m), 1165 (s), 1139 (s), 967 (m), 846 (m), 732 (m) cm
‒1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 4.67 (1H, br s), 3.07 (2H, s), 1.46‒1.43 (2H, m), 1.41 (9H, s), 
1.38‒1.29 (1H, m), 1.21 (24H, s), 1.13‒1.04 (2H, m), 0.86 (1H, dd, J = 16.0, 9.2 Hz), 
0.76 (1H, dd, J = 15.6, 6.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 156.1, 83.0, 83.0, 78.7, 
40.7, 30.6, 28.6, 25.1, 25.0, 25.0, 24.9, 24.9, 18.1, 12.7; HRMS (ESI
+
): Calcd for 
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C22H44B2N1O6 [M+H]
+
: 440.33547, Found: 440.33376. Specific Rotation: [α]D
20
 ‒3.82 (c 
2.09, CHCl3) for an enantiomerically enriched sample of 93.5:6.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived tri-Boc protected derivative, which was 
prepared by monobenzoylation of the diol, followed by Boc-protection with Boc2O 
(Chiralpak OD column, 99/1 hexanes/i-PrOH, 0.5 mL/min, 220 nm). 
 
(R)-2,2'-(6-tert-Butoxyhexane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(1.39). IR (neat): 2975 (m), 2930 (w), 2864 (w),  1361 (s), 1310 (s), 1268 (w), 1231 (w), 
1198 (s), 1140 (m), 1080 (m), 967 (m), 845 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 
3.27 (2H, t, J = 6.4 Hz), 1.49‒1.40 (3H, m), 1.35‒1.23 (3H, m), 1.21 (12H, s), 1.19 (12H, 
s), 1.13 (9H, s), 1.10‒1.03 (1H, m), 0.83 (1H, dd, J = 15.6, 9.6 Hz), 0.76 (1H, dd, J = 
15.6, 6.0 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 82.8, 82.8, 72.3, 61.6, 33.7, 31.0, 27.6, 
25.6, 24.9, 24.9, 24.8, 24.8, 18.5, 12.7; HRMS (ESI
+
): Calcd for C22H45B2O5  [M+H]
+
: 
411.34531, Found: 411.34620. Elemental Analysis: Calcd for C22H44B2O5: C, 64.42; H, 
10.81; Found: C, 64.68; H, 11.07. Specific Rotation: [α]D
20
 ‒0.51 (c 2.15, CHCl3) for an 
enantiomerically enriched sample of 96.5:3.5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralpak AS column, 
99/1 hexanes/i-PrOH, 1.0 mL/min, 220 nm). 
 
(R)-2-(3-Cyclopentyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-4,4,5,5-
tetra-methyl-1,3,2-dioxaborolane (1.40). IR (neat): 2977 (m), 2946 (m), 2867 (w), 1369 
(s), 1309 (s), 1268 (m), 1213 (m), 1139 (s), 967 (m), 847 (m), 671 (w), 578 (w) cm
‒1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 1.83‒1.76 (1H, m), 1.76‒1.67 (2H, m), 1.57‒1.42 (5H, m), 
1.31‒1.26 (1H, m), 1.23 (12H, s), 1.21 (12H, s), 1.17‒1.12 (1H, m), 1.08‒1.00 (2H, m), 
0.85 (1H, dd, J = 16.0, 8.4 Hz),  0.81 (1H, dd, J = 15.6, 6.4 Hz); 
13
C NMR (CDCl3, 100 
MHz): δ 82.9, 82.8, 40.3, 39.4, 32.9, 32.9, 25.4, 25.2, 25.0, 24.9, 24.9, 24.9, 17.5, 13.2; 
HRMS (ESI
+
): Calcd for C20H39B2O4 [M+H]
+
: 365.30344, Found: 365.30443. Elemental 
Analysis: Calcd for C20H38B2O4: C, 65.97; H, 10.52; Found: C, 65.99; H, 10.78. Specific 
Rotation: [α]D
20
 ‒3.09 (c 2.00, CHCl3) for an enantiomerically enriched sample of 
96.5:3.5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralpak OJ-H 
column, 99/1 hexanes/i-PrOH, 0.5 mL/min, 220 nm). 
 
 
(R)-4,4,5,5-Tetramethyl-2-(3-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propyl)-1,3,2-dioxaborolane (1.41). IR (neat): 2977 (m), 2928 (w), 1369 (s), 1311 (s), 
1269 (m), 1214 (m), 1139 (s), 967 (m), 846 (m), 698 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.24‒7.17 (4H, m), 7.13‒7.09 (1H, m), 2.79 (1H, dd, J = 13.2, 7.6 Hz), 2.59 
(1H, dd, J = 13.2, 8.0 Hz), 1.47‒1.43 (1H, m), 1.21 (12H, s), 1.17 (6H, s), 1.15 (6H, s), 
0.81 (2H, d, J = 7.6 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 142.4, 129.2, 128.0, 125.6, 
83.0, 82.9, 39.6, 25.0, 24.9, 24.9, 24.8 20.7, 12.4; HRMS (ESI
+
): Calcd for C21H35B2O4 
[M+H]
+
: 373.27214, Found: 373.27372. Elemental Analysis: Calcd for C21H34B2O4: C, 
67.78; H, 9.21; Found: C, 68.03; H, 9.58. Specific Rotation: [α]D
20
 +6.48 (c 2.00, CHCl3) 
for an enantiomerically enriched sample of 96.5:3.5 e.r. 
(S)-3-Phenylpropane-1,2-diol (Oxidation of 1.41, This compound 
has been previously reported and spectra data match those 
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described).
33
 
1
H NMR (400 MHz, CDCl3): δ 7.33‒7.29 (2H, m), 7.26‒7.21 (3H, m), 
3.96‒3.91 (1H, m), 3.67 (1H, dd, J = 11.2, 3.2 Hz), 3.50 (1H, dd, J = 11.2, 6.8 Hz), 2.79 
(1H, dd, J = 13.6, 5.6 Hz), 2.74 (1H, dd, J = 13.6, 8.0 Hz), 2.22 (2H, s); 
13
C NMR (100 
MHz, CDCl3): δ 137.9, 129.5, 128.8, 126.8, 73.2, 66.2, 40.0. Specific Rotation: [α]D
20
 ‒
13.4 (c 1.81, EtOH) for an enantiomerically enriched sample of 95:5 e.r. 
Proof of Stereochemistry: Literature value ([α]D
20
 +33.2 (c 1.00, EtOH), 97.5:2.5 e.r.) is 
assigned to the (R) enantiomer.
33 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived diol (Chiralpak OD-R column, 98/2 
hexanes/i-PrOH, 1.0 mL/min, 220 nm). 
 
 
(R)-2,2'-(1-Cyclohexylethane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(1.42). IR (neat): 2977 (w), 2921 (w), 2850 (w), 1368 (s), 1307 (s), 1271 (w), 1237 (w), 
1214 (w), 1140 (s), 1105 (w), 969 (m), 845 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 
1.68‒1.57 (5H, m), 1.37‒1.26 (1H, m), 1.23 (12H, s), 1.22 (12H, s), 1.20‒0.95 (6H, m), 
                                                 
(33) Cardillo, G.; Orena, M.; Romero, M.; Sandri, S. Tetrahedron 1989, 45, 1501‒1508. 
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0.86 (1H, dd, J = 16.0, 11.2 Hz), 0.76 (1H, dd, J = 15.6, 5.2 Hz); 
13
C NMR (CDCl3, 100 
MHz): δ 82.8, 82.8, 41.6, 32.2, 32.0, 27.0, 26.9, 26.8, 25.0, 25.0, 24.9, 24.8, 9.6; HRMS 
(ESI
+
): Calcd for C20H39B2O4  [M+H]
+
: 365.30344, Found: 365.30358. Elemental 
Analysis: Calcd for C20H38B2O4: C, 65.97; H, 10.52; Found: C, 66.33; H, 10.92. Specific 
Rotation: [α]D
20
 ‒4.73 (c 2.44, CHCl3) for an enantiomerically enriched sample of 97:3 
e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralcel OJ-H 
column, 98/2 hexanes/i-PrOH, 0.5 mL/min, 220 nm). 
 
 
(R)-2,2'-(1-Phenylethane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (1.43). 
IR (neat): 2977 (w), 2929 (w), 1492 (w), 1467 (w), 1354 (s), 1313 (s), 1264 (m), 1213 
(m), 1164 (m), 1139 (s), 966 (m), 843 (m), 731 (m), 699 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.20 (4H, d, J = 4.0 Hz), 7.10‒7.05 (1H, m), 2.50 (1H, dd, J = 11.2, 5.6 Hz), 
1.36 (1H, dd, J = 16.0, 10.8 Hz), 1.18 (12H, s), 1.17 (6H, s), 1.15 (6H, s), 1.09 (1H, dd, J 
= 15.6, 6.0 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 145.5, 128.2, 128.0, 125.0, 83.2, 83.1, 
26.7, 25.0, 24.8, 24.7, 24.5, 14.6; HRMS (ESI
+
): Calcd for C20H33B2O4  [M+H]
+
: 
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359.25649, Found: 359.25766. Elemental Analysis: Calcd for C20H32B2O4: C, 67.08; H, 
9.01; Found: C, 67.24; H, 9.27. Specific Rotation: [α]D
20
 ‒24.2 (c 2.80, CHCl3) for an 
enantiomerically enriched sample of 94.5:5.5 e.r. 
(S)-1-Phenylethane-1,2-diol (Oxidation of 1.43, This compound has 
been previously reported and spectra data match those described).
34
 
1
H 
NMR (400 MHz, CDCl3): δ 7.38‒7.26 (5H, m), 4.84 (1H, dt, J = 8.4, 
3.2 Hz), 3.78 (1H, ddd, J = 11.2, 7.6, 4.0 Hz), 3.68 (1H, ddd, J = 11.2, 8.0, 4.4 Hz), 2.43 
(1H, d, J = 3.2 Hz), 1.97 (1H, dd, J = 7.6, 4.8 Hz); 
13
C NMR (100 MHz, CDCl3): δ 140.6, 
128.5, 128.0, 126.1, 74.7, 68.1. Specific Rotation: [α]D
20
 +68.1 (c 0.50, CHCl3) for an 
enantiomerically enriched sample of 97.5:2.5 e.r. 
Proof of Stereochemistry: Literature value ([α]D
20
 ‒63.7 (c 5.45, CDCl3), >99:1 e.r.) is 
assigned to the (R) enantiomer.
35
 
 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived diol (Chiralcel OB-H column, 93/7 hexanes/i-
PrOH, 0.5 mL/min, 220 nm). 
 
                                                 
(34) Miller, S. P.; Morgan, J. B.; Nepveux V, F. J.; Morken, J. P. Org. Lett. 2004, 6, 131‒133. 
(35) Dale, J. A.; Mosher, H. S. J. Org. Chem. 1970, 35, 4002‒4003. 
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(R)-2-(3-tert-Butoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propyl)-4,4,5,5-
tetra-methyl-1,3,2-dioxaborolane (1.46). IR (neat): 2975 (m), 1366 (s), 1311 (s), 1199 
(m), 1141 (s), 1075 (m), 968 (m), 846 (m), 734 (w) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 
3.37 (1H, dd, J = 8.0, 6.4 Hz), 3.32 (1H, dd, J = 8.0, 7.6 Hz), 1.37‒1.32 (1H, m), 1.22 
(12H, s), 1.20 (12H, s), 1.13 (9H, s), 0.92 (1H, dd, J = 16.0, 9.2 Hz), 0.84 (1H, dd, J = 
16.0, 5.6 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 82.9, 82.8, 72.1, 65.0, 27.7, 25.0, 24.9, 
20.5, 9.7; HRMS (ESI
+
): Calcd for C19H39B2O5 [M+H]
+
: 369.29836, Found: 369.30005. 
Specific Rotation: [α]D
20
 +3.85 (c 2.41, CHCl3) for an enantiomerically enriched sample 
of 97:3 e.r. 
(R)-3-tert-Butoxypropane-1,2-diol (Oxidation of 1.46, This 
compound has been previously reported and spectra data match those 
described).
36
 
1
H NMR (400 MHz, CDCl3): δ 3.79 (1H, m), 3.72‒3.66 
(2H, m), 3.50 (1H, dd, J = 9.2, 4.0 Hz), 3.45 (1H, dd, J = 9.2, 5.6 Hz), 2.69 (1H, br s), 
2.34 (1H, br s), 1.20 (9H, s); 
13
C NMR (100 MHz, CDCl3): δ 73.7, 70.6, 64.7, 64.0, 27.6. 
Specific Rotation: [α]D
20
 +8.5 (c 0.20, CHCl3) for an enantiomerically enriched sample of 
97:3 e.r. 
Proof of Stereochemistry: Literature value ([α]D
20
 ‒1.00 (c 0.76, CHCl3), 87:13 e.r.)  is 
assigned to the (S) enantiomer.
36a
 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralpak AS column, 
99.5/0.5 hexanes/i-PrOH, 1.0 mL/min, 220 nm). 
                                                 
(36) (a) Zhao, Y.; Mitra, A. W.; Hoveyda, A. H.; Snapper, M. L. Angew. Chem., Int. Ed. 2007, 46, 8471‒
8474. (b) Verheij, H. M.; Bonsen, P. P. M.; van Deenen, L. L. M. Chem. Phys. Lipids. 1971, 6, 46‒57. 
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(R)-tert-Butyl 2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propylcarbamate 
(1.48). IR (neat): 3379 (w), 2977 (w), 2930 (w), 1713 (m), 1506 (w), 1365 (m), 1313 (m), 
1247 (m), 1212 (w), 1165 (m), 1139 (s), 1109 (w), 966 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 
MHz): δ 4.92 (1H, s), 3.13 (2H, dd, J = 6.4, 5.6 Hz), 1.37 (9H, s), 1.31‒1.21 (1H, m), 
1.18 (12H, s), 1.18 (12H, s), 0.84 (1H, dd, J = 16.4, 8.4 Hz), 0.77 (1H, dd, J = 16.0, 6.4 
Hz); 
13
C NMR (CDCl3, 100 MHz): δ 156.1, 83.3, 83.2, 78.6, 43.9, 28.6, 25.0, 24.9, 19.4, 
10.5; HRMS (ESI
+
): Calcd for C20H40B2N1O6 [M+H]
+
: 412.30417, Found: 412.30305. 
Specific Rotation: [α]D
20
 ‒1.28 (c 2.50, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralcel OJ-H 
column, 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm). Four peaks from two rotamers of 
the carbamate are shown below: 
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(E)-2-(3-tert-Butoxyprop-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.49, This 
compound has been previously reported and spectra data match those described).
37
 
1
H 
NMR (CDCl3, 400 MHz): δ 6.64 (1H, dt, J = 18.0, 4.4 Hz), 5.69 (1H, dt, J = 18.0, 1.6 
Hz), 3.95 (2H, dd, J = 4.8, 4.0 Hz), 1.22 (12H, s), 1.17 (9H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 151.0, 118.5, 83.1, 73.2, 63.8, 27.6, 24.8. 
2-(3-tert-Butoxyprop-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.50). IR 
(neat): 2975 (m), 2871 (w), 1625 (w), 1364 (s), 1344 (s), 1307 (s), 1196 (m), 1142 (s), 
1074 (s), 946 (m), 863 (m), 743 (w), 672 (w) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.95‒
5.94 (1H, m), 5.86‒5.85 (1H, m), 3.99‒3.98 (2H, m), 1.24 (12H, s), 1.20 (9H, s); 13C 
NMR (CDCl3, 100 MHz): δ 139.5, 128.3, 83.4, 73.0, 63.3, 27.8, 24.9; HRMS (ESI
+
): 
Calcd for C13H26B1O3  [M+H]
+
: 241.18968, Found: 241.24772. 
                                                 
(37) Pandya, S. U.; Pinet, S. Chavant, P. Y.; Vallée, Y. Eur. J. Org. Chem. 2003, 3621‒3627. 
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(E)-tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allylcarbamate (1.51, 
This compound has been previously reported and spectra data match those described).
38
 
IR (neat): 3357 (br), 2977 (w), 2931 (w), 1698 (m), 1643 (w), 1512 (m), 1364 (s), 1320 
(s), 1269 (m), 1246 (m), 1165 (s), 1140 (s), 970 (m), 849 (m), 731 (m) cm
‒1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 6.49 (1H, dt, J = 18.0, 4.4 Hz), 5.49 (1H, dt, J = 18.0, 2.0 Hz), 4.80 
(1H, br s), 3.74 (2H, br s), 1.35 (9H, s), 1.17 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 
155.8, 149.5, 118.4, 83.3, 79.3, 44.0, 28.4, 24.9, 24.8.  
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allylcarbamate (1.52). IR 
(neat): 3358 (br), 2977 (m), 1705 (m), 1366 (m), 1311 (m), 1247 (m), 1140 (s), 1047 (w), 
949 (m), 860 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.81 (1H, t, J = 1.4 Hz), 5.70 (1H, 
s), 4.80 (1H, s), 3.78 (2H, d, J = 4.4 Hz), 1.39 (9H, s), 1.21 (12H, s); 
13
C NMR (CDCl3, 
100 MHz): δ 155.9, 137.6, 129.1, 83.6, 78.9, 44.4, 28.4, 25.0, 24.8; HRMS (ESI+): Calcd 
for C14H27B1N1O4  [M+H]
+
: 284.20331, Found: 284.20343. 
(R)-tert-Butyl allyl(2,3-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propyl)carbamate (1.54). IR (neat): 2976 (w), 2929 (w), 1692 (s), 1643 (w), 1458 (w), 
1405 (w), 1364 (s), 1314 (s), 1245 (s), 1163 (s), 1139 (s), 968 (w), 876 (w), 850 (w) cm
‒1
; 
1
H NMR spectrum exists as a 10:1 mixture of rotamers. 
1
H NMR (CDCl3, 400 MHz): δ 
5.74 (1H, m), 5.08 (2H, m), 3.89 (1H, br s), 3.76 (dd, J = 16.0, 5.6 Hz), 3.21 (2H, br s), 
1.41‒1.36 (10H, m), 1.20 (12H, s), 1.19 (12H, s), 0.79 (1H, dd, J = 6.0, 6.0 Hz); 13C 
NMR (CDCl3, 100 MHz): δ 148.7, 134.5, 115.9, 83.3, 83.1, 83.0, 79.7, 49.2, 28.6, 25.0, 
24.9, 18.2, 10.1; HRMS (ESI
+
): Calcd for C23H44B2N1O6 [M+H]
+
: 452.33547, Found: 
                                                 
(38) Berrée, F.; Bleis, P. G-L.; Carboni, B. Tetrahedron Lett. 2002, 43, 4935‒4938. 
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452.33386. Specific Rotation: [α]D
20
 +5.80 (c 2.70, CHCl3) for an enantiomerically 
enriched sample of 93.5:6.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived monobenzoyl-alcohol (Chiralcel OJ-H 
column, 99/1 hexanes/i-PrOH, 0.5 mL/min, 220 nm). Four peaks from two rotamers of 
the carbamate are shown below: 
 
 
 Experimental procedures for Pd-catalyzed cross-coupling: To a flame-dried round 
bottom flask equipped with reflux condenser were added diboron 1.46 (50.0 mg, 0.135 
mmol), Pd(dppf)Cl2·CH2Cl2 (9.80 mg, 0.0135 mmol, 10 mol %), Cs2CO3 (132 mg, 0.405 
mmol, 3.0 equiv.) and 3-bromo-5,5-dimethylcyclohex-2-enone 1.55 (54.8 mg, 0.270 
mmol, 2.0 equiv.). The vessel was purged under N2 atm for 10 min. To the mixture were 
added thf (5 mL) and H2O (0.5 mL), which was allowed to stir at 80 °C for 14 h. After 
this time, the solution was allowed to cool to 22 °C, diluted with Et2O (10 mL), dried 
over MgSO4 and filtered. The filtrate was concentrated in vacuo to provide a bright red 
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oil, which was purified by silica gel chromatography (hexanes:EtOAc=10:1) to afford the 
diboron product as a pale yellow oil (37.2 mg, 0.102 mmol, 76% yield). To a solution of 
diboron (37.2 mg, 0.102 mmol) in thf (1 mL) and H2O (1 mL) at 22 °C was added 
NaBO3·4H2O (78.5 mg, 0.511 mmol, 5.0 equiv.). The resulting solution was allowed to 
stir for one hour. After this time, the mixture was diluted with water (2 mL), washed with 
Et2O (3 x 1 mL), and filtered through a plug of MgSO4. The filtrate was concentrated in 
vacuo to provide a colorless oil, which was purified by silica gel chromatography 
(hexanes:Et2O=3:1) to afford the desired product 1.56 as a colorless oil (24.8 mg, 0.0975 
mmol, 95% yield). 
(R)-3-(3-tert-Butoxy-2-hydroxypropyl)-5,5-dimethylcyclohex-2-enone (1.56). IR 
(neat): 3438 (br), 2972 (m), 2869 (w), 1656 (s), 1365 (s), 1194 (s), 1084 (s), 903 (m), 731 
(s), 525 (m) cm
‒1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.93 (1H, s), 3.92 (1H, m), 3.37 (1H, 
dd, J = 8.8, 3.2 Hz), 3.21 (1H, dd, J = 8.8, 7.2 Hz), 2.55 (1H, s), 2.36‒2.33 (2H, m), 2.26 
(2H, s), 2.21 (2H, s), 1.18 (9H, s), 1.03 (3H, s), 1.02 (3H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 200.0, 160.6, 126.7, 73.6, 68.8, 65.5, 51.1, 44.3, 42.0, 33.8, 28.5, 28.3, 27.6; 
HRMS (ESI
+
): Calcd for C15H27O3 [M+H]
+
: 255.19602, Found: 255.19701. Specific 
Rotation: [α]D
20
 +0.635 (c 1.44, CHCl3) for an enantiomerically enriched sample of 
96.5:3.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralcel OJ-H column, 98/2 hexanes/i-PrOH, 0.5 mL/min, 220 nm). 
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Chapter Two 
Site-Selective NHC–Cu-Catalyzed Protoboryl 
Addition to Terminal Alkynes for Synthesis of 
Internal (α-) or Terminal (β-) Alkenylborons. 
Utility in Chemical Synthesis and Mechanistic 
Basis for Site Selectivity 
 
2.1. Introduction 
Alkenylboron reagents are useful key intermediates in chemical synthesis.
1
 The C–B 
bond of an alkenylboron can be easily transformed into a variety of other chemical bonds: 
C–H, C–O, C–N, C–X, and C–C. 2 , 3  While terminal (β-) alkenylborons are readily 
                                                 
(1) (a) Brown, H. C.; Campbell, J. B., Jr. Aldrichimica Acta 1981, 14, 3–11. (b) Matteson, D. S. Tetrahedron 
1989, 45, 1859–1885. 
(2) For applications of alkenylborons in C–C bond formation, see: (a) Miyaura, N.; Suzuki, A. Chem. Rev. 
1995, 95, 2457–2483. (b) Suzuki, A. J. Organomet. Chem. 1999, 576, 147–168. (c) Kotha, S.; Lahiri, K.; 
Kashinath, D. Tetrahedron 2002, 58, 9633–9695. (d) Tobisu, M.; Chatani, N. Angew. Chem., Int. Ed. 2009, 
48, 3565–3568. For syntheses of various cyclic and acyclic alkenylborons through Pd-catalyzed cross-
coupling reactions involving the corresponding alkenyl bromides and triflates, see: (e) Takagi, J.; 
Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 8001–8006. For a review regarding 
applications of alkenyltrifluoroborates, which can be accessed via alkenylborons, in C–C bond forming 
reactions, see: (f) Molander, G. A.; Ellis, N. Acc. Chem. Res. 2007, 40, 275–286. 
(3) For examples of C–C bond forming methods that utilize alkenylborons but are not considered cross-
coupling reactions, see: (a) Batey, R. A.; Quach, T. D.; Shen, M.; Thadani, A. N.; Smil, D. V.; Li, S.-W.; 
MacKay, D. B. Pure Appl. Chem. 2002, 74, 43–55. and references cited therein. (b) Sasaki, K.; Hayashi, T. 
Angew. Chem., Int. Ed. 2010, 49, 8145–8147. 
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accessible through simple processes such as hydroboration,
4
 haloboration,
5
 and 
organometal synthesis,
6
 protocols for synthesis of internal (α-) alkenylborons in high site 
selectivity is severely underdeveloped and the existing approaches involve stepwise and 
requiring relatively harsh reaction conditions. Especially, hydroborations of readily 
accessible terminal alkynes cannot be performed with effective control of site selectivity 
leading to afford internal alkenylborons predominantly.
4
 Internal alkenylborons can be 
prepared by a three-step, two-vessel process including synthesis of an α-alkenyl halide, 
converting to the corresponding α-alkenyllithium species, and treatment of 
isopropoxy(pinacolato)boron reagent.
7
 Pd-catalyzed cross-coupling of an internal alkenyl 
halide with B2(pin)2 can be an alternative method to generate an α-alkenylborons.
2e
 The 
preparation of the internal alkenyl halides, however, is necessary for both approaches and 
requires strongly acidic conditions. For instance, α-alkenyl bromides may be synthesized 
by selective B–Br addition to an alkyne with BBr3, followed by protonation of the C–B 
bond with excess amount of acetic acid.
8
 Alternatively, Ishii group prepared internal 
alkenyl iodides through site-selective hydroiodination of an alkyne and HI was generated 
in situ from TMSCl/NaI in the presence of water.
9
 Furthermore, synthesis of internal 
alkenyl metals from the corresponding α-alkenyl halides bearing an allylic nitrogen or 
                                                 
(4) (a) Lane, C. F.; Kabalka, G. W. Tetrahedron 1976, 32, 981–990. (b) Tucker, C. E.; Davidson, J.; 
Knochel, P. J. Org. Chem. 1992, 57, 3482–3485. (c) Pereira, S.; Srebnik, M. Organometallics 1995, 14, 
3127–3128. (d) Ohmura, T.; Yamamoto, Y.; Miyaura, N. J. Am. Chem. Soc. 2000, 122, 4990–4991. (e) 
PraveenGanesh, N.; d’Hondt, S.; Chavant, P. Y. J. Org. Chem. 2007, 72, 4510–4514. (f) Karamov, D. M.; 
Rosen, E. L.; Er, J. A. V.; Vu, P. D.; Lynch, V. M.; Bielawski, C. W. Tetrahedron 2008, 64, 6853–6862. 
(5) (a) Suzuki, A. Pure & Appl. Chem. 1986, 58, 629–638. (b) Satoh, Y.; Serizawa, H.; Miyaura, N.; Hara, 
S.; Suzuki, A. Tetrahedron Lett. 1988, 29, 1811–1814. 
(6) (a) Matteson, D. S.; Liedtke, J. D. J. Am. Chem. Soc. 1965, 87, 1526–1531. (b) Brown, H. C.; Cole, T. E. 
Organometallics 1983, 2, 1316–1319. 
(7) (a) Morrill, C.; Funk, T. W.; Grubbs, R. H. Tetrahedron Lett. 2004, 45, 7733–7736. (b) Moran, W. J.; 
Morken, J. P. Org. Lett. 2006, 8, 2413–2415. 
(8) Hara, S.; Dojo, H.; Takinami, S.; Suzuki, A. Tetrahedron Lett. 1983, 24, 731–734. 
(9) Kamiya, N.; Chikami, Y.; Ishii, Y. Synlett 1990, 675–676. 
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oxygen atom is challenging due to the elimination reactions.
10
 To avoid these limitations, 
the site-selective hydroboration of a terminal alkyne would be the most direct route for 
synthesis of an internal alkenyl boron compound. However, efficient and catalytic 
protocols for hydroboration of a terminal alkyne to deliver α-alkenylboron have not been 
disclosed yet.
11,12
 Thus, the development of efficient and selective process for generating 
α-alkenylboron compounds is of high value. 
 
As discussed in Chapter 1, we observed that site selectivity can be controlled to 
achieve either α- or β-alkenylborons efficiently and selectively by altering the structure of 
NHC–Cu complex. Herein, we have disclosed site-selective protoboryl additions to a 
wide array of terminal alkynes to provide α-alkenylborons in the presence of N-aryl-
substituted NHC–Cu complex. In addition, by changing the electronic attributes of the 
NHC–Cu complexes, preparation of β-alkenyl–B(pin) compounds will be illustrated 
(Scheme 2.1). 
                                                 
(10) Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961–10963. 
(11) For a Cu-catalyzed hydroboration of phenylacetylene that affords the terminal alkenylboron, see: Lee, 
J. E.; Kwon, J.; Yun, J. Chem. Commun. 2008, 733–734. This procedure is ineffective with alkylsubstituted 
alkynes. 
(12) Alkyl-substituted α-alkenylborons can be accessed through hydroborations that require stoichiometric 
amounts of a Cu complex (1.1 equiv. of CuCl, KOAc, and LiCl or a phosphine), and only in up to 91% 
selectivity (typically 9–71%). See: Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Organomet. Chem. 2001, 
625, 47–53. 
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2.2. Background 
 Efficient and selective protocols for preparation of terminal alkenylborons have 
been developed by a lot of chemists. However, there are no catalytic methods for 
selective generation of internal alkenylboron products. Thus, in this section, we will 
summarize the advances regarding selective synthesis for α-alkenylborons. 
 In 2001, Miyaura and coworkers reported selective addition of borylcopper 
species, in situ generated from CuCl and B2(pin)2, to terminal alkyne 2.1, delivering a 
91:9 mixture of  internal- (2.2a) and terminal- (2.2b) alkenylborons after work-up in 90% 
yield (Scheme 2.2).
12
 Reaction of propargyl tert-butyl ether proceeded with the same 
level of selectivity (2.3a:2.3b = 91:9). When they utilized sterically more hindered t-Bu-
bearing-alkyne, however, reaction underwent with minimal selectivity (2.4a:2.4b = 
49:51). Furthermore, reaction of phenylacetylene afforded β-alkenylboron product as a 
major regioisomer with a moderate selectivity (2.5a:2.5b = 38:62). There are several 
drawbacks in this transformation; (1) stoichiometric amount of CuCl salt is necessary 
(non-catalytic), (2) substrate scope is extremely limited (only four substrates illustrated), 
(3) the level of selectivity is not ideal (up to 91% to internal isomer). 
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 Ishiyama, Miyaura, and coworkers demonstrated that α-alkenylboron 2.5a is 
obtained efficiently (88% yield) by phosphine–Pd-catalyzed cross-coupling of alkenyl 
bromide 2.6 with 1.1 equiv. of B2(pin)2 (Scheme 2.3).
13
 Internal alkenyl (pinacolato) 
boron compounds 2.2a and 2.7a–2.9a, which are bearing an alkyl chain, are prepared in 
70–92% yield. Since they used internal alkenyl bromide as a cross-coupling partner, the 
alkenylboron product is also obtained as pure internal isomeric form. Although relatively 
wide range of α-alkenylborons can be generated through the aforementioned 
transformation, several issues need to be addressed. First, the synthesis of internal alkenyl 
bromide is not trivial, which can be synthesized by selective B–Br addition to an alkyne 
with BBr3, followed by protodeboration with AcOH. Additionally, the use of precious 
metal (Pd salt) is required for the cross-coupling reaction. 
 
 Another indirect method to prepare internal alkenylboron compounds was 
illustrated by Grubbs and coworkers in 2004.
14
 The authors developed Pd-catalyzed 
cross-coupling of internal alkenyl–B(pin) with monosubstituted olefin to afford 
trisubstituted alkenylboron compound. In their study, they provided the protocol to 
                                                 
(13) Takagi, J.; Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 8001–8006. 
(14) Morrill, C.; Funk, T. W.; Grubbs, R. H. Tetrahedron Lett. 2004, 45, 7733–7736. 
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synthesize α-alkenyl–B(pin) compound, which included preparation of alkenyl iodide, 
transformation to alkenyllithium species, and treatment of (pin)BOi-Pr (Scheme 2.4). 
Internal alkenyl iodides were prepared by a previously reported method by Ishii,
9
 which 
is site-selective hydroiodination of terminal alkyne with HI, which was generated in situ 
from TMSCl/NaI in the presence of water. Various internal (pinacolato) alkenylborons 
are prepared by the aforementioned process, although no isolated product yields are 
reported.
15
 
 
 Both of above methods to synthesize internal alkenylboron compounds require 
initial preparation of corresponding alkenyl halides. Either BBr3 and acetic acid or HI is 
included in the reaction solution during the preparation of alkenyl halides. Thus, the 
synthesis of acid-sensitive substituent-bearing alkenylboron compound might not be 
effective by these methods. Herein, we present a catalytic selective protocol for synthesis 
of various α-alkenylborons from readily available terminal alkynes. 
  
                                                 
(15) The authors mentioned that they obtained with moderate to high yields. 
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2.3. NHC–Cu-Catalyzed α-Selective Protoborations of Terminal Alkynes 
2.3.1. Examination of Various NHC–Cu Complexes 
 Preliminary observations, which are mentioned in Section 1.3.3 allow us to begin 
our studies regarding site-selective NHC–Cu-catalyzed protoborations of terminal 
alkynes. As shown in Scheme 1.11, with bis-N-mesityl-NHC–Cu complex 1.29, reaction 
of propargyl t-butyl ether 1.45 proceeds to internal alkenylboron 1.50 with 83% site 
selectivity. In contrast, when chiral bidentate NHC–Cu complex derived from A.6 is 
utilized, terminal alkenylboron 1.49 becomes a major product (89:11 1.49:1.50). To 
further explore the preference for generation of the α-alkenylborons, we investigated a 
number of achiral monodentate NHC–Cu complexes for reaction of propargyl ether 2.13 
(Scheme 2.5). N-Mesityl-containing NHC–Cu 2.14 promotes the reaction with 77:23 site 
selectivity at 22 ˚C, which is slightly lower than that obtained at 0 ˚C (83:17 2.19a:2.19b; 
Scheme 1.11). With unsaturated backbone-bearing NHC–Cu complex 2.15, on the other 
hand, same amount of two regioisomers 2.19a and 2.19b are afforded (50:50 
2.19a:2.19b). In the presence of sterically congested 2,6-(i-Pr)2-phenyl-bearing complex 
2.16, reaction of 2.13 undergoes with higher site selectivity (82% of 2.19a), although 
much longer reaction time is required for reaction completion (12 h vs 0.5 h for 2.14). In 
contrast, N-alkyl-containing NHC–Cu complexes 2.17 and 2.18 deliver β-alkenylboron 
2.19b preferentially (67–84% of 2.19b). Especially, bis-adamantyl-based complex 2.18 
promotes reaction of 2.13, affording 2.19b with 84% selectivity, which is totally reversed 
to that with complex 2.16 (82% of 2.19a). Even though we obtained higher level of 
selectivity with 2.16 (vs 2.14), when we lowered the reaction temperature to –50 ˚C to 
improve selectivity, which is guided by the above observation (2.19a:2.19b = 77:23 at 22 
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˚C vs 83:17 at 0 ˚C), reaction with complex 2.16 becomes sluggish (only 14% conv in 21 
h). On the other hand, reaction with NHC–Cu 2.14 proceeds with 89:11 site selectivity 
and 96% conversion in 21 hours at –50 ˚C. Thus, we chose the complex 2.14 as an 
optimal catalyst for further study. 
 
 
2.3.2. α-Selective Protoborations of Propargyl Alcohols, Amines and Derivatives 
 With 5 mol % of NHC–Cu complex 2.14, we obtained desired internal 
alkenylboron compound 2.19a in 84% yield at –50 ˚C, isolated from a 89:11 mixture of 
2.19a and 2.19b (Scheme 2.6). We have examined different protecting group-containing 
propargyl alcohols as well as unprotected ones. Reaction of propargyl alcohol affords 
corresponding α-alkenylboron 2.20a in 82% yield (93:7 2.20a:2.20b). In this reaction, 
since the substrate propargyl alcohol can serve as the proton source, we do not need to 
use MeOH. Internal alkenylborons containing a benzyloxy (2.21a) or a tert-
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butyldimethylsiloxy (2.3a) are isolated in 76–78% yield from a 84:16 or a 85:15 mixture 
of α- and β-isomers by silica gel chromatography. Then, propargyl amine and amides are 
investigated for α-selective protoboryl addition reaction. When propargyl amine is used, 
similar level of site selectivity (83:17 a:b) relative to propargyl ethers is obtained. 
Because of its instability on silica gel, however, purification and isolation of 2.22a was 
not successful. Unlike the case with propargyl alcohol, when we performed the reaction 
of propargyl amine without addition of MeOH, reaction becomes sluggish, which means 
that an amine might not be acidic enough to protonate the C–Cu bond in the intermediate. 
Several different protecting group-containing propargyl amides are prepared. Site 
selectivities for propargyl amides are exclusive (>98% α) and corresponding 
alkenylborons are obtained in up to 93% yield. The products formed in α-selective 
protoboration reactions illustrated in Scheme 2.6 are not able to be easily prepared by 
other methods. For instance, as we mentioned in Section 2.1, Ni-catalyzed 
hydroalumination of propargyl ether or amide to generate α-alkenyl–Al species, followed 
by treatment of methoxy(pinacolato)boron, cannot afford the desired product, because of 
competitive elimination.
10
 And also previously developed protocols as depicted in 
Scheme 2.3 and 2.4, might not be operative, because either an alkenyl–Pd or an alkenyl–
Li is generated in situ from alkenylhalide, which can suffer from the aforementioned 
elimination. 
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2.3.3. α-Selective Protoborations of Aryl- and Heteroaryl-Substituted Terminal Alkynes 
 To expand the substrate scope, we investigated different types of alkynes bearing 
an aryl- or a heteroaryl unit as substrates for α-selective protoborations. Initially, we 
examined reaction temperature with 5 mol % of NHC–Cu complex 2.14 (Table 2.1). 
Reaction of phenylacetylene 2.26 at 0 ˚C proceeded with moderate site selectivity 
favoring β-alkenylboron isomer (2.5a:2.5b = 33:67; entry 1). When we lowered the 
reaction temperature to –15 ˚C and –30 ˚C, α-selectivity is slightly increased to 38% and 
44%, respectively (entries 2 and 3). Lowering temperature to –50 ˚C, however, did not 
give high site selectivity (53:47 a:b; entry 4). The above results led us to utilize the less 
active but more sterically hindered 2,6-(i-Pr)2-phenyl-substituted NHC–Cu complex 2.16 
for reaction of aryl-bearing alkyne. Interestingly, with 5 mol % of 2.16, 79:21 site 
selectivity favoring to α-alkenylboron 2.5a was obtained (entry 5). After further 
temperature screening, we found that at lower temperature (–15 ˚C), NHC–Cu complex 
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2.16 promoted reaction of 2.26 in 94% conv with 88:12 site selectivity (entry 6). The 
latter condition was chosen as optimal one for reactions of aryl alkynes. 
 
 Various aryl and heteroaryl alkynes are examined, which undergo α-selective 
protoboryl addition in up to 96:4 site selectivity (Scheme 2.7). Pure α-alkenylborons 
(>98% α) are isolated by silica gel chromatography in up to 87% yield. Reactions of 
ortho-halogen-bearing phenylacetylenes (2.27a, 2.28a, and 2.29a) are more selective 
(91:9–94:6 a:b vs 88:12 for 2.5a) and efficient (72–87% yield). It seems that electron-
withdrawing substituted aryl alkynes undergo protoboration reaction with higher α 
selectivity. In addition, reactions of alkynes bearing a meta-F and a para-F unit proceed 
with 94% and 87% α selectivity, respectively (2.33a and 2.36a). When fluorine atom is 
placed more proximal to the alkyne, higher site selectivity was obtained, which shows the 
importance of the inductive effect. Then, electron-withdrawing, trifluoromethyl-
substituted phenyl acetylenes are investigated, that are converted to α-alkenylborons 
bearing an ortho-CF3 (2.30a), a meta-CF3 (2.34a), or a para-CF3 (2.37a) in 35–70% 
Chapter 2, Page 63 
 
 
yield. Interestingly, we observed completely reversed selectivity trend compare to F-
containing substrates. When we locate CF3 unit close to the alkyne, α selectivity is 
decreased (83% α for 2.30a, 89% α for 2.34a, and 96% α for 2.37a). This unexpected 
trend might be explained as follows; (1) since trifluoromethyl group attracts electrons 
through σ-bond framework as well as those that do so through resonance, the electron-
withdrawing ability of m-CF3-bearing substrate is weaker (no resonance effects are 
possible), (2) although o-CF3-containing substrate might have stronger ability to attract 
electrons through σ-bond framework, it also might have negative steric effect (with o-
Me-phenylacetylene, only 70% α selectivity is obtained; 2.32a). Phenylacetylenes 
bearing other electron-withdrawing group, such as a nitro or a methyl ester unit were 
subjected to the α-selective protoboration reaction, both of which gave higher α 
selectivity (91% α for 2.38a and 92% α for 2.41a). In contrast, reactions of electron-
donating, methoxy-containing aryl alkynes proceed with lower site selectivity (41% α for 
2.31a, 79% α for 2.35a, and 62% α for 2.39a). As we mentioned above, meta-substituted 
phenylacetylene has weaker electronic effect compared to ortho- or para-substituted one, 
which might be a reason why 2.35a is obtained with relatively higher α selectivity. 
Additionally, heteroaryl-bearing substrates were utilized, and moderate to high site 
selectivity is obtained (90% α for 2.42a and 78% α for 2.43a). However, because of 
instability of these alkenylboron compounds 2.42a and 2.43a, we fail to isolate them. It 
should be noted that, based on the above observations, there is a general trend that 
electron-withdrawing groups prefer α selectivity and more β-alkenylborons are generated 
with electron-donating substituents. 
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2.3.4. The Utility of Cu-Catalyzed α-Selective Protoboration of Terminal Alkyne 
 The utility of NHC–Cu-catalyzed process is illustrated by gram scale procedure 
(eq 2.1). Reaction of propargyl Boc amide 2.44 (1.0 gram; 6.44 mmol) with 1.1 equiv. of 
B2(pin)2 and 1.5 equiv. of MeOH in the presence of only 1 mol % of NHC–Cu complex 
2.14, which can be prepared readily from CuCl, commercially available N-Mes 
imidazolinium salt, and NaOt-Bu, delivers affording α-alkenylboron product 2.23a in 
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91% yield (1.66 gram) after purification with perfect site selectivity (>98% α). Internal 
alkenylboron 2.23a can be utilized for metal-catalyzed cross-coupling reaction, and also 
recently, was used for NHC–Cu-catalyzed enantioselective allylic alkenyl addition to 
allylic phosphate.
16
  
 
In addition, since the conversion of C–B bond to C–O bond is widely used and 
very efficient, through the present Cu-catalyzed protocol, a methyl ketone might be 
synthesized from the corresponding terminal alkyne. Although a methyl ketone can be 
accessed by Pd-catalyzed Wacker oxidation of terminal alkene,
17
 our strategy has still a 
significant advantage, which is high chemoselectivity. As illustrated in Scheme 2.8, 
enyne 2.45 is subjected to Cu-catalyzed protoboration, affording internal alkenylboron 
compound 2.46 in 95% yield with complete α selectivity (>98% α) and perfect 
chemoselectivity (<2% addition to alkene). The corresponding methyl ketone 2.47 is 
obtained in 82% yield by H2O2-mediated oxidation. The alternative pathway, which 
includes Wacker oxidation, might not operative due to low chemoselectivity. 
                                                 
(16) Gao, F.; Carr, J. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 2149−2161. 
(17) (a) Smidt, J.; Hafner, W.; Jira, R.; Sieber, R.; Sedlmeier, J.; Sabel, A. Angew. Chem., Int. Ed. Engl. 
1962, 1, 80–88. (b) Muzart, J. Tetrahedron 2007, 63, 7505–7521. 
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Synthetically useful intermediate, cyclic alkenylboron compounds
18
 can be 
prepared through the Cu-catalyzed α-selective protoboration of terminal alkynes. As 
shown in Scheme 2.9, cyclic alkenylboron 2.51 was obtained in 71% yield by ring-
closing metathesis of α-alkenylboron bearing terminal alkene 2.49 in the presence of 5 
mol% of Ru complex 2.50.
19
 The desired diene compound 2.49 was synthesized in 88% 
yield through Cu-catalyzed protoboration of enyne 2.48 with exceptional site- and 
chemoselectivity (>98% α and <2% addition to alkene).  Because of the allylic oxygen 
atom on compound 2.49, the synthesis of 2.49 might not be possible by other methods we 
mentioned above (Section 2.2). 
 
                                                 
(18) For a method for synthesis of cyclic alkenylborons through the use of β-borylallylsilanes, prepared by 
Pd-catalyzed silaboration of allenes, see: (a) Suginome, M.; Ohmori, Y.; Ito, Y. J. Am. Chem. Soc. 2001, 
123, 4601–4602. For synthesis of cyclic alkenylborons through Pd-catalyzed C–H borylation, see: (b) 
Olsson, V. J.; Szabó, K. J. Angew. Chem., Int. Ed. 2007, 46, 6891–6893. (c) Selander, N.; Willy, B.; Szabó, 
K. J. Angew. Chem., Int. Ed. 2010, 49, 4051–4053. Cyclic alkenylborons have also been prepared through 
Ni-catalyzed borylation processes that involve C–O activation: (d) Huang, K.; Yu, D.-G.; Zheng, S.-F.; Wu, 
Z.-H.; Shi, Z.-J. Chem. –Eur. J. 2011, 17, 786–791. 
(19) (a) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168–
8179. For an early report regarding the synthesis of cyclic alkenylborons through catalytic RCM of dienes, 
see: (b) Renaud, J.; Ouellet, S. G. J. Am. Chem. Soc. 1998, 120, 7995–7996. 
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2.4. NHC–Cu-Catalyzed β-Selective Protoborations of Terminal Alkynes 
 Various synthetic strategies for selective preparation of β-alkenylboron 
compounds have been reported including the most straightforward method, hydroboration 
of terminal alkynes.
20
 Metal-catalyzed variants have been also developed with a variety 
of metals including Rh, Ir,
21
 Ti,
22
 and Zr.
23
 Although there are plenty of methods 
regarding synthesis of β-alkenylborons, no Cu-catalyzed protocol has been reported yet. 
Moreover, mechanistically, the present study might be useful for establishing the origins 
of α selectivity obtained with N-aryl-bearing NHC–Cu complexes 2.14 and 2.16. As we 
illustrated in Scheme 2.5, N-alkyl-substituted NHC–Cu complexes 2.17 and 2.18 generate 
the terminal alkenylboron isomer as a major product (67% and 84% of β, respectively). 
With Cu complex 2.18 as an optimal catalyst for β-selective protoboration of terminal 
alkynes, we investigated wide array of alkynes. 
 As shown in Scheme 2.10, reaction of propargyl tert-butyl ether 2.13 with 5 mol 
% of 2.18 at ambient temperature in 12 h affords terminal alkenylboron 2.19b in 80% 
yield with high β selectivity (88%). Propargyl alcohol was converted to β-alkenylboron 
product 2.20 in 65% yield with 87% of selectivity. Although the level of selectivity is 
                                                 
(20) For protocols with catecholborane, see: (a) Brown, H. C.; Gupta, S. K. J. Am. Chem. Soc. 1975, 97, 
5249–5255. (b) Hoffmann, R. W.; Dresely, S. Synthesis 1988, 103–106.  (c) Arase, A.; Hoshi, M.; Mijin, 
A.; Nishi, K. Synth. Commun. 1995, 25, 1957–1962. For protocols with di(isocamphenyl)borane, see: (d) 
Martinez-Fresneda, P.; Vaultier, M. Tetrahedron Lett. 1989, 30, 2929–2932. (e) Kamabuchi, A.; Moriya, 
T.; Miyaura, N.; Suzuki, A. Synth. Commun. 1993, 23, 2851–2859. (f) Gravel, M.; Toure, B. B.; Hall, D. G. 
Org. Prep. Proced. Int. 2004, 36, 573–579. For a protocol with pinacolborane, see: (g) Tucker, C. E.; 
Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482–3485. For a protocol with 
di(isopropylprenyl)borane, see: (h) Kalinin, A. V.; Scherer, S.; Snieckus, V. Angew. Chem., Int. Ed. 2003, 
42, 3399–3404. 
(21) (a) Pereira, S.; Srebnik, M. Tetrahedron Lett. 1996, 37, 3283–3286. (b) Ohmura, T.; Yamamoto, Y.; 
Miyaura, N. J. Am. Chem. Soc. 2000, 122, 4990–4991. (c) Khramov, D. M.; Rosen, E. L.; Er, J. A. V.; Vu, 
P. D.; Lynch, V. M.; Bielawski, C. W. Tetrahedron 2008, 64, 6853–6862. 
(22) He, X.; Hartwig, J. F. J. Am. Chem. Soc. 1996, 118, 1696–1702. 
(23) (a) Pereira, S.; Srebnik, M. Organometallics 1995, 14, 3127–3128. (b) Wang, Y. D.; Kimball, G.; 
Prashad, A. S.; Wang, Y. Tetrahedron Lett. 2005, 46, 8777–8780. (c) PraveenGanesh, N.; d’Hondt, S.; 
Chavant, P. Y. J. Org. Chem. 2007, 72, 4510–4514. 
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somewhat lower than α-selective variants, reactions of propargyl amides undergo β-
selective protoboration to afford terminal B(pin)-substituted allylic amides 2.24b and 
2.25b in 56–70% yield with 73–87% β selectivity. With aryl-bearing terminal alkynes, on 
the other hand, we obtained higher site selectivities regardless of electronic nature of 
substituents for β-selective protoboration compared to α-selective variants. For instance, 
although only 41% of α-selectivity is obtained from reaction of ortho-MeO-
phenylacetylene with NHC–Cu 2.16 (2.31a; Scheme 2.7), β-selective protoboration of the 
same substrate in the presence of Cu complex 2.18 proceeds with exclusive β selectivity 
(2.31b; >98% β). There might be minor steric effects for β-selective protoboration since 
we obtained slightly decreased site selectivity with some of ortho-substituted 
phenylacetylenes (93% β for 2.27b, 95% β for 2.30b, and 97% β for 2.32b). 
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2.5. Mechanistic Basis for Site Selectivity in NHC–Cu-Catalyzed Protoboration 
of Terminal Alkynes 
 Based on above observations, we suggest plausible pathways for the generation of 
α-alkenylboron products in reactions catalyzed by N-aryl-NHC–Cu complex 2.14 or 2.16 
(Scheme 2.11), and also for the synthesis of β-alkenylborons in reactions promoted by N-
alkyl-NHC–Cu complex 2.18 (Scheme 2.12). Generally, since the electron-donating 
ability of an N-aryl-bearing NHC is weaker than that of an N-alkyl-containing NHC 
ligand based on Tolman electronic parameter (TEP),
24
 structure of an NHC–Cu–B(pin) 
species is more linear with an N-aryl-bearing NHC. Therefore, when it is approaching to 
the Cu center, terminal alkyne substrate is placed parallel to NHC–Cu–B(pin) (“syn-to-
NHC” mode). When a terminal alkyne bearing electron-withdrawing unit (Scheme 
2.11a), the coordination mode I is preferred (vs II), mainly due to steric repulsion 
between substituent of alkyne (G) and N-aryl moiety of the NHC in mode II, which is 
consistent with our previous observation in Scheme 2.5; when we use more sizeable aryl-
bearing NHC, higher α selectivity we obtained. The transformation might proceed to 
metallacyclopropene IC, which is converted to copper–boron addition species IV through 
B(pin) unit migration to adjacent α carbon. Subsequent protonation of C–Cu bond in IV 
generates the α-alkenylboron product, and at the same, catalytic active NHC–Cu–OMe 
species 2.52 is regenerated. 
In general, the HOMO coefficient of β carbon on terminal alkynes is larger than α 
carbon. Thus, a more advanced Cβ–Cu bond is expected than Cα–Cu bond (shorter 
                                                 
(24) For a review of the Tolman electronic parameter (TEP) for phosphine ligands, see: (a) Tolman, C. A. 
Chem. Rev. 1977, 77, 313–348. The TEP values for NHC ligands were obtained from: (b) Kelly, R. A., III; 
Clavier, H.; Giudice, S.; Scott, N. M.; Stevens, E. D.; Bordner, J.; Samardjiev, I.; Hoff, C. D.; Cavallo, L.; 
Nolan, S. P. Organometallics 2008, 27, 202–210. 
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distance) in the transition state (mode I). However, as depicted in Scheme 2.11, two 
bonds are similarly advanced in transition state (mode I), because with an electron-
withdrawing substituent, the electron density at α carbon is increased, which causes more 
similar HOMO coefficients at the two alkynyl carbons. On the other hand, the electron-
donating substituent may enhance the electron density at β carbon, which causes the less 
advanced Cα–Cu bond (mode IIA in Scheme 2.11). With this electronic effect, the 
distance of Cα–Cu bond becomes relatively longer, which makes the steric repulsion 
between N-aryl unit and substituent on alkyne (G) weaker. Thus, with electron-donating 
substrates such as o-MeO-bearing phenylacetylene, mode IIA may be more competitive, 
which lowers the α selectivity (41:59 α:β for 2.31a; Scheme 2.7). 
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 When the more electron-donating alkyl-substituted NHC–Cu complex 2.18 is 
used, because of stronger trans effect by NHC ligand, the conformation of NHC–Cu–
B(pin) may be bent from the linear structure (Scheme 2.12),
25
 compare to that with less 
                                                 
(25) For computational studies regarding the connection between substrate coordination to distortion of d
10
 
metal complexes [Cu(I), Ag(I), and Au(I)] from linearity, see: (a) Carvajal, M. A.; Novoa, J. J.; Alvarez, S. 
J. Am. Chem. Soc. 2004, 126, 1465–1477. These investigations indicate that the barrier to distortion in 
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electron-donation aryl-bearing NHC–Cu complex (Scheme 2.11). This distortion would 
make an available coordination site more trans-to-NHC direction, which allows alkyne 
substrates to approach the NHC–Cu–B(pin) with “anti-to-NHC” mode. Since alkyne 
approaches from an angle, which positions it more distal to NHC, steric factors become 
less dominant in mode III and IV (Scheme 2.12). Therefore, in this case of a more 
electron-donating NHC, electronic effects are the key factors to determine site selectivity. 
When more electron donating NHC–Cu–B(pin) reacts with an alkyne, mode IV would be 
more favored because in mode IV, Cβ (larger LUMO coefficient) is located trans to the 
NHC ligand, which allows more effective hyperconjugation. Therefore, β-alkenylboron 
compounds are afforded through metallacyclopropene IVC, and B(pin)-substituted 
alkenylcopper species IVV. The lower selectivity with propargyl heteroatom-bearing 
substrates (73–88% β in Scheme 2.10), compare to those with aryl alkynes (93 to >98% β 
in Scheme 2.10), might be because resonance-based effects (aryl alkynes) is more 
dominant than inductive effects by an electronegative heteroatom (O or N). 
                                                                                                                                                 
Cu(I) complexes, much of which is due to the bending in L–Cu–L’ systems, is diminished with the more 
strongly donating ligands. For examples of distortion from linearity in an NHC–metal–ligand bond and 
related discussions, see: (b) Poater, A.; Ragone, F.; Correa, A.; Szadkowska, A.; Barbasiewicz, M.; Grela, 
K.; Cavallo, L. Chem. –Eur. J. 2010, 16, 14354–14364. For examples of structural distortion as a result of 
trans-influence, see: (c) Lövqvist, K. C.; Wendt, O. F.; Leipoldt, J. G. Acta Chem. Scand. 1996, 50, 1069–
1073. (d) Wendt, O. F.; Elding, L. I. J. Chem. Soc., Dalton Trans. 1997, 4725–4731. (e) Fernández, D.; 
García-Seijo, I.; Sevillano, P.; Castineiras, A.; García-Fernández, M. E. Inorg. Chim. Acta 2005, 358, 
2575–2584. 
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2.6. Conclusions 
 We have developed an efficient and practical protocol for selective synthesis of 
internal alkenylboron compounds. Reactions of a wide range of terminal alkynes with 
readily available B2(pin)2 and MeOH, catalyzed by 5 mol % NHC–Cu complexes derived 
from commercially available imidazolinium salt, CuCl, and NaOt-Bu, deliver α-
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alkenylborons with high site selectivity (up to >98% α). The present method is amenable 
to gram scale process with only 1 mol % of NHC–Cu complex, affording α-alkenylboron 
without diminution of site selectivity. The efficient syntheses of useful intermediates such 
as a methyl ketone and a cyclic alkenylboron compound are accomplished by chemo- and 
site-selective protoboryl addition to alkene-bearing terminal alkynes. With N-adamantyl-
NHC–Cu complex, site selectivity of reactions of terminal alkynes is reversed. By 
changing the NHC–Cu complex, various β-alkenylborons are provided by catalytic 
protoboration method with high selectivity (73–>98% β). 
To account for the sense and the level of site selectivity, we propose plausible 
pathways, which show the steric and electronic effects from the NHC ligands and the 
alkyne substrates. Based on proposed stereochemical models, with less electron-donating 
NHC–Cu complex, steric repulsion between aryl groups on NHC and substituent of 
alkyne is a key factor to determine the site selectivity. In the case of electron-donating 
group-containing alkynes, the aforementioned steric repulsion is relieved to lower the 
selectivity for generation of α-alkenylboron compounds. On the other hand, with more 
electron-donating NHC–Cu complex, because of the stronger trans effect, the structure of 
NHC–Cu–B(pin) is bended, which weakens the steric repulsion between N-alkyl unit and 
alkyne substituent. Thus electronic factor becomes more dominant to control site 
selectivity to afford β-alkenylborons. The investigations presented above illustrate that, 
by altering the electronic nature of the NHC ligand, high level of site selectivity can be 
achieved for either α-alkenylborons, which are not easy to prepare by other methods, or 
alternative β-alkenylborons. 
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2.7. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, max in cm
−1
. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 
1
H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, sb = sebtet, br s = broad singlet, m = multiplet), and coupling constant 
(Hz). 
13
C NMR spectra were recorded on a Varian Unity INOVA 400 (100 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.16 
ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF DART 
(positive mode) at the Mass Spectrometry Facility, Boston College. Unless otherwise 
noted, all reactions were carried out with distilled and degassed solvents under an 
atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with standard dry box 
or vacuum-line techniques. Solvents were purified under a positive pressure of dry argon 
by a modified Innovative Technologies purification system: toluene, benzene and 
hexanes were purified through a copper oxide and alumina column; CH2Cl2 and Et2O 
were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. Methanol 
(Aldrich Chemical Co.) was distilled over CaH2. All work-up and purification procedures 
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were carried out with reagent grade solvents (purchased from Fisher Scientific, Inc.) in 
air. 
 
2.7.1. Reagents and Ligands 
Aryl-substituted terminal alkynes: purchased from Aldrich Chemical Co. and purified 
by distillation over CaH2 prior to use. 
Bis(pinacolato)diboron: purchased from Frontier Scientific, Inc. and recrystallized from 
pentane. 
(1,3-Bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(o-
isopropoxyphenylmethylene)ruthenium (2.50): obtained from Materia, Inc. and 
purified by silica gel column chromatography and recrystallization (CH2Cl2/n-pentane) 
prior to use.
26
 
3-tert-Butoxyprop-1-yne (2.13): prepared according to a previously reported 
procedure.
27
 
tert-Butyldimethyl(prop-2-yn-1-yloxy)silane: prepared according to a previously 
reported procedure.
28
 
tert-Butyl allyl(prop-2-yn-1-yl)carbamate (2.45): prepared according to previously 
reported procedures.
29
 
tert-Butyl pent-4-ynylcarbamate: prepared according to a previously reported 
procedure.
30
 
                                                 
(26) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168–8179. 
(27) Alexakis, A.; Gardette, M.; Colin, S. Tetrahedron Lett. 1988, 29, 2951–2954. 
(28) Falck, J. R.; He, A.; Fukui, H.; Tsutsui, H.; Radha, A. Angew. Chem., Int. Ed. 2007, 46, 4527–4529. 
(29) Becker, D. P.; Flynn, D. L. Tetrahedron 1993, 49, 5047–5054. 
(30) Saito, Y.; Matsumoto, K.; Bag, S. S.; Ogasawara, S.; Fujimoto, K.; Hanawa, K.; Saito, I. Tetrahedron 
2008, 64, 3578–3588. 
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tert-Butyl prop-2-yn-1-ylcarbamate (2.44): purchased from Aldrich Chemical Co. and 
purified by flash silica gel chromatography (hexanes:EtOAc = 10:1). 
5-Chloro-1-pentyne: purchased from Aldrich Chemical Co. and purified by distillation 
over CaCl2 prior to use. 
6-Chloro-1-pentyne: purchased from Aldrich Chemical Co. and purified by distillation 
over CaCl2 prior to use. 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Cu−NHC complex (2.14−2.18): prepared according to previously reported procedures.31 
Ethynylcyclohexane: purchased from Aldrich Chemical Co. and purified by distillation 
over CaH2 under reduced pressure. 
Hydrogen peroxide (35 wt. % solution in water): purchased from Aldrich Chemical 
Co. and used as received. 
Methyl 4-ethynylbenzoate: prepared according to previously reported procedures.
32
 
Methyl hex-5-ynoate: purchased from Acros Organics Co. and purified by distillation 
over CaCl2 prior to use. 
4-Methyl-N-(prop-2-yn-1-yl)benzenesulfonamide: prepared according to a previously 
reported procedure.
33
 
Prop-2-yn-1-amine: purchased from Aldrich Chemical Co. and purified by distillation 
over CaH2 prior to use. 
                                                 
(31) Díez-González, S.; Kaur, H.; Zinn, F. K.; Stevens, E. D.; Nolan, S. P. J. Org. Chem. 2005, 70, 4784–
4796. 
(32) Niamnont, N.; Siripornnoppakhun, W.; Rashatasakhon, P.; Sukwattanasinitt, M. Org. Lett. 2009, 11, 
2768–2771. 
(33) Lo, M. M. -C.; Neumann, C. S.; Nagayama, S.; Perlstein, E. O.; Schreiber, S. L. J. Am. Chem. Soc. 
2004, 126, 16077–16086. 
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Prop-2-yn-1-ol: purchased from Aldrich Chemical Co. and purified by distillation over 
CaH2 prior to use. 
Prop-2-yn-1-ylbenzene: purchased from Aldrich Chemical Co. and purified by 
distillation over CaH2 under reduced pressure. 
Prop-2-yn-1-ylcyclopentane: purchased from Aldrich Chemical Co. and purified by 
distillation over CaCl2 prior to use. 
2-(Prop-2-yn-1-yl)isoindoline-1,3-dione: purchased from Aldrich Chemical Co. and 
purified by flash silica gel chromatography (hexanes:EtOAc = 10:1). 
((Prop-2-yn-1-yloxy)methyl)benzene: prepared according to a previously reported 
procedure.
34
 
1-(Prop-2-yn-1-yloxy)-2-vinylbenzene (2.48): prepared according to previously 
reported procedures.
35
 
Sodium tert-butoxide (98%): purchased from Strem Chemicals Inc. and used as received. 
 
2.7.2. Experimental Procedure and Characterization Data 
 Representative Experimental Procedure for -Selective NHC−Cu-catalyzed 
Protoboration of tert-Butyl prop-2-yn-1-ylcarbamate 2.44: In an N2-filled glove-box, 
an oven-dried vial (4 mL, 17 x 38 mm) with magnetic stir bar was charged with NHC–Cu 
complex 2.14 (4.1 mg, 0.0100 mmol, 5.0 mol %), NaOt-Bu (1.0 mg, 0.0100 mmol, 5.0 
mol %) and thf (0.3 mL). The mixture was sealed with a cap (phenolic open top cap with 
red PTFE/white silicone septum) and allowed to stir for 10 min. Bis(pinacolato)diboron 
(50.8 mg, 0.200 mmol, 1.0 equiv.) was added to the solution, causing it to turn dark 
                                                 
(34) Fischer, D. F.; Xin, Z-q.; Peters, R. Angew. Chem., Int. Ed. 2007, 46, 7704–7707. 
(35) Pérez-Serrano, L.; Blanco-Urgoiti, J.; Casarrubios, L.; Domínguez, G.; Pérez-Castells, J. J. Org. Chem. 
2000, 65, 3513–3519. 
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brown immediately. The vial was re-sealed with a cap (phenolic open top cap with red 
PTFE/white silicone septum) and removed from the glove-box. The mixture was allowed 
to stir at 22 °C for 30 min under an atmosphere of N2. After this time, the mixture was 
allowed to cool to –78 °C (dry ice/acetone bath) under atmosphere of N2. A solution of 
tert-butyl prop-2-yn-1-ylcarbamate 2.44 (31.0 mg, 0.200 mmol, 1.0 equiv.) in thf (0.2 mL) 
and MeOH (8.9 µL, 0.220 mmol, 1.1 equiv.) were added (syringe). The vial was placed 
in a –50 °C cryocool. After 9 h, the solution was allowed to cool to –78 °C and the 
reaction was quenched by passing the mixture through a short plug of celite and silica gel 
and washed with Et2O (3 x 2 mL). The filtrate was concentrated in vacuo to provide 
brown oil, which was purified by silica gel chromatography (hexanes:Et2O=10:1) to 
afford the desired product 2.23a as colorless oil (52.7 mg, 0.186 mmol, 93% yield). 
2-(3-tert-Butoxyprop-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.19a, This 
compound has been previously reported and spectra data match those described).
36
 
1
H 
NMR (CDCl3, 400 MHz): δ 5.95–5.94 (1H, m), 5.86–5.85 (1H, m), 3.99–3.98 (2H, m), 
1.24 (12H, s), 1.20 (9H, s); 
13
C NMR (CDCl3, 100 MHz): δ 139.5, 128.3, 83.4, 73.0, 63.3, 
27.8, 24.9. 
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol (2.20a). IR (neat): 
3431 (br), 2979 (m), 2929 (w), 1624 (w), 1372 (s), 1307(s), 1214 (m), 1139 (s), 1033 (s), 
968 (m), 905(m), 859 (s), 730 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.83 (1H, s), 5.80 
(1H, s), 4.18 (2H, d, J = 1.6 Hz), 2.36 (1H, s), 1.23 (12H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 128.7, 83.7, 65.6, 24.8; HRMS (ESI+): Calcd for C9H18B1O3 [M+H]
+
: 
185.13490, Found: 185.13456. 
                                                 
(36) Lee, Y.; Jang, H.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 18234–18235. 
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2-(3-(Benzyloxy)prop-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.21a). IR 
(neat): 2978 (m), 2852 (w), 1623 (w), 1420 (s), 1369 (s), 1310 (s), 1142 (s), 1093 (s), 
1028 (m), 948 (s), 862 (s), 735 (s), 697 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.37–
7.26 (5H, m), 5.98 (1H, br s), 5.95 (1H, d, J = 1.2 Hz), 4.55 (2H, s), 4.15 (2H, t, J = 1.2 
Hz), 1.26 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 138.9, 129.6, 128.4, 127.6, 127.5, 
83.6, 72.3, 72.0, 24.9; HRMS (ESI
+
): Calcd for C16H24B1O3 [M+H]
+
: 275.18185; Found: 
275.18211. 
tert-Butyldimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)silane 
(2.3a, This compound has been previously reported and spectra data match those 
described).
37
 
1
H NMR (CDCl3, 400 MHz): δ 5.96–5.95 (1H, m), 5.88–5.86 (1H, m), 
4.28–4.27 (2H, m), 1.25 (12H, s), 0.91 (9H, s), 0.60 (6H, s); 13C NMR (CDCl3, 100 
MHz): δ 127.1, 83.3, 64.5, 25.9, 24.7, 18.4, –5.4. 
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allylcarbamate (2.23a, This 
compound has been previously reported and spectra data match those described).
35
 
1
H 
NMR (CDCl3, 400 MHz): δ 5.81 (1H, t, J = 1.4 Hz), 5.70 (1H, s), 4.80 (1H, s), 3.78 (2H, 
d, J = 4.4 Hz), 1.39 (9H, s), 1.21 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 155.9, 137.6, 
129.1, 83.6, 78.9, 44.4, 28.4, 25.0, 24.8. 
4-Methyl-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl)benzenesulfonamide (2.24a). IR (neat): 3285 (br), 2978 (w), 2927 (w), 1372 (m), 
1315 (s), 1139 (s), 1093 (m), 969 (w), 859 (m), 814 (m), 664 (s), 550 (s) cm
−1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 7.72 (2H, d, J = 8.4 Hz), 7.26 (2H, d, J = 8.4 Hz), 5.78 (1H, t, J = 
1.2 Hz), 5.72 (1H, d, J = 1.2 Hz), 4.97 (1H, t, J = 6.4 Hz), 3.68 (2H, dt, J = 6.4, 1.2 Hz), 
                                                 
(37) Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Organomet. Chem. 2001, 625, 47–53. 
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2.40 (3H, s), 1.21 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 143.3, 137.5, 131.5, 129.6, 
127.4, 84.0, 47.8, 24.8, 21.6; HRMS (ESI
+
): Calcd for C16H25B1N1O4S1 [M+H]
+
: 
338.15973; Found: 338.16078. 
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)isoindoline-1,3-dione (2.25a). 
IR (neat): 2979 (w), 1772 (w), 1712 (s), 1370 (s), 1314 (s), 1136 (s), 1112 (m), 955 (m), 
907 (m), 859 (m), 712 (s), 529 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.84 (2H, dd, J 
= 5.6, 2.8 Hz), 7.70 (2H, dd, J = 5.6, 2.8 Hz), 5.88 (1H, d, J = 2.0 Hz), 5.55 (1H, d, J = 
2.0 Hz), 4.41 (2H, t, J = 2.0 Hz), 1.20 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 168.3, 
133.9, 132.4, 129.0, 123.3, 83.8, 41.1, 24.8; HRMS (ESI
+
): Calcd for C17H21B1N1O4 
[M+H]
+
: 314.15636; Found: 314.15650. 
4,4,5,5-Tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane (2.5a). IR (neat): 2978 (m), 
1371 (s), 1306 (s), 1210 (s), 1142 (s), 1095 (m), 966 (m), 887 (m), 849 (s), 781 (m), 730 
(m), 698 (m), 512 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.50–7.48 (2H, m), 7.34–
7.30 (2H, m), 7.27–7.23 (1H, m), 6.09 (1H, d, J = 2.8 Hz), 6.07 (1H, d, J = 2.8 Hz), 1.33 
(12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 141.5, 131.0, 128.3, 127.3, 127.1, 83.9, 24.9; 
HRMS (ESI
+
): Calcd for C14H20B1O2 [M+H]
+
: 231.15564; Found: 231.15565. 
2-(1-(2-Fluorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.27a). IR 
(neat): 2979 (m), 1487 (m), 1413 (m), 1372 (s), 1319 (s), 1266 (m), 1196 (m), 1144 (s), 
1104 (m), 967 (m), 852 (m), 827 (m), 753 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.29 
(1H, ddd, J = 7.6, 7.6, 2.0 Hz), 7.21–7.17 (1H, m), 7.08 (1H, ddd, J = 7.6, 7.6, 1.2 Hz), 
7.01 (1H, ddd, J = 10.4, 8.4, 1.2 Hz), 6.10 (1H, d, J = 3.2 Hz), 6.01 (1H, d, J = 2.8 Hz), 
1.30 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 160.0 (d, J = 245 Hz), 132.6 (d, J = 2.3 
Hz), 129.9 (d, J = 14.1 Hz), 129.7 (d, J = 3.8 Hz), 128.8 (d, J = 8.2 Hz), 124.2 (d, J = 3.0 
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Hz), 115.4 (d, J = 22.3 Hz), 84.0, 24.8; HRMS (ESI
+
): Calcd for C14H19B1F1O2 [M+H]
+
: 
249.14621; Found: 249.14681. 
2-(1-(2-Chlorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.28a). IR 
(neat): 2979 (m), 1471 (m), 1369 (s), 1316 (s), 1261 (m), 1209 (m), 1143 (s), 1100 (s), 
1045 (m), 966 (m), 889 (w), 849 (m), 744 (s), 697 (m) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.32 (1H, dd, J = 8.0, 1.2 Hz), 7.24–7.16 (3H, m), 6.11 (1H, d, J = 3.2 Hz), 5.84 
(1H, d, J = 3.2 Hz), 1.29 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 141.8, 132.7, 132.6, 
129.8, 129.1, 128.4, 127.1, 84.0, 24.9; HRMS (ESI
+
): Calcd for C14H19B1Cl1O2 [M+H]
+
: 
265.11666; Found: 265.11782. 
2-(1-(2-Bromophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.29a). IR 
(neat): 2978 (m), 1468 (m), 1369 (s), 1317 (s), 1259 (m), 1212 (m), 1144 (s), 1099 (m), 
1024 (m), 966 (m), 849 (m), 742 (m), 689 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.51 
(1H, dd, J = 8.0, 1.2 Hz), 7.26 (1H, ddd, J = 7.6, 7.6, 1.2 Hz), 7.20 (1H, dd, J = 7.6, 2.0 
Hz), 7.09 (1H, ddd, J = 8.0, 8.0, 2.0 Hz), 6.10 (1H, d, J = 3.6 Hz), 5.78 (1H, d, J = 3.2 
Hz), 1.29 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 143.9, 132.6, 132.2, 129.8, 128.5, 
127.7, 123.0, 84.1, 24.9; HRMS (ESI
+
): Calcd for C14H19B1Br1O2 [M+H]
+
: 309.06615; 
Found: 309.06523. 
4,4,5,5-Tetramethyl-2-(1-(2-(trifluoromethyl)phenyl)vinyl)-1,3,2-dioxaborolane 
(2.30a). IR (neat): 2980 (w), 1369 (m), 1313 (s), 1212 (w), 1124 (s), 1052 (m), 1035 (m), 
966 (w), 850 (m), 766 (m), 697 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.61 (1H, d, J = 
7.6 Hz), 7.47 (1H, ddd, J = 7.6, 7.6, 0.4 Hz), 7.33 (1H, dd, J = 7.6, 7.6 Hz), 7.16 (1H, d, J 
= 7.6 Hz), 6.20 (1H, d, J = 3.6 Hz), 5.76 (1H, d, J = 3.2 Hz), 1.26 (12H, s); 
13
C NMR 
(CDCl3, 100 MHz): δ 142.3, 133.6 (q, J = 3.6 Hz), 131.6, 130.5, 127.8 (q, J = 29.0 Hz), 
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126.7, 125.9 (q, J = 3.0 Hz), 124.6 (q, J = 266 Hz), 84.1, 24.8; HRMS (ESI
+
): Calcd for 
C15H22B1F3N1O2 [M+NH4]
+
: 316.16957; Found: 316.17040. 
4,4,5,5-Tetramethyl-2-(1-(o-tolyl)vinyl)-1,3,2-dioxaborolane (2.32a). IR (neat): 2978 
(m), 2926 (w), 1367 (s), 1312 (s), 1216 (m), 1143 (s), 1087 (m), 966 (m), 889 (w), 850 
(m), 772 (m), 737 (m), 688 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.17–7.14 (3H, m), 
7.11–7.08 (1H, m), 6.16 (1H, d, J = 4.0 Hz), 5.80 (1H, d, J = 3.6 Hz), 2.27 (3H, s), 1.28 
(12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 142.8, 135.1, 133.1, 129.8, 128.5, 127.0, 125.9, 
83.9, 24.9, 20.4; HRMS (ESI
+
): Calcd for C15H22B1O2 [M+H]
+
: 245.17129; Found: 
245.17158. 
2-(1-(3-Fluorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.33a). IR 
(neat): 2979 (m), 1577 (m), 1371 (s), 1314 (s), 1237 (s), 1140 (s), 932 (m), 867 (s), 843 
(m), 787 (m), 735 (m), 672 (m), 521 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.30–7.24 
(2H, m), 7.22–7.19 (1H, m), 6.95–6.90 (1H, m), 6.09 (2H, s), 1.32 (12H, s); 13C NMR 
(CDCl3, 100 MHz): δ 163.0 (d, J = 243 Hz), 143.7 (d, J = 8.2 Hz), 132.0, 129.6 (d, J = 
8.2 Hz), 122.9 (d, J = 3.0 Hz), 114.2 (d, J = 21.6 Hz), 113.9 (d, J = 20.8 Hz), 84.1, 24.9; 
HRMS (ESI
+
): Calcd for C14H19B1F1O2 [M+H]
+
: 249.14621; Found: 249.14641. 
4,4,5,5-Tetramethyl-2-(1-(3-(trifluoromethyl)phenyl)vinyl)-1,3,2-dioxaborolane 
(2.34a). IR (neat): 2980 (w), 1371 (m), 1324 (s), 1204 (m), 1121 (s), 1073 (s), 966 (w), 
901 (w), 855 (m), 806 (m), 742 (w), 696 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.75–
7.74 (1H, m), 7.67 (1H, dd, J = 8.0, 1.2 Hz), 7.51 (1H, dd, J = 7.6, 0.8 Hz), 7.43 (1H, ddd, 
J = 7.2, 7.2, 0.8 Hz), 6.16 (1H, d, J = 2.8 Hz), 6.14 (1H, d, J = 2.4 Hz), 1.34 (12H, s); 
13
C 
NMR (CDCl3, 100 MHz): δ 142.3, 132.6, 130.7 (d, J = 1.5 Hz), 130.6 (q, J = 31.3 Hz), 
Chapter 2, Page 84 
 
 
128.7, 124.5 (q, J = 271 Hz), 124.1 (q, J = 3.7 Hz), 123.8 (q, J = 3.7 Hz), 84.2, 24.9; 
HRMS (ESI
+
): Calcd for C15H19B1F3O2 [M+H]
+
: 299.14302; Found: 299.14410. 
2-(1-(3-Methoxyphenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.35a). IR 
(neat): 2977 (m), 1598 (m), 1574 (m), 1371 (s), 1311 (s), 1285 (m), 1244 (s), 1195 (m), 
1142 (s), 1048 (m), 967 (m), 863 (m), 786 (m), 743 (m), 682 (m) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.23 (1H, m, J = 8.0, 8.0, 1.2 Hz), 7.09–7.04 (2H, m), 6.80 (1H, ddd, J = 8.0, 
2.4, 0.8 Hz), 6.08 (1H, d, J = 3.2 Hz), 6.05 (1H, d, J = 2.8 Hz), 3.80 (3H, s), 1.32 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 159.6, 142.9, 131.1, 129.2, 119.8, 113.0, 112.7, 83.9, 
55.3, 24.9; HRMS (ESI
+
): Calcd for C15H22B1O3 [M+H]
+
: 261.16620; Found: 261.16634. 
2-(1-(4-Fluorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.36a). IR 
(neat): 2979 (w), 1508 (s), 1371 (s), 1315 (s), 1298 (m), 1207 (s), 1142 (s), 1084 (m), 966 
(m), 889 (w), 840 (s), 751 (w), 670 (w), 586 (w), 515 (w) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.46 (2H, dd, J = 8.8, 5.6 Hz), 7.01 (2H, dd, J = 8.8, 8.8 Hz), 6.05 (2H, m), 1.33 
(12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 162.4 (d, J = 244 Hz), 137.5, 130.9 (d, J = 1.5 
Hz), 128.9 (d, J = 8.2 Hz), 115.1 (d, J = 20.8 Hz), 84.0, 24.9; HRMS (ESI
+
): Calcd for 
C14H19B1F1O2 [M+H]
+
: 249.14621; Found: 249.14663. 
4,4,5,5-Tetramethyl-2-(1-(4-(trifluoromethyl)phenyl)vinyl)-1,3,2-dioxaborolane 
(2.37a). IR (neat): 2980 (w), 1372 (m), 1320 (s), 1213 (m), 1113 (s), 1090 (s), 1065 (s), 
1017 (m), 966 (m), 849 (s), 743 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.58 (4H, s), 
6.18 (1H, d, J = 2.4 Hz), 6.13 (1H, d, J = 2.4 Hz), 1.34 (12H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 145.2, 133.1, 129.1 (q, J = 32 Hz), 127.6, 125.2 (q, J = 4.0 Hz), 124.5 (q, J = 
270 Hz), 84.2, 24.9; HRMS (ESI
+
): Calcd for C15H19B1F3O2 [M+H]
+
: 299.14302; Found: 
299.14348. 
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4,4,5,5-Tetramethyl-2-(1-(4-nitrophenyl)vinyl)-1,3,2-dioxaborolane (2.38a, This 
compound has been previously reported and spectra data match those described).
38
 
1
H 
NMR (CDCl3, 400 MHz): δ 8.17 (2H, dd, J = 7.2, 2.0 Hz), 7.62 (2H, dd, J = 7.2, 2.0 Hz), 
6.25 (1H, d, J = 2.4 Hz), 6.19 (1H, d, J = 2.4 Hz), 1.33 (12H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 148.3, 147.0, 134.5, 128.1, 123.6, 84.4, 24.9. 
Methyl 4-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzoate (2.41a). IR 
(neat): 2978 (w), 1719 (s), 1607 (w), 1434 (m), 1370 (s), 1319 (m), 1273 (s), 1210 (s), 
1143 (s), 1106 (s), 1019 (m), 966 (m), 850 (s), 785 (m), 734 (s) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.98 (2H, dd, J = 6.8, 1.6 Hz), 7.54 (2H, dd, J = 6.8, 2.0 Hz), 6.15 (2H, d, J 
= 1.6 Hz), 3.90 (3H, s), 1.32 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 167.2, 146.2, 
132.9, 129.7, 128.7, 127.3, 84.1, 52.1, 24.9; HRMS (ESI
+
): Calcd for C16H22B1O4 
[M+H]
+
: 289.16111; Found: 289.16028. 
 
 Experimental Procedure for -Selective NHC−Cu-Catalyzed Protoboration of 
tert-Butyl prop-2-yn-1-ylcarbamate 2.44 on Gram Scale: In an N2-filled glove-box, an 
oven-dried round-bottom flask (50 mL) with magnetic stir bar was charged with NHC–
Cu complex 2.14 (26.1 mg, 0.0644 mmol, 1.0 mol %), NaOt-Bu (6.2 mg, 0.0644 mmol, 
1.0 mol %) and toluene (10 mL). The vessel was sealed with a septum and allowed to stir 
for 10 min. Bis(pinacolato)diboron (1.80 g, 7.09 mmol, 1.1 equiv.) was added to the 
solution, causing to turn dark brown immediately. The flask was resealed with a septum 
and removed from the glovebox. The mixture was allowed to stir at 22 °C for 30 min 
under N2 atm. After that, it was allowed to cool to –78 °C (dry ice/acetone bath) under N2 
                                                 
(38) Khramov, D. M.; Rosen, E. L.; Er, J. A. V.; Vu, P. D.; Lynch, V. M.; Bielawski, C. W. Tetrahedron 
2008, 64, 6853–6862. 
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atm. A solution of tert-butyl prop-2-yn-1-ylcarbamate 2.44 (1.00 g, 6.44 mmol, 1.0 equiv.) 
in toluene (5 mL) and MeOH (392 µL, 9.67 mmol, 1.5 equiv.) were added (syringe). The 
flask was placed in a –50 °C cryocool. After nine hours, the solution was allowed to cool 
to –78 °C and the reaction was quenched by passing through a short plug of celite and 
silica gel and washed with Et2O (3 x 20 mL). The filtrate was concentrated in vacuo to 
provide brown oil, which was purified by silica gel column chromatography 
(hexanes:Et2O=10:1) to afford the desired product 2.23a as colorless oil (1.66 g, 5.85 
mmol, 91% yield). 
tert-Butyl allyl(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate (2.46, 
This compound has been previously reported and spectra data match those described).
39
 
1
H NMR (CDCl3, 400 MHz): δ 5.85–5.84 (1H, m), 5.74–5.70 (1H, m), 5.60 (1H, d, J = 
2.8 Hz), 5.07 (1H, br s), 5.04 (1H, br s), 3.92–3.71 (4H, m), 1.41 (9H, s), 1.22 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 155.8 (155.6), 148.6, 134.2 (133.9), 128.8 (128.5), 116.3 
(115.8), 83.6 (83.3), 79.3 (79.7), 49.6 (48.9), 28.5, 24.8. 
 
 Experimental Procedure for Oxidation of Alkenylboron 2.46: To a solution of 
vinylboronate 14 (119 mg, 0.368 mmol) in thf (2 mL) at 0 °C (ice bath) were added H2O2 
(179 μL, 1.84 mmol, 5.00 equiv.) and 2 N NaOH (921 μL, 1.84 mmol, 5.00 equiv.). The 
resulting solution was allowed to stir at 22 °C for one hour. After this time, the mixture 
was diluted with water (4 mL), washed with Et2O (3 x 2 mL). Combined organic layers 
were filtered through a plug of MgSO4. The filtrate was concentrated in vacuo to provide 
                                                 
(39) Renaud, J.; Ouellet, S. G. J. Am. Chem. Soc. 1998, 120, 7995–7996. 
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brown oil, which was purified by silica gel chromatography (hexanes:Et2O=10:1) to 
afford the desired product 2.47 as a pale yellow oil (64.5 mg, 0.302 mmol, 82% yield). 
tert-Butyl allyl(2-oxopropyl)carbamate (2.47). IR (neat): 2979 (w), 2929 (w), 1688 (s), 
1454 (m), 1393 (m), 1366 (m), 1247 (s), 1164 (s), 910 (s), 728 (s), 647 (m), 568 (w), 529 
(w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.77–5.69 (1H, m), 5.12–5.04 (2H, m), 3.94 
(1H, s), 3.89 (1H, d, J = 6.0 Hz), 3.82 (1H, s), 3.81 (1H, d, J = 6.0 Hz), 2.08 (3H, d, J = 
4.8 Hz), 1.41 (9H, d, J = 16.4 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 204.6 (204.5), 155.7 
(155.1), 133.8 (133.7), 117.7 (116.9), 80.4, 56.2 (55.9), 50.9 (50.6), 28.4 (28.3), 27.0 
(26.8); HRMS (ESI
+
): Calcd for C11H20N1O3 [M+H]
+
: 214.14432; Found: 214.14369. 
4,4,5,5-Tetramethyl-2-(3-(2-vinylphenoxy)prop-1-en-2-yl)-1,3,2-dioxaborolane (2.49). 
IR (neat): 2979 (w), 1626 (w), 1598 (w), 1486 (m), 1450 (m), 1422 (m), 1381 (m), 1372 
(m), 1350 (s), 1314 (s), 1242 (s), 1141 (m), 1035 (m), 951 (w), 907 (w), 864 (w), 749 (s) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.49 (1H, dd, J = 7.6, 1.6 Hz), 7.21–7.19 (1H, m), 
7.16 (1H, dd, J = 17.6, 11.2 Hz), 6.95–6.89 (2H, dd, J = 13.6, 7.2 Hz), 6.08 (1H, s), 6.04 
(1H, dd, J = 3.2, 1.6 Hz), 5.75 (1H, dd, J = 18.0, 1.6 Hz), 5.25 (1H, dd, J = 11.2, 1.6 Hz), 
4.68 (2H, t, J = 1.6 Hz), 1.30 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 156.0, 131.9, 
130.1, 128.8, 127.1, 126.4, 120.7, 114.2, 112.7, 83.8, 69.9, 24.9; HRMS (ESI
+
): Calcd for 
C17H24B1O3 [M+H]
+
: 287.18185; Found: 287.18252. 
 
 Experimental Procedure for Ru-Catalyzed Ring-closing Metathesis of 
Alkenylboron 2.49: To a solution of alkenylboron 2.49 (28.6 mg, 0.100 mmol, 1.0 equiv.) 
in anhydrous benzene (9 mL) was added a solution of the Ru carbene 2.50 (3.1 mg, 
0.00500 mmol, 5.0 mol %) in benzene (1 mL) via syringe. The mixture was allowed to 
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stir at 22 °C under N2 atm. After 60 h, the reaction was quenched by passing through a 
short plug of celite and silica gel and the mixture was washed with Et2O (3 x 10 mL). The 
filtrate was concentrated in vacuo to provide yellow oil, which was purified by silica gel 
chromatography (hexanes:Et2O=20:1) to afford the desired product 2.51 as a pale yellow 
oil (18.2 mg, 0.0705 mmol, 71% yield). 
2-(2H-Chromen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.51). IR (neat): 2977 
(w), 1627 (m), 1485 (w), 1355 (s), 1309 (m), 1211 (m), 1141 (s), 987 (m), 847 (m), 754 
(m), 662 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.14 (1H, ddd, J = 8.0, 7.2, 1.6 Hz), 
7.10 (1H, s), 7.01 (1H, dd, J = 7.6, 1.6 Hz), 6.86 (1H, ddd, J = 7.2, 1.2, 1.2 Hz), 6.78 (1H, 
d, J = 8.0 Hz), 4.87 (2H, d, J = 1.6 Hz), 1.30 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 
155.4, 137.4, 130.6, 127.7, 122.6, 121.4, 116.0, 83.9, 67.1, 24.9; HRMS (ESI
+
): Calcd for 
C15H20B1O3 [M+H]
+
: 259.15055; Found: 259.15032. 
 
 Representative Experimental Procedure for -Selective NHC−Cu-Catalyzed 
Protoboration of Phenylacetylene 2.26: In an N2-filled glovebox, an oven-dried vial (4 
mL, 17 x 38 mm) with magnetic stir bar was charged with NHC–Cu complex 2.18 (4.4 
mg, 0.0100 mmol, 5.0 mol %), NaOt-Bu (1.0 mg, 0.0100 mmol, 5.0 mol %) and thf (0.5 
mL). The vessel was sealed with a cap (phenolic open top cap with red PTFE/white 
silicone septum) and allowed to stir for 10 min. Bis(pinacolato)diboron (50.8 mg, 0.200 
mmol, 1.0 equiv.) was added, causing the solution to turn dark brown immediately. The 
vial was re-sealed with a cap (phenolic open top cap with red PTFE/white silicone) and 
removed from the glove-box. The mixture was allowed to stir at 22 °C for 30 min under 
N2 atm. At this time, phenylacetylene 2.26 (22.0 µL, 0.200 mmol, 1.0 equiv.) and MeOH 
(8.9 µL, 0.220 mmol, 1.1 equiv.) were added (syringe). The solution was allowed to stir 
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at 22 °C for 12 h. After 12 h, the reaction was quenched by passing through a short plug 
of celite and silica gel and washed with Et2O (3 x 2 mL). The filtrate was concentrated in 
vacuo to provide brown oil, which was purified by silica gel chromatography 
(hexanes:Et2O=50:1) to afford the desired product 2.5b as pale yellow oil (37.1 mg, 
0.161 mmol, 81% yield). 
(E)-2-(3-tert-Butoxyprop-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.19b, 
This compound has been previously reported and spectra data match those described).
40
 
1
H NMR (CDCl3, 400 MHz): δ 6.64 (1H, dt, J = 18.0, 4.4 Hz), 5.69 (1H, dt, J = 18.0, 1.6 
Hz), 3.95 (2H, dd, J = 4.8, 4.0 Hz), 1.22 (12H, s), 1.17 (9H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 151.0, 118.5, 83.1, 73.2, 63.8, 27.6, 24.8. 
(E)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-en-1-ol (2.20b). IR (neat): 
3426 (br), 2979 (m), 2929 (w), 1643 (m), 1359 (s), 1317 (s), 1141 (s), 1088 (m), 1003 
(m), 970 (s), 921 (m), 849 (s), 732 (s), 627 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 6.68 
(1H, dt, J = 18.4, 4.0 Hz), 5.65 (1H, dt, J = 18.4, 2.0 Hz), 4.17 (2H, m), 2.36 (1H, br s), 
1.22 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 152.1, 83.4, 64.4, 24.8; HRMS (ESI
+
): 
Calcd for C9H18B1O3 [M+H]
+
: 185.13490; Found: 185.13563. 
(E)-4-Methyl-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl)benzenesulfonamide (2.24b). IR (neat): 3275 (br), 2978 (m), 2928 (w), 1644 
(m), 1364 (s), 1322 (s), 1143 (s), 1094 (s), 971 (s), 848 (s), 663 (s), 550 (s) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.70 (2H, d, J = 8.4 Hz), 7.26 (2H, d, J = 8.0 Hz), 6.39 (1H, 
dt, J = 18.0, 5.2 Hz), 5.50 (1H, dt, J = 18.0, 1.6 Hz), 4.74 (1H, t, J = 6.4 Hz), 3.62 (2H, 
m), 2.38 (3H, s), 1.19 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 146.8, 143.5, 137.1, 
                                                 
(40) Pandya, S. U.; Pinet, S.; Chavant, P. Y.; Vallée, Y. Eur. J. Org. Chem. 2003, 3621–3627. 
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129.8, 127.3, 83.5, 46.8, 24.8, 21.6; HRMS (ESI
+
): Calcd for C16H28B1N2O4S1 
[M+NH4]
+
: 355.18628; Found: 355.18570. 
(E)-2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)isoindoline-1,3-dione 
(2.25b). IR (neat): 2978 (m), 2928 (w), 1773 (m), 1712 (s), 1645 (m), 1326 (s), 1143 (s), 
955 (m), 850 (m), 714 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.84 (2H, dd, J = 5.6, 2.8 
Hz), 7.71 (2H, dd, J = 5.6, 2.8 Hz), 6.58 (1H, dt, J = 18.0, 4.4 Hz), 5.47 (1H, dt, J = 18.0, 
1.6 Hz), 4.37 (2H, dd, J = 4.4, 2.0 Hz), 1.22 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 
167.9, 145.3, 134.1, 132.2, 123.4, 83.5, 41.0, 24.9; HRMS (ESI
+
): Calcd for 
C17H21B1N1O4 [M+H]
+
: 314.15636; Found: 314.15697. 
(E)-4,4,5,5-Tetramethyl-2-styryl-1,3,2-dioxaborolane (2.5b, This compound has been 
previously reported and spectra data match those described).
41
 
1
H NMR (CDCl3, 400 
MHz): δ 7.49–7.47 (2H, m), 7.40 (1H, d, J = 18.4 Hz), 7.35–7.27 (3H, m), 6.17 (1H, d, J 
= 18.4 Hz), 1.30 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 149.6, 137.6, 129.0, 128.7, 
127.2, 83.4, 24.9. 
(E)-2-(2-Fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.27b). IR (neat): 
2979 (w), 1625 (m), 1486 (m), 1349 (s), 1227 (w), 1144 (s), 970 (w), 849 (w), 755 (m) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.59 (1H, d, J = 18.4 Hz), 7.56 (1H, dt, J = 7.6, 1.6 
Hz), 7.26 (1H, m), 7.11 (1H, dt, J = 7.6, 0.8 Hz), 7.03 (1H, ddd, J = 10.4, 8.4, 1.2 Hz), 
6.24 (1H, d, J = 18.8 Hz), 1.32 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 160.9 (d, J = 
250 Hz), 141.4 (d, J = 3.7 Hz), 130.3 (d, J = 8.2 Hz), 127.5 (d, J = 3.0 Hz), 125.5 (d, J = 
11.1 Hz), 124.2 (d, J = 3.8 Hz), 115.9 (d, J = 21.5 Hz), 83.6, 25.0; HRMS (ESI
+
): Calcd 
for C14H19B1F1O2 [M+H]
+
: 249.14621; Found: 249.14654. 
                                                 
(41) Tucker, C. E.; Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482–3485. 
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(E)-4,4,5,5-Tetramethyl-2-(2-(trifluoromethyl)styryl)-1,3,2-dioxaborolane (2.30b). IR 
(neat): 2980 (w), 1625 (w), 1484 (w), 1349 (s), 1311 (s), 1270(m), 1208 (w), 1121(s), 
1060 (m), 1036 (m), 996 (m), 969 (m), 850 (m), 764 (m), 744 (m), 647 (m) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.74 (1H, d, J = 18.4 Hz), 7.71 (1H, d, J = 8.0 Hz), 7.63 (1H, 
dd, J = 8.0, 0.8 Hz), 7.52 (1H, dd, J = 7.6, 7.6 Hz), 7.38 (1H, dd, J = 7.6, 7.6 Hz), 6.16 
(1H, d, J = 18.4 Hz), 1.31 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 144.9 (d, J = 1.5 Hz), 
137.1, 132.0, 128.3, 127.9 (q, J = 29.8 Hz), 127.6, 125.8 (q, J = 6.0 Hz), 124.3 (q, J = 
272 Hz), 83.7, 24.9; HRMS (ESI
+
): Calcd for C15H19B1F3O2 [M+H]
+
: 299.14302; Found: 
299.14395. 
(E)-2-(2-Methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.31b, This 
compound has been previously reported and spectra data match those described).
42
 
1
H 
NMR (CDCl3, 400 MHz): δ 7.76 (1H, d, J = 18.4 Hz), 7.53 (1H, dd, J = 7.6, 1.6 Hz), 
7.25 (1H, ddd, J = 8.4, 7.6, 2.0 Hz), 6.92 (1H, dd, J = 7.6, 7.6 Hz), 6.85 (1H, dd, J = 8.4, 
0.8 Hz), 6.17 (1H, d, J = 18.4 Hz), 3.83 (3H, s), 1.30 (12H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 157.5, 144.2, 130.1, 127.2, 126.7, 120.7, 111.0, 83.3, 55.5, 24.9. 
(E)-4,4,5,5-Tetramethyl-2-(2-methylstyryl)-1,3,2-dioxaborolane (2.32b). IR (neat): 
2977 (w), 1620 (m), 1483 (w), 1345 (s), 1203 (w), 1143 (s), 996 (m), 970 (m), 850 (m), 
749 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.66 (1H, d, J = 18.4 Hz), 7.58–7.55 (1H, 
m), 7.21–7.18 (2H, m), 7.17–7.14 (1H, m), 6.09 (1H, d, J = 18.4 Hz), 2.43 (3H, s), 1.33 
(12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 147.3, 136.8, 136.4, 130.5, 128.7, 126.2, 125.9, 
83.4, 25.0, 19.9; HRMS (ESI
+
): Calcd for C15H22B1O2 [M+H]
+
: 245.17129; Found: 
245.17119. 
                                                 
(42) Stewart, S. K.; Whiting, A. J. Organomet. Chem. 1994, 482, 293–300. 
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(E)-4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane (2.34b). IR 
(neat): 2980 (w), 1627 (m), 1438 (w), 1350 (s), 1329 (s), 1206 (m), 1128 (s), 1074 (m), 
995 (w), 970 (w), 849 (m), 795 (m), 697 (w), 665 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): 
δ 7.72 (1H, s), 7.64 (1H, d, J = 8.0 Hz), 7.53 (1H, d, J = 8.0 Hz), 7.46 (1H, d, J = 8.0 Hz), 
7.40 (1H, d, J = 18.4 Hz), 6.24 (1H, d, J = 18.4 Hz), 1.31 (12H, s); 
13
C NMR (CDCl3, 
100 MHz): δ 147.8, 138.4, 131.2 (q, J = 32 Hz), 130.1 (d, J = 1.5 Hz), 129.2, 125.4 (q, J 
= 4.0 Hz), 124.1 (q, J = 272 Hz), 123.9 (q, J = 3.7 Hz), 83.7, 24.9; HRMS (ESI
+
): Calcd 
for C15H19B1F3O2 [M+H]
+
: 299.14302; Found: 299.14400. 
(E)-4,4,5,5-Tetramethyl-2-(4-(trifluoromethyl)styryl)-1,3,2-dioxaborolane (2.37b). IR 
(neat): 2980 (w), 1628 (w), 1351 (m), 1322 (s), 1126 (m), 1067 (m), 970 (w), 816 (w) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.60–7.55 (4H, m), 7.40 (1H, d, J = 18.4 Hz), 6.26 
(1H, d, J = 18.4 Hz), 1.32 (12H, s); 
13
C NMR (CDCl3, 100 MHz): δ 147.8, 140.9, 130.6 
(q, J = 32 Hz), 127.3, 125.7 (q, J = 4.0 Hz), 124.2 (q, J = 271 Hz), 83.8, 24.9; HRMS 
(ESI
+
): Calcd for C15H19B1F3O2 [M+H]
+
: 299.14302; Found: 299.14311. 
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Chapter Three 
(E)- and β-Selective NHC–Cu-Catalyzed Protosilyl 
Addition to Terminal Alkynes and Site- and 
Enantioselective Protoboryl Addition to the 
Resulting Alkenylsilanes: Synthesis of 
Enantiomerically Enriched Vicinal and Geminal 
Borosilanes 
 
3.1. Introduction 
 Borosilanes are useful intermediates in chemical synthesis
1
 since both boron and 
silicon form stable bonds to carbon, which can be readily elaborated into a variety of 
other chemical bonds.
1,2
 Vicinal or geminal enantiomerically enriched borosilanes can be 
accessed through metal-catalyzed silaboration of alkenes;
3
 however, there are no reports 
for methods that efficiently deliver these synthetically useful structural units in high 
                                                 
(1) (a) Ohmura, T.; Suginome, M. Bull. Chem. Soc. Jpn. 2009, 82, 29−49. (b) Burks, H. E.; Morken, J. P. 
Chem. Commun. 2007, 4717−4725. 
(2) For transformations of C−B bonds, see: (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457−2483. 
(b) Doucet, H. Eur. J. Org. Chem. 2008, 2013−2030. (c) Brown, H. C.; Singh, S. M.; Rangaishenvi, M. V. 
J. Org. Chem. 1986, 51, 3150−3155. For transformations of C−Si bonds, see: (d) Miura, K.; Hondo, T.; 
Nakagawa, T.; Takahashi, T.; Hosomi, A. Org. Lett. 2000, 2, 385−388. (e) Heitzman, C. L.; Lambert, W. 
T.; Mertz, E.; Shotwell, J. B.; Tinsley, J. M.; Va, P.; Roush, W. R. Org. Lett. 2005, 7, 2405−2408. 
(3) (a) Suginome, M.; Nakamura, H.; Ito, Y. Angew. Chem. Int., Ed. Engl. 1997, 36, 2516−2518. (b) 
Ohmura, T.; Furukawa, H.; Suginome, M. J. Am. Chem. Soc. 2006, 128, 13366−13367. 
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enantiomeric purity. Recently, Ito, Toyoda, and Sawamura reported a protocol for 
preparation of cyclic 1,2-silylborylalkanes through phosphine–Cu-catalyzed boron–
copper addition to aliphatic alkenylsilanes followed by cyclization.
4
 More recently, Ito 
and coworkers developed the efficient and highly site-selective transformation of aryl 
olefins to the corresponding borosilanes by activation of a B–Si bond with KOt-Bu.5 
Although several catalytic enantioselective methods for preparation of borosilanes have 
been disclosed,
6
 protocols leading to the synthesis of products of the type in Scheme 3.1 
have not been described. Although silaboration is less efficient than the corresponding 
diboration, one significant merit silylboranes hold over diboranes is that the C–B bond 
and C–Si bond can be differentially functionalized easily, whereas differentiation of two 
C–B bonds is potentially more challenging. Therefore, development of an efficient and 
enantioselective protocol to achieve silylboranes is an attractive objective in chemical 
synthesis. 
Previously, we have reported that styrenes
7
 and alkenylborons
8
 undergo highly 
enantioselective protoborations with chiral NHC–Cu–B(pin) complexes, leading to the 
formation of the corresponding organoboron products in high enantiomeric purity. A key 
attribute of the above transformations is their exceptional site selectivity. Selective 
addition of the NHC–Cu occurs at the carbon bearing the aryl or the B(pin) unit, which 
                                                 
(4) Ito, H.; Toyoda, T.; Sawamura, M. J. Am. Chem. Soc. 2010, 132, 5990−5992. 
(5) Ito, H.; Horita, Y.; Yamamoto, E. Chem. Commun. 2012, 48, 8006–8008. 
(6) (a) Ohmura, T.; Furukawa, H.; Suginome, M. J. Am. Chem. Soc. 2006, 128, 13366−13367. (b) Ohmura, 
T.; Suginome, M. Org. Lett. 2006, 8, 2503–2506. (c) Ito, H.; Kosaka, Y.; Nonoyama, K.; Sasaki, Y.; 
Sawamura, M. Angew. Chem., Int. Ed. 2008, 47, 7424–7427. (d) Park, J. K.; McQuade, D. T. Synthesis 
2012, 44, 1485–1490. For an efficient (non-catalytic) method for enantioselective synthesis of geminal 
borosilanes, see: (e) Aggarwal, V. K.; Binanzer, M.; de Ceglie, M. C.; Gallanti, M.; Glasspoole, B. W.; 
Kendrick, S. J. F.; Sonawane, R. P.; Vázquez-Romero, A.; Webster, M. P. Org. Lett. 2011, 13, 1490–1493. 
(7) (a) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160–3161. (b) Corberán, R.; Mszar, N. W.; 
Hoveyda, A. H. Angew. Chem., Int. Ed. 2011, 50, 7079–7082. 
(8) (a) Lee, Y.; Jang, H.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 18234–18235. 
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can stabilize the incipient C–Cu bond due to the adjacent aryl or B(pin) group 
(hyperconjugation with aryl π* or boron p orbital, respectively). Since silyl groups can 
also lower the LUMO energy of the adjacent olefin through hyperconjugation of the  
electron density of the alkene with the low lying Si–C * orbital, we have investigated 
alkenylsilanes as suitable substrates for the enantioselective protoboration reaction. 
Mechanistically, the study for protoboration of alkenylsilanes would have several 
interesting aspects. Based on previous studies, as illustrated in Scheme 3.1, we predicted 
that in reactions of alkyl-substituted alkenylsilanes, vicinal borosilyl products would be 
generated with high site selectivity due to the stabilization of C–Cu bond by silyl group. 
Although we might be able to achieve high site selectivity, it was still unclear whether 
transformations would take place with high efficiency and enantioselectivity. On the 
other hand, when we utilize aryl-substituted silyl olefins, since the olefin contains two 
functional groups (silyl and aryl), both of which can stabilize the incipient C–Cu bond, an 
additional site selectivity issue presents itself. 
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In addition, since alkenylsilanes can be prepared by site- and stereoselective 
protosilylation (Si–Cu addition followed by C–Cu protonation) of terminal alkynes, we 
examined a Cu-catalyzed process for preparation of alkenylsilanes and another Cu-
catalyzed transformation for synthesis of enantiomerically enriched vicinal or geminal 
borosilanes selectively. Herein, we have disclosed a protocol for an efficient, general and 
exceptionally site- and stereoselective protosilylation of terminal alkynes bearing an alkyl 
or an aryl group. Substantial quantities of (E)-β-alkenylsilanes are obtained through the 
use of a readily available PhMe2SiB(pin) reagent with exclusive stereo- and site 
selectivity (>98:2 E:Z and β:α for all the cases). We then have disclosed NHC–Cu-
catalyzed site- and enantioselective protoboration of (E)-β-alkenylsilanes, 9  affording 
enantiomerically enriched vicinal or geminal borosilanes in up to >98% site selectivity 
and 98.5:1.5 e.r. In the presence of 5 mol % monodentate chiral NHC–Cu complex, 
alkyl- and alkenyl-containing alkenylsilanes are successfully converted to vicinal 
silylboryl products efficiently and selectively. Additions to aryl-bearing alkenylsilanes 
require bidentate chiral sulfonate-bearing NHC ligands for optimal selectivity, which 
react with the opposite sense of site selectivity and generate geminal silylborons 
predominantly with high enantioselectivity. We will demonstrate representative 
functionalizations to show the utility of the aforementioned protocol, including a formal 
enantioselective synthesis of antibacterial agent bruguierol A. Furthermore, 
stereochemical models will be presented to account for the levels and trends in site- and 
enantioselectivities we observed.  
 
                                                 
(9) Enantioselective hydroboration reactions of alkenyl(trimethyl)silanes in the presence of stoichiometric 
amounts of a chiral borohydride reagent have been reported (up to >98% geminal selectivity and 70:30 e.r.). 
See: Soderquist, J. A.; Lee, S. -J. H. Tetrahedron 1988, 44, 4033–4042. 
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3.2. Background 
 Enantiomerically enriched silylboryl compounds are useful intermediates in 
chemical synthesis since we can easily functionalize C–B and C–Si bonds independently. 
Thus, protocols for either vicinal or geminal borosilanes enantioselectively have been 
developed. In this section, we will introduce the advances regarding catalytic synthesis of 
vicinal borosilanes and also approaches to prepare geminal silylborylalkanes. 
 
3.2.1. Metal-Catalyzed Silaborations of Terminal Alkenes 
 In 1997, a pioneering work was reported by Suginome, Nakamura, and Ito, 
involving Pt-catalyzed site-selective silaboration of terminal olefins.
10
 Reactions are 
promoted by 2 mol % of Pt salt in the presence of PhMe2SiB(pin) reagent (Scheme 3.2). 
Conversion of styrene 3.1 to the corresponding 1,2-borosilane 3.2 is highly selective 
(>98% vicinal). The authors utilized aryl- or alkyl-substituted olefins, both of which 
undergo boron–silicon addition catalyzed by Pt catalyst to afford vicinal borosilyl 
products with similar level of efficiency (53% yield for 3.3 and 3.4). Reaction of n-hexyl-
bearing alkene is, however, less site-selective than those of aryl-olefins (87% vicinal for 
3.4 vs >98% vicinal for 3.2 and 3.3). Additionally, the borosilylation of ethylene with 2 
mol % Pt(CH2=CH2)(PPh3)2 delivers 1,2-borylsilylethane 3.5 in 73% yield with perfect 
site selectivity. 
                                                 
(10) Suginome, M.; Nakamura, H.; Ito, Y. Angew. Chem. Int., Ed. Engl. 1997, 36, 2516−2518. 
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 Suginome and coworkers described intramolecular boron–silicon addition to 
tethered terminal olefins catalyzed by Pt–phosphine complex.11 As illustrated in Scheme 
3.3, silicon-tethered olefin 3.6, which is prepared by the reaction of homoallylic alcohol 
with ClPh2SiB(pin) reagent in the presence of pyridine, undergoes Ph2CyP–Pt-catalyzed 
intramolecular silaboration to afford a 81:19 mixture of two stereoisomers 3.7a and 3.7b 
in 71% yield. Reactions of i-Bu- and t-Bu-bearing substrates are investigated, delivering 
anti-addition products 3.8a and 3.9a as major isomers with 82–92% selectivity. 
Intramolecular borosilylation of phenyl-containing silicon-tethered olefin, promoted by 
Pt complex derived from Pt(dba)2 and PCyPh2, proceed to furnish trans isomer 3.10a 
with 88% selectivity in 80% yield. Thus, trans/cis selectivity is not affected by whether 
substituent is alkyl or aryl unit. 
Interestingly, high cis-selectivity is observed when reaction is carried out with 
sterically more hindered phosphine ligand 3.11. Under identical reaction conditions to the 
above mentioned transformation except with the use of 11 mol % 3.11, intramolecular 
silaborations are performed, resulting in complete reversal of trans/cis selectivity. The 
                                                 
(11) Ohmura, T.; Furukawa, H.; Suginome, M. J. Am. Chem. Soc. 2006, 128, 13366−13367. 
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major products are cis-isomers with higher levels of selectivity (trans/cis = 7:93–6:94 for 
3.7b–3.10b). 
 
 
3.2.2. Base-Mediated Selective Silaboration of Aryl Alkenes 
 Ito and coworkers demonstrated that efficient and site-selective borosilylation of 
aryl olefins can be achieved by use of potassium alkoxide base for activation of boron–
silicon bond.
12
 As described in Scheme 3.4, site-selective B–Si addition to styrene 3.1 in 
the presence of 10 mol % of KOt-Bu proceeds to deliver vicinal silylborane 3.2 
efficiently (95% yield). Then, methyl-substituted styrenes are investigated, affording 
                                                 
(12) Ito, H.; Horita, Y.; Yamamoto, E. Chem. Commun. 2012, 48, 8006–8008. 
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B(pin)-bearing quaternary center 3.12 in 66% yield from α-methyl styrene, and a 92:8 
mixture of anti- and syn-isomers of 3.13 in 85% yield from β-methyl styrene. Although 
readily accessible alkoxide base, KOt-Bu was utilized as a catalyst (non-transition metal 
catalyst), silaborations of aryl alkenes are relatively efficient (up to 95% yield) and highly 
selective (<2% geminal) in mild condition, which makes this transformation practical and 
useful. However, substrate scope is limited; only aryl-bearing olefins are investigated, 
and an enantioselective variant is not presented. 
 
 
3.2.3. Cu-Catalyzed Selective Synthesis of Cyclic Vicinal Borosilanes 
 Ito, Sawamura, and coworkers reported phosphine–Cu-catalyzed Cu–B addition 
to alkenylsilanes followed by Cu–alkoxide elimination to generate cyclic 1,2-
borosilanes.
13
 As illustrated in eq 3.1, in the presence of 5 mol % of (R)-segphos–Cu 
complex, reaction of (Z)-silyl-olefin 3.14, which bearing an allylic carbonate, with 2 
equiv. of B2(pin)2 furnishes trans-1,2-boryl,silyl-cyclopropane 3.15 in 86% yield and 
98.5:1.5 e.r. The (Z)-olefin geometry is essential for high efficiency and selectivity; when 
                                                 
(13) Ito, H.; Kosaka, Y.; Nonoyama, K.; Sasaki, Y.; Sawamura, M. Angew. Chem., Int. Ed. 2008, 47, 7424–
7427. 
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(E)-isomeric 3.14 is utilized instead, trans-silylborane 3.15 is obtained in much lower 
yield along with a significant amount of cis-isomer. 
 
 Another noteworthy advance was illustrated by Ito, Toyoda, and Sawamura in 
2010.
14
 With 5 mol % of achiral bidentate 1,3-bis(diphenylphosphino)propane (dppp), 5 
mol % of CuCl, and 1 equiv. of KOt-Bu, (Z)-homoallylic sulfonate 3.16 was successfully 
converted to trans-1-boryl-2-silylcyclobutane 3.17 in 74% yield and 99% trans 
selectivity (Scheme 3.5). In contrast, when (E)-stereoisomer of 3.16 was utilized, cis-
cyclobutylborosilane 3.18 was obtained in 76% yield and 95% cis selectivity. The 
reactions of (Z)- and (E)-bis-homoallylic sulfonates provided five-membered-borosilanes 
with high stereoselectivity (97% trans selectivity for 3.19 and 94% cis selectivity for 
3.20). When the authors tried to achieve 1-boryl-2-silylcyclohexane 3.21, however, they 
only observed trace amounts of the products. 
                                                 
(14) Ito, H.; Toyoda, T.; Sawamura, M. J. Am. Chem. Soc. 2010, 132, 5990−5992. 
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 Although the transformations for cyclic vicinal borosilanes developed by Ito, 
Sawamura, and coworkers are efficient and highly stereoselective, there are limitations. 
First, substrate scope is limited. Only certain sized cyclic products (3-, 4-, and 5-
membered) are provided and no functional groups (such as halogens, ethers, amides, 
etc.)-bearing products are shown. In addition, enantioselective variants are not described 
yet. 
 
3.2.4. Non-Catalytic Synthesis of Enantiomerically Enriched Geminal Borosilanes 
 In 2011, Aggarwal and coworkers reported enantioselective synthesis of allyl- and 
crotylsilanes.
15
 Their substrates for the aforementioned transformation are 1,1-
borosilanes, which are prepared through a single-vessel protocol described in Scheme 
3.6. Conversion of i-propyl-bearing carbamate 3.22 to corresponding geminal silylborane 
3.23 is effective (68% yield). With a similar efficiency, 1,1-silylborane 3.24 is also 
prepared in 69% yield. Even though this transformation requires the use of a 
                                                 
(15) Aggarwal, V. K.; Binanzer, M.; de Ceglie, M. C.; Gallanti, M.; Glasspoole, B. W.; Kendrick, S. J. F.; 
Sonawane, R. P.; Vázquez-Romero, A.; Webster, M. P. Org. Lett. 2011, 13, 1490–1493. 
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stoichiometric amount of expensive (–)-sparteine, enantiomerically enriched geminal 
borosilanes, not easily prepared by other methods, can be obtained efficiently. 
 
 Since there have been no reports for efficient and catalytic enantioselective 
synthesis of vicinal or geminal borosilanes, development of protocols for the site- and 
enantioselective catalysis to afford either isomeric borosilane is very attractive. 
 
 3.3. Site- and Stereoselective Synthesis of alkenylsilanes by NHC–Cu-Catalyzed 
Protosilylation of Terminal Alkynes 
 Before beginning our investigation into NHC–Cu-catalyzed protoboration of 
alkenylsilanes, we focused on the development of an efficient and selective protocol for 
preparation of alkenylsilanes.
16
 Although there are protocols for (E)- and β-selective 
hydrosilylation of terminal alkynes,
17
 most of them require the use of precious metals 
such as Rh,
18
 Pt,
19
 or Ru.
20
 In addition, selective hydrosilylation of terminal alkynes with 
                                                 
(16) For selected reviews regarding the utility of alkenylsilanes, see: (a) Blumenkopf, T. A.; Overman, L. E. 
Chem. Rev. 1986, 86, 857–873. (b) Curtis-Long, M. J.; Aye, Y. Chem. –Eur. J. 2009, 15, 5402–5416. (c) 
Denmark, S. E.; Liu, J. H.-C. Angew. Chem., Int. Ed. 2010, 49, 2978–2986. 
(17) For a review regarding catalytic hydrosilylation reactions of alkynes, see: (a) Trost, B. M.; Ball, Z. T. 
Synthesis 2005, 853–887. For an α-selective catalytic hydrosilylation of terminal alkynes, see: (b) Wang, 
P.; Yeo, X.-L.; Loh, T.-P. J. Am. Chem. Soc. 2011, 133, 1254–1256. 
(18) For examples of Rh-catalyzed hydrosilylation of terminal alkynes, see: (a) Faller, J. W.; D’Alliessi, D. 
G. Organometallics 2002, 21, 1743–1746. (b) Mori, A.; Takahisa, E.; Yamamura, Y.; Kato, T.; Mudalige, 
A. P.; Kajiro, H.; Hirabayashi, K.; Nishihara, Y.; Hiyama, T. Organometallics 2004, 23, 1755–1765. 
(19) For examples of Pt-catalyzed hydrosilylation of terminal alkynes, see: (a) Aneetha, H.; Wu, W.; 
Verkade, J. G. Organometallics 2005, 24, 2590–2596. (b) Berthon-Gelloz, G.; Schumers, J-M.; De Bo, G.; 
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stoichiometric amounts of Cr salts
21
 and Ti-catalyzed transformation for alkyl-substituted 
alkynes
22
 are also illustrated. Thus, development of selective Cu-catalyzed protocol for 
alkenylsilanes with a broad substrate scope is highly attractive. 
As illustrated in Scheme 3.7, alkyl- or aryl-substituted (E)-β-alkenylsilanes are 
obtained efficiently (79–98% yield) with complete stereo- and site selectivity (>98% (E) 
and β) for all cases through NHC–Cu-catalyzed protosilylation of alkynes. Reactions of 
terminal alkynes with commercially available PhMe2SiB(pin), which can be prepared 
through a simple procedure,
23
 in the presence of 1 mol % NHC–Cu complex derived 
from achiral imidazolinium salt 3.26, CuCl, and NaOt-Bu undergo Cu–Si addition 
followed by C–Cu bond protonation by MeOH. Reactions of linear or α-branched alkyl 
chain-bearing terminal alkynes, containing functional group (halide, ester, or silyl ether) 
deliver desired alkenylsilanes 3.27–3.32 efficiently (up to 98% yield) with perfect 
selectivities (>98% (E)- and β-selectivity). A variety of electronically and/or sterically 
different aryl-alkynes are examined, affording (E)-β-silyl-styrenes 3.33–3.40 exclusively 
in 79–93% yield. Noticeably, we observe exclusive site selectivity for all the terminal 
alkyne substrates (>98% β-selectivity), which suggests that a large PhMe2Si unit is 
placed at the terminal carbon preferentially regardless of the substituent of the alkyne 
substrate. Then, C–Cu bond is protonated by MeOH to form C–H bond, which 
                                                                                                                                                 
Markó, I. E. J. Org. Chem. 2008, 73, 4190–4197. For related catalytic silaboration of alkynes, see: (c) 
Suginome, M.; Matsuda, T.; Nakamura, H.; Ito, Y. Tetrahedron 1999, 55, 8787–8800. 
(20) For Ru-catalyzed hydrosilylation of terminal alkynes, see: Katayama, H.; Taniguchi, K.; Kobayashi, 
M.; Sagawa, T.; Minami, T.; Ozawa, F. J. Organomet. Chem. 2002, 645, 192–200. 
(21) Lim, D. S. W.; Anderson, E. A. Org. Lett. 2011, 13, 4806–4809. 
(22) Takahashi, T.; Bao, F.; Gao, G.; Ogasawara, M. Org. Lett. 2003, 5, 3479–3481. 
( 23 ) For a procedure for preparation of PhMe2SiB(pin), see: Suginome, M.; Matsuda, T.; Ito, Y. 
Organometallics 2000, 19, 4647–4649. 
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regenerates the catalytic active NHC–Cu–OMe species and provides the protosilylation 
product. 
 
 
3.4. Site- and Enantioselective NHC–Cu-Catalyzed Protoboration of 
Alkenylsilanes 
3.4.1. Examination of Various Chiral NHC–Cu Complexes 
We investigated the ability of chiral Cu–NHC complexes to promote efficient 
site- and enantioselective protoborations. Initially, we examined the reactions of alkyl-
bearing alkenylsilane 3.27 in the presence of 5 mol % various chiral NHC–Cu complexes 
to obtain vicinal borosilane 3.41 (Scheme 3.7). As we predicted above, Cu–B addition 
occurs such that the copper is located at the carbon bearing silicon unit (Section 3.1). We 
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began the screening by examination of three representative NHCs derived from A.1–A.3. 
Among them, monodentate NHC–Cu complex derived from A.1 shows promising 
efficiency and selectivity (61% conv, 56% yield, and 79.5:80.5 e.r.). When we utilize C2-
symmetric monodentate NHC–Cu complex, both efficiency and enantioselectivity are 
reduced (32% conv, 30% yield, and 57:43 e.r. for A.10). Thus, we decide to modify the 
structure of C1-symmetric monodentate NHC (A.1), preparing di-m-methyl-substituted N-
phenyl imidazolinium salt A.11 and sterically more hindered A.12, o-Et2-phenyl variant 
of A.1. Both of them, however, do not promote reaction of 3.27 with high efficiency 
and/or enantioselectivity (52% conv, 51% yield, and 51:49 e.r. for A.11; 56% conv, 54% 
yield, and 81.5:18.5 e.r. for A.12). Since reaction with bidentate sulfonate A.3 is efficient, 
affording 3.41 in 78% yield, although selectivity is moderate (60:40 e.r.), we examine 
chiral sulfonates A.6 and A.8 for NHC precursors. Unfortunately, selectivities obtained 
by both NHC–Cu complexes are moderate (34.5:65.5 e.r. for A.6 and 45:55 e.r. for A.8). 
The observations with A.6 and A.8 led us to focus on further modification of C1-
symmetric monodentate NHCs. Interestingly, when we introduce sterically demanding 
mesityl unit on the ortho position of N-phenyl moiety (A.13), complete consumption of 
3.27 is observed (93% yield) with slightly higher enantioselectivity (85:15 e.r.). For 
further enhancement of selectivity, we prepared three modified imidazolinium salts A.14, 
A.15, and A.16, all of which contain o-mesityl-phenyl substituent. An NHC–Cu 
generated from 2,6-Et2-phenyl-variant A.14 catalyzes boron–copper addition with higher 
enantioselectivity (87:13 e.r. vs 85:15 e.r. for A.13). With an NHC–Cu complex derived 
from even longer, n-propyl-containing variant A.16, however, enantioselectivity is lower 
(82:18 e.r.). Thus, we chose A.14 as an optimal NHC precursor for further study. 
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 Next, we have investigated reactions of aryl-alkenylsilane 3.33, which cause 
additional site selectivity issues. Since both aryl and silyl groups can stabilize adjacent 
C–Cu bond, achievement of high site-selective boron–copper addition might not be trivial. 
As illustrated in Scheme 3.9, the trends in site selectivity and the most effective chiral 
catalysts are totally different. Site selectivity for protoboration of silyl olefin 3.33 in the 
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presence of monodentate or phenoxy-bidentate NHC–Cu complex is moderate (3.42:3.43 
= 37:63 for A.10 and 35:65 for A.2). With a sulfonate salt A.3, reaction takes place with 
minimal selectivity (3.42:3.43 = 52:48), with relatively high enantioselectivity for 
geminal borosilane 3.43 (87.5:12.5 e.r.). Interestingly, slightly modified sulfonate salts 
A.6 and A.8 promote Cu–B additions, providing 1,1-silylborane 3.43 predominantly 
(92% and 90% respectively). Moreover, Cu–NHC complexes generated from 
imidazolinium salts A.6 and A.8 deliver products with higher enantioselectivities (95:5–
98:2 e.r.). Since we obtained high efficiency and selectivity for the reaction of alkyl-
bearing alkenylsilane 3.29 with monodentate NHC–Cu derived from A.14, we tested the 
same complex for the reaction of aryl-alkenylsilane 3.33, unfortunately, delivering a 
30:70 mixture of vicinal (3.42) and geminal borosilanes (3.43) with low 
enantioselectivity (63:37 e.r.). 
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3.4.2. NHC–Cu-Catalyzed Enantioselective Protoborations of Alkyl- and Alkenyl-
Substituted Alkenylsilanes 
 With the optimal NHC–Cu complex, which is derived from chiral imidazolinium 
A.14, for enantioselective protoboration of alkyl-substituted alkenylsilanes in hand, we 
performed reactions of alkenylsilanes containing an alkyl group at –15 ˚C to achieve the 
maximum enantioselectivity (91:9 e.r. for 3.41 vs 87:13 e.r. at 22 ˚C; Scheme 3.8). 
Chlorine- or methyl ester-bearing substrates are converted to vicinal borosilane 
efficiently and enantioselectively (89–95% yield and 91.5:8.5 to 92:8 e.r. for 3.44 and 
3.45). When silyl ether-containing alkenylsilane is used, however, desired product 3.46 is 
obtained in only 59% yield and 84:16 e.r., probably due to the sterics of bulky TBS group. 
We also observe low efficiency for cyclohexyl-containing substrate (33% yield for 3.48), 
which has α-branched alkyl group causing steric repulsion with the sizeable B(pin) unit. 
 
Chapter 3, Page 147 
 
 
 In addition to alkyl-bearing substrates, catalytic protoboration of alkene-
substituted alkenylsilane 3.49 is performed with 5 mol % A.14 and CuCl. NHC–Cu-
catalyzed copper–boron addition/protonation of silyl-diene 3.49 followed by treatment 
with excess amount of benzaldehyde affords a 7:1 mixture of trisubstituted allylsilanes 
3.51 and 3.52 (85% combined overall yield, 95:5 e.r. and >98:2 e.r. for both isomers; eq 
3.2). Based on isolated products 3.51 and 3.52, we suggest that the transformation 
proceeds through the intermediate 3.50, which has C–B bond at the carbon carrying an 
alkene. This indicates that initial C–Cu bond formation happens at the carbon bearing the 
silicon group although alkene might be able to stabilize C–Cu bond as well. Thus, in 
contrast to an aryl group, an alkenyl substituent does not compete with a silyl group. 
 
 
3.4.3. NHC–Cu-Catalyzed Enantioselective Protoborations of Aryl-Substituted 
Alkenylsilanes 
 As illustrated in Scheme 3.11, NHC–Cu-catalyzed enantioselective protoborations 
of aryl- and heteroaryl-containing alkenylsilanes with sulfonate salt A.6 or A.8 provide 
geminal borosilanes preferentially (up to >98%) with high enantioselectivities at 22 ˚C 
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(93:7–98.5:1.5 e.r.). For these substrates, lowering of reaction temperature does not 
enhance enantioselectivities. Although enantioselectivities for aryl- or heteroaryl-
containing substrates is relatively higher than those for alkyl,silyl-olefins (84:16–96.5:3.5 
e.r.), site selectivities are not exclusive (84.5–>98%). Since both aryl and silyl group can 
stabilize the incipient C–Cu bond, they compete with each other, which lowers the site 
selectivity. Consistent with the above rationale, reaction of substrates with aryl units that 
carry an electron-withdrawing group such as trifluoromethyl unit leads to higher degree 
of site selectivity (>98% geminal for 3.55). In contrast, when we utilize electron-donating, 
MeO-substituted phenyl-alkenylsilane, site selectivity is reduced (84.5% geminal for 
3.56). 
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3.4.4. Functionalization and Utility in Chemical Synthesis 
To show the utility of the aforementioned protocol, we examined other methods 
to prepare borosilanes selectively. Vicinal borosilanes that carry an alkyl group can be 
synthesized by the Cu-catalyzed protocol detailed above efficiently and selectively. 
When we use common hydroboration methods, however, a mixture of geminal and 
vicinal isomers are generated; reaction of 3.29 with BH3·thf at 22 ˚C in three hours or 
with 9-BBN at 60 ˚C in two hours proceeds to a 1:1 or 2:1 mixture of geminal:vicinal 
borosilanes, respectively. Thus, the site selectivity of Cu-catalyzed protoboration is 
unique and can be used to prepare silylboranes that cannot be prepared efficiently or 
selectively through the use of traditional methods. Furthermore, when phenyl-bearing 
alkenylsilane 3.33 is subjected to the hydroboration reaction under the same conditions, 
we obtain a 4:1 mixture of the two isomers (BH3·thf at 22 ˚C) or recovered starting 
material completely (<2% conv with 9-BBN). To further demonstrate the utility of the 
Cu-catalyzed method, we have examined the possibility of applying sequential NHC–Cu-
catalyzed protosilylation/protoboration transformations towards enantioselective formal 
synthesis of bruguierol A. Bruguierols A–C24 are members of a family of natural products 
which have activity against both Gram-positive and Gram-negative bacteria, and were 
isolated in 2005 from the stem of the Bruguiera gymmorrhiza tree.
25
 
                                                 
(24) For previous enantioselective synthesis of bruguierols, see: (a) Ramana, C. V.; Salian, S. R.; Gonnade, 
R. G. Eur. J. Org. Chem. 2007, 5483–5486. (b) Solorio, D. M.; Jennings, M. P. J. Org. Chem. 2007, 72, 
6621–6623. (c) Fananás, F. J.; Fernández, A.; Cevic, D.; Rodríguez, F. J. Org. Chem. 2009, 74, 932–934. 
(25) Han, L.; Huang, X.; Sattler, I.; Moellmann, U.; Fu, H.; Lin, W. Grabley, S. Planta Med. 2005, 71, 
160–164. 
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Our synthetic route for enantioselective preparation of bruguierol A is depicted in 
Scheme 3.12. Site-selective NHC–Cu-catalyzed protosilylation of m-MeO-
phenylacetylene 3.60, followed by site- and enantioselective NHC–Cu-catalyzed 
protoboration of the resulting alkenylsilane proceeds to the formation of geminal 
borosilane 3.61 in 77% overall yield (two steps), 97% site selectivity and 97.5:2.5 e.r. 
Then, selective functionalization of the C–B bond over the C–Si bond is examined. An 
efficient protocol for conversion of geminal borosilanes to synthetically useful 
allylsilanes
26
 was reported by Aggarwal and coworkers.
27
 Enantiomerically enriched 
allylsilane 3.62 is synthesized in 85% yield by the use of Aggarwal’s procedure. Linear-
selective Rh-catalyzed hydroformylation
28
 of terminal alkene followed by NaBH4-
reduction delivers primary alcohol as a 7:1 mixture of linear and branched isomers. Pure 
linear product 3.63 is isolated in 80% yield by column chromatography. Next, Fleming–
Tamao oxidation of C–Si bond29 is performed based on a reported procedure,30 which 
                                                 
(26) For reviews on the utility of allylsilanes in organic synthesis, see: (a) Masse, C. E.; Panek, J. C. Chem. 
Rev. 1995, 95, 1293–1316. (b) Barbero, A.; Pulido, F. J. Acc. Chem. Res. 2004, 37, 817–825. (c) Chabaud, 
L.; James, P.; Landais, Y. Eur. J. Org. Chem. 2004, 3173–3199. 
(27) (a) Ref 6e. For other relevant procedures, see: (b) Tsai, D. J. S.; Matteson, D. S. Organometallics 1983, 
2, 236–241. (c) Carosi, L.; Lachance, H.; Hall, D. G. Tetrahedron Lett. 2005, 46, 8981–8985. 
(28) For representative reviews on catalytic hydroformylation reactions, see: (a) Ojima, I.; Tsai, C.-Y.; 
Tzamarioudaki, M.; Bonafoux D. in Organic Reactions, Vol. 50 (Ed.: Overman, L. E.), Wiley, New York, 
2000, pp. 1–354. (b) Diéguez, M.; Pàmies, O.; Claver, C. Tetrahedron:Asymmetry 2004, 15, 2113–2122. 
(c) Klozin, J.; Landis, C. R. Acc. Chem. Res. 2007, 40, 1251–1259. (d) Gual, A.; Godard, C.; Castillón, S.; 
Claver, C. Tetrahedron:Asymmetry 2010, 21, 1135–1146. 
(29) For a review on oxidation of C–Si bonds, see: Jones, G. R.; Landais, Y. Tetrahedron 1996, 52, 7599–
7662. 
(30) (a) Krohn, K.; Khanbabaee, K. Liebigs Ann. Chem. 1994, 1109–1112. (b) Krohn, K.; Khanbabaee, K. 
Liebigs Ann. Chem. 1995, 1529–1537. 
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affords diol 3.64 efficiently (84% overall yield). Ru-catalyzed oxidative cyclization
31
 of 
diol delivers lactone 3.65 in 79% yield. To construct tricyclic core structure, methyl 
addition to lactone followed by cyclization is performed, which leads to the desired 
product 3.66 in 65% overall yield. Transformation of tricycle 3.66 to the natural product 
is previously reported.
32
 Although the synthetic route illustrated in Scheme 3.12 has a 
slightly longer sequence than a previously reported approach,
18c
 there are several 
advantages compare to other methods. Our sequence is the first catalytic enantioselective 
approach for introducing enantiomerically enrichment (vs. the use of chiral pool as the 
substrate source) and utilizes minimal amount of precious metal (0.5 mol % Rh salt). 
                                                 
(31) For a review on catalytic procedures involving ruthenium oxo complexes, see: (a) Griffith, W. P. 
Chem. Soc. Rev. 1992, 21, 179–185. For a review on oxidation reactions catalyzed by 
tetrapropylammonium perruthenate, see: (b) Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. 
Synthesis 1994, 639–666. 
(32) Hu, B.; Xing, S.; Ren, J.; Wang, Z. Tetrahedron 2010, 66, 5671–5674. 
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3.4.5. Stereochemical Models to Account for Levels and Trends in Site- and 
Enantioselectivity 
 We built up the stereochemical models
33
 in order to rationalize the levels and 
trends in site- and enantioselectivity for Cu-catalyzed protoborations of alkenylsilanes. 
As illustrated in Scheme 3.13 and 3.14, we propose that the association of alkenylsilane 
                                                 
(33) The stereochemical models represented for the chiral NHC–Cu complexes are based on the strong 
structural preferences indicated by spectroscopic as well as crystallographic data available for sulfonate-
bridged bidentate and monodentate complexes and/or ligands. For sulfonate-bridged bidentate complex, 
see: (a) Lee, Y.; Li, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 11625–11633. For monodentate 
complex, see: (b) Lee, K-s.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455–4462. (c) Vieira, E. M.; 
Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. 
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with the chiral cuprate occurs through the manner in mode I, II, V, and VI. Because of 
the syn-orientation for the sulfonate bridge and the phenyl unit of the NHC backbone, a 
relatively spacious binding pocket might be generated, which allows the sterically 
demanding, silyl group-bearing olefin substrate to be accommodated, as shown in modes 
I, II, V, and VI. For alkyl-substituted substrates, regardless of NHC–Cu complex used 
(either monodentate or bidentate), we obtain complete site selectivity (>98% vicinal) for 
all the cases because of stabilization of C–Cu bond by silicon unit. As illustrated in 
Scheme 3.8, with the monodentate NHC–Cu complex derived from A.14, maximum 
enantioselectivity was achieved (87:13 e.r.). We believe that the major enantiomer of 
product is generated preferentially through mode III since there is a significant energetic 
difference between modes III and IV, which arises from the severe steric repulsion 
between sizeable dimethylphenylsilyl group and phenyl group on NHC backbone in 
mode IV (Scheme 3.13). In contrast, when sulfonate-containing bidentate complex was 
used (A.3, A.6, or A.8), two possible modes I and II seem to be similarly preferred 
because similar unfavorable steric interactions are present in both modes I and II 
(Scheme 3.13). Thus, we obtain moderate enantioselectivities (34.5:65.5–60:40 e.r.) 
Moreover, with sterically demanding ortho-substituent, i-propyl-containing complex 
(A.6), reactivity of the reaction suffered due to these steric interactions (53% conv; 
Scheme 3.8), supporting the above contention. 
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In the case of aryl-bearing alkenylsilanes, on the other hand, since either the silyl 
or the aryl group can control site selectivity, only certain sulfonate-bridged bidentate 
NHC–Cu complexes deliver the geminal borosilanes with a relatively strong preference 
(Scheme 3.9). In catalytic protoborations of aryl-substituted alkenylsilanes, copper–boron 
addition can occur via modes V or VI (Scheme 3.14). The steric repulsion between the 
ortho-substituent of N-Ar moiety and sizeable dimethylphenylsilyl group in mode VI is 
severe, making mode VI less favorable than mode V. Based on this model, lower 
enantioselectivity obtained with A.3 (o-methyl) than with A.6 (o-isopropyl) can be 
explained (87.5:12.5 e.r. with A.3 vs 98:2 e.r. with A.6; Scheme 3.9). Significant 
energetic difference between III and IV is mainly due to the steric repulsion of backbone 
phenyl group with the large dimethylphenylsilyl unit in mode IV. In modes VII and VIII, 
however, the preference for VII is minimized because the aforementioned steric repulsion 
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is less severe with relatively smaller aryl group of substrate (vs dimethylphenylsilyl unit). 
Thus, with monodentate NHC–Cu complexes, we obtained borosilane products of low 
enantiomeric purity. 
 
 For aryl-bearing alkenylsilane substrates, there is an additional site selectivity 
issue. Since either the silyl or the aryl group can serve to stabilize the C–Cu bond, when 
monodentate salts A.10 and A.14 are used, we obtain moderate site selectivities (63–70% 
geminal; Scheme 3.9). With bidentate sulfonate-containing NHC–Cu complex derived 
from A.3, almost equal amount of the two isomers is obtained (52:48 vicinal:geminal; 
Scheme 3.9). The sterically more demanding 2,4,6-triisopropyl- (A.6) or 2-methyl-6-
phenyl- (A.8) substituted bidentate salt promotes reaction of silyl-bearing styrene with 
high level of site selectivity (92% and 90% geminal, respectively). To explain these 
observations, we introduce additional stereochemical models, which can generate vicinal 
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borosilane products (Scheme 3.15). Because of severe steric interactions between ortho-
substituent on N-Ar and either the large silyl group (mode IX) or the aryl unit (mode X), 
with A.6 or A.8, mode V might be the most favorable, affording geminal product with 
high site selectivity. When sulfonate salt A.3 is utilized as an NHC precursor, the smaller 
ortho methyl substituent does not present the same degree of steric hindrance as is 
observed with A.6 or A.8 and site selectivity suffers (modes IX and X become more 
competitive). In cases of monodentate NHC–Cu complexes, the size difference between 
the aryl and the silyl groups is not large enough (compare to that between the alkyl and 
the silyl units), the alternative pathway via mode XI would be similarly preferred, which 
leads to low site selectivity. 
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3.5. Conclusions 
 We have developed efficient and selective NHC–Cu-catalyzed protosilyl addition 
to various terminal alkynes to afford (E)-β-alkenylsilanes with an exceptional selectivity 
(>98% E and β). A number of functional group-bearing alkyl-, aryl-, and heteroaryl-
substituted alkenylsilanes are prepared in up to 97% yield. Site- and enantioselective 
protoboryl addition to alkenylsilanes promoted by chiral NHC–Cu complexes are 
illustrated as well. With chiral monodentate NHC–Cu complex, alkyl- or alkenyl-
substituted alkenylsilanes are converted to corresponding vicinal borosilanes with high 
enantioselectivity (84:16–96.5:3.5 e.r.). In contrast, protoborations of aryl-bearing 
alkenylsilanes generate geminal borosilanes predominantly (84–>98% geminal) in the 
presence of bidentate sulfonate-bridged NHC–Cu complex with high enantioselectivity 
(93:7–98:2 e.r.). Since C–Si bond is more robust, C–B bond can be converted to C–H, C–
C, C–O or C–N bonds by well-established procedures, then C–Si bond also might be 
converted to C–H, C–C, of C–O bonds. By use of this strategy, we illustrate the 
enantioselective formal synthesis of natural product bruguierol A from enantiomerically 
enriched geminal borosilane, which is prepared by Cu-catalytic process. Furthermore, we 
propose plausible stereochemical models to account for site- and/or enantioselectivities 
with two different types of NHC–Cu complexes. 
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3.6. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, max in cm
−1
. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 
1
H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet, app = apparent), and coupling 
constant (Hz). 
13
C NMR spectra were recorded on a Varian Unity INOVA 400 (100 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in 
ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomeric 
ratios were determined by high-performance liquid chromatography (HPLC) with a 
Shimadzu chromatograph (Chiral Technologies Chiralpak AD-H (4.6 x 250 mm), 
Chiralcel OD-H (4.6 x 250 mm), Chiralcel OJ-H (4.6 x 250 mm)) in comparison with 
authentic racemic materials. Optical rotations were measured on a Rudolph Research 
Analytical Autopol IV Polarimeter. Unless otherwise noted, all reactions were carried out 
with distilled and degassed solvents under an atmosphere of dry N2 in oven- (135 °C) or 
flame-dried glassware with standard dry box or vacuum-line techniques. Solvents were 
purified under a positive pressure of dry argon by a modified Innovative Technologies 
purification system: toluene, benzene and hexanes were purified through a copper oxide 
and alumina column; CH2Cl2 and Et2O were purged with Ar and purified by passage 
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through two alumina columns. Tetrahydrofuran (Aldrich Chemical Co.) was purified by 
distillation from sodium benzophenone ketyl immediately prior to use unless otherwise 
specified. Methanol (Aldrich Chemical Co.) was distilled over CaH2. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific, Inc.) in air. 
 
3.6.1. Reagents and Ligands 
Aryl-substituted terminal alkynes: purchased from Aldrich Chemical Co. and purified 
by distillation over CaH2 prior to use. 
Benzaldehyde: purchased from Aldrich Chemical Co. and purified by bulb to bulb 
distillation prior to use. 
Bis(pinacolato)diboron: purchased from Frontier Scientific, Inc. and recrystallized from 
pentane. 
1,3-Bis-(2,4,6-trimethylphenyl)imidazolinium chloride (3.26): purchased from Aldrich 
Chemical Co. and used as received. 
Boron trifluoride diethyl etherate: purchased from Aldrich Chemical Co. and used as 
received. 
n-Butyllithium, 15% in hexane (1.6 M): purchased from Strem Chemicals Inc. and 
titrated prior to use. 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Dicarbonylacetylacetonato rhodium(I): purchased from Strem Chemicals Inc. and used 
as received. 
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Dimethyl(phenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)silane: prepared 
according to previously reported procedure.
34
 
Hex-1-yne (3.25): purchased from Aldrich Chemical Co. and purified by distillation over 
CaH2 prior to use. 
Hydrogen peroxide solution (35 wt. % in H2O): purchased from Aldrich Chemical Co. 
and used as received. 
Imidazolinium salt A.2,
35
 A.3,
30
 A.6,
36
 A.8,
37
 A.10,
38
 and A.13
39
: prepared according to 
previously reported procedures. 
Methyllithium, 1.6 M solution in diethyl ether: purchased from Acros Organics Co. 
and titrated prior to use. 
4-Methylmorpholine N-oxide: purchased from Aldrich Chemical Co. and used as 
received. 
Potassium fluoride: purchased from Aldrich Chemical Co. and used as received. 
Prop-2-yn-1-ol: purchased from Aldrich Chemical Co. and purified by distillation over 
CaH2 prior to use. 
Sodium borohydride: purchased from Aldrich Chemical Co. and used as received. 
Sodium tert-butoxide (98%): purchased from Strem Chemicals Inc. and used as received. 
Sodium perborate: purchased from Aldrich Chemical Co. and used as received. 
Sodium thiosulfide: purchased from Aldrich Chemical Co. and used as received. 
                                                 
(34) Suginome, M.; Matsuda, T.; Ito, Y. Organometallics 2000, 19, 4647–4649. 
(35) Lee, K-s.; Brown, M. K.; Hird, A. W.; Hoveyda, A. H. J. Am. Chem. Soc. 2006, 128, 7182–7184. 
(36) (a) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 1097–
1100. (b) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7468–7472. 
(37) Corbeŕan, R.; Mszar, N. W.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2011, 50, 7079–7082. 
(38) (a) Chaulagain, M. R.; Sormunen, G. J.; Montgomery, J. J. Am. Chem. Soc. 2007, 129, 9568–9569. (b) 
Lillo, V.; Prieto, A.; Bonet, A.; Diaz-Requejo, M. M.; Ramirez, J.; Perez, P. J.; Fernandez, E. 
Organometallics 2009, 28, 659–662. 
(39) Lee, K-s.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455–4462. 
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Tetrafluoroboric acid dimethyl ether complex: purchased from Aldrich Chemical Co. 
and used as received. 
Tetrapropylammonium perruthenate: purchased from TCI Chemical Co. and used as 
received. 
Tetravinyltin: purchased from Aldrich Chemical Co. and used as received. 
Triphenylphosphine: purchased from Aldrich Chemical Co. and used as received. 
 
3.6.2. Experimental Procedure and Characterization Data 
 Experimental Procedure for Preparation of Borosilane Reagent: A 100 mL flame-
dried Schlenk flask equipped with a magnetic stir bar was charged with Li (4.2 g, 600 
mmol, 6.0 equiv.) and mineral oil (20 mL) under argon. The mixture was heated to 
180 °C under vigorous stirring. The suspension was allowed to cool to 22 °C. The Li 
particles were washed with thf (3 × 20 mL). Then, 100 mL of thf was added to the Li 
particles. To the suspension, chlorodimethylphenylsilane (16.8 mL, 100 mmol, 1.0 
equiv.) was added at 0 °C. The resulting suspension was allowed to stir at 0 °C for 6 h. 
To a stirred solution of pinacolborane (29.0 mL, 200 mmol, 2.0 equiv.) in hexanes (100 
mL) in another flame-dried Schlenk flask was added the dimethylphenylsilyllithium 
solution slowly at 0 °C. The resulting solution was allowed to stir at 22 °C for 12 h. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo. To the resulting 
light yellow oil were added 50 mL of hexanes. After the precipitate was filtered, the 
filtrate was concentrated in vacuo. The resulting light yellow oil (24.5 g, 93.4 mmol, 93% 
yield) was used directly without any further purification. 
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 Representative Experimental Procedure for Protosilylation of Terminal Alkynes: 
In a N2-filled glove-box, an oven-dried vial (4 mL, 17 × 38 mm) with a magnetic stir bar 
was charged with imidazolinium salt 3.26 (30.8 mg, 0.0900 mmol, 1.0 mol %), CuCl (9.0 
mg, 0.090 mmol, 1.0 mol%), NaOt-Bu (34.6 mg, 0.360 mmol, 4.0 mol %) and thf (10 
mL). The reaction vessel was sealed with a cap (phenolic open top cap with red 
PTFE/white silicone septum) and the solution was allowed to stir at 22 °C for two hours. 
Borosilane (2.478 g, 9.450 mmol, 1.05 equiv.) was added to the solution, causing it to 
turn dark brown immediately. The vial was resealed with a cap (phenolic open top cap 
with red PTFE/white silicone septum) and removed from the glove-box. The mixture was 
allowed to stir at 22 °C for 30 min under an atmosphere of N2. Phenylacetylene (988 μL, 
9.00 mmol, 1.0 equiv.) and MeOH (547 μL, 12.5 mmol, 1.5 equiv.) were added through 
syringes. The resulting mixture was allowed to stir at 22 °C for 12 h before the reaction 
was quenched by passing the mixture through a short plug of celite and silica gel and 
eluted with Et2O (3 × 2 mL). The filtrate was concentrated in vacuo to provide brown oil, 
which was purified by silica gel chromatography (hexanes:Et2O=80:1) to afford the 
desired product 3.33 as colorless oil (1.988 g, 0.927 mmol, 93% yield). 
(E)-Hex-1-en-1-yldimethyl(phenyl)silane (3.27). The title compound has been 
previously reported and spectra data match those described.
40
 
1
H NMR (400 MHz, 
CDCl3): δ 7.54–7.51 (2H, m), 7.37–7.34 (3H, m), 6.12 (1H, dt, J = 18.4, 6.4 Hz), 5.75 
(1H, dt, J = 18.4, 1.6 Hz), 2.15 (2H, tdd, J = 6.4, 6.4, 1.6 Hz), 1.44–1.30 (4H, m), 0.91 
(3H, t, J = 7.6 Hz), 0.32 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 149.6, 139.6, 134.0, 
128.9, 127.8, 127.3, 36.7, 31.0, 22.4, 14.1, –2.3. 
                                                 
(40) (a) Fleming, I.; Newton, T. W.; Roessler, F. J. Chem. Soc., Perkin Trans.1 1981, 2527–2532. (b) 
Chen, H.-M.; Oliver, J. P. J. Organomet. Chem. 1986, 316, 255–260. 
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(E)-(5-Chloropent-1-en-1-yl)dimethyl(phenyl)silane (3.28). The title compound has 
been previously reported and spectra data match those described.
41
 
1
H NMR (400 MHz, 
CDCl3): δ 7.56–7.54 (2H, m), 7.40–7.37 (3H, m), 6.11 (1H, dt, J = 18.4, 6.4 Hz), 5.87 
(1H, dt, J = 18.4, 1.6 Hz), 3.56 (2H, t, J = 6.8 Hz), 2.34 (2H, tdd, J = 6.8, 6.8, 1.6 Hz), 
1.93 (2H, tt, J = 6.8, 6.8 Hz), 0.37 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 147.0, 139.1, 
133.9, 129.3, 129.0, 127.9, 44.5, 33.9, 31.6, –2.4. 
(E)-Methyl 6-(dimethyl(phenyl)silyl)hex-5-enoate (3.29). IR (neat): 3069 (w), 2952 
(m), 1738 (s), 1616 (m), 1428 (m), 1364 (w), 1316 (w), 1247 (s), 1203 (m), 1172 (m), 
1141 (m), 1112 (m), 1078 (w), 989 (m), 837 (s), 821 (s), 784 (m), 730 (s), 699 (s), 638 
(w), 470 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.52–7.50 (2H, m), 7.37–7.33 (3H, m), 
6.07 (1H, dt, J = 18.4, 6.0 Hz), 5.79 (1H, dt, J = 18.8, 1.2 Hz), 3.67 (3H, s), 2.32 (2H, t, J 
= 7.6 Hz), 2.19 (2H, tdd, J = 7.6, 7.6, 1.6 Hz), 1.76 (2H, tt, J = 7.6, 7.6 Hz), 0.31 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 174.2, 147.8, 139.2, 133.9, 129.0, 128.8, 127.9, 51.7, 
36.1, 33.6, 23.9, –2.4; HRMS (ESI+): Calcd for C15H23O2Si1 [M+H]
+
: 263.1467; Found: 
263.1469. 
(E)-tert-Butyl((3-(dimethyl(phenyl)silyl)allyl)oxy)dimethylsilane (3.30). IR (neat): 
2955 (w), 2929 (w), 2894 (w), 2856 (w), 1471 (w), 1428 (w), 1361 (w), 1249 (m), 1195 
(w), 1113 (m), 1097 (m), 1049 (w), 987 (w), 939 (w), 909 (w), 857 (m), 832 (s), 774 (s), 
728 (s), 697 (s), 666 (m), 522 (m), 469 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.53–
7.51 (2H, m), 7.36–7.33 (3H, m), 6.17 (1H, dt, J = 18.8, 4.0 Hz), 6.04 (1H, dt, J = 18.4, 
1.6 Hz), 4.23 (2H, dd, J = 4.0, 1.6 Hz), 0.92 (9H, s), 0.34 (6H, s), 0.07 (6H, s); 
13
C NMR 
(100 MHz, CDCl3): δ 147.3, 139.0, 134.0, 129.0, 127.9, 126.0, 65.9, 26.1, 18.6, –2.4, –
5.0; HRMS (ESI
+
): Calcd for C17H34N1O1Si2 [M+NH4]
+
: 324.2179; Found: 324.2181. 
                                                 
(41) Nakamura, S.; Uchiyama, M.; Ohwada, T. J. Am. Chem. Soc. 2004, 126, 11146–11147. 
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(E)-(3-Cyclopentylprop-1-en-1-yl)dimethyl(phenyl)silane (3.31). IR (neat): 3068 (w), 
3050 (w), 2950 (m), 2866 (m), 1615 (m), 1451 (w), 1427 (m), 1313 (w), 1247 (m), 1112 
(m), 990 (m), 926 (w), 880 (w), 816 (s), 780 (s), 727 (s), 697 (s), 638 (m), 469 (m), 417 
(m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.55–7.51 (2H, m), 7.37–7.34 (3H, m), 6.12 
(1H, dt, J = 18.4, 6.4 Hz), 5.75 (1H, dt, J = 18.8, 1.6 Hz), 2.17 (2H, dt, J = 6.4, 1.6 Hz), 
1.91 (1H, septet, J = 7.6 Hz), 1.78–1.71 (2H, m), 1.63–1.49 (4H, m), 1.19–1.10 (2H, m), 
0.32 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 149.0, 139.6, 134.0, 128.9, 128.0, 127.8, 
43.6, 39.5, 32.4, 25.3, –2.2; HRMS (ESI+): Calcd for C16H28N1Si1 [M+NH4]
+
: 262.1991; 
Found: 262.1985. 
(E)-(2-Cyclohexylvinyl)dimethyl(phenyl)silane (3.32). The title compound has been 
previously reported and spectra data match those described.
36
 
1
H NMR (400 MHz, 
CDCl3): δ 7.61–7.58 (2H, m), 7.43–7.40 (3H, m), 6.17 (1H, dd, J = 18.8, 6.0 Hz), 5.80 
(1H, dd, J = 18.8, 1.6 Hz), 2.16–2.07 (1H, m), 1.86–1.79 (4H, m), 1.76–1.71 (1H, m), 
1.38–1.16 (5H, m), 0.40 (6H, s); 13C NMR (100 MHz, CDCl3): δ 155.0, 139.7, 134.0, 
128.9, 127.8, 124.0, 44.2, 32.5, 26.4, 26.2, –2.2. 
(E)-Dimethyl(phenyl)(styryl)silane (3.33). IR (neat): 3067 (w), 2995 (w), 2955(w), 
1947 (w), 1604 (m), 1427 (m), 1301 (m), 1112 (m), 1027 (w), 989 (m), 827 (s), 726 (s), 
688 (s) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.46–7.40 (2H, m), 
7.38–7.36 (3H, m), 7.35–7.31 (3H, m), 6.94 (1H, d, J = 19.2 Hz), 6.59 (1H, d, J = 19.2 
Hz), 0.44 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 145.5, 138.7, 138.3, 134.1, 129.2, 
128.7, 128.3, 128.0, 127.2, 126.6, –2.4; HRMS (ESI+): Calcd for C16H22N1Si1 [M+NH4]
+
: 
256.1521, Found: 256.1519. 
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(E)-Dimethyl(2-methylstyryl)(phenyl)silane (3.34). IR (neat): 3067 (w), 3017 (w), 
2955 (w), 1597 (w), 1479 (w), 1427 (m), 1288 (m), 1248 (w), 1113 (m), 989 (m), 841 (s), 
829 (s), 699 (s), 644 (s) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.60–7.58 (2H, m), 7.56–
7.54 (1H, m), 7.39–7.37 (3H, m), 7.21 (1H, d, J = 19.2 Hz), 7.19–7.12 (3H, m), 6.50 (1H, 
d, J = 19.2 Hz), 2.36 (3H, s), 0.45 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 143.3, 138.9, 
137.6, 135.5, 134.1, 130.5, 129.2, 129.0, 128.0, 127.9, 126.2, 125.5, 19.7, –2.3; HRMS 
(ESI
+
): Calcd for C17H20Si1 [M]
+
: 252.1334, Found: 252.1338. 
(E)-(2-Fluorostyryl)dimethyl(phenyl)silane (3.35). IR (neat): 3068 (w), 3020 (w), 2957 
(w), 1601 (w), 1482 (m), 1456 (m), 1279 (m), 1248 (m), 1150 (m), 1093 (w), 843 (s), 753 
(s), 731 (s), 699 (s) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.54 (3H, m), 7.38–7.37 
(3H, m), 7.24–7.20 (1H, m), 7.17 (1H, d, J = 19.6 Hz), 7.12–7.09 (1H, m), 7.05–7.01 (1H, 
m), 6.66 (1H, d, J = 19.2 Hz), 0.45 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 161.7, 138.5, 
137.1 (d, J = 4.4 Hz), 134.0, 130.3 (d, J = 3.7 Hz), 129.6, 129.5, 129.3, 128.0, 127.0 (d, J 
= 3.0 Hz), 124.2 (d, J = 3.0 Hz), 115.9 (d, J = 22.4 Hz), –2.5; HRMS (ESI+): Calcd for 
C16H21F1N1Si1 [M+NH4]
+
: 274.1427, Found: 274.1438. 
(E)-Dimethyl(phenyl)(2-(trifluoromethyl)styryl)silane (3.36). IR (neat): 3070 (w), 
2958 (w), 1481 (w), 1312 (s), 1250 (m), 1158 (s), 1116 (s), 1037 (m), 831 (s), 764 (s), 
730 (m), 698 (m), 655 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.71 (1H, d, J = 7.6 Hz), 
7.63 (1H, d, J = 8.0 Hz), 7.59–7.57 (2H, m), 7.51 (1H, t, J = 7.6 Hz), 7.39–7.33 (5H, m), 
6.60 (1H, d, J = 19.2 Hz), 0.46 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 140.7 (app. d, J = 
2.2 Hz), 138.2, 137.8 (app. d, J = 1.5 Hz), 134.0, 133.0, 131.9, 129.3, 128.1 (q, J = 231.0 
Hz), 128.0, 127.7, 127.4, 125.6 (q, J = 5.8 Hz), 123.1, –2.6; HRMS (ESI+): Calcd for 
C17H17F3Si1 [M]
+
: 306.1052, Found: 306.1045. 
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(E)-(2-Methoxystyryl)dimethyl(phenyl)silane (3.37). IR (neat): 3068 (w), 2955 (w), 
2836 (w), 1597 (m), 1485 (m), 1288 (w), 1243 (s), 1113 (m), 1050 (w), 842 (s), 766 (s), 
700 (m), 434 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.60–7.55 (3H, m), 7.41–7.35 (4H, 
m), 7.25–7.22 (1H, m), 6.92 (1H, t, J = 7.2 Hz), 6.87 (1H, d, J = 8.4 Hz), 6.57 (1H, d, J = 
19.2 Hz), 3.85 (3H, s), 0.44 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 156.9, 139.7, 139.2, 
134.1, 129.3, 129.1, 127.9, 127.5, 126.5, 120.7, 111.1, 55.6, –2.3; HRMS (ESI+): Calcd 
for C17H21O1Si1 [M+H]
+
: 269.1362, Found: 269.1372. 
(E)-(3-Fluorostyryl)dimethyl(phenyl)silane (3.38). IR (neat): 3068 (w), 2996 (w), 2957 
(w), 1609 (w), 1577 (m), 1484 (w), 1249 (s), 1199 (w), 1073 (m), 986 (m), 841 (s), 825 
(s), 730 (s), 677 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.40–7.38 
(3H, m), 7.32–7.28 (1H, m), 7.21–7.15 (1H, m), 6.96 (1H, td, J = 8.4, 1.6 Hz), 6.90 (1H, 
d, J = 19.2 Hz), 6.61 (1H, d, J = 19.6 Hz), 0.45 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 
162.1(d, J = 260.0 Hz), 144.1 (d, J = 2.2 Hz), 140.7 (d, J = 7.5 Hz), 138.3, 134.1, 130.1 
(d, J = 8.2 Hz), 129.3, 129.2, 128.0, 122.6 (d, J = 3.0 Hz), 115.1 (d, J = 21.6 Hz), 112.9 
(d, J = 21.6 Hz), –2.5; HRMS (ESI+): Calcd for C16H17F1Si1 [M]
+
: 256.1084, Found: 
256.1067. 
(E)-(4-Fluorostyryl)dimethyl(phenyl)silane (3.39). IR (neat): 3068 (w), 2957 (w), 1601 
(m), 1506 (s), 1427 (w), 1248 (m), 1156 (m), 1114 (m), 987 (m), 841 (s), 821 (s), 732 (m), 
699 (m), 471 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.44–7.37 (5H, 
m), 7.04–7.00 (2H, m), 6.89 (1H, d, J = 19.2 Hz), 6.49 (1H, d, J = 19.2 Hz), 0.44 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 162.8 (d, J = 245.5 Hz), 144.1, 138.6, 134.6 (d, J = 3.7 
Hz), 134.0, 129.2, 128.2 (d, J = 7.4 Hz), 128.0, 127.0 (d, J = 2.2 Hz), 115.6 (d, J = 21.6 
Hz), –2.4; HRMS (ESI+): Calcd for C16H17F1Si1 [M]
+
: 256.1084, Found: 256.1098. 
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(E)-Dimethyl(phenyl)(2-(thiophen-3-yl)vinyl)silane (3.40). IR (neat): 3067 (w), 2955 
(w), 1601 (m), 1427 (m), 1245 (m), 1198 (w), 1156 (w), 1113 (m), 984 (m), 830 (s), 729 
(s), 698 (s), 606 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.38–7.37 
(3H, m), 7.30–7.25 (2H, m), 7.22–7.21 (1H, m), 6.94 (1H, d, J = 18.8 Hz), 6.36 (1H, d, J 
= 19.2 Hz), 0.42 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 142.1, 139.2, 138.7, 134.1, 
129.2, 128.0, 126.9, 126.1, 125.1, 123.1, –2.4; HRMS (ESI+): Calcd for C14H17S1Si1 
[M+H]
+
: 245.0820, Found: 245.0826. 
 
 Representative Experimental Procedure for Site- and Enantioselective NHC–Cu- 
Catalyzed Protoboration of Alkyl-substituted Alkenylsilanes: In a N2-filled glove-
box, an oven-dried vial (4 mL, 17 × 38 mm) with a magnetic stir bar was charged with 
imidazolinium salt A.14 (3.2 mg, 0.0050 mmol, 5.0 mol %), CuCl (0.5 mg, 0.0050 mmol, 
5.0 mol%), NaOt-Bu (7.7 mg, 0.0800 mmol, 80.0 mol %) and thf (0.5 mL). The reaction 
vessel was sealed with a cap (phenolic open top cap with red PTFE/white silicone 
septum) and the solution was allowed to stir at 22 °C for two hours. 
Bis(pinacolato)diboron (27.9 mg, 0.110 mmol, 1.1 equiv.) was added to the solution, 
causing it to turn dark brown immediately. The vial was re-sealed with a cap (phenolic 
open top cap with red PTFE/white silicone septum) and removed from the glove-box. 
The resulting mixture was allowed to stir at 22 °C for 30 min under an atmosphere of N2. 
At this time, the mixture was allowed to cool to –78 °C (dry ice/acetone bath) and a 
solution of (E)-hex-1-en-1-yldimethyl(phenyl)silane 3.27 (21.8 mg, 0.100 mmol, 1.0 
equiv.) in thf (0.2 mL) followed by MeOH (8.2 µL, 0.200 mmol, 2.0 equiv.) were added 
through a syringe. The vial was placed in a –15 °C cryocool. After 24 h, the solution was 
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allowed to cool to –78 °C and the reaction was quenched by passing the mixture through 
a short plug of celite and silica gel and eluted with Et2O (3 × 2 mL). The filtrate was 
concentrated in vacuo to provide brown oil, which was purified by silica gel 
chromatography (hexanes:Et2O=50:1) to afford the desired product 3.41 as colorless oil 
(29.1 mg, 0.0840 mmol, 84% yield). 
(R)-Dimethyl(phenyl)(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexyl)silane 
(3.41). IR (neat): 2977 (w), 2956 (w), 2925 (w), 2857 (w), 1377 (m), 1315 (m), 1247 (m), 
1143 (s), 1112 (m), 968 (w), 829 (s), 727 (s), 699 (s), 468 (w) cm
–1
; 
1
H NMR (400 MHz, 
CDCl3): δ 7.55–7.52 (2H, m), 7.35–7.32 (3H, m), 1.43–1.33 (1H, m), 1.29–1.22 (5H, m), 
1.21 (12H, s), 1.08–1.06 (1H, m), 1.05–0.97 (1H, m), 0.85 (3H, t, J = 6.8 Hz), 0.76 (1H, 
dd, J = 14.4, 5.2 Hz), 0.28 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 140.3, 133.8, 128.7, 
127.7, 82.9, 34.7, 31.3, 25.0, 24.9, 23.0, 16.7, 14.2, –2.1, –2.3; HRMS (ESI+): Calcd for 
C20H39B1N1O2Si1 [M+NH4]
+
: 364.2843; Found: 364.2860. Specific Rotation: [α]D
20 –
7.61 (c 1.96, CHCl3) for an enantiomerically  enriched sample of 91:9 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borosilane product with NaBO3•4H2O (Chiralcel OD-H column, 99/1 hexanes/i-
PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 34.102 50.418 1 32.524 8.982 
2 36.429 49.582 2 34.328 91.018 
(R)-Hexane-1,2-diol (Synthesized by oxidation of 3.41 with NaBO3•4H2O followed by 
another oxidation with KBr, AcO2H and NaOAc.
42
 The title compound has been 
previously reported and spectra data match those described).
43
 
1
H NMR (400 MHz, 
CDCl3): δ 3.73–3.69 (1H, m), 3.66 (1H, dd, J = 10.8, 3.2 Hz), 3.44 (1H, dd, J = 11.2, 7.6 
Hz), 2.01 (2H, br s), 1.47–1.25 (6H, m), 0.91 (3H, t, J = 7.2 Hz); 13C NMR (100 MHz, 
CDCl3): δ 72.5, 67.0, 33.1, 27.8, 22.9, 14.1; Specific Rotation: [α]D
20
 +4.51 (c 1.25, 
EtOH) for an enantiomerically enriched sample of 91:9 e.r. 
Proof of Stereochemistry: Literature value ([α]D
20
 +14.8 (c = 0.76, EtOH), 98:2 e.r.) is 
assigned to the (R) enantiomer.
38c
 
(R)-(5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pentyl)dimethyl(phenyl)silane (3.44). IR (neat): 2977 (w), 1379 (m), 1317 (m), 1247 
(m), 1142 (s), 1112 (m), 968 (w), 828 (s), 727 (s), 699 (s), 468 (w) cm
–1
; 
1
H NMR (400 
MHz, CDCl3): δ 7.54–7.51 (2H, m), 7.36–7.33 (3H, m), 3.43 (2H, t, J = 6.8 Hz), 1.78–
                                                 
(42) Fleming, I.; Sanderson, P. E. J. Tetrahedron Lett. 1987, 28, 4229–4232. 
(43) (a) Hasegawa, J.; Ogura, M.; Tsuda, S.; Maemoto, S.-i.; Kutsuki, H.; Ohashi, T. Agric. Biol. Chem. 
1990, 54, 1819–1827. (b) Brown, S. P.; Brochu, M. P.; Sinz, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 
2003, 125, 10808–10809. (c) Notte, G. T.; Sammakia, T.; Steel, P. J. J. Am. Chem. Soc. 2005, 127, 13502–
13503. 
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1.69 (2H, m), 1.54–1.45 (2H, m), 1.21 (12H, s), 1.11–1.00 (2H, m), 0.73 (1H, dd, J = 
14.4, 5.2 Hz), 0.29 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 139.9, 133.8, 128.9, 127.8, 
83.2, 45.3, 32.1, 25.0, 24.9, 16.7, –2.1, –2.4; HRMS (ESI+): Calcd for 
C19H36B1Cl1N1O2Si1 [M+NH4]
+
: 384.2297; Found: 384.2313. Specific Rotation: ([α]D
20
 –
4.64 (c 2.43, CHCl3) for an enantiomerically enriched sample of 91.5:8.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borylsilane product with NaBO3•4H2O (Chiralcel OD-H column, 99/1 hexanes/i-
PrOH, 0.5 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 45.459 49.737 1 44.290 8.534 
2 48.057 50.263 2 45.981 91.466 
(R)-Methyl 6-(dimethyl(phenyl)silyl)-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hexanoate (3.45). IR (neat): 2977 (w), 2951 (w), 1739 (s), 1427 
(w), 1379 (m), 1371 (m), 1317 (m), 1247 (m), 1212 (m), 1166 (m), 1142 (s), 1112 (m), 
970 (w), 829 (s), 728 (m), 700 (m), 469 (w) cm
–1
; 
1
H NMR (400MHz, CDCl3): δ 7.52–
7.50 (2H, m), 7.33–7.32 (3H, m), 3.64 (3H, s), 2.21 (2H, t, J = 7.6 Hz), 1.60–1.56 (2H, 
m), 1.44–1.24 (2H, m), 1.19 (12H, s), 1.08–0.97 (2H, m), 0.73 (1H, dd, J = 14.4, 5.2 Hz), 
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0.27 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 174.3, 140.0, 133.8, 128.8, 127.8, 83.1, 
51.5, 34.4, 34.3, 25.0, 24.9, 24.3, 16.6, –2.2, –2.4; HRMS (ESI+): Calcd for  
C21H39B1N1O4Si1 [M+NH4]
+
: 408.2741; Found: 408.2747. Optical Rotation: [α]D
20
 +3.12 
(c 0.87, CHCl3) for an enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borylsilane product with NaBO3•4H2O (Chiralcel OJ-H column, 92/8 hexanes/i-
PrOH, 1.0 mL/min, 220 nm). 
 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.402 49.813 1 15.091 91.971 
2 16.494 50.187 2 16.140 8.029 
(R)-tert-Butyl(3-(dimethyl(phenyl)silyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)propoxy)dimethylsilane (3.46). IR (neat): 2955 (w), 2930 (w), 2857 (w), 1471 (w), 
1389 (m), 1371 (m), 1319 (m), 1254 (m), 1144 (m), 1083 (m), 906 (s), 832 (s), 776 (m), 
727 (s), 700 (s), 649 (m), 578 (w), 469 (w) cm
–1
; 
1
H NMR (400MHz, CDCl3): δ 7.54–
7.51 (2H, m), 7.34–7.31 (3H, m), 3.57 (2H, d, J = 7.2 Hz), 1.35–1.28 (1H, m), 1.20 (12H, 
s), 0.94–0.88 (1H, m), 0.87 (9H, s), 0.83–0.78 (1H, m), 0.28 (6H, s), 0.00 (3H, s), –0.01 
(3H, s); 
13
C NMR (100 MHz, CDCl3): δ 140.0, 133.8, 128.8, 127.8, 83.1, 67.5, 26.1, 
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25.0, 18.5, 12.8, –2.1, –2.4, –5.2, –5.3; HRMS (ESI+): Calcd for C17H38B1O3Si2 [M–
C6H5]
+
: 357.2452; Found: 357.2435. Specific Rotation: [α]D
20
 –5.87 (c 2.15, CHCl3) for 
an enantiomerically enriched sample of 84:16 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borylsilane product with NaBO3•4H2O (Chiralcel OJ-H column, 99/1 hexanes/i-
PrOH, 0.2 mL/min, 220 nm). 
 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 26.967 49.399 1 27.088 16.293 
2 28.227 50.601 2 28.319 83.707 
(R)-(3-Cyclopentyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)propyl)dimethyl(phenyl)silane (3.47). IR (neat): 2977 (w), 2949 (w), 2908 (w), 2866 
(w), 1377 (m), 1315 (m), 1246 (m), 1213 (w), 1142 (s), 1112 (m), 966 (w), 828 (s), 727 
(s), 698 (s), 467 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.54–7.52 (2H, m), 7.35–7.32 
(3H, m), 1.78–1.61 (3H, m), 1.58–1.44 (5H, m), 1.31–1.24 (1H, m), 1.21 (12H, s), 1.11 
(1H, tt, J = 6.4, 6.4 Hz), 1.05–0.93 (3H, m), 0.78 (1H, dd, J = 14.4, 5.6 Hz), 0.29 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 140.2, 133.8, 128.8, 127.7, 82.9, 41.2, 39.5, 33.0, 32.8, 
25.4, 25.2, 25.0, 24.9, 16.8, –2.1, –2.2; HRMS (ESI+): Calcd for C22H41B1N1O2Si1 
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[M+NH4]
+
: 390.3000; Found: 390.2994. Specific Rotation: [α]D
20
 –12.61 (c 1.76, CHCl3) 
for an enantiomerically enriched sample of 91.5:8.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borylsilane product with NaBO3•4H2O (Chiralcel OD-H column, 99.5/0.5 
hexanes/i-PrOH, 0.6 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 28.268 49.422 1 26.790 91.491 
2 30.510 50.578 2 29.854 8.509 
(R)-(2-Cyclohexyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)dimethyl(phenyl)silane (3.48). IR (neat): 2977 (w), 2923 (s), 2851 (m), 1448 
(w), 1427 (w), 1371 (m), 1313 (m), 1246 (m), 1214 (w), 1144 (s), 1112 (m), 970 (w), 832 
(s), 728 (m), 699 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.53–7.50 (2H, m), 7.33–7.31 
(3H, m), 1.69–1.61 (5H, m), 1.38–1.25 (1H, m), 1.19 (12H, s), 1.18–0.94 (7H, m), 0.75 
(1H, d, J = 11.2), 0.25 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 140.2, 133.8, 128.7, 
127.7, 83.0, 42.8, 32.3, 31.5, 27.1, 27.0, 26.8, 25.2, 25.1, 13.5, –2.2, –2.6; HRMS (ESI+): 
Calcd for C22H41B1N1O2Si1 [M+NH4]
+
: 390.3000; Found: 390.2996. Optical Rotation: 
[α]D
20
 –24.63 (c 1.03, CHCl3) for an enantiomerically enriched sample of 96.5:3.5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was synthesized by oxidation 
of the borylsilane product with NaBO3•4H2O (Chiralcel OD-H column, 99.5/0.5 
hexanes/i-PrOH, 0.6 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 13.754 50.649 1 14.616 3.343 
2 17.856 49.351 2 19.058 96.657 
 
 Experimental Procedure for NHC–Cu-Catalyzed Site- and Enantioselective 
Protoboration of a Si-Substituted Diene (3.49): In a N2-filled glove-box, an oven-dried 
vial (4 mL, 17 × 38 mm) with a magnetic stir bar was charged with imidazolinium salt 
A.14 (3.2 mg, 0.0050 mmol, 5.0 mol %), CuCl (0.5 mg, 0.0050 mmol, 5.0 mol %), NaOt-
Bu (7.7 mg, 0.080 mmol, 80.0 mol %) and thf (0.5 mL). The reaction vessel was sealed 
with a cap (phenolic open top cap with red PTFE/white silicone septum) and the mixture 
was allowed to stir at 22 °C for two hours. Bis(pinacolato)diboron (27.9 mg, 0.110 mmol, 
1.1 equiv.) was added to the solution, causing it to turn dark brown immediately. The vial 
was re-sealed with a cap (phenolic open top cap with red PTFE/white silicone septum) 
and removed from the glove-box. The mixture was allowed to stir at 22 °C for 30 min 
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under an atmosphere of N2. (E)-(2-(Cyclohex-1-en-1-yl)vinyl)dimethyl(phenyl)silane 
3.49 (24.2 mg, 0.100 mmol, 1.0 equiv.) followed by MeOH (8.2 µL, 0.200 mmol, 2.0 
equiv.) were added through a syringe. The mixture was allowed to stir at 22 °C for 24 h, 
after which, benzaldehyde (15.3 µL, 0.150 mmol, 1.5 equiv.) was added through a 
syringe. The mixture was allowed to stir for an additional 12 h. Then the reaction was 
quenched by passing the mixture through a short plug of celite and silica gel and eluted 
with Et2O (3 × 2 mL). The filtrate was concentrated in vacuo to provide brown oil, which 
was purified by silica gel chromatography (hexanes:Et2O=15:1 to 10:1) to afford a 7:1 
mixture of  3.51 and 3.52 as colorless oil (29.9 mg, 0.0853 mmol, 85% yield). 
(E)-(2-(Cyclohex-1-en-1-yl)vinyl)dimethyl(phenyl)silane (3.49). IR (neat): 2926 (w), 
2858 (w), 1633 (w), 1427 (w), 1246 (m), 1203 (w), 1112 (m), 985 (m), 860 (s), 841 (s), 
728 (s), 697 (s), 513 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.56–7.53 (2H, m), 7.37–
7.35 (3H, m), 6.60 (1H, d, J = 18.8 Hz), 5.84–5.79 (2H, m), 2.19–2.15 (4H, m), 1.69–
1.60 (4H, m), 0.37 (6H, s); 
13
C NMR (100 MHz, CDCl3): δ 149.2, 139.4, 137.5, 134.0, 
131.8, 129.0, 127.9, 122.1, 26.1, 24.2, 22.7, 22.6, –2.2; HRMS (ESI+): Calcd for 
C16H23Si1 [M+H]
+
: 243.1569, Found: 243.1565. 
3.51 and 3.52 are not separable on silica gel. Characterization data for 3.51 and 3.52 are 
not shown. 
1
H NMR of mixture of 3.51 and 3.52 is provided. 
Enantiomeric purity of 3.51 was determined by HPLC analysis in comparison with 
authentic racemic material (95:5 e.r. shown; Chiralcel OD-H column, 99/1 hexanes/i-
PrOH, 0.3 mL/min, 220 nm). 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 26.305 49.918 1 25.725 95.259 
2 33.351 50.082 2 32.586 4.741 
Enantiomeric purity of 3.52 was determined by HPLC analysis in comparison with 
authentic racemic material (95:5 e.r. shown; Chiralcel OD-H column, 99/1 hexanes/i-
PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 23.941 50.298 1 23.319 5.172 
2 40.769 49.702 2 40.013 94.828 
Proof of Stereochemistry: (S)-((R)-2-Oxocyclohexyl)(phenyl)methyl 4-bromobenzoate, 
the spectroscopic data of which match those reported previously,
44
 was obtained through 
ozonolysis of mixture of 3.51 and 3.52, followed by benzoylation with para-
                                                 
(44) Denmark, S. E.; Stavenger, R. A.; Wong, K.; Su, X. J. Am. Chem. Soc. 1999, 121, 4982–4991. 
Chapter 3, Page 177 
 
 
bromobenzoyl chloride. Specific rotation of (S)-((R)-2-oxocyclohexyl)(phenyl)methyl 4-
bromobenzoate : [α]D
20
 +92.4 (c 0.251, CHCl3), 95:5 e.r. Literature value ([α]D
20
 +111.6 
(c 1.21, CHCl3), >98:2 e.r.) is assigned to (S)-((R)-2-oxocyclohexyl)(phenyl)methyl 4-
bromobenzoate. 
 
 Representative Experimental Procedure for Site- and Enantioselective NHC–Cu- 
Catalyzed Protoboration of Aryl-Substituted Alkenylsilanes: In a N2-filled glove-box, 
an oven-dried vial (4 mL, 17 × 38 mm) with a magnetic stir bar was charged with 
imidazolinium salt A.6 (2.9 mg, 0.0050 mmol, 5.0 mol %), CuCl (0.5 mg, 0.0050 mmol, 
5.0 mol %), NaOt-Bu (7.7 mg, 0.080 mmol, 80.0 mol %) and thf (0.5 mL). The reaction 
vessel was sealed with a cap (phenolic open top cap with red PTFE/white silicone 
septum) and the mixture was allowed to stir at 22 °C for two hours. 
Bis(pinacolato)diboron (27.9 mg, 0.110 mmol, 1.1 equiv.) was added to the above 
solution, causing it to turn dark brown immediately. The vial was re-sealed with a cap 
(phenolic open top cap with red PTFE/white silicone septum) and removed from the 
glove-box. The mixture was allowed to stir at 22 °C for 30 min under an atmosphere of 
N2. After this time, (E)-dimethyl(phenyl)(styryl)silane 3.33 (23.8 mg, 0.100 mmol, 1.0 
equiv.) followed by MeOH (8.2 µL, 0.200 mmol, 2.0 equiv.) were added via syringes. 
The mixture was allowed to stir at 22 °C for 24 h. The reaction was quenched by passing 
the mixture through a short plug of celite and silica gel and eluted with Et2O (3 × 2 mL). 
The filtrate was concentrated in vacuo to provide brown oil, which was purified by silica 
gel chromatography (hexanes:Et2O=80:1) to afford a mixture of 3.43 as colorless oil 
(33.0 mg, 0.0901 mmol, 90% yield). 
Chapter 3, Page 178 
 
 
3 (R)-Dimethyl(phenyl)(2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)silane (3.43). IR (neat): 3067 (w), 3025 (w), 2977 (m), 1494 (m), 1351 (s), 1248 
(m), 1143 (s), 1113 (m), 837 (m), 814 (m), 774 (m), 730 (s) cm
–1
; 
1
H NMR (400 MHz, 
CDCl3): δ 7.60–7.58 (2H, m), 7.38–7.36 (3H, m), 7.21–7.16 (4H, m), 7.11–7.09 (1H, m), 
2.78 (1H, dd, J = 14.0, 12.0 Hz), 2.68 (1H, dd, J = 14.0, 3.2 Hz), 1.09–1.05 (7H, m), 1.02 
(6H, s), 0.39 (3H, s), 0.37 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 144.9, 138.7, 134.0, 
129.1, 128.3, 128.1, 127.8, 125.5, 83.0, 31.7, 25.0, 24.8, 16.2, –2.2, –3.3; HRMS (ESI+): 
Calcd for C22H35B1N1O2Si1 [M+NH4]
+
: 384.2530, Found: 384.2523. Specific Rotation: 
[α]D
20
 +14.8 (c 1.73, CHCl3) for  an  enantiomerically  enriched sample of 98:2 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 12.844 49.666 1 12.792 1.818 
2 14.168 50.334 2 14.104 98.182 
Proof of stereochemistry: The corresponding (R)-1-phenylbutan-2-ol was obtained after 
olefination, reduction and oxidation of 3.43.
45
 Specific Rotation of (R)-1-phenylbutan-2-
ol: [α]D
20
 –14.2 (c 0.52, CHCl3). Literature value ([α]D
20
 –8.3 (c 1.02, CHCl3), 71:29 e.r.) 
                                                 
(45) Aggarwal, V. K.; Binanzer, M.; de Ceglie, M. C.; Gallanti, M.; Glasspoole, B. W.; Kendrick, S. J. F.; 
Sonawane, R. P.; Vázquez-Romero, A.; Webster, M. P. Org. Lett. 2011, 13, 1490–1493. 
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is assigned to the (R) enantiomer.
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(R)-Dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(o-
tolyl)ethyl)silane (3.53). IR (neat): 3068 (w), 2876 (w), 1603 (w), 1348 (s), 1309 (m), 
1213 (m), 1142 (s), 1112 (m), 969 (w), 833 (s), 731 (s), 698 (s), 635 (w), 468 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.62–7.59 (2H, m), 7.38–7.35 (3H, m), 7.22–7.21 (1H, 
m), 7.05–7.01 (3H, m), 2.78 (1H, dd, J =  14.0, 12.0 Hz), 2.64 (1H, dd, J = 14.0, 3.2 Hz), 
2.13 (3H, s), 1.09 (6H, s), 1.07 (6H, s), 1.02 (1H, dd,  J = 12.0, 3.2 Hz), 0.43 (3H, s), 0.41 
(3H, s); 
13
C NMR (100 MHz, CDCl3): δ 142.9, 138.7, 135.8, 134.1, 130.0, 129.1, 128.6, 
127.8, 125.6, 83.0, 28.8, 25.03, 24.96, 19.3, 14.8, –2.4, –3.4; HRMS (ESI+): Calcd for 
C23H37B1N1O2Si1 [M+NH4]
+
: 398.2687, Found: 398.2696. Specific Rotation: [α]D
20
 
+12.7 (c 1.13, CHCl3) for an enantiomerically enriched sample of 96.5:3.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 11.447 48.161 1 11.448 3.450 
2 11.963 51.839 2 11.965 96.550 
(R)-(2-(2-Fluorophenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)ethyl)dimethyl(phenyl)silane (3.54). IR (neat): 3068 (w), 2976 (w), 2927 (w), 1583 
                                                 
(46) Matsunaga, H.; Ishizuka, T.; Kunieda, T. Tetrahedron Lett. 2005, 46, 3645–3648. 
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(m), 1352 (s), 1313 (m), 1248 (m), 1143 (s), 1113 (w), 865 (m), 755 (m), 733 (w), 700 
(w), 502 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.61–7.58 (2H, m), 7.37–7.34 (3H, m), 
7.21 (1H, td, J = 7.6, 1.6 Hz), 7.11–7.05 (1H, m), 6.98–6.89 (2H, m), 2.82–2.71 (2H, m), 
1.11 (1H, dd, J = 11.6, 4.4 Hz), 1.08 (6H, s), 1.03 (6H, s), 0.40 (3H, s), 0.38 (3H, s); 
13
C 
NMR (100 MHz, CDCl3): δ 161.1 (d, J = 244.1 Hz), 138.5, 134.0, 131.7 (d, J = 15.7 Hz), 
130.3 (d, J = 5.2 Hz), 129.1, 127.8, 127.0 (d, J = 8.2 Hz), 123.5 (d, J = 3.7 Hz), 115.0 (d, 
J = 21.6 Hz), 83.0, 30.5, 25.1, 24.8, 14.3, –2.3, –3.3; HRMS (ESI+): Calcd for 
C22H34B1F1N1O2Si1 [M+NH4]
+
: 402.2436, Found: 402.2443. Specific Rotation: [α]D
20
 
+13.7 (c 1.33, CHCl3) for an enantiomerically enriched sample of 93.5:6.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 11.479 51.984 1 11.587 6.450 
2 12.873 48.016 2 13.109 93.550 
(R)-Dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2- 
(trifluoromethyl)phenyl)ethyl)silane (3.55). IR (neat): 3071 (w), 2978 (w), 1483 (w), 
1352 (m), 1249 (s), l142 (s), 1116 (s), 1037 (m), 815 (m), 766 (m), 732 (m), 699 (m), 634 
(m), 469 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.60–7.58 (2H, m), 7.52 (2H, dd, J = 
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14.0, 8.0 Hz), 7.39–7.35 (4H, m), 7.21 (1H, t, J = 7.6 Hz), 2.97–2.95 (2H, m), 1.11 (1H, 
dd, J = 9.2, 6.0 Hz), 1.08 (6H, s), 1.03 (6H, s), 0.42 (3H, s), 0.41 (3H, s); 
13
C NMR (100 
MHz, CDCl3): δ 143.6 (app. d, J = 1.5 Hz), 138.3, 134.1, 131.4, 130.7, 129.1, 128.1, 
127.8, 125.9 (q, J = 5.9 Hz), 125.7, 124.8 (q, J = 272.3 Hz), 83.1, 28.3, 25.1, 25.0, 15.7, –
2.8, –3.0; HRMS (ESI+): Calcd for C23H34B1F3N1O2Si1 [M+NH4]
+
: 452.2404, Found: 
452.2425. Specific Rotation: [α]D
20
 +5.62 (c 1.99, CHCl3) for an enantiomerically 
enriched sample of 93:7 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99.5/0.5 hexanes/i-PrOH, 0.3 mL/min, 220 
nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 11.162 49.493 1 10.799 7.000 
2 11.591 50.507 2 11.395 93.000 
(R)-(2-(2-Methoxyphenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)ethyl)dimethyl(phenyl)silane (3.56). IR (neat): 3069 (w), 2976 (w), 2835 (w), 1492 
(m), 1350 (s), 1240 (s), 1143 (s), 1112 (m), 996 (w), 835 (m), 750 (m), 699 (m), 521 (w) 
cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.64–7.61 (2H, m), 7.37–7.34 (3H, m), 7.19 (1H, 
dd, J = 7.2, 1.6 Hz), 7.09 (1H, td, J = 8.0, 1.6 Hz), 6.81–6.73 (2H, m), 3.74 (3H, s), 2.80 
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(1H, dd, J = 14.0, 3.2 Hz), 2.71–2.65 (1H, m), 1.18 (1H, dd, J = 12.0, 3.2 Hz), 1.09 (6H, 
s), 1.06 (6H, s), 0.40 (3H, s), 0.37 (3H, s); 
13
C NMR (100 MHz, CDCl3): δ 157.4, 139.1, 
134.1, 133.2, 129.5, 128.9, 127.6, 126.7, 119.9, 109.9, 82.9, 55.1, 26.3, 25.1, 24.9, 13.8, –
2.2, –3.1; HRMS (ESI+): Calcd for C23H37B1N1O3Si1 [M+NH4]
+
: 414.2636, Found: 
414.2620. Specific Rotation: [α]D
20
 +18.0 (c 1.58, CHCl3) for an enantiomerically 
enriched sample of 93:7 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99.5/0.5 hexanes/i-PrOH, 0.3 mL/min, 220 
nm). 
 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 12.802 49.537 1 12.647 6.539 
2 14.303 50.463 2 14.207 93.461 
(R)-(2-(3-Fluorophenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)ethyl)dimethyl(phenyl)silane (3.57). IR (neat): 3070 (w), 2977 (w), 2929 (w), 1615 
(w), 1349 (s), 1307 (m), 1249 (m), 1142 (s), 1113 (m), 971 (w), 836 (m), 778 (m), 731 
(m), 699 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.60–7.57 (2H, m), 7.39–7.36 (3H, 
m), 7.17–7.12 (1H, m),  6.93–6.87 (2H, m), 6.79 (1H, td, J = 8.4, 2.4 Hz), 2.81–2.74 (1H, 
m), 2.65 (1H, dd, J = 14.0, 3.2 Hz), 1.08 (6H, s), 1.05 (7H, m), 0.40 (3H, s), 0.38 (3H, s); 
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13
C NMR (100 MHz, CDCl3): δ 162.9 (d, J = 243.3 Hz), 147.7 (d, J = 7.5 Hz), 138.5, 
134.1, 129.4 (d, J = 8.2 Hz), 129.2, 127.9, 123.9 (d, J = 2.2 Hz), 115.2 (d, J = 20.8 Hz), 
112.3 (d, J = 20.8 Hz), 83.1, 31.5, 25.0, 24.8, 16.4, –2.2, –3.4; HRMS (ESI+): Calcd  for  
C22H34B1F1N1O2Si1 [M+NH4]
+
: 402.2436, Found: 402.2430. Specific Rotation: [α]D
20
 
+15.1 (c 1.82, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 11.302 49.408 1 11.282 4.884 
2 11.960 50.592 2 11.944 95.116 
(R)-(2-(4-Fluorophenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)ethyl)dimethyl(phenyl)silane (3.58). IR (neat): 3069 (w), 2977 (w), 2928 (w), 1508 
(s), 1348 (s), 1312 (m), 1220 (m), 1141 (s), 1112 (m), 970 (w), 840 (s), 731 (s), 700 (m), 
502 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.56 (2H, m), 7.37–7.35 (3H, m), 
7.10 (2H, dd, J = 8.8, 6.0 Hz), 6.87 (2H, t, J = 8.8 Hz), 2.78–2.71 (1H, m), 2.63 (1H, dd, 
J = 14.0, 3.6 Hz), 1.08 (6H, s), 1.06–1.01 (7H, m), 0.39 (3H, s), 0.36 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 161.2 (d, J = 241.1 Hz), 140.6 (d, J = 3.8 Hz), 138.6, 134.0, 129.6 
(d, J = 7.4 Hz), 129.1, 127.9, 114.7 (d, J  = 20.8 Hz), 83.0, 30.9, 25.0, 24.8, 16.6, –2.2, –
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3.4; HRMS (ESI
+
): Calcd for C22H34B1F1N1O2Si1 [M+NH4]
+
: 402.2436, Found: 
402.2445. Specific Rotation: [α]D
20
 +15.7 (c 1.62, CHCl3) for an enantiomerically 
enriched sample of 98:2 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 11.759 49.650 1 11.494 2.233 
2 12.963 50.350 2 12.546 97.767 
(R)-Dimethyl(phenyl)(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(thiophen-3- 
yl)ethyl)silane (3.59). IR (neat): 3069 (w), 2976 (w), 2957 (w), 1427 (w), 1347 (s), 1303 
(m), 1248 (s), 1142 (s), 1112 (m), 1007 (w), 908 (w), 814 (s), 771 (m), 730 (s), 699 (s), 
578 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.55 (2H, m), 7.37–7.34 (3H, m), 
7.16–7.14 (1H, m),  6.90–6.89 (2H, m), 2.85 (1H, dd, J = 14.8, 12.8 Hz), 2.65 (1H, dd, J 
= 14.8, 3.6 Hz), 1.11 (6H, s), 1.07–1.03 (7H, m), 0.38 (3H, s), 0.36 (3H, s); 13C NMR 
(100 MHz, CDCl3): δ 145.5, 138.6, 134.0, 129.1, 128.4, 127.8, 124.9, 119.6, 83.0, 30.5, 
25.0, 24.8, 15.5, –2.3, –3.3; HRMS (ESI+): Calcd for C20H33B1N1O2S1Si1 [M+NH4]
+
: 
390.2094, Found: 390.2096. Specific Rotation: [α]D
20
 +20.5 (c 1.56, CHCl3) for an 
enantiomerically enriched sample of 98.5:1.5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
  
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 12.030 49.309 1 11.887 1.487 
2 15.426 50.691 2 14.953 98.513 
 
 Enantioselective Synthesis of Bruguierol A 
Procedure for Synthesis of Alkenylsilane 3.60a from Protosilylation of Alkyne 3.60: 
The experimental procedure for synthesis of compound 3.60a is the same as described 
above in the representative experimental procedure. 
(E)-(3-Methoxystyryl)dimethyl(phenyl)silane (3.60a). IR (neat): 2921 (w), 2851 (w), 
1737 (s), 1446 (w), 1364 (m), 1219 (s), 1084 (m), 1024 (m), 965 (m), 834 (w), 762 (w), 
738 (w), 672 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.57 (2H, m), 7.38–7.36 
(3H, m), 7.25 (1H, t, J = 8.0 Hz), 7.05–7.03 (1H, m), 7.00–6.99 (1H, m), 6.92 (1H, d, J = 
19.2 Hz), 6.84–6.81 (1H, m), 6.58 (1H, d, J = 18.8 Hz), 3.82 (3H, s), 0.44 (6H, s); 13C 
NMR (100 MHz, CDCl3): δ 160.0, 145.3, 139.8, 138.7, 134.1, 129.6, 129.2, 128.0, 127.6, 
119.4, 114.3, 111.5, 55.4, –2.4; HRMS (ESI+): Calcd for C17H21O1Si1 [M+H]
+
: 269.1385, 
Found: 269.1380. 
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Procedure for Enantioselective Protoboration of Alkenylsilane 3.60a: The 
experimental procedure for synthesis of compound 3.61 is the same as described above in 
the representative experimental procedure. 
(R)-(2-(3-Methoxyphenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)dimethyl(phenyl)silane (3.61). IR (neat): 3068 (w), 2977 (w), 1600 (w), 1488 
(w), 1379 (m), 1349 (s), 1308 (m), 1259 (m), 1143 (s), 1113 (w), 1049 (w), 838 (m), 698 
(m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.59–7.57 (2H, m), 7.37–7.36 (3H, m), 7.12 
(1H, t, J = 8.0 Hz), 6.78–6.65 (3H, m), 3.77 (3H, s), 2.83–2.76 (1H, m), 2.68 (1H, dd, J = 
14.0, 3.2 Hz), 1.12–1.09 (7H, m), 1.04 (6H, s), 0.39 (3H, s), 0.36 (3H, s); 13C NMR (100 
MHz, CDCl3): δ 159.5, 146.6, 138.7, 134.0, 129.1, 129.0, 127.8, 120.7, 113.7, 111.2, 
83.0, 55.2, 31.7, 25.0, 24.8, 16.2, –2.2, –3.3; HRMS (ESI+): Calcd for C23H37B1N1O3Si1 
[M+NH4]
+
: 414.2636, Found: 414.2646. Specific Rotation: [α]D
20
 +17.5 (c 2.20, CHCl3) 
for an enantiomerically enriched sample of 97.5:2.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material (Chiralpak AD-H column, 99/1 hexanes/i-PrOH, 0.3 mL/min, 220 nm). 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 12.064 50.118 1 12.084 2.483 
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2 13.118 49.882 2 13.130 97.517 
Procedure for Synthesis of Allylsilane 3.62: The experimental procedure has been 
reported previously.
47
 
(S)-(1-(3-Methoxyphenyl)but-3-en-2-yl)dimethyl(phenyl)silane (3.62). IR (neat): 2956 
(w), 2916 (w), 1625 (m), 1488 (m), 1428 (m), 1257 (s), 1190 (m), 1083 (m), 833 (s), 775 
(s), 699 (s) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.55–7.52 (2H, m), 7.39–7.34 (3H, m), 
7.13 (1H, t, J = 8.0 Hz), 6.69–6.63 (3H, m), 5.65 (1H, td, J = 17.2, 10.0 Hz), 4.86–4.84 
(1H, m), 4.76–4.72 (1H, m), 3.76 (3H, s), 2.79 (1H, dd, J = 14.8, 3.6 Hz), 2.59 (1H, dd, J 
= 14.4, 11.2 Hz), 2.17–2.10 (1H, m), 0.32 (3H, s), 0.31 (3H, s); 13C NMR (100 MHz, 
CDCl3): δ 159.5, 144.0, 139.0, 137.5, 134.2, 129.2, 129.1, 127.9, 121.2, 114.5, 113.4, 
111.0, 55.2, 36.0, 34.9, –4.3, –5.0; HRMS (ESI+): Calcd for C19H25O1Si1 [M+H]
+
: 
297.1675, Found: 297.1676. Specific Rotation: [α]D
20
 –13.5 (c 0.99, CHCl3) for an 
enantiomerically enriched sample of 97.5:2.5 e.r. 
Procedure for Hydroformylation/Reduction: Compound 3.63 was prepared according 
to a known procedure.
48
 
(R)-4-(Dimethyl(phenyl)silyl)-5-(3-methoxyphenyl)pentan-1-ol (3.63). IR (neat): 3359 
(br), 2924 (s), 2853 (m), 1600 (m), 1454 (m), 1258 (s), 1190 (m), 1048 (s), 814 (s), 733 
(s), 699 (s), 472 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.54–7.51 (2H, m), 7.37–7.34 
(3H, m), 7.15 (1H, t, J = 8.0 Hz), 6.73–6.66 (3H, m), 3.77 (3H, s), 3.43–3.40 (2H, m), 
2.78 (1H, dd, J = 14.0, 4.8 Hz), 2.44 (1H, dd, J = 14.0, 10.4 Hz), 1.57 (1H, s), 1.48–1.33 
(4H, m), 1.32–1.22 (1H, m), 0.31 (3H, s), 0.29 (3H, s); 13C NMR (100 MHz, CDCl3): δ 
159.7, 144.5, 138.7, 134.0, 129.2, 129.1, 127.9, 121.4, 114.8, 111.0, 63.2, 55.3, 36.3, 
                                                 
(47) Aggarwal, V. K.; Binanzer, M.; de Ceglie, M. C.; Gallanti, M.; Glasspoole, B. W.; Kendrick, S. J. F.; 
Sonawane, R. P.; Vázquez-Romero, A.; Webster, M. P. Org. Lett. 2011, 13, 1490–1493. 
(48) (a) Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210–9211. (b) 
Sun, X.; Frimpong, K.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 11841–11843. 
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32.3, 27.2, 25.5, –3.7, –3.8; HRMS (ESI+): Calcd for C20H32N1O2Si1 [M+NH4]
+
: 
346.2202, Found: 346.2206. Specific Rotation: [α]D
20
 +7.1 (c 0.16, CHCl3) for an 
enantiomerically enriched sample of 97.5:2.5 e.r. 
Procedure for Fleming Oxidation of 3.63: To a solution of 3.63 (358.1 mg, 1.090 
mmol, 1.0 equiv.) in CH2Cl2 (3 mL) was added HBF4·OEt2 (598 µL, 4.360 mmol, 4.0 
equiv.) at 22 °C. The mixture was allowed to stir at 22 °C for 3.0 h. A saturated aqueous 
solution of sodium bicarbonate (5 mL) was added to quench the reaction. Layers were 
separated and the organic layer was washed with a saturated aqueous solution of sodium 
bicarbonate. The aqueous layer was extracted by diethyl ether (3 × 3 mL). The combined 
organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo. The yellow oil was dissolved in thf/MeOH (1/1) (6 mL). NaHCO3 (137.5 mg, 
1.635 mmol, 1.5 equiv.), KF (107.7 mg, 1.835 mmol, 1.7 equiv.) and H2O2 (744 µL, 
6.540 mmol, 6.0 equiv.) were added sequentially at 22 °C. The resulting mixture was 
allowed to stir at 22 °C for 12 h. The reaction was quenched by passing the mixture 
through a short plug of silica gel and eluting with CH2Cl2. The filtrate was concentrated 
in vacuo and the crude product was purified by silica gel chromatography 
(hexanes:EtOAc=1:1) to afford the desired diol 3.64 as colorless oil (192.5 mg, 0.915 
mmol, 84% yield over two steps). 
(R)-5-(3-Methoxyphenyl)pentane-1,4-diol (3.64). IR (neat): 3328 (br), 2922 (s), 2852 
(m), 1713 (w), 1584 (m), 1488 (m), 1436 (m), 1258 (s), 1153 (m), 1044 (s), 780 (m), 697 
(m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.23 (1H, t, J = 8.0 Hz), 6.81–6.76 (3H, m), 
3.90–3.84 (1H, m), 3.80 (3H, s), 3.68–3.63 (2H, m), 2.80 (1H, dd, J = 13.6, 4.4 Hz), 2.68 
(1H, dd, J = 13.2, 8.4 Hz),  2.28 (2H, br s), 1.76–1.67 (3H, m), 1.62–1.56 (1H, m); 13C 
Chapter 3, Page 189 
 
 
NMR (100 MHz, CDCl3): δ 159.9, 140.2, 129.7, 121.8, 115.2, 112.0, 72.7, 63.0, 55.3, 
44.3, 33.9, 29.4; HRMS (ESI
+
): Calcd for C12H19O3 [M+H]
+
: 211.1334, Found: 
211.1340. Specific Rotation: [α]D
20
 –4.5 (c 0.28, CHCl3) for an enantiomerically enriched 
sample of 97.5:2.5 e.r. 
Procedure for Synthesis of Lactone 3.65: To a solution of diol 3.64 (205.0 mg, 0.975 
mmol, 1.0 equiv.) in CH2Cl2 (10 mL) was added TPAP (17.1 mg, 0.049 mmol, 0.05 
equiv.) and NMO (342.7 mg, 2.925 mmol, 3.0 equiv.) at 22 °C. The mixture was allowed 
to stir at 22 °C for 1.0 h. The reaction was quenched by passing the mixture through a 
short plug of silica gel and eluting with CH2Cl2. The filtrate was concentrated in vacuo 
and the crude product was purified by silica gel chromatography (hexanes:EtOAc=4:1) to 
afford the desired lactone 3.65 (160.9 mg, 0.780 mmol, 80% yield) as colorless oil. 
(R)-5-(3-Methoxybenzyl)dihydrofuran-2(3H)-one (3.65). IR (neat): 2945 (w), 1769 (s),     
1601 (m), 1490 (w), 1437 (w), 1259 (m), 1175 (s), 1040 (m), 918 (w), 783 (w), 699 (w), 
649 (w) cm
–1
; 
1
H NMR (400 MHz, CDCl3): δ 7.23 (1H, t, J = 8.0 Hz), 6.84–6.76 (3H, 
m), 4.77–4.70 (1H, m), 3.79 (3H, s), 3.05 (1H, dd, J = 14.0, 6.0 Hz), 2.90 (1H, dd, J = 
14.0, 6.0 Hz), 2.51–2.36 (2H, m), 2.29–2.21 (1H, m), 2.00–1.90 (1H, m); 13C NMR (100 
MHz, CDCl3): δ 177.1, 159.9, 137.5, 129.8,  121.9,  115.3,  112.4,  80.8,  55.3,  41.5,  
28.8,  27.3;  HRMS  (ESI
+
):  Calcd  for  C12H15O3 [M+H]
+
: 207.1021, Found: 207.1014. 
Specific Rotation: [α]D
20
 –5.1 (c 0.34, CHCl3) for an enantiomerically enriched sample of 
97.5:2.5 e.r. 
Procedure for Synthesis of 3.66: The experimental procedure has been reported 
previously.
49
 
                                                 
(49) Solorio, D. M.; Jennings, M. P. J. Org. Chem. 2007, 72, 6621–6623. 
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(5R,8S)-2-Methoxy-5-methyl-6,7,8,9-tetrahydro-5H-5,8-epoxybenzo[7]annulene 
(3.66). IR (neat): 2935 (m), 1607 (m), 1577 (m), 1496 (s), 1375 (w), 1274 (w), 1248 (s), 
1082 (s), 999 (s), 843 (m), 741 (w), 601 (w), 547 (m) cm
–1
; 
1
H NMR (400 MHz, CDCl3): 
δ 7.07 (1H, d, J = 8.4 Hz), 6.69 (1H, dd, J = 8.4, 2.4 Hz), 6.18–6.12 (1H, m), 4.74–4.70 
(1H, m), 3.77 (3H, s), 3.35 (1H, dd, J = 16.4, 5.2 Hz), 2.49 (1H, d, J = 16.4 Hz), 2.29–
2.20 (1H, m), 2.03–1.97 (1H, m), 1.86–1.80 (1H, m), 1.75–1.67 (4H, m); 13C NMR (100 
MHz, CDCl3): δ 158.4, 136.6, 133.5, 123.9, 114.4, 111.7, 80.4, 74.4, 55.3, 43.1, 37.9, 
30.6, 23.0; HRMS (ESI
+
): Calcd for C13H17O2 [M+H]
+
: 205.1229, Found: 205.1225. 
Specific Rotation: [α]D
20
 +25.0 (c 1.48, CHCl3) for an  enantiomerically enriched sample 
of 97.5:2.5 e.r. 
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Chapter Four 
Site- and Enantioselective NHC–Cu-Catalyzed 
Protoboryl Additions to Disubstituted Allenes: 
Access to Enantiomerically Enriched 
Alkenylborons 
 
4.1. Introduction 
 Allylmetal complexes have been utilized widely in organic chemistry field.
1
 
Nucleophilic additions of these nucleophilic agents to electrophiles such as carbonyl- and 
imine-containing compounds are powerful methods of chemical synthesis.  
Enantioselective protonation
2
 of allylmetal species, however, are rare.
3
 In 2013, site-
selective NHC–Cu-catalyzed protoboration of monosubstituted allenes was reported by 
our group.
4
 In this transformation, with a sterically demanding NHC–Cu complex, Cu–B 
is inserted into the less hindered olefin of the allene to generate an allylcopper bearing a 
B(pin) unit at the center carbon, which is protonated γ-selectively by MeOH to generate 
1,1-disubstituted alkenylboron. Since protoboration of 1,1-disubstituted allene can deliver 
                                                 
(1) Yus, M.; Gonzalez-Gomez, J. C.; Foubelo, F. Chem. Rev. 2013, 113, 5595–5698. 
(2) For recent reviews on enantioselective protonations, see: (a) Blanchet, J.; Baudoux, J.; Amere, M.; 
Lasne, M.-C.; Rouden, J. Eur. J. Org. Chem. 2008, 5493–5506. (b) Mohr, J. T.; Hong, A. Y.; Stoltz, B. M. 
Nat. Chem. 2009, 1, 359–369. For a recent relevant report, see: (c) Cheon, C. H.; Kanno, O.; Toste, F. D. J. 
Am. Chem. Soc. 2011, 133, 13248–13251. 
(3) (a) Nishimura, T.; Hirabayashi, S.; Yasuhara, Y.; Hayashi, T. J. Am. Chem. Soc. 2006, 128, 2556–2557. 
(b) Sawano, T.; Ou, K.; Nishimura, T.; Hayashi, T. J. Org. Chem. 2013, 78, 8986–8993. 
(4) Meng, F.; Jung, B.; Haeffner, F.; Hoveyda, A. H. Org. Lett. 2013, 15, 1414–1417. 
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alkenylboron containing stereogenic carbon center, we have probed the transformation of 
1,1-disubstituted allenes to achieve enantiomerically enriched alkenylboron. The 
identification of a proper chiral ligand–Cu complex has challenges: (1) Initial copper–
boron addition to 1,1-disubstituted allene needs to be highly site selective. (2) The chiral 
ligand–Cu complex requires containing sufficient bulk to cause stereochemical 
differentiation for high enantioselectivity. As illustrated in Scheme 1, we wondered that if 
a 1,1-disubstituted allene (i) could undergo site-selective reaction with a chiral ligand–
Cu–B(pin) complex, 5  and the resulting 2-B(pin)-substituted allylcopper (ii) could be 
protonated γ- and enantioselectively through a chair-like transition state (iii), 6 
enantiomerically enriched alkenylboron compounds (iv) would be obtained efficiently. 
Since the enantioselective protonation of C–Cu bond would proceed γ-selectively, which 
is distinct from other catalytic protoborations (direct Cu–C bond protonation), the 
resulting organoboron compounds might not be able to be accessed by traditional metal-
catalyzed hydroboration reactions.
7
 
                                                 
(5) (a) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160–3161. (b) Lee, Y.; Jang, H.; Hoveyda, 
A. H. J. Am. Chem. Soc. 2009, 131, 18234–18235. (c) Coberán, R.; Mszar, N. M.; Hoveyda, A. H. Angew. 
Chem., Int. Ed. 2011, 50, 7079–7082. (d) Meng, F.; Jang, H.; Hoveyda, A. H. Chem. Eur. J. 2013, 19, 
3204–3214. See also: (e) Matsuda, N.; Hirano, K.; Satoh, T.; Miura, M. J. Am. Chem. Soc. 2013, 135, 
4934–4937. (f) Meng, F.; Haeffner, J.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 11304–11307. 
(6) (a) Meng, F.; Jung, B.; Haeffner, F.; Hoveyda, A. H. Org. Lett. 2013, 15, 1414–1417. For related 
studies, see: (b) Yuan, W.; Ma, S. Adv. Synth. Catal. 2012, 354, 1867–1872. (c) Semba, K.; Shinomiya, M.; 
Fujihara, T.; Terao, J.; Tsuji, Y. Chem. –Eur. J. 2013, 19, 7125–7132. 
(7) Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials, Vol. 2; 
Hall, D. G., Ed.; Wiley-VCH: Weinheim, Germany, 2011. 
Chapter 4, Page 223 
 
 
 
 Enantiomerically enriched α-stereogenic center-containing alkenylboron product 
is a synthetically useful intermediate, since C–B bond can be readily functionalized to 
other bonds. After simple oxidation, we can obtain corresponding methyl ketone, and 
also another synthetically useful alkenyl bromide might be afforded through Cu-mediated 
conversion of C–B bond to C–Br bond. Catalytic direct oxidation to carboxylic acid may 
illustrate further utility of alkenylboron product. In addition, alkenylboron has been 
utilized as an alkenyl-metal precursor for a wide range of C–C bond forming reactions 
such as allylic substitution. Herein, we have disclosed Cu-catalyzed enantioselective 
protoboryl addition to 1,1-disubstituted allenes to afford enantiomerically enriched 
alkenylboron products, and also describe the transformation of them to other useful 
intermediates including methyl ketones, alkenyl bromides, and carboxylic acids. 
Moreover, we illustrate NHC–Cu-catalyzed allylic substitution with an alkenylboron to 
introduce another stereogenic center. 
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4.2. Background 
 In this section, we will summarize the advances regarding catalytic synthesis of 
optically active α-stereogenic center-containing ketones as well as the protocol for 
preparation of corresponding alkenyl bromides. Additionally, we will introduce catalytic 
enantioselective allylic substitutions with alkenylboron reagent as well. 
 
4.2.1. Catalytic Enantioselective Synthesis of α-Stereogenic Center-bearing Ketones 
 Catalytic enantioselective protocols for synthesis of α-tertiary stereogenic center-
bearing ketones have been the subject of synthetic chemistry field due to the versatility of 
them for the natural product and pharmaceutical syntheses.
8
 We will summarize recent 
advances regarding catalytic enantioselective methods for preparing ketones containing 
α-tertiary stereogenic center. 
 In 2010, Fu and coworkers described enantioselective Kumada coupling of α-
bromo ketones with aryl–Grignard reagents catalyzed by 7 mol % of a chiral Ni–
bis(oxazoline) complex to afford a wide range of coupled products with high 
enantioselectivities (up to 97.5:2.5 e.r.).
9
 Coupling of racemic α-bromo ketone 4.1 with 
phenyl magnesium bromide in the presence of 7 mol % of a chiral Ni complex derived 
from NiCl2·glyme and chiral bis(oxazoline) 4.2 furnishes α,α-phenyl,methyl-bearing 
phenyl ketone 4.3 in 81% yield and 96:4 e.r. (Scheme 4.2). To expand the substrate scope, 
they examine various aryl Grignard reagents as coupling partner, one of which is Boc-
                                                 
(8) (a) Trost, B. M.; Xu, J. J. Am. Chem. Soc. 2005, 127, 17180−17181. (b) Yan, X.-X.; Liang, C.-G.; 
Zhang, Y.; Hong, W.; Cao, B.-X.; Dai, L.-X.; Hou, X.-L. Angew. Chem., Int. Ed. 2005, 44, 6544−6546. (c) 
Zheng, W.-H.; Zheng, B.-H.; Zhang, Y.; Hou, X.-L. J. Am. Chem. Soc. 2007, 129, 7718−7719. (d) Lundin, 
P. M.; Esquivias, J.; Fu, G. C. Angew. Chem., Int. Ed. 2009, 48, 154−156. (e) Lou, S.; Fu, G. C. J. Am. 
Chem. Soc. 2010, 132, 1264−1266. (f) Cherney, A. H.; Kadunce, N. T.; Reisman, S. E. J. Am. Chem. Soc. 
2013, 135, 7442−7445. 
(9) Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 1264−1266. 
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protected indole magnesium bromide, delivering desired product 4.4 efficiently and 
selectively (73% yield and 95:5 e.r.). Heterocycle-containing ketone 4.5 can be accessed 
through Ni-catalyzed Kumada coupling without reduced selectivity (93.5:6.5 e.r.). In 
addition, α-bromo ketone containing longer chain with a halide group is subjected to the 
coupling reaction, and successfully converted to α,α-aryl,alkyl-phenyl ketone 4.6 with 
similar level of efficiency and selectivity (73% yield and 93:7 e.r.). When the authors 
utilize dialkyl ketones (e.g., 4.7), the use of structurally modified bis(oxazoline) ligand 
4.8 is required for maximum efficiency and enantioselectivity. They obtained α- 
stereogenic center-bearing alkyl ketones 4.9–4.12 with slightly lower selectivities 
(86.5:13.5–95:5 e.r.), but high efficiency (70–90% yield). The above transformation has a 
broad substrate scope including aryl- or alkyl-ketones bearing two substituents on α-
carbon. They haven’t report, however, corresponding methyl ketones. 
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 Recently, Reisman and coworkers reported that reaction of acyl chloride 4.13 and 
alkyl chloride 4.14 with 10 mol % Ni complex, derived from bis(oxazoline) 4.2 and 
Ni(II) salt, and 3 equiv. of reductant Mn(0), proceeds to reductive cross-coupling product 
4.9 in 60% yield and 95.5:4.5 e.r. (Scheme 4.3).
10
 Various α,α-disubstituted ketones 
bearing linear (4.15 and 4.17) and β-branched (4.16) alkyl chains are provided with high 
selectivity (92.5:7.5–96.5:3.5 e.r.). In comparison with previous Kumada coupling to 
afford alkyl ketones,
11
 the aforementioned process can deliver α,α-disubstituted alkyl 
ketones with higher level of enantioselectivity. However, no aryl ketones as well as no 
                                                 
(10) Cherney, A. H.; Kadunce, N. T.; Reisman, S. E. J. Am. Chem. Soc. 2013, 135, 7442−7445. 
(11) Lou, S.; Fu, G. C. J. Am. Chem. Soc. 2010, 132, 1264−1266. 
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methyl ketones are reported. Thus, although lots of efforts by various organic chemists 
have been made, there are still some unsolved problems such as efficient and selective 
synthesis of methyl ketone containing α-tertiary stereogenic center. 
 
 
4.2.2. Preparation of α-Stereogenic Center-containing Alkenyl Bromides 
 Since alkenyl bromides have been utilized widely for a lot of transformations to 
build a C–C bond such as metal-catalyzed cross-coupling reactions. Thus, development 
of efficient protocol for synthesis of bromo alkenes is of high value. Especially, α-
stereogenic center-bearing alkenyl bromides might be useful, can be applied to various 
transformations. However, only one example has been reported to generate this class of 
alkenyl bromide by Alexakis and coworkers in 2012.
12
 As described in Scheme 4.4, 
enantioselective allylic ethyl addition to bromo-substituted allylic bromide 4.18 with 
ethyl Grignard reagent in the presence of 2 mol % of chiral imidazolinium salt 4.19 
delivers desired internal alkenyl bromide 4.20 in 70% yield with 88% SN2’ selectivity 
and 92.5:7.5 e.r. When they introduce methyl magnesium bromide, unfortunately, 
                                                 
(12) Grassi, D.; Alexakis, A. Org. Lett. 2012, 14, 1568−1571. 
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reaction becomes less efficient (40% yield for 4.21). With a Grignard reagent carrying a 
longer alkyl chain, similar level of efficiency is obtained (50% yield for 4.22). Both of 
them afford α,α-disubstituted alkenyl bromides with high site- and enantioselectivities 
(93–>98% γ and 86.5:13.5–96.5:3.5 e.r.). Their substrate scope is, however, very limited; 
less than ten examples are reported. Thus, the aforementioned protocol cannot be a 
general method to provide this type of alkenyl bromide.  
 
 
4.2.3. Catalytic Enantioselective Allylic Substitutions with Alkenylboron Reagent 
 Development of catalytic enantioselective allylic substitution reactions with 
alkenylboron compounds have been interested by organic chemists because boron 
reagents are robust and have functional group compatibility. In comparison with other 
alkenylmetal reagents, however, alkenylboron reagents are far less reactive. Because of 
poor reactivity of alkenylboron compounds, there have been rarely developed catalytic 
protocols for allylic substitution with this type of alkenyl-group source. In 2011, Shintani, 
Hayashi, and coworkers described NHC–Cu-catalyzed allylic aryl additions to allylic 
Chapter 4, Page 229 
 
 
phosphate to achieve enantiomerically enriched terminal olefins.
13
 Addition to their aryl 
boronate cases, they examine an alkenyl boronate (cyclohexenyl; 4.24) as a substrate for 
allylic alkenyl addition with allylic phosphate 4.23 in the presence of Cu–NHC complex 
generated from chiral salt 4.25, delivering product 4.26 in 84% yield and 86.5:13.5 e.r. 
with high site selectivity (99% SN2’). Although the aforementioned reaction is highly 
efficient and selective, they only illustrated a single example. 
 
NHC–Cu-catalyzed enantioselective allylic alkenyl additions to trisubstituted 
allylic phosphate by the use of alkenylboron pinacol esters, generating quaternary 
stereogenic centers are illustrated by our laboratory in 2012.
14
 No example for the 
preparation of tertiary center, however, is addressed. 
In 2013, Carreira and coworkers reported that coupling of secondary alcohols and 
alkenyltrifluoroborates with catalytic amount of a chiral phosphoramidite–Ir complex 
affords desired products efficiently and highly selectively (Scheme 4.5).
15
 When they 
utilize secondary alcohol 4.27 and internal alkenyl (trifluoro)boron potassium salt 4.46 in 
the presence of 8 mol % Ir complex derived from [Ir(cod)Cl]2 salt and a chiral 
phosphoramidite 4.29, allylic substitution product 4.30 is obtained in 63% yield and 97:3 
                                                 
(13) Shintani, R.; Takatsu, K.; Takeda, M.; Hayashi, T. Angew. Chem., Int. Ed. 2011, 50, 8656−8659. 
(14) Gao, F.; Carr, J. L.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2012, 51, 6613−6617. 
(15) Hamilton, J. Y.; Sarlah, D.; Carreira, E. M. J. Am. Chem. Soc. 2013, 135, 994−997. 
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e.r. with exclusive site selectivity (>98% SN2). The authors demonstrate that wide range 
of (E)-alkenylboron salts can be used for alkenyl-group transferring reagents. Phenyl- or 
cyclohexyl-bearing (E)-alkene addition products 4.31 and 4.32 are furnished by the 
aforementioned transformation in 60–81% yield and perfect site- and enantioselectivity 
(>98% SN2 and >99:1 e.r.). Reaction of secondary allylic alcohol with either (Z)-alkenyl- 
or trisubstituted-trifluoroborate undergoes Ir-catalyzed allylic substitution to deliver 
desired product 4.34 or 4.35 as a single regioisomer (>98% SN2) efficiently (70–71% 
yield) with high enantioselectivity (>99:1 and 98.5:1.5 e.r., respectively). In some cases 
(e.g., indole-substituted, 4.33 and cyclopentenyl-bearing, 4.36), they observe significant 
decrease of site selectivity (75:25 SN2:SN2’ for both 4.33 and 4.36). A significant 
advantage of their approach is that unactivated secondary allylic alcohol can be used for 
the catalysis. There are several points, however, they cannot address; (1) only aryl-
bearing allylic alcohols are utilized, (2) preparation of trifluoroboron reagent from 
another boron compound [e.g., (pinacolato)boron] is required, (3) the use of precious 
metal, Ir, is necessary. 
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 A year later, our laboratory developed NHC–Cu-catalyzed enantioselective allylic 
substitution of allylic phosphate with an alkenyl (pinacolato)boron compound.
16
 With 5 
mol % of NHC–Cu complex derived from CuCl, chiral imidazolinium salt A.17, and 
NaOMe, allylic phosphate 4.37 is coupled with internal (pinacolato) alkenylboron 4.38, 
prepared vis α-selective protoboration of terminal alkyne,17 to afford allylic substitution 
product 4.39 in 89% yield, >98% SN2’ and 98:2 e.r. (Scheme 4.6). When silyl-substituted 
allylic phosphate serves as a substrate, allylic substitution with phenyl-bearing internal 
alkenylboron proceeds to provide desired product 4.40 in 93% yield and 97:3 e.r. as a 
                                                 
(16) Gao, F.; Carr, J. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 2149−2161. 
(17) Jang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7859−7871. 
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single regioisomer (>98% SN2’). Both (E)- and (Z)-alkenyl groups are successfully added 
to an allylic phosphate to achieve corresponding diol products 4.41–4.43 efficiently (61–
90% yield) and selectively (96–>98% SN2’ and 93:7–99:1 e.r.). It is worth mentioning 
that enantiomerically enriched products 4.41 and 4.42 are obtained, which are carrying a 
relatively acidic proton, although stoichiometric amount of base is used in the reaction 
solution. Reactions of alkyl-substituted allylic phosphate with trisubstituted alkenylboron 
in the presence of slightly modified NHC–Cu complex derived from A.18 afford products 
4.44 and 4.45 with high level of selectivities (>98% SN2’ and up to 96:4 e.r.). 
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 As shown in Scheme 4.5 and 4.6, a variety of alkenylboron reagents can be 
utilized for catalytic processes such as allylic alkenyl addition reactions. There are, 
however, still unsolved problems need to be addressed. One of them is that there is no 
example to utilize alkenylboron reagent which carries a stereogenic center already. Thus, 
we will address this issue by the use of protoboration of 1,1-disubstituted allene, bearing 
an α-stereogenic center for Cu-catalyzed enantioselective allylic alkenyl addition 
reactions to afford synthetically useful 1,4-diol compounds. 
 
4.3. Practical Method for Preparation of 1,1-Disubstituted Allenes 
 First, we developed a Cu-catalyzed protocol to prepare 1,1-disubstituted allenes 
efficiently. The representative examples are illustrated in Scheme 4.7. Reaction of a 
propargylic phosphate 4.46 with a phenylaluminum species, prepared in situ by reaction 
of an dimethyl aluminum chloride and a phenyl–Li reagent, in the presence of 5 mol % 
CuCl, affords 1,1-disubstituted allene 4.47 in 80% yield with a perfect site selectivity 
(>98% SN2’) in only five minute.
18
 The efficiency and site selectivity of the 
aforementioned reaction is not affected by electronic nature of aryl substituent. We 
successfully synthesized p-MeO-phenyl- and p-CF3-phenyl-containing 1,1-disubstituted 
allenes 4.48 and 4.49 in 79–84% yield as a single regioisomer (>98% SN2’) under the 
same condition. Transformation proceeds to completion in one hour for a one half gram 
scale, providing allene 4.47 in 63% yield. 
                                                 
(18) For a related catalytic protocol involving Ni(acac)2 and Grignard reagents, see: Li, Q.; Gau, H. Synlett 
2012, 23, 747–750. 
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4.4. Catalytic Enantioselective Protoboration of 1,1-Disubstituted Allenes 
4.4.1. Evaluation of Chiral NHC–Cu and Bisphosphine–Cu Complexes 
 We began by examining various chiral NHC–Cu complexes for protoboryl 
addition to phenyl,methyl-allene 4.47 with 1.5 equiv. of i-BuOH as a proton source 
(Scheme 4.8). With 5 mol % of monodentate NHC–Cu complex derived from A.13, we 
obtained a mixture of three regioisomers 4.50a, 4.50b, and 4.50c (76:14:10) in 55% yield 
and 87:13 e.r. Encouraged by the result with A.13, we examined another monodentate 
NHC–Cu complex generated from C2-symmetric salt A.19, proceeding to moderate site 
selectivity (40:40:20) and low enantioselectivity (52:48 e.r.). Since the isolation of pure 
4.48a isomer from a mixture of three isomers is not trivial, the achievement of high site 
selectivity is significant. We turned our attention to bidentate sulfonate-bridging NHC–
Cu complexes. Reaction of 4.47 in the presence of N-Mes-bearing sulfonate salt A.3, 
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delivered a mixture of products in 65% yield with 73% selectivity for 4.50a and 80:20 
e.r. We prepared N-3,5-(t-Bu)2-phenyl-containing imidazolinium salt A.20 to investigate 
the effect of substitution pattern to site- and/or enantioselectivities. Since the ratio of 
4.50a:b:c is 23:45:32, Cu–NHC complex with m-substituted phenyl unit seems not 
suitable to achieve high site selectivity for this transformation. In addition, mono phenyl 
backbone-bearing variant of A.20 was also tested, giving a similar level of site selectivity 
(4.50a:b:c = 46:19:35 for A.21). Based on these observations, we decided to examine 
reaction of 4.47 with Cu complex carrying sterically more demanding, 1,3,5-(i-Pr)3-
phenyl-bearing NHC (A.6), delivering 82% yield of 95:5 mixture of 4.50a and 4.50b 
(<2% of 4.50c) with 87:13 e.r. Thus, we chose a chiral imidazolinium A.6 as an optimal 
NHC precursor for further study. 
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 To improve site- and enantioselectivity, we have investigated the proton source 
for the reaction (Table 4.1). We reasoned that use of a more sterically hindered alcohol 
might exacerbate the steric interactions with in situ generated allylcopper species in the 
competing transition states for enantioselective protonation, leading to a rise in 
enantioselectivity (see section 4.4.3 for detailed analysis). We therefore examined 
protoboration of 1,1-disubstituted allene 4.47 with various alcohols in the presence of 
NHC–Cu complex derived from A.6. As shown in entry 1, with a small methyl-bearing 
alcohol, much lower enantioselectivity (63:37 e.r.), and also lower site selectivity 
(4.50a:b:c = 86:14:<2) are obtained. On the other hand, with α-branched i-PrOH, as we 
expected, the enantioselectivity is slightly increased (90:10 vs 87:13 e.r.; entry 3 vs entry 
2). When sterically more demanding t-butanol was utilized as a proton source, reaction of 
4.47 proceeded to 97.5% of 4.50a isomer in 77% yield with 93:7 e.r. (entry 4). 
 
Since we observed that chiral bisphosphine–Cu complex can promote Cu–B 
addition to monosubstituted allene followed by addition to aldehyde with high 
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enantioselectivity,
19
 these complexes are also examined for catalytic protoboration of 
disubstituted allenes. As illustrated in Scheme 4.9, with 1.5 equiv. of t-BuOH, we 
examined NHC–Cu-catalyzed protoboration of 4.47 in the presence of commercially 
available chiral phosphine ligands (4.51–4.56) and a further structurally modified 
imidazolinium salt A.22. Based on our screening results, generally, chiral bisphosphine–
Cu complexes catalyze protoboration reaction with either low efficiency (23% conv for 
4.53 and 4.56) or minimal site selectivity (50:50:<2 for 4.51). On the other hand, with a 
phosphine ligand 4.55, tetrasubstituted alkenylboron compound 4.50b was generated as a 
major regioisomer (27:73:<2). Reaction with bisphosphine 4.52 [(R)-segphos] generated 
4.50a in 53% yield and 93:7 e.r. along with 9% of byproducts (4.50b and 4.50c). 
Although the level of enantioselectivity is compatible, site selectivity with 4.52 is lower 
than that with A.6 (91% vs 97.5% of 4.50a), and significantly lower yield (53% vs 77%) 
is obtained with 4.52. Further efforts to improve site- and enantioselectivities lead us to 
prepare a chiral imidazolinium sulfonate A.22, p-naphthyl-bearing variant of A.6, which 
providing even higher enantioselectivity (95:5 e.r.) and a perfect site selectivity (>98% 
4.50a). Based on the chiral Cu complex screening results, we chose the chiral 
imidazolinium salt A.22, which contains a large naphthyl unit on the para position of N-
Ar group as an optimal NHC precursor. 
                                                 
(19) Meng, F.; Jang, H.; Jung, B.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2013, 52, 5046−5051. 
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4.4.2. Cu-Catalyzed Enantioselective Protoboration of 1,1-Disubstituted Allenes 
 A wide array of 1,1-disubstituted allenes serve as substrates for Cu-catalyzed 
enantioselective protoboration reaction to deliver α-tertiary stereogenic center-bearing 
internal alkenylboron products efficiently and highly selectively (Scheme 4.10). When o-
Cl-containing allene is used, alkenylboron 4.59a is provided with lower enantioselectivity 
(90.5:9.5 e.r.). Since we obtain even lower enantioselectivity (71:29 e.r.) with o-Me-
bearing substrate (4.61a), the diminution of selectivity might be due to a steric effect. 
Especially, in the latter case, site selectivity for the reaction is low as well (81:19:<2 
a:b:c). With sterically less demanding fluorine-bearing substrate, on the other hand, 
4.58a is achieved without diminution of enantioselectivity (95:5 e.r.), which is consistent 
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with the above hypothesis. Since the structure of NHC derived from A.22 is sterically 
congested, especially near Cu center, when sterically demanding substrate is used, severe 
interaction might occur to allow the competing other pathways to become more 
dominant. Allenes containing a meta-, or para-substituted aryl group are suitable 
substrates, leading to corresponding alkenylborons 4.62a–4.66a with high levels of 
selectivities (95–>98% site selectivity and 94:6–96:4 e.r.). Additionally, heterocycle-
bearing alkenylboron products 4.69a and 4.70a are delivered through Cu-catalyzed 
protoboration reaction with up to <98% site selectivity and 93:7 e.r. Similar efficiency 
and stereoselectivity levels are observed with substrates with an alkyl and a silyl 
substituent (96% yield, 95% site selectivity, and 95:5 e.r. for 4.71a). Then, NHC–Cu-
catalyzed enantioselective protoboration of Et- and i-Pr-substituted allenes is probed. 
Reaction of Et-substutitued allene is more selective than i-Pr-bearing one (95% vs 81% 
site selectivity and 96:4 vs 87:13 e.r.; 4.72a vs 4.73a). This observation is consistent with 
the results from reaction of o-Me-containing allene (4.61a). Moreover, we examine 
enantioselective protoboration of exocyclic 1,1-disubstituted allenes, furnishing desired 
alkenylboron 4.75a or 4.76a efficiently, site- and enantioselectively (88–95% yield, 
>98% site selectivity and up to 96.5:3.5 e.r.). 
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Since we obtained similar level of enantioselectivity with chiral NHC–Cu 
complex derived from A.6 or bisphosphine–Cu complex from (R)-segphos 4.52, Cu-
catalyzed process in the presence of either one of these Cu complexes is also examined 
for the cases in Scheme 4.10 to compare efficiency and selectivity to those obtained with 
A.22-mediated Cu complex. In many instances, the phosphine–Cu complex provided 
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substantial amounts of inseparable isomeric products. The worst case is that with o-
methoxy-substituted 4.60a, only 5% of the product mixture is desired isomer (a:b:c = 
5:80:15). Moreover, in many cases, the use of bisphosphine 4.52 resulted in low 
enantioselectivity (e.g., 33:67 e.r. for 4.60a and 23.5:76.5 e.r. for 4.71a). Although 
reaction of 4.47 with either A.6 or A.22 results in similar efficiency and selectivity [77% 
yield, 97.5% site selectivity, and 93:7 e.r. for A.6 (Table 4.1) vs 79% yield, >98% site 
selectivity, and 95:5 e.r. for A.22 (Scheme 4.9)], in some cases, the latter afforded 
significantly higher site selectivities. For instance, pyridine-bearing alkenylboron product 
4.69a was generated less site-selectively with A.6 (a:b:c = 77:23:<2 vs 90:10:<2 for 
A.22). 
 
4.4.3. Stereochemical Models to Account for Enantioselectivity 
As illustrated in Scheme 4.11, we build up the stereochemical models to account 
for the selectivity trends with various NHC–Cu complexes and influence of different 
alcohols. Allylcopper bearing B(pin) unit (I), generated through site-selective copper–
boron addition to 1,1-disubstituted allene, reacts with alcohol either by front- (mode II) or 
rear-face approach (mode III). There are two steric interactions can make mode III less 
preferred than mode II, one of which is the interaction between alcohol substituent (R) 
and ortho-substituent on N-Ar of the NHC. Because of the tilt of the N-Ar, this 
interaction is more severe in mode III than in mode II, which render III less favorable. 
This point led us to screen various alcohols, and to observe increased enantioselectivity 
with sterically more demanding alcohol [93:7 e.r. with t-BuOH vs 63:37 e.r. with MeOH 
(Table 4.1)). Another factor can control the enantioselectivity is the interaction between 
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para-substituent on N-Ar of the NHC and aryl unit of substrate. This repulsive interaction 
might make mode III less dominant. With a large p-naphthyl-containing A.22, we 
obtained slightly higher enantioselecitivity (95:5 e.r.) compared to one (93:7 e.r.) with p-
isopropyl A.6, which is consistent with our hypothesis. 
 
 
4.4.4. Representative Functionalizations 
Since C–B bond in alkenylboron product is readily converted to other useful 
bonds, we have focused on development of functionalization methods to synthesize 
synthetically useful molecules. First, as illustrated in Scheme 4.12, the mild oxidation of 
enantiomerically enriched alkenylboron 4.50a (95:5 e.r.) is complete in 30 min with 5 
equiv. of sodium perborate in a 1:1 mixture of thf and buffered water (pH = 7) to afford 
corresponding methyl ketone 4.77 in 94:6 e.r. (98% e.s.). As we mentioned in Section 
4.2.1, synthesis of enantiomerically enriched α-tertiary stereogenic center-containing 
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methyl ketone is not presented yet.
20
 Thus, Cu-catalyzed enantioselective protoboration 
of 1,1-disubstituted allene can be a unique strategy to access those types of compounds. 
Three different substituent-bearing methyl ketones 4.78–4.80 are achieved under the 
same oxidation condition without significant diminution of enantioselectivity (97–>98% 
e.s.) with high efficiency (89–>98% yield). 
 
Next, the transformation of alkenyl–B(pin) to alkenyl bromide, which has been 
widely utilized for various C–C bond forming reactions such as metal-catalyzed cross-
coupling reaction, is demonstrated in Scheme 4.13. With 7 equiv. of CuBr2, 
enantiomerically enriched α,α-disubstituted alkenyl bromides 4.81–4.83 and ent-4.20 are 
successfully synthesized with a perfect enantiospecificity (>98% e.s. for all cases) under 
the reflux condition in 14 hours. As we also mentioned in Section 4.2.1, catalytic 
enantioselective protocol for prepare this type of product is rare. 
                                                 
(20) For enzyme-catalyzed enantioselective synthesis of 2-arylsubstituted butanones, see: Rodríguez, C.; de 
Gonzalo, G.; Pazmiño, D. E. T.; Fraaije, M. W.; Gotor, V. Tetrahedron: Asymmetry 2009, 20, 1168−1173. 
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In addition, direct oxidation of alkenylboron product to corresponding carboxylic 
acid with a catalytic amount of OsO4 is examined. Enantiomerically enriched α,α-
disubstituted carboxylic acid 4.84 is obtained in 72% overall yield with high 
enantioselectivity (95:5 e.r.) by the sequential NHC–Cu-catalyzed protoboration of 4.47 
and the aforementioned process (eq 4.2).
21
 Enantioselective synthesis of nonsteroidal 
anti-inflammatory agent (S)-naproxen is illustrated in eq 4.3 by use of this strategy. With 
only 1 mol % of NHC–Cu complex from A.22, the sequential transformation underwent 
to deliver (S)-naproxen in 75% overall yield and 95:5 e.r. (94% e.s.). 
                                                 
(21) For recent catalytic enantioselective synthesis of α,α-disubstituted carboxylic acids, see: (a) Bigot, A.; 
Williamson, A. E.; Gaunt, M. J. J. Am. Chem. Soc. 2011, 133, 13778−13781. (b) Harvey, J. S.; Simonovich, 
S. P.; Jamison, C. R.; MacMillan, D. W. C. J. Am. Chem. Soc. 2011, 133, 13782−13785. (c) Huang, Z.; Liu, 
Z.; Zhou, J. J. Am. Chem. Soc. 2011, 133, 15882−15885. 
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4.4.5. Catalytic Allylic Substitutions with Enantiomerically Enriched Alkenylboron 
Alkenylboron reagents have been used for catalytic enantioselective allylic 
substitution reactions. However, chiral nucleophiles have not been utilized. Thus, we 
tried to develop this class of reaction by direct use of enantiomerically enriched alkenyl–
B(pin), the protoboration product. Initially, we performed reaction of 4.50a with allylic 
phosphate 4.23 in the presence of achiral sulfonate-bearing salt A.23, CuCl, and NaOMe, 
proceeded to <2% conversion (Scheme 4.14). To facilitate transmetallation of C–B bond 
to C–Cu bond, more accessible alkenylboron reagents such as neopentyl glycol ester 4.87 
and the trifluoroborate 4.88 were prepared. However, no desired products are observed 
with these alkenylboron reagents (<2% conv). Then, we prepared sterically less hindered 
alkenylboronic acid 4.89 by previously reported simple transformation of alkenylboron 
pinacol ester 4.50a (83% yield).
22
 When we subjected 4.89 to the reaction with 4.23, 
                                                 
(22) Wang, H.-Y.; Anderson, L. L. Org. Lett. 2013, 15, 3362−3365. 
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desired allylic alkenyl addition product 4.86 was delivered with >98% conv, 54% yield, 
98:2 site selectivity, and 75:25 d.r. (Scheme 4.14). 
 
To improve selectivity, various chiral NHC–Cu complexes are investigated, and 
as shown in eq 4.4, we found that the complex derived from imidazolinium salt A.17 
promotes allylic alkenyl addition reaction with enantiomerically enriched alkenylboronic 
acid 4.89 (95:5 e.r.), to afford 1,4-diene 4.86 in 62% yield with 98% SN2’ selectivity and 
96:4 d.r. Since we use alkenylboronic acid 4.89 as a 95:5 mixture of enantiomers, the 
stereoselectivity for the allylic substitution reaction is exclusive. With ent-4.89, an 
opposite enantiomer, diastereoisomer 4.90 was generated with similar efficiency and site 
selectivity (62% yield and 96% SN2’) in the presence of NHC–Cu derived from different 
sulfonate salt A.24 (eq 4.5). The stereoselectivity for allylic substitution reaction is 
slightly reduced in the latter case (95%) because an alkenylboron reagent might be 
mismatched with the chiral Cu complex. 
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4.5. Conclusions 
 We have demonstrated site- and enantioselective protonation of B(pin)-substituted 
allylcopper species, which is in situ generated from 1,1-disubstituted allene promoted by 
chiral NHC–Cu complex in a single vessel process. A wide assortment of allenes is 
utilized, affording α-stereogenic center-bearing alkenylboron compounds in up to 98% 
yield and 98:2 e.r. Based on proposed stereochemical models, we successfully found an 
optimal NHC and alcohol source to achieve high efficiency and enantioselectivity. To 
show the utility of aforementioned transformation, we illustrate simple and practical 
methods to convert alkenylboron product to corresponding methyl ketone, alkenyl 
bromide, or carboxylic acid efficiently without diminution of enantiomeric enrichment 
(>94% e.s.). We also have developed NHC–Cu-catalyzed enantioselective allylic alkenyl 
addition to allylic phosphate with alkenylboronic acid, which is prepared from 
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alkenyl(pinacolato)boron product, providing 1,4-diene with high selectivity (61–62% 
yield, 96–98% SN2’, and 89:11–96:4 d.r.). 
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4.6. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, max in cm
−1
. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 
1
H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet, app = apparent), and coupling 
constant (Hz). 
13
C NMR spectra were recorded on a Varian Unity INOVA 400 (100 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in 
ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Unless 
otherwise noted, all reactions were carried out with distilled and degassed solvents under 
an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with standard dry 
box or vacuum-line techniques. Solvents were purified under a positive pressure of dry 
argon by a modified Innovative Technologies purification system: toluene, benzene and 
hexanes were purified through a copper oxide and alumina column; CH2Cl2 and Et2O 
were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific, Inc.) under air atmosphere. Enantiomeric ratios were determined by GC 
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analysis (Alltech Associated Chiraldex B-DM (30 m x 0.25 mm), Chiraldex G-TA (30 m 
x 0.25 mm), and β-dex 120 column (30 m x 0.25 mm)), or HPLC analysis (Chiral 
Technologies Chiralpak
®
 AD-H (4.6 x 250 mm), Chiralcel
®
 OD-H (4.6 x 250 mm), OJ-H 
(4.6 x 250 mm)) in comparison with authentic racemic materials. Specific rotations were 
measured on a ATAGO
®
 AP-300 Automatic Polarimeter. Melting points were measured 
on a Thomas Hoover capillary melting point apparatus and are uncorrected. 
 
4.6.1. Reagents and Ligands 
Acetyl chloride: purchased from Aldrich Chemical Co. and used as received. 
Ammonium acetate: purchased from Aldrich Chemical Co. and used as received. 
Bis(dibenzylideneacetone)palladium(0): purchased from Strem Chemicals Inc. and 
used as received. 
Bis(pinacolato)diboron [B2(pin)2]: purchased from Frontier Scientific Inc., 
recrystallized from pentane and dried under vacuum prior to use. 
Bis(triphenylphosphine)palladium (II) dichloride: purchased from Aldrich Chemical 
Co. and used as received. 
4-Bromoanisole: purchased from Aldrich Chemical Co. and distilled from CaH2 prior to 
use. 
Bromobenzene: purchased from Aldrich Chemical Co. and distilled from CaH2 prior to 
use. 
4-Bromobenzotrifluoride: purchased from Aldrich Chemical Co. and distilled from 
CaH2 prior to use. 
3-Bromo-3-buten-1-ol: purchased from Aldrich Chemical Co. and used as received. 
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1-Bromo-2-butyne: purchased from Aldrich Chemical Co. and used as received. 
2-Bromo-5-iodo-1,3-diisopropylbenzene: prepared according to a previously reported 
procedure.
23
 
n-Butyllithium: purchased from Strem Chemicals Inc. and used as received. 
2-Butyn-1-ol: purchased from Aldrich Chemical Co. and used as received. 
2-Butyn-1-yl diethyl phosphate: prepared according to a previously reported 
procedure.
24
 
Chiral bis-phosphines: purchased from Strem Chemicals Inc. and used as received. 
Copper (II) bromide: purchased from Strem Chemicals Inc. and used as received. 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Diethyl chlorophosphate: purchased from Aldrich Chemical Co. and used as received. 
Dimethylaluminum chloride (neat): purchased from Aldrich Chemical Co. and used as 
received. 
N,N-Dimethylformamide (99.8% purity): purchased from Acros Organics Co. and used 
as received. 
Dimethylmethylideneammonium iodide (Eschenmoser’s salt): purchased from 
Aldrich Chemical Co. and used as received. 
Dioxane: purchased from Acros Organics Co. and used as received. 
(–)-(S,S)-Diphenylethylenediamine (99% purity): purchased from Ivy Chemical 
Company and used as received. 
Glacial acetic acid: purchased from Aldrich Chemical Co. and used as received. 
                                                 
(23) Cheng, X.; Goddard, R.; Buth, G.; List, B. Angew. Chem., Int. Ed. 2008, 47, 5079–5081.  
(24) Sanders, T. C.; Hammond, G. B. J. Org. Chem. 1993, 58, 5598–5599. 
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Methanol: purchased from Acros and purified by distillation from Na (Aldrich Chemical 
Co.) prior to use. 
Methylmagnesium bromide (3.0 M in Et2O): purchased from Aldrich Chemical Co. 
and used as received. 
2-Methyl-1-propanol (99.5% purity, i-BuOH): purchased from Aldrich Chemical Co. 
and used as received. 
2-Methyl-2-propanol (t-BuOH): purchased from Aldrich Chemical Co. and purified by 
distillation from Na (Aldrich Chemical Co.) prior to use. 
1-Naphthalenylboronic acid: purchased from Aldrich Chemical Co. and used as 
received. 
Osmium tetroxide (4 wt % in H2O solution): purchased from Aldrich Chemical Co. and 
used as received. 
Palladium (II) acetate: purchased from Strem Chemicals Inc. and used as received. 
Phenylboronic acid: purchased from Aldrich Chemical Co. and used as received. 
Phenylmagnesium bromide (3.0 M in Et2O): purchased from Aldrich Chemical Co. 
and used as received. 
Potassium phosphate tribasic: purchased from Aldrich Chemical Co. and used as 
received. 
Sodium borohydride (NaBH4): purchased from Aldrich Chemical Co. and used as 
received. 
Sodium t-butoxide (NaOt-Bu): purchased from Strem Chemicals Inc. and used as 
received. 
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Sodium hydroxide (NaOH): purchased from Fischer Scientific, Inc. and used as 
received. 
Sodium methoxide (NaOMe): purchased from Strem Chemicals Inc. and used as 
received. 
Sodium perborate tetrahydrate (NaBO3·4H2O): purchased from Aldrich Chemical Co. 
and used as received. 
Sodium periodate (NaIO4): purchased from Acros Organics Co. and used as received. 
Tetrabutylammonium fluoride: purchased from Aldrich Chemical Co. and used as 
received. 
Tetrakis(triphenylphosphine)palladium(0): purchased from Strem Chemicals Inc. and 
used as received. 
Triethylamine (Et3N): purchased from Fisher Scientific, Inc. and distilled over CaH2 
prior to use. 
Triphenylphosphine: purchased from Aldrich Chemical Co. and used as received. 
 
4.6.2. Experimental Procedure and Characterization Data 
 Representative Procedure for Preparation of 1,1-Disubstituted Allenes:25 To a 
flame-dried 10 mL round bottom flask equipped with a stir bar was added bromobenzene 
(0.42 mL, 4.00 mmol) and thf (2 mL). The mixture was allowed to cool to –78 °C before 
n-BuLi (2.52 mL, 4.00 mmol) was added drop-wise by a syringe and the solution was 
allowed to stir at –78 °C for one hour. At this point, Me2AlCl (0.37 mL, 4.00 mmol) was 
added drop-wise by a syringe and the solution was allowed to warm to 22 °C and stir for 
                                                 
(25) Dabrowski, J. A.; Villaume, M. T.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2013, 52, 8156–8159. 
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12 h. Pentane (2 mL) was added and the solution was allowed to stir for an additional 
hour. The mixture was then allowed to stand for approximately one hour before removal 
and use of the top pentane layer in reactions. (The lower thf layer contains LiCl salts, 
which are detrimental to the site selectivity (SN2’) of the reaction significantly.) A flame-
dried 50 mL round bottom flask equipped with a stir bar was charged with CuCl (13.1 mg, 
0.130 mmol) in an N2 filled glove box. The flask was capped with a septum and removed 
from the glove box. Tetrahydrofuran (15 mL) was added to the flask and the previously 
prepared solution of dimethylphenylaluminum (0.581 M, 6.8 mL, 4.00 mmol) was added 
slowly and the resulting solution was allowed to stir for five minutes at 0 °C. A solution 
of 2-butyn-1-yl diethylphosphate 4.46 (536 mg, 2.60 mmol) in thf (6 mL) was added 
drop-wise through cannula and the solution was allowed to warm to 22 °C and stir for 
one hour. The reaction was quenched by addition of saturated solution of sodium 
potassium tartrate (30 mL, added slowly). The solution was diluted with Et2O and the 
mixture was allowed to stir at 22 °C until the layers were separated clearly. The aqueous 
layer was washed with Et2O (3 × 10 mL) and the combined organic layer was dried over 
MgSO4, concentrated in vacuo (caution: The product is volatile. Use house-vacuum only) 
and purified by silica gel chromatography (100% pentane) to afford 212 mg of 1-(buta-
2,3-dien-2-yl)benzene 4.47 as colorless oil (1.63 mmol, 63% yield). 
The following substrates were prepared according to the above procedure. 
Characterization data match the reported ones: 1-(Buta-2,3-dien-2-yl)benzene (4.47),
26
 
1-(Buta-2,3-dien-2-yl)-4-methoxybenzene (4.48),
27
 Buta-2,3-dien-2-yl(tert-butyl) 
                                                 
(26) (a) Ngai, M.-Y.; Skucas, E.; Krische, M. J. Org. Lett. 2008, 10, 2705–2708. (b) Rubina, M.; Rubin, M.; 
Gevorgyan, V. J. Am. Chem. Soc. 2002, 124, 11566–11567. (c) Baird, M. S.; Nizovtsev, A. V.; Bolesov, I. 
G. Tetrahedron 2002, 58, 1581–1593. 
(27) Schmittel, M.; Wöhrle, C.; Bohn, I. Chem. Eur. J. 1996, 2, 1031–1040.  
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diphenylsilane (substrate for 4.71a),
28
 Penta-1,2-dien-3-ylbenzene (substrate for 
4.72a).
29
 
1-(Buta-2,3-dien-2-yl)-4-trifluoromethylbenzene (4.49): IR (neat): 2987 (w), 2929 (w), 
1943 (w), 1616 (m), 1577 (w), 1458 (w), 1441 (w), 1426 (w), 1409 (w), 1322 (s), 1277 
(w), 1233 (w), 1163 (w), 1108 (s), 1073 (s), 1058 (m), 1015 (m), 953 (w), 927 (w), 839 
(s), 778 (w), 706 (m), 618 (m), 581 (w), 526 (w), 498 (m) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.56 (2H, app d, J = 8.0 Hz), 7.49 (2H, app d, J = 8.0 Hz), 5.09 (2H, q, J = 3.2 
Hz), 2.11 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.6, 140.7, 129.1 (q, JCF 
= 133 Hz), 128.7, 125.8 (d, JCF = 15.2 Hz), 125.3 (d, JCF = 3.8 Hz), 123.1, 77.4, 99.3, 
16.6; HRMS: Calcd for C11H10F3 [M+H]
+
: 199.0734; Found: 199.0739. 
1-(Buta-2,3-dien-2-yl)-2-fluorobenzene (4.57): IR (neat): 2960 (w), 2929 (w), 2872 (w), 
1945 (w), 1576 (w), 1490 (s), 1448 (m), 1373 (w), 1301 (w), 1278 (w), 1260 (w), 1223 
(m), 1106 (w), 1063 (w), 1034 (w), 937 (w), 849 (m), 818 (m), 753 (s), 606 (w), 554 (w), 
543 (w), 489 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.30 (1H, dt, J = 8.0, 1.6 Hz), 
7.21–7.17 (1H, m), 7.09 (1H, dt, J = 7.6, 1.6 Hz), 7.03 (1H, ddd, J = 11.2, 8.0, 1.6 Hz), 
4.91 (2H, q, J = 3.2 Hz), 2.12 (3H, dt, J = 3.2, 1.6 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 
210.1, 160.4 (d, JCF = 248 Hz), 129.1 (d, JCF = 3.8 Hz), 128.4 (d, JCF = 8.3 Hz), 124.1 (d, 
JCF = 3.8 Hz), 116.1 (d, JCF = 22.0 Hz), 116.0, 95.7, 75.1 (d, JCF = 2.2 Hz), 18.8 (d, JCF = 
3.0 Hz); HRMS: Calcd for C10H10F1 [M+H]
+
: 149.0767; Found: 149.0766. 
1-(Buta-2,3-dien-2-yl)-2-chlorobenzene (substrate for 4.59a): IR (neat): 3059 (w), 2982 
(w), 2922 (w), 2856 (w), 1953 (w), 1701 (w), 1591 (w), 1565 (w), 1474 (m), 1432 (m), 
                                                 
(28) (a) Kim, Y.; George, D.; Prior, A. M.; Prasain, K.; Hao, S.; Le, D. D.; Hua, D. H.; Chang, K.-O. Eur. J. 
Med. Chem. 2012, 50, 311–318. (b) Evans, D. A.; Sweeney, Z. K.; Rovis, T.; Tedrow, J. S. J. Am. Chem. 
Soc. 2001, 123, 12095–12096. 
(29) (a) Kobayashi, K.; Naka, H.; Wheatley, A. E. H.; Kondo, Y. Org. Lett. 2008, 10, 3375–3377. (b) Li, J.; 
Zhou, C.; Fu, C.; Ma, S. Tetrahedron 2009, 65, 3695–3703. 
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1370 (w), 1296 (w), 1125 (w), 1084 (m), 1038 (s), 943 (w), 848 (s), 755 (s), 739 (m), 730 
(m), 666 (w), 607 (m), 547 (w), 464 (w), 448 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 
7.37 (1H, dd, J = 7.6, 1.6 Hz), 7.29 (1H, dd, J = 7.6, 1.6 Hz), 7.25–7.16 (2H, m), 4.83 
(2H, q, J = 3.2 Hz), 2.08 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 208.3, 137.6, 
133.0, 130.2, 129.9, 128.4, 126.9, 98.5, 75.2, 19.8; HRMS: Calcd for C10H10Cl1 [M+H]
+
: 
165.0471; Found: 165.0474. 
1-(Buta-2,3-dien-2-yl)-2-methoxybenzene (substrate for 4.60a): IR (neat): 2955 (w), 
2834 (w), 1946 (w), 1594 (w), 1578 (w), 1490 (m), 1461 (m), 1433 (m), 1367 (w), 1301 
(m), 1268 (s), 1241 (m), 1179 (w), 1161 (m), 1117 (m), 1063 (m), 1042 (s), 1026 (w), 
930 (w), 843 (m), 794 (m), 746 (s), 690 (w), 581 (w), 539 (w) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.22 (1H, d, J = 7.6 Hz), 7.21 (1H, dd, J = 8.8, 7.6 Hz), 6.91 (1H, dd, J = 
7.6, 7.6 Hz), 6.87 (1H, d, J = 8.8 Hz), 4.78 (2H, q, J = 3.2 Hz), 3.82 (3H, s), 2.08 (3H, t, J 
= 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.4, 157.0, 129.3, 128.3, 127.3, 120.8, 
111.4, 97.9, 73.6, 55.6, 19.3; HRMS: Calcd for C11H13O1 [M+H]
+
: 161.0966; Found: 
161.0977. 
1-(Buta-2,3-dien-2-yl)-3-fluorobenzene (substrate for 4.62a): IR (neat): 3063 (w), 2985 
(w), 2952 (w), 2927 (w), 2859 (w), 1943 (m), 1610 (m), 1583 (m), 1523 (w), 1486 (s), 
1461 (m), 1437 (m), 1371 (w), 1304 (w), 1286 (w), 1266 (w), 1239 (m), 1224 (m), 1178 
(m), 1157 (m), 1080 (w), 1062 (w), 951 (m), 853 (s), 778 (s), 691 (s), 634 (w), 615 (m), 
605 (m), 566 (w), 522 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.28–7.23 (1H, m), 7.20 
(1H, s), 7.09 (1H, d, J = 10.4 Hz), 6.88 (1H, dd, J = 8.4, 8.4 Hz), 5.04 (2H, q, J = 3.2 Hz), 
2.06 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.2, 163.2 (d, JCF = 244 Hz), 
139.5 (d, JCF = 7.6 Hz), 129.7 (d, JCF = 8.4 Hz), 121.3 (d, JCF = 2.3 Hz), 113.4 (d, JCF = 
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21.3 Hz), 112.7 (d, JCF = 22 Hz), 99.3 (d, JCF = 2.2 Hz), 77.5, 16.7; HRMS: Calcd for 
C10H10F1 [M+H]
+
: 149.0767; Found: 149.0759. 
1-(Buta-2,3-dien-2-yl)-3-bromobenzene (substrate for 4.63a): IR (neat): 3060 (w), 2983 
(w), 2950 (w), 2924 (w), 2860 (w), 1941 (m), 1589 (m), 1559 (m), 1473 (s), 1440 (w), 
1424 (m), 1371 (w), 1299 (w), 1281 (w), 1271 (w), 1250 (w), 1079 (w), 1065 (m), 994 
(m), 932 (w), 850 (s), 778 (s), 749 (s), 689 (s), 659 (s), 607 (s), 440 (w), 417 (w) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.54 (1H, t, J = 1.6 Hz), 7.32 (2H, dd, J = 7.2, 1.6 Hz), 7.18 
(1H, dd, J = 8.4, 7.2 Hz), 5.07 (2H, q, J = 3.2 Hz), 2.07 (3H, t, J = 3.2 Hz); 
13
C NMR 
(CDCl3, 100 MHz): δ 209.1, 139.3, 129.9, 129.6, 128.8, 124.3, 122.8, 99.1, 77.7, 16.7; 
HRMS: Calcd for C10H10Br1 [M+H]
+
: 208.9966; Found: 208.9966. 
1-(Buta-2,3-dien-2-yl)-4-bromobenzene (substrate for 4.66a): IR (neat): 2954 (w), 2924 
(m), 2854 (w), 1941 (w), 1485 (m), 1456 (w), 1420 (w), 1395 (w), 1367 (w), 1293 (w), 
1206 (w), 1103 (w), 1075 (m), 1005 (m), 924 (w), 851 (m), 822 (s), 755 (w), 725 (m), 
715 (m), 699 (w), 630 (w), 612 (m), 547 (m), 528 (m), 490 (m) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.42 (2H, app d, J = 6.8 Hz), 7.25 (2H, app d, J = 6.8 Hz), 5.01 (2H, q, J = 
3.2 Hz), 2.06 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.0, 135.8, 131.4, 
127.4, 120.5, 99.2, 77.4, 16.7; HRMS: Calcd for C10H10Br1 [M+H]
+
: 208.0966; Found: 
208.0969. 
2-(Buta-2,3-dien-2-yl)naphthalene (substrate for 4.67a): white solid, mp = 65–67 °C, 
IR (neat): 3052 (m), 3018 (w), 2983 (w), 2957 (m), 2925 (w), 2857 (w), 1937 (m), 1626 
(w), 1596 (w), 1501 (m), 1438 (m), 1373 (w), 1351 (w), 1278 (w), 1127 (m), 1065 (w), 
950 (w), 888 (m), 857 (s), 824 (s), 770 (w), 743 (s), 620 (w), 594 (m), 477 (s) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.81 (1H, dd, J = 8.8, 2.0 Hz), 7.79 (1H, dd, J = 8.4, 2.0 Hz), 
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7.76 (1H, app d, J = 8.8 Hz), 7.72 (1H, s), 7.64 (1H, dd, J = 8.4, 1.2 Hz), 7.48–7.40 (2H, 
m), 5.11 (2H, q, J = 3.2 Hz), 2.22 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 
209.8, 134.2, 133.7, 132.4, 128.0, 127.8, 127.6, 126.2, 125.7, 125.0, 123.4, 100.2, 77.3, 
16.8; HRMS: Calcd for C14H13 [M+H]
+
: 181.1017; Found: 181.1014. 
3-(Buta-2,3-dien-2-yl)pyridine (substrate for 4.69a): [Note: 3-(Buta-2,3-dien-2-
yl)pyridine is unstable even at –30 °C. 3-(Buta-2,3-dien-2-yl)pyridine is colorless oil, but 
it becomes yellowish after one hour at ambient temperature. For this reason, it is 
imperative that this material is used immediately after preparation.] IR (neat): 3397 (br), 
3033 (w), 2984 (w), 2949 (w), 2923 (w), 2860 (w), 1941 (m), 1569 (w), 1479 (m), 1458 
(w), 1424 (m), 1408 (m), 1373 (w), 1332 (w), 1289 (w), 1242 (w), 1183 (w), 1123 (w), 
1101 (w), 1076 (m), 1034 (w), 1020 (m), 989 (w), 946 (w), 923 (w), 851 (s), 805 (s), 706 
(s), 625 (m), 606 (s), 533 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 8.64 (1H, d, J = 2.4 
Hz), 8.43 (1H, dd, J = 4.4, 1.6 Hz), 7.66 (1H, d, J = 8.4 Hz), 7.24–7.21 (1H, m), 5.08 (2H, 
q, J = 3.2 Hz), 2.10 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 208.7, 147.6, 
147.2, 132.7, 132.4, 123.0, 97.3, 77.6, 16.2; HRMS: Calcd for C9H10N1 [M+H]
+
: 
132.0813; Found: 132.0818. 
3-(Buta-2,3-dien-2-yl)thiophene (substrate for 4.70a): [Note: 3-(Buta-2,3-dien-2-
yl)thiophene is unstable even at –30 °C. For this reason, it is recommended that 
protoboration reaction is performed as soon as 3-(buta-2,3-dien-2-yl)thiophene is 
prepared.] IR (neat): 3109 (w), 2919 (w), 1942 (w), 1621 (m), 1493 (w), 1398 (w), 1353 
(m), 1249 (w), 1195 (w), 1074 (w), 1085 (m), 951 (w), 880 (m), 845 (s), 797 (w), 760 (s), 
677 (m), 612 (m), 584 (s), 484 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.26–7.24 (1H, 
m), 7.12 (1H, dd, J = 5.2, 1.2 Hz), 7.04 (1H, dd, J = 2.8, 1.2 Hz), 4.97 (2H, qd, J = 3.2, 
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0.8 Hz), 2.07 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.1, 126.4, 126.2, 
119.8, 109.5, 96.2, 76.4, 17.0; HRMS: Calcd for C8H9S1 [M+H]
+
: 137.0425; Found: 
137.0418. 
(4-Methylpenta-1,2-dien-3-yl)benzene (substrate for 4.73a): IR (neat): 3058 (w), 3031 
(w), 2963 (m), 2929 (w), 2869 (w), 1942 (w), 1596 (w), 1494 (m), 1451 (m), 1383 (w), 
1364 (w), 1075 (w), 1056 (w), 1033 (w), 965 (w), 909 (w), 847 (s), 763 (s), 794 (s), 639 
(m), 609 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.41 (2H, d, J = 8.4 Hz), 7.33 (2H, dd, 
J = 8.4, 7.2 Hz), 7.20 (1H, t, J = 7.2 Hz), 5.09 (2H, d, J = 2.8 Hz), 2.85–2.78 (1H, m), 
1.15 (6H, d, J = 6.8 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 207.8, 136.6, 128.5, 126.6, 
126.5, 112.3, 79.2, 27.5, 22.3; HRMS: Calcd for C12H15 [M+H]
+
: 159.1174; Found: 
159.1173. 
5-(tert-Butyldimethylsilyloxy)-3-phenyl-penta-1,2-diene (substrate for 4.74a): IR 
(neat): 2953 (w), 2928 (w), 2885 (w), 2855 (w), 1940 (w), 1597 (w), 1494 (w), 1471 (w), 
1462 (w), 1452 (w), 1387 (w), 1360 (w), 1253 (m), 1216 (w), 1095 (s), 1030 (w), 1005 
(w), 982 (w), 937 (w), 907 (w), 832 (s), 773 (s), 760 (s), 717 (w), 692 (s), 664 (m), 636 
(w), 606 (w), 573 (w), 525 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.40 (2H, app d, J = 
8.0 Hz), 7.31 (2H, dd, J = 8.0, 7.2 Hz), 7.19 (1H, t, J = 7.2 Hz), 5.06 (2H, t, J = 3.2 Hz), 
3.81 (2H, app t, J = 7.2 Hz), 2.65 (2H, tt, J = 7.2, 3.2 Hz), 0.89 (9H, s), 0.04 (6H, s); 
13
C 
NMR (CDCl3, 100 MHz): δ 208.7, 136.0, 128.3, 126.6, 125.9, 101.6, 78.0, 62.0, 32.8, 
25.9, 18.2, –5.3; HRMS: Calcd for C17H27O1Si1 [M+H]
+
: 275.1831; Found: 275.1820. 
1-Vinylidene-1,2,3,4-tetrahydronaphthalene (substrate for 4.75a): IR (neat): 3059 (w), 
3020 (w), 2932 (s), 2862 (w), 2838 (w), 1940 (m), 1745 (w), 1719 (w), 1684 (m), 1599 
(w), 1489 (s), 1452 (s), 1284 (m), 1014 (w), 849 (s), 760 (s), 728 (s), 577 (m), 482 (w), 
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437 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.49 (1H, d, J = 8.4 Hz), 7.16–7.12 (1H, 
m), 7.10 (2H, dd, J = 5.2, 1.2 Hz), 5.07 (2H, t, J = 3.2 Hz), 2.81 (2H, t, J = 6.4 Hz), 2.60–
2.56 (2H, m), 1.93–1.87 (2H, m); 13C NMR (CDCl3, 100 MHz): δ 206.7, 136.5, 131.3, 
129.3, 127.0, 126.6, 126.2, 101.1, 78.1, 30.2, 28.8, 22.9; HRMS: Calcd for C12H13 
[M+H]
+
: 157.1017; Found: 157.1020. 
4-Vinylidenechroman (substrate for 4.76a): IR (neat): 3068 (w), 3036 (w), 2962 (w), 
2930 (w), 2874 (w), 1944 (w), 1688 (w), 1603 (m), 1577 (m), 1486 (s), 1452 (s), 1293 
(m), 1252 (m), 1219 (s), 1116 (m), 1042 (s), 867 (m), 803 (m), 753 (s), 580 (w), 507 (w) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.37 (1H, dd, J = 7.6, 1.6 Hz), 7.10 (1H, td, J = 7.2, 
1.6 Hz), 6.89 (1H, td, J = 7.6, 1.2 Hz), 6.83 (1H, dd, J = 8.4, 1.2 Hz), 5.16 (2H, t, J = 3.2 
Hz), 4.24 (2H, t, J = 5.6 Hz), 2.76–2.72 (2H, m); 13C NMR (CDCl3, 100 MHz): δ 205.1, 
154.1, 128.4, 127.3, 121.1, 118.5, 117.5, 96.1, 79.6, 66.0, 27.9; HRMS: Calcd for 
C11H11O1 [M+H]
+
: 159.0810; Found: 159.0803. 
2-(Buta-2,3-dien-2-yl)-6-methoxynaphthalene (4.85): yellow solid, mp = 113–115 °C. 
IR (neat): 3054 (m), 3006 (m), 2958 (m), 2933 (w), 2836 (w), 1936 (m) 1625 (m), 1598 
(m), 1499 (m), 1481 (m), 1453 (m), 1438 (m), 1389 (m), 1369 (m), 1336 (w), 1276 (m), 
1250 (m), 1223 (m), 1199 (m), 1186 (m), 1162 (m), 1150 (m), 1121 (m), 1064 (w), 1026 
(m), 991 (w), 958 (w), 938 (w), 898 (w), 884 (m), 852 (s), 811 (s), 761 (w), 733 (w), 678 
(m), 655 (w), 617 (m), 546 (m), 522 (w), 476 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 
7.71 (1H, d, J = 8.8 Hz), 7.66 (1H, d, J = 8.4 Hz), 7.65 (1H, s), 7.60 (1H, app dd, J = 8.4, 
1.6 Hz), 7.14 (1H, app dd, J = 8.8, 2.8 Hz), 7.11 (1H, s), 5.09 (2H, q, J = 3.2 Hz), 3.92 
(3H, s), 2.20 (3H, t, J = 3.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.5, 157.7, 133.5, 
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131.9, 129.6, 129.1, 126.7, 125.5, 123.3, 118.8, 105.9, 100.1, 77.3, 55.4, 16.9; HRMS: 
Calcd for C15H15O1 [M+H]
+
: 211.1122; Found: 211.1126. 
 
 Representative Procedure for NHC–Cu-Catalyzed Enantioselective Protoboration 
of 1,1-Disubstituted Allenes: An oven-dried vial equipped with a stir bar was charged 
with imidazolinium salt A.22 (3.4 mg, 5.50 µmol), NaOt-Bu (3.8 mg, 0.0400 mmol), 
CuCl (0.5 mg, 5.00 µmol) and thf (0.3 mL) in a N2 filled glove box. The vessel was 
sealed with a cap (phenolic open top cap with red PTFE/white silicone septum) and the 
solution was allowed to stir at 22 °C for one hour. Bis(pinacolato)diboron (27.9 mg, 
0.110 mmol) was added to the solution, which turned dark brown immediately and the 
wall of a reaction vial was rinsed with additional thf (0.2 mL). The vial was resealed with 
a cap (phenolic open top cap with red PTFE/white silicone septum) and removed from 
the glove box. The solution was allowed to stir at 22 °C for 30 min under a N2 
atmosphere. Buta-2,3-dien-2-ylbenzene 4.47 (13.1 mg, 0.100 mmol) and t-BuOH (14.3 
µL, 0.150 mmol) were added through a syringe. The resulting solution was allowed to stir 
at 22 °C for 16 hours before the reaction was quenched by passing the mixture through a 
short plug of celite and silica gel and eluted with Et2O (3 × 2 mL). The filtrate was 
concentrated in vacuo to afford yellow oil, which was purified by silica gel 
chromatography (hexanes:Et2O = 50:1) to afford 4.50a as colorless oil (20.4 mg, 0.0790 
mmol, 79% yield). 
(R)-4,4,5,5-Tetramethyl-2-(3-phenylbut-1-en-2-yl)-1,3,2-dioxaborolane (4.50a): IR 
(neat): 3062 (w), 3026 (w), 2976 (m), 2931 (w), 2876 (w), 1613 (w), 1492 (w), 1451 (w), 
1414 (m), 1370 (m), 1358 (m) 1306 (s), 1270 (w), 1214 (w), 1164 (w), 1138 (s), 1111 (w), 
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1068 (w), 1053 (w), 1029 (w), 1004 (w), 992 (m), 967 (m), 941 (w), 907 (w), 856 (s), 
834 (w), 822 (w), 785 (w), 757 (m), 734 (m), 698 (s), 670 (w), 644 (w), 613 (w), 579 (w), 
562 (w), 539 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.26–7.22 (3H, m), 7.14 (1H, t, J 
= 6.4 Hz), 5.81 (1H, dd, J = 2.8, 1.2 Hz), 5.56 (1H, d, J = 2.8 Hz), 3.70 (1H, q, J = 7.2 
Hz), 1.40 (3H, d, J = 7.2 Hz), 1.17 (6H, s), 1.12 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 
145.9, 128.1, 128.0, 126.8, 125.8, 83.4, 43.8, 24.7, 24.6, 20.3; HRMS: Calcd for 
C16H24B1O2 [M+H]
+
: 259.1869; Found: 259.1862; specific rotation: [α]D
22
 +8.33 (c 1.20, 
CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 90 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
194.452 3145.64 50.632 194.748 31.04 4.947 
200.107 3067.04 49.368 201.061 596.55 95.053 
(R)-2-(3-(2-Fluorophenyl)but-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(4.58a): IR (neat): 3068 (w), 2977 (m), 2932 (w), 2875 (w), 1617 (w), 1584 (w), 1489 
(m), 1452 (m), 1423 (m), 1371 (s), 1358 (s), 1309 (s), 1270 (m), 1227 (s), 1138 (s), 1111 
(m), 1070 (m), 967 (m), 943 (m), 858 (s), 834 (m), 753 (s), 689 (m), 580 (w), 521 (w), 
483 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.21–7.11 (2H, m), 7.04 (1H, dt, J = 7.6, 
1.2 Hz), 6.97 (1H, ddd, J = 10.4, 8.0, 1.2 Hz), 5.86 (1H, dd, J = 2.4, 1.6 Hz), 5.57 (1H, br 
s), 4.04 (1H, q, J = 7.2 Hz), 1.38 (3H, d, J = 7.2 Hz), 1.19 (6H, s), 1.12 (6H, s); 
13
C NMR 
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(CDCl3, 100 MHz): δ 160.8 (d, JCF = 244 Hz), 132.9 (d, JCF = 15.2 Hz), 129.1 (d, JCF = 
4.6 Hz), 127.4, 127.3 (d, JCF = 5.3 Hz), 123.7 (d, JCF = 3.8 Hz), 115.1 (d, JCF = 22.8 Hz), 
83.5, 36.2 (d, JCF = 3.1 Hz), 24.8, 24.6, 19.3; HRMS: Calcd for C16H23B1F1O2 [M+H]
+
: 
277.1775; Found: 277.1781; specific rotation: [α]D
20
 –4.46 (c 2.24, CHCl3) for an 
enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
106.106 233.34 49.886 106.127 30.04 5.069 
109.840 234.41 50.114 109.865 562.51 94.931 
(R)-2-(3-(2-Chlorophenyl)but-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(4.59a): IR (neat): 3068 (w), 2976 (w), 2931 (w), 2874 (w), 1617 (w), 1472 (m), 1423 
(m), 1371 (s), 1356 (s), 1309 (s), 1271 (m), 1214 (m), 1139 (s), 1034 (m), 967 (m), 943 
(m), 857 (s), 751 (s), 675 (m), 579 (w), 460 (w), 417 (w) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.32 (1H, dd, J = 7.6, 1.2 Hz), 7.20 (1H, dt, J = 8.0, 2.0 Hz), 7.17 (1H, dt, J = 
8.0, 1.6 Hz), 7.09 (1H, ddd, J = 7.6, 6.8, 2.0 Hz), 5.87 (1H, dd, J = 2.8, 1.2 Hz), 5.54 (1H, 
br s), 4.19 (1H, q, J = 7.2 Hz), 1.36 (3H, d, J = 6.8 Hz), 1.19 (6H, s), 1.10 (6H, s); 
13
C 
NMR (CDCl3, 100 MHz): δ 143.5, 134.2, 129.4, 128.8, 127.4, 127.1, 126.6, 83.5, 39.7, 
24.8, 24.5, 19.3; HRMS: Calcd for C16H23B1Cl1O2 [M+H]
+
: 293.1480; Found: 293.1481; 
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specific rotation: [α]D
20
 +13.4 (c 1.49, CHCl3) for an enantiomerically enriched sample of 
90.5:9.5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
247.528 372.96 49.362 247.691 89.91 9.461 
254.590 382.59 50.638 254.930 860.48 90.539 
(R)-4,4,5,5-Tetramethyl-2-(3-(2-methoxyphenyl)but-1-en-2-yl)-1,3,2-dioxaborolane 
(4.60a): IR (neat): 3066 (w), 2976 (m), 2932 (w), 2835 (w), 1614 (w), 1598 (w), 1585 
(w), 1490 (m), 1458 (w), 1413 (w), 1370 (m), 1356 (m), 1305 (s), 1271 (w), 1238 (s), 
1214 (w), 1163 (m), 1138 (s), 1110 (m), 1070 (m), 1049 (m), 1030 (m), 998 (m), 967 (w), 
939 (m), 907 (w), 858 (w), 828 (m), 796 (w), 750 (w), 691 (s), 670 (m), 644 (w), 619 (w), 
579 (w), 521 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.14 (1H, dd, J = 7.6, 7.2 Hz), 
7.12 (1H, d, J = 7.6 Hz), 6.87 (1H, ddd, J = 7.6, 7.2, 1.2 Hz), 6.83 (1H, d, J = 7.6 Hz), 
5.79 (1H, dd, J = 3.2, 1.2 Hz), 5.52 (1H, d, J = 3.2 Hz), 4.14 (1H, q, J = 7.2 Hz), 1.33 (3H, 
d, J = 7.2 Hz), 1.18 (6H, s), 1.10 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 156.9, 134.5, 
127.9, 126.6, 126.3, 120.2, 110.5, 83.1, 55.5, 35.7, 24.6, 24.3, 19.2; HRMS: Calcd for 
C17H25B1Na1O3 [M+Na]
+
: 311.1794; Found: 311.1798; specific rotation: [α]D
24
 +8.32 (c 
1.32, CHCl3) for an enantiomerically enriched sample of 92:8 e.r. 
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Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 110 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
179.729 190.94 49.014 179.510 51.10 7.897 
186.096 198.62 50.986 186.411 595.95 92.103 
(R)-4,4,5,5-Tetramethyl-2-(3-(3-fluorophenyl)but-1-en-2-yl)-1,3,2-dioxaborolane 
(4.62a): IR (neat): 2977 (w), 2932 (w), 2876 (w), 1612 (w), 1588 (w), 1485 (w), 1420 
(w), 1371 (m), 1357 (m), 1308 (s), 1271 (w), 1261 (w), 1241 (w), 1227 (w), 1215 (w), 
1165 (m), 1139 (s), 1112 (w), 1068 (w), 1055 (w), 1005 (w), 967 (m), 945 (m), 925 (m), 
888 (m), 871 (m), 853 (s), 834 (w), 808 (w), 783 (m), 745 (m), 729 (m), 698 (w), 670 (w), 
622 (w), 579 (w), 521 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.20 (1H, app q, J = 7.2 
Hz), 6.98 (1H, d, J = 7.6 Hz), 6.94 (1H, d, J = 10.8 Hz), 6.84 (1H, dd, J = 10.8, 7.6 Hz), 
5.84 (1H, d, J = 2.4 Hz), 5.59 (1H, d, J = 2.4 Hz), 3.69 (1H, q, J = 7.2 Hz), 1.38 (3H, d, J 
= 7.2 Hz), 1.17 (6H, s), 1.12 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 162.9 (d, JCF = 244 
Hz), 148.7 (d, JCF = 6.8 Hz), 129.3 (d, JCF = 8.4 Hz), 127.4, 123.6 (d, JCF = 2.2 Hz), 
114.8 (d, JCF = 20.5 Hz), 112.6 (d, JCF = 20.5 Hz), 83.5, 43.7, 24.7, 24.5, 20.0; HRMS: 
Calcd for C16H23B1F1O2 [M+H]
+
: 277.1775; Found: 277.1768; specific rotation: [α]D
23
 
+8.69 (c 2.30, CHCl3) for an enantiomerically enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 83 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
301.218 86.50 49.807 301.531 12.67 3.990 
308.889 87.17 50.193 308.439 305.02 96.010 
(R)-2-(3-(3-Bromophenyl)but-1-en-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(4.63a): IR (neat): 3063 (w), 2976 (w), 2931 (w), 2874 (w), 1615 (w), 1592 (w), 1566 
(w), 1420 (m), 1371 (s), 1357 (s), 1308 (s), 1271 (m), 1138 (s), 1074 (m), 997 (w), 966 
(m), 945 (m), 858 (s), 831 (m), 779 (m), 716 (s), 690 (s), 579 (w), 438 (w) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.39 (1H, d, J = 2.0 Hz), 7.28 (1H, dt, J = 6.8, 2.0 Hz), 7.16–
7.09 (2H, m), 5.84 (1H, dd, J = 2.8, 1.2 Hz), 5.60 (1H, br s), 3.65 (1H, q, J = 7.2 Hz), 
1.38 (3H, d, J = 7.2 Hz), 1.18 (6H, s), 1.13 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 148.5, 
131.1, 129.7, 128.9, 127.5, 126.7, 122.2, 83.6, 43.8, 24.8, 24.6, 20.0; HRMS: Calcd for 
C16H23B1Br1O2 [M+H]
+
: 337.0975; Found: 337.0988; specific rotation: [α]D
20
 +6.28 (c 
3.18, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDG-TA column, 90 °C, 15 psi. 
 
!
!
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Retention Time Area Area% Retention Time Area Area% 
624.487 532.24 49.542 625.165 45.18 4.823 
645.696 542.08 50.458 645.610 891.54 95.177 
(R)-4,4,5,5-Tetramethyl-2-(3-(4-methoxyphenyl)but-1-en-2-yl)-1,3,2-dioxaborolane 
(4.64a): IR (neat): 2976 (w), 2932 (w), 2834 (w), 1610 (w), 1582 (w), 1509 (s), 1459 (w), 
1441 (w), 1417 (w), 1370 (m), 1355 (m), 1306 (s), 1242 (s), 1214 (w), 1176 (m), 1138 (s), 
1110 (m), 1068 (w), 1055 (w), 1035 (m), 995 (w), 967 (m), 942 (m), 906 (w), 857 (m), 
830 (s), 800 (w), 733 (w), 719 (w), 680 (w), 666 (w), 640 (w), 612 (w), 578 (w), 549 (w) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.13 (2H, d, J = 9.2 Hz), 6.81 (2H, d, J = 9.2 Hz), 
5.78 (1H, d, J = 2.8 Hz), 5.53 (1H, d, J = 2.8 Hz), 3.77 (3H, s), 3.64 (1H, q, J = 7.2 Hz), 
1.37 (3H, d, J = 7.2 Hz), 1.17 (6H, s), 1.13 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 157.8, 
138.1, 128.9, 126.4, 113.5, 83.4, 55.3, 43.0, 24.8, 24.6, 20.4; HRMS: Calcd for 
C17H26B1O3 [M+H]
+
: 289.1975; Found: 289.1986; specific rotation: [α]D
25
 +4.34 (c 2.30, 
CHCl3) for an enantiomerically enriched sample of 94:6 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 60 min, 0.1 °C/min to 115 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
299.954 281.87 49.354 299.914 55.83 6.338 
305.639 289.25 50.646 305.819 825.05 93.662 
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(R)-4,4,5,5-Tetramethyl-2-(3-(4-trifluoromethylphenyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (4.65a): IR (neat): 2978 (w), 2932 (w), 1616 (w), 1416 (w), 1371 (w), 
1354 (w), 1322 (s), 1267 (w), 1213 (w), 1162 (m), 1120 (s), 1069 (s), 1016 (s), 967 (m), 
947 (w), 907 (w), 857 (m), 842 (s), 728 (w), 689 (w), 670 (w), 645 (w), 607 (w), 578 (w), 
528 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.50 (2H, d, J = 8.0 Hz), 7.33 (2H, d, J = 
8.0 Hz), 5.87 (1H, d, J = 2.8 Hz), 5.60 (1H, d, J = 2.8 Hz), 3.75 (1H, q, J = 7.2 Hz), 1.41 
(3H, d, J = 7.2 Hz), 1.16 (6H, s), 1.11 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 150.2, 
128.3, 128.1 (q, JCF = 19.8 Hz), 127.7, 125.0 (q, JCF = 3.8 Hz), 124.6 (q, JCF = 270 Hz), 
83.5, 43.8, 24.6, 20.0; HRMS: Calcd for C17H23B1F3O2 [M+H]
+
: 327.1743; Found: 
327.1749; specific rotation: [α]D
22
 +8.81 (c 3.40, CHCl3) for an enantiomerically enriched 
sample of 95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
109.645 369.67 50.091 109.859 118.29 4.967 
114.564 368.33 49.909 113.586 2263.10 95.033 
(R)-4,4,5,5-Tetramethyl-2-(3-(4-bromophenyl)but-1-en-2-yl)-1,3,2-dioxaborolane 
(4.66a): IR (neat): 2976 (w), 2931 (w), 2875 (w), 1613 (w), 1487 (w), 1459 (w), 1415 
(w), 1370 (m), 1356 (w), 1307 (s), 1270 (w), 1213 (w), 1164 (w), 1137 (s), 1111 (w), 
1074 (m), 1009 (m), 966 (m), 944 (m), 906 (w), 856 (m), 828 (m), 778 (w), 736 (w), 722 
!
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(w), 695 (w), 670 (w), 638 (w), 592 (w), 578 (w), 536 (w) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.36 (2H, d, J = 8.4 Hz), 7.09 (2H, d, J = 8.4 Hz), 5.83 (1H, dd, J = 2.8, 1.2 Hz), 
5.57 (1H, d, J = 2.8 Hz), 3.65 (1H, q, J = 7.2 Hz), 1.36 (3H, d, J = 7.2 Hz), 1.17 (6H, s), 
1.13 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 145.0, 131.1, 129.8, 127.3, 119.5, 83.5, 
43.3, 24.8, 20.1; HRMS: Calcd for C16H23B1Br1O2 [M+H]
+
: 337.0974; Found: 337.0982; 
specific rotation: [α]D
23
 +5.00 (c 4.00, CHCl3) for an enantiomerically enriched sample of 
95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 130 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
108.138 252.74 49.727 108.073 23.41 4.883 
111.251 255.51 50.273 111.234 456.09 95.117 
(R)-4,4,5,5-Tetramethyl-2-(3-(2-naphthyl)but-1-en-2-yl)-1,3,2-dioxaborolane (4.67a): 
IR (neat): 3054 (w), 2975 (w), 2931 (w), 2873 (w), 1632 (w), 1613 (w), 1600 (w), 1506 
(w), 1418 (w), 1370 (m), 1353 (m), 1306 (s), 1270 (w), 1213 (w), 1164 (w), 1137 (s), 
1069 (m), 1018 (w), 1004 (w), 966 (m), 946 (m), 909 (w), 892 (w), 893 (w), 851 (s), 818 
(m), 771 (w), 744 (s), 724 (m), 677 (w), 619 (w), 578 (w), 543 (w), 520 (w), 475 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.81 (1H, d, J = 2.4 Hz), 7.79 (1H, d, J = 2.4 Hz), 7.76 
(1H, d, J = 8.8 Hz), 7.69 (1H, s), 7.46–7.38 (3H, m), 5.90 (1H, d, J = 2.8 Hz), 5.64 (1H, d, 
!
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J = 2.8 Hz), 3.90 (1H, q, J = 7.2 Hz), 1.52 (3H, d, J = 7.2 Hz), 1.17 (6H, s), 1.11 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 143.4, 133.6, 132.2, 127.7, 127.6, 127.5, 127.3, 127.2, 
125.9, 125.7, 125.1, 83.4, 43.9, 24.7, 24.6, 20.2; HRMS: Calcd for C20H26B1O2 [M+H]
+
: 
309.2025; Found: 309.2024; specific rotation: [α]D
22
 +4.00 (c 5.00, CHCl3) for an 
enantiomerically enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDG-TA column, 110 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
870.278 531.97 46.440 867.978 90.34 3.688 
891.016 613.52 53.560 895.182 2359.20 96.312 
(R)-4,4,5,5-Tetramethyl-2-(3-(6-methoxy-2-naphthyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (4.68a): IR (neat): 3058 (w), 2975 (w), 2934 (w), 1633 (w), 1604 (m), 
1504 (w), 1482 (w), 1462 (w), 1416 (w), 1389 (w), 1370 (w), 1356 (w), 1307 (s), 1263 
(s), 1229 (w), 1213 (m), 1162 (m), 1137 (s), 1070 (w), 1033 (m), 966 (w), 944 (w), 927 
(m), 907 (w), 852 (s), 808 (m), 730 (s), 672 (m), 647 (w), 622 (w), 578 (w), 521 (w), 474 
(m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.67 (1H, d, J = 10.0 Hz), 7.64 (1H, d, J = 8.4 
Hz), 7.59 (1H, s), 7.33 (1H, dd, J = 8.4, 2.0 Hz), 7.10 (1H, dd, J = 8.4, 2.8 Hz), 7.09 (1H, 
s), 5.85 (1H, dd, J = 2.8, 1.6 Hz), 5.60 (1H, dd, J = 2.8, 1.6 Hz), 3.90 (3H, s), 3.84 (1H, q, 
J = 7.2 Hz), 1.48 (3H, d, J = 7.2 Hz), 1.15 (6H, s), 1.10 (6H, s); 
13
C NMR (CDCl3, 100 
MHz): δ 157.1, 141.1, 133.1, 129.2, 129.1, 127.6, 127.0, 126.4, 125.8, 118.4, 105.6, 83.4, 
!
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55.3, 43.7, 24.7, 20.2; HRMS: Calcd for C21H28B1O3 [M+H]
+
: 339.2131; Found: 
339.2132; specific rotation: [α]D
21
 +3.43 (c 1.06, CHCl3) for an enantiomerically enriched 
sample of 98:2 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OJ-H column, 100% hexanes, 0.5 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
40.073 6.10 × 10
7
 50.252 37.267 2.91 × 10
8
 97.949 
49.069 6.04 × 10
7
 49.748 48.209 6.11 × 10
6
 2.051 
(R)-4,4,5,5-Tetramethyl-2-(3-(3-pyridyl)but-1-en-2-yl)-1,3,2-dioxaborolane (4.69a): 
IR (neat): 3297 (br), 2976 (w), 2931 (w), 1617 (w), 1574 (w), 1473 (w), 1457 (w), 1419 
(m), 1370 (s), 1352 (s), 1304 (s), 1270 (m), 1213 (w), 1139 (s), 1110 (m), 1071 (w), 1024 
(w), 967 (m), 949 (m), 885 (m), 857 (w), 831 (w), 809 (w), 715 (s), 688 (m), 670 (m), 
621 (w), 578 (w), 549 (w), 520 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 8.48 (1H, s), 
8.39 (1H, s), 7.50 (1H, dt, J = 8.0, 1.6 Hz), 7.16 (1H, dd, J = 7.6, 4.8 Hz), 5.86 (1H, d, J = 
2.8 Hz), 5.61 (1H, d, J = 2.8 Hz), 3.69 (1H, q, J = 7.2 Hz), 1.39 (3H, d, J = 7.2 Hz), 1.24 
(6H, s), 1.22 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 149.6, 146.9, 135.2, 127.6, 83.4, 
76.6, 74.9, 41.3, 24.6, 19.7; HRMS: Calcd for C15H23B1N1O2 [M+H]
+
: 260.1821; Found: 
260.1821; specific rotation: [α]D
23
 +9.99 (c 2.00, CHCl3) for an enantiomerically enriched 
sample of 93:7 e.r. 
!
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Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDG-TA column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
228.651 4184.22 49.943 230.380 28.77 7.174 
236.325 4153.76 50.057 238.369 372.32 92.826 
(R)-4,4,5,5-Tetramethyl-2-(3-(3-thiophenyl)but-1-en-2-yl)-1,3,2-dioxaborolane 
(4.70a): IR (neat): 3068 (w), 2976 (w), 2931 (w), 2875 (w), 1614 (w), 1422 (w), 1371 
(m), 1355 (s), 1307 (s), 1271 (w), 1213 (w), 1182 (w), 1165 (w), 1139 (s), 1111 (w), 
1070 (w), 1005 (w), 967 (w), 945 (w), 895 (w), 853 (m), 832 (w), 806 (w), 779 (m), 723 
(w), 671 (w), 649 (w), 579 (w), 518 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.20 (1H, 
dd, J = 4.8, 2.8 Hz), 6.96 (1H, d, J = 4.8 Hz), 6.94 (1H, d, J = 2.8 Hz), 5.78 (1H, d, J = 
2.8 Hz), 5.53 (1H, d, J = 2.8 Hz), 3.76 (1H, q, J = 7.2 Hz), 1.41 (3H, d, J = 7.2 Hz), 1.20 
(6H, s), 1.19 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 146.7, 127.9, 127.0, 124.5, 119.7, 
83.2, 39.6, 24.5, 20.2; HRMS: Calcd for C14H22B1O2S1 [M+H]
+
: 265.1433; Found: 
265.1442; specific rotation: [α]D
23
 +10.9 (c 0.92, CHCl3) for an enantiomerically enriched 
sample of 88:12 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 90 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
242.017 77.57 50.023 242.268 15.34 12.410 
251.059 77.50 49.977 250.985 108.31 87.590 
(R)-4,4,5,5-Tetramethyl-2-(3-(tert-butyldiphenylsilyl)but-1-en-2-yl)-1,3,2-
dioxaborolane (4.71a): IR (neat): 3070 (w), 2976 (w), 2930 (w), 2857 (w), 1599 (w), 
1460 (m), 1426 (w), 1389 (m), 1372 (m), 1352 (w), 1306 (m), 1270 (w), 1212 (w), 1186 
(w), 1131 (s), 1102 (s), 1000 (m), 966 (m), 933 (m), 907 (s), 857 (m), 818 (m), 731 (s), 
698 (s), 671 (w), 635 (s), 617 (w) 598 (m), 578 (w), 492 (s) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.65 (4H, dd, J = 16.4, 7.6 Hz), 7.41–7.30 (6H, m), 5.76 (1H, d, J = 2.8 Hz), 
4.98 (1H, d, J = 2.8 Hz), 2.81 (1H, q, J = 7.2 Hz), 1.26 (12H, s), 1.14 (3H, d, J = 7.2 Hz), 
1.06 (9H, s); 
13
C NMR (CDCl3, 100 MHz): δ 137.2, 136.8, 135.3, 133.7, 129.2, 128.8, 
127.0, 83.4, 28.7, 25.0, 20.8, 19.0, 18.6; HRMS: Calcd for C26H37B1Na1O2Si1 [M+Na]
+
: 
443.2554; Found: 443.2559; specific rotation: [α]D
23
 +36.4 (c 3.75, CHCl3) for an 
enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OD-H column, 100% hexanes, 1.0 mL/min, 220 nm. 
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Retention Time Area Area% Retention Time Area Area% 
5.722 4.61 × 10
6
 50.054 6.817 1.17 × 10
6
 7.844 
6.935 4.60 × 10
6
 49.946 9.880 1.38 × 10
7
 92.156 
(R)-4,4,5,5-Tetramethyl-2-(3-phenylpent-1-en-2-yl)-1,3,2-dioxaborolane (4.72a): IR 
(neat): 3062 (w), 3027 (w), 2976 (m), 2930 (w), 2873 (w), 1602 (w), 1414 (m), 1361 (s), 
1306 (s), 1262 (m), 1214 (m), 1139 (s), 1028 (w), 969 (m), 942 (m), 902 (w), 865 (s), 839 
(m), 768 (m), 748 (m), 700 (s), 671 (m), 579 (w), 541 (w) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.27–7.21 (4H, m), 7.16–7.13 (1H, m), 5.82 (1H, dd, J = 2.8, 0.8 Hz), 5.61 (1H, 
d, J = 1.6 Hz), 3.38 (1H, t, J = 6.8 Hz), 1.98–1.91 (1H, m), 1.81–1.73 (1H, m), 1.18 (6H, 
s), 1.14 (6H, s), 0.85 (3H, t, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 144.5, 128.6, 
128.1, 127.4, 125.8, 83.4, 52.3, 26.8, 24.8, 24.6, 12.8; HRMS: Calcd for C17H26B1O2 
[M+H]
+
: 273.2026; Found: 273.2016; specific rotation: [α]D
20
 +16.6 (c 2.40, CHCl3) for 
an enantiomerically enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDG-TA column, 70 °C, 15 psi. 
!
Chapter 4, Page 275 
 
 
 
Retention Time Area Area% Retention Time Area Area% 
667.539 957.32 48.635 667.417 68.90 3.666 
684.086 1011.05 51.365 683.666 1810.37 96.334 
(R)-4,4,5,5-Tetramethyl-2-(4-methyl-3-phenylpent-1-en-2-yl)-1,3,2-dioxaborolane 
(4.73a): IR (neat): 3062 (w), 3026 (w), 2975 (m), 2868 (w), 1601 (w), 1428 (m), 1413 
(m), 1379 (s), 1357 (s), 1305 (m), 1165 (s), 966 (m), 942 (m), 865 (s), 839 (m), 758 (m), 
701 (s), 591 (m), 522 (w), 496 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.29 (1H, dd, J 
= 8.0, 1.6 Hz), 7.23 (1H, dt, J = 6.4, 1.6 Hz), 7.17 (1H, tt, J = 7.2, 1.6 Hz), 5.80 (1H, d, J 
= 3.2 Hz), 5.69 (1H, d, J = 2.8 Hz), 3.02 (1H, d, J = 10.4 Hz), 2.48–2.42 (1H, m), 1.23 
(6H, s), 1.19 (6H, s), 0.95 (3H, d, J = 6.4 Hz), 0.73 (3H, d, J = 6.4 Hz); 
13
C NMR 
(CDCl3, 100 MHz): δ 145.0, 128.9, 128.7, 128.1, 125.7, 83.4, 61.0, 30.2, 24.8, 24.7, 22.2, 
21.7; HRMS: Calcd for C18H28B1O2 [M+H]
+
: 287.2182; Found: 287.2179; specific 
rotation: [α]D
20
 +4.66 (c 2.14, CHCl3) for an enantiomerically enriched sample of 88:12 
e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 85 °C, 15 psi. 
!
Chapter 4, Page 276 
 
 
 
Retention Time Area Area% Retention Time Area Area% 
467.299 211.54 50.078 468.541 939.00 87.597 
478.072 210.89 49.922 478.514 132.957 12.403 
(R)-4,4,5,5-Tetramethyl-2-(1-(1,2,3,4-tetrahydronaphthalen-1-yl)vinyl)-1,3,2-
dioxaborolane (4.75a): IR (neat): 3059 (w), 2977 (m), 2931 (m), 2861 (w), 1613 (w), 
1449 (m), 1429 (m), 1412 (m), 1359 (s), 1306 (s), 1272 (m), 1214 (m), 1134 (s), 966 (m), 
946 (m), 865 (m), 851 (m), 737 (s), 687 (m), 671 (m), 579 (w), 444 (w) cm
−1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 7.07–7.03 (3H, m), 7.02–6.99 (1H, m), 5.91 (1H, d, J = 2.8 Hz), 
5.25 (1H, d, J = 2.8 Hz), 3.77 (1H, t, J = 6.4 Hz), 2.83–2.69 (2H, m), 1.93–1.77 (3H, m), 
1.71–1.64 (1H, m), 1.25 (6H, s), 1.17 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 139.1, 
137.9, 130.1, 128.8, 125.6, 125.4, 83.4, 44.3, 29.8, 29.4, 25.1, 24.4, 20.0; HRMS: Calcd 
for C18H26B1O2 [M+H]
+
: 285.2026; Found: 285.2012; specific rotation: [α]D
20 
+4.36 (c 
1.53, CHCl3) for an enantiomerically enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of the ketone (oxidation product of 4.75a) obtained through sodium 
perborate-mediated oxidative work-up. 
(S)-1-(1,2,3,4-Tetrahydronaphthalen-1-yl)ethanone (Oxidation product of 4.75a): IR 
(neat): 3060 (w), 3017 (w), 2934 (m), 2864 (w), 1702 (s), 1493 (m), 1450 (m), 1355 (s), 
1227 (m), 1188 (m), 1037 (w), 970 (w), 818 (w), 740 (s), 551 (m), 498 (w), 441 (w) cm
−1
; 
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1
H NMR (CDCl3, 400 MHz): δ 7.20–7.11 (3H, m), 7.00–6.97 (1H, m), 3.83 (1H, t, J = 
6.8 Hz), 2.80 (2H, q, J = 6.0 Hz), 2.12 (3H, s), 2.09–1.87 (3H, m), 1.78–1.70 (1H, m); 
13
C NMR (CDCl3, 100 MHz): δ 211.0, 137.5, 133.8, 129.7, 129.4, 127.0, 126.1, 53.9, 
29.4, 27.9, 26.3, 21.0; HRMS: Calcd for C12H15O1 [M+H]
+
: 175.1123; Found: 175.1129; 
specific rotation:  [α]D
20
 –15.6 (c 1.92, CHCl3) for an enantiomerically enriched sample 
of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
38.710 241.82 50.197 38.947 21.13 3.868 
42.632 239.92 49.803 42.349 525.11 96.132 
(R)-2-(1-(Chroman-4-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4.76a): IR 
(neat): 2975 (w), 2927 (w), 2874 (w), 1607 (w), 1580 (w), 1487 (m), 1450 (m), 1361 (m), 
1304 (s), 1268 (m), 1248 (m), 1221 (s), 1136 (s), 1113 (m), 1062 (m), 1017 (w), 967 (w), 
950 (w), 855 (w), 833 (w), 752 (s), 722 (w), 687 (w), 579 (w), 468 (w) cm
−1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 7.08 (1H, t, J = 8.0 Hz), 6.95 (1H, d, J = 7.2 Hz), 6.81 (2H, t, J = 
8.0 Hz), 6.01 (1H, d, J = 3.2 Hz), 5.34 (1H, d, J = 2.0 Hz), 4.13–4.10 (2H, m), 3.75 (1H, t, 
J = 5.6 Hz), 2.12–2.07 (1H, m), 2.02–1.97 (1H, m), 1.26 (6H, s), 1.20 (6H, s); 13C NMR 
(CDCl3, 100 MHz): δ 155.3, 132.3, 130.7, 127.6, 124.1, 120.0, 116.6, 83.7, 63.1, 39.8, 
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28.1, 25.1, 24.5; HRMS: Calcd for C17H24B1O3 [M+H]
+
: 287.1819; Found: 287.1824; 
specific rotation: [α]D
20
 +3.98 (c 2.51, CHCl3) for an enantiomerically enriched sample of 
95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
194.796 18.27 48.818 195.015 26.98 4.764 
199.596 19.16 51.182 199.859 539.27 95.236 
 
 Representative Procedure for Conversion of Alkenylborons to Methyl Ketones: 
(R)-4,4,5,5-Tetramethyl-2-(3-phenylbut-1-en-2-yl)-1,3,2-dioxaborolane 4.50a (25.8 mg, 
0.100 mmol) was dissolved in a mixture of thf (0.5 mL) and pH = 7 buffer (0.5 mL). 
NaBO3•4H2O (76.9 mg, 0.500 mmol) was added to the mixture and it was allowed to stir 
at 22 °C for 30 min. The reaction was quenched by addition of H2O (2 mL) and water 
layer was washed with Et2O (3 x 2 mL). The combined organic layer was dried over 
MgSO4 and concentrated under reduced pressure (Note: Most of methyl ketones are quite 
volatile. It is recommended not to dry the unpurified mixture under high-vacuum. House-
vacuum was used exclusively for concentrating the products). The product 4.77 was 
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isolated by silica gel chromatography (hexanes:Et2O=20:1) as colorless oil (10.5 mg, 
0.07080 mmol, 71% yield). 
(S)-3-Phenylbuta-2-one (4.77): [Note: The analytical data are fully consistent with those 
reported previously.]
30
 IR (neat): 3061 (w), 3027 (w), 2976 (w), 2932 (w), 1710 (s), 1600 
(w), 1583 (w), 1493 (m), 1452 (m), 1372 (m) 1354 (w), 1317 (w), 1248 (w), 1195 (w), 
1164 (m), 1068 (m), 1024 (w), 949 (w), 912 (w), 804 (w), 765 (m), 738 (w), 698 (s), 635 
(w), 591 (w), 541 (s), 472 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.35–7.34 (2H, m), 
7.32–7.31 (1H, m), 7.21 (2H, d, J = 7.2 Hz), 3.74 (1H, q, J = 7.2 Hz), 2.04 (3H, s), 1.39 
(3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 208.8, 140.5, 128.9, 127.7, 127.1, 
53.7, 28.3, 17.1; HRMS: Calcd for C10H13O1 [M+H]
+
: 149.0966; Found: 149.0972; 
specific rotation: [α]D
21
 +212.9 (c 0.61, CHCl3) for an enantiomerically enriched sample 
of 94:6 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 90 °C, 15 psi. 
Stereochemistry Proof is based on the optical rotation for the R enantiomer: [α]D
20
 –234 
(c 1.0, CHCl3) for a 83.5:16.5 e.r. sample.
27
 
 
Retention Time Area Area% Retention Time Area Area% 
20.935 618.53 49.947 21.085 150.94 6.019 
                                                 
(30) Roy, O.; Riahi, A.; Hénin, F.; Muzart, J. Eur. J. Org. Chem. 2002, 3986–3994. 
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23.135 619.83 50.053 22.577 2356.84 93.981 
(S)-3-(4-Trifluoromethylphenyl)buta-2-one (4.78): IR (neat): 2981 (w), 2937 (w), 1715 
(s), 1618 (w), 1455 (w), 1418 (w), 1356 (w), 1322 (s), 1250 (w), 1161 (s), 1113 (s), 1067 
(s), 1017 (m), 952 (w), 843 (s), 776 (w), 750 (w), 729 (w), 654 (w), 635 (w), 603 (m), 
535 (w), 505 (w), 452 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.59 (2H, d, J = 8.0 Hz), 
7.34 (2H, d, J = 8.0 Hz), 3.82 (1H, q, J = 7.2 Hz), 2.07 (3H, s), 1.41 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 207.8, 172.4 (d, JCF = 0.7 Hz), 144.6, 128.2 (d, JCF = 
10.6 Hz), 126.0 (d, JCF = 3.0 Hz), 124.2 (q, JCF = 271 Hz), 53.5, 28.6, 17.4; HRMS: 
Calcd for C11H12F3O1 [M+H]
+
: 217.0840; Found: 217.0849; specific rotation: [α]D
22
 
+135.1 (c 2.44, CHCl3) for an enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
21.280 187.98 49.899 21.438 25.31 7.950 
25.680 188.74 50.101 25.560 293.11 92.050 
(S)-3-(6-Methoxy-2-naphthyl)buta-2-one (4.79): [Note: The synthesis of racemic 4.79 
is already reported, but the analytical data of 4.79 is not reported.] IR (neat): 2984 (w), 
2960 (w), 2938 (w), 2886 (w), 1712 (s), 1703 (s), 1629 (w), 1601 (m), 1503 (w), 1483 
(w), 1457 (w), 1437 (w), 1414 (w), 1390 (w), 1372 (w), 1353 (m), 1311 (w), 1265 (m), 
1224 (m), 1194 (w), 1169 (s), 1121 (w), 1065 (m), 1025 (s), 959 (w), 943 (w), 921 (w), 
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890 (m), 854 (s), 815 (s), 765 (w), 742 (w), 691 (w), 672 (w), 631 (w), 600 (w), 586 (w), 
533 (w), 520 (w), 477 (s), 456 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.71 (1H, d, J = 
4.4 Hz), 7.69 (1H, d, J = 4.4 Hz), 7.60 (1H, d, J = 1.2 Hz), 7.28 (1H, dd, J = 8.4, 2.0 Hz), 
7.15 (1H, dd, J = 8.4, 2.0 Hz), 7.11 (1H, d, J = 2.0 Hz), 3.92 (3H, s), 3.87 (1H, q, J = 7.2 
Hz), 2.06 (3H, s), 1.46 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 209.1, 157.8, 
135.8, 133.8, 129.3, 129.2, 127.6, 126.5, 126.4, 119.3, 105.7, 55.4, 53.8, 28.5, 17.3; 
HRMS: Calcd for C15H16Na1O2 [M+Na]
+
: 251.1048; Found: 251.1041; specific rotation: 
[α]D
20
 +343 (c 1.66, CHCl3) for an enantiomerically enriched sample of 96.5:3.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AD-H column, 99:1 hexanes:i-PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
32.379 1.69 × 10
8
 49.109 30.557 1.08 × 10
8
 96.454 
36.135 1.75 × 10
8
 50.891 34.253 3.98 × 10
6
 3.546 
(S)-5-(tert-Butyldimethylsilyloxy)-3-phenylpenta-2-one (4.80): IR (neat): 2953 (w), 
2928 (w), 2884 (w), 2856 (w), 1713 (s), 1493 (w), 1471 (w), 1454 (w), 1431 (w), 1387 
(w), 1355 (m), 1252 (m), 1159 (w), 1100 (s), 1064 (m), 1030 (w), 1006 (w), 969 (w), 926 
(w), 830 (s), 811 (m), 774 (s), 699 (s), 663 (w), 593 (w), 548 (w) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.34–7.30 (2H, m), 7.27–7.25 (1H, m), 7.22–7.19 (2H, m), 3.89 (1H, t, J = 
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7.2 Hz), 3.59–3.54 (2H, m), 3.45–3.40 (2H, m), 2.30–2.24 (1H, m), 2.06 (3H, s), 1.86–
1.78 (1H, m), 0.88 (9H, s), 0.00 (6H, s); 
13
C NMR (CDCl3, 100 MHz): δ 208.4, 138.9, 
129.0, 128.5, 127.3, 60.5, 55.7, 34.9, 29.3, 26.0, 18.4, –5.2; HRMS: Calcd for 
C17H28Na1O2Si1 [M+Na]
+
: 315.1756; Found: 315.1759; specific rotation: [α]D
22
 +149.9 (c 
2.00, CHCl3) for an enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralcel OD-H column, 100% hexanes, 0.1 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
87.313 9.93 × 10
7
 47.891 82.608 1.63 × 10
7
 7.477 
95.450 1.08 × 10
8
 52.109 88.828 2.02 × 10
8
 92.523 
 
 Representative Procedure for Synthesis of Alkenyl Bromides: A vial was charged 
with CuBr2 (156.3 mg, 0.700 mmol), (R)-4,4,5,5-tetramethyl-2-(3-phenylbut-1-en-2-yl)-
1,3,2-dioxaborolane 4.58a (27.6 mg, 0.100 mmol) and MeOH/H2O (1 mL/1 mL). The 
mixture was sealed with a cap and allowed to stir at 90 °C for 14 h. After cooling to 22 
°C, the mixture was diluted with water (5 mL) and washed with Et2O (3 x 2 mL). The 
combined organic layer was dried over MgSO4, filtered, and concentrated under reduced 
pressure. The unpurified material was purified by silica gel chromatography 
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(hexanes:Et2O=50:1) to afford the desired product 4.81 as colorless oil (19.7 mg, 0.0860 
mmol, 86% yield). 
(S)-1-(3-Bromobut-3-en-2-yl)-2-fluorobenzene (4.81): IR (neat): 2976 (w), 2928 (w), 
1627 (m), 1586 (w), 1490 (s), 1453 (m), 1401 (w), 1375 (w), 1264 (w), 1229 (s), 1131 
(m), 1111 (m), 1067 (m), 938 (w), 891 (s), 820 (s), 752 (s), 644 (m), 580 (m), 537 (m), 
484 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.31–7.22 (2H, m), 7.13 (1H, td, J = 7.6, 
1.2 Hz), 7.03 (1H, ddd, J = 10.0, 7.6, 1.2 Hz), 5.74 (1H, dd, J = 3.2, 1.6 Hz), 5.57 (1H, d, 
J = 2.0 Hz), 4.12 (1H, q, J = 6.8 Hz), 1.48 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 
MHz): δ 160.8 (d, JCF = 245 Hz), 137.3, 129.7 (d, JCF = 14.4 Hz), 128.6 (d, JCF = 8.3 Hz), 
128.5 (d, JCF = 4.6 Hz), 124.3 (d, JCF = 3.8 Hz), 117.0, 115.6 (d, JCF = 22.8 Hz), 42.7 (d, 
JCF = 3.0 Hz), 19.8; HRMS: Calcd for C10H11Br1F1 [M+H]
+
: 229.0028; Found: 229.0032; 
specific rotation: [α]D
20
 –6.57 (c 1.52, CHCl3) for an enantiomerically enriched sample of 
95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDG-TA column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
14.985 1238.95 50.436 15.001 1638.16 96.203 
16.753 1217.55 49.564 16.934 64.65 3.797 
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(S)-1-Bromo-3-(3-bromobut-3-en-2-yl)benzene (4.82): IR (neat): 3060 (w), 2974 (w), 
2933 (w), 2873 (w), 1624 (m), 1592 (m), 1568 (m), 1475 (m), 1424 (m), 1372 (w), 1192 
(w), 1159 (w), 1127 (m), 1074 (m), 997 (m), 884 (s), 802 (m), 780 (s), 709 (s), 691 (s), 
666 (s), 640 (m), 605 (m), 577 (m), 554 (m), 435 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): 
δ 7.41–7.38 (2H, m), 7.23–7.19 (2H, m), 5.75 (1H, dd, J = 2.0, 1.2 Hz), 5.57 (1H, d, J = 
2.0 Hz), 3.73 (1H, q, J = 6.8 Hz), 1.47 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): 
δ 145.0, 138.1, 130.7, 130.2, 130.1, 126.3, 122.7, 117.0, 49.6, 20.5; HRMS: Calcd for 
C10H11Br2 [M+H]
+
: 288.9228; Found: 288.9222; specific rotation: [α]D
20
 –7.62 (c 1.31, 
CHCl3) for an enantiomerically enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
45.993 290.68 49.974 46.009 360.02 96.010 
47.648 290.98 50.026 47.901 14.96 3.990 
(R)-3-(2-Naphthyl)-2-bromobut-1-ene (4.83): IR (neat): 3052 (w), 3020 (w), 2972 (w), 
2933 (w), 2874 (w), 1622 (m), 1599 (w), 1506 (w), 1450 (w), 1390 (w), 1374 (w), 1270 
(w), 1242 (w), 1200 (w), 1172 (w), 1155 (w), 1125 (m), 1048 (w), 1018 (w), 988 (w), 
949 (w), 889 (s), 855 (s), 815 (s), 769 (w), 747 (s), 658 (w), 640 (w), 622 (w), 568 (w), 
539 (w), 516 (w), 475 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.83–7.80 (3H, m), 7.81 
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(1H, d, J = 4.0 Hz), 7.71 (1H, s), 7.50–7.45 (2H, m), 7.39 (1H, dd, J = 8.4, 2.0 Hz), 5.78 
(1H, d, J = 1.2 Hz), 5.60 (1H, d, J = 1.2 Hz), 3.93 (1H, q, J = 7.2 Hz), 1.58 (3H, d, J = 7.2 
Hz); 
13
C NMR (CDCl3, 100 MHz): δ 140.0, 139.0, 133.6, 132.6, 128.2, 127.9, 127.7, 
126.2, 126.1, 125.9, 125.8, 116.7, 50.0, 20.6; HRMS: Calcd for C14H14Br1 [M+H]
+
: 
261.0278; Found: 261.0287; specific rotation: [α]D
23
 –13.1 (c 1.52, CHCl3) for an 
enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 115 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
293.207 234.30 48.862 289.231 1573.94 95.088 
299.694 245.20 51.138 298.119 81.31 4.912 
(S)-(2-Bromopent-1-en-3-yl)benzene (ent-4.20): IR (neat): 3062 (w), 3028 (w), 2963 
(m), 2929 (m), 2874 (w), 1621 (m), 1601 (w), 1493 (m), 1453 (m), 1379 (w), 1155 (m), 
1143 (m), 1129 (m), 1064 (w), 1029 (w), 888 (s), 842 (w), 769 (m), 744 (m), 698 (s), 655 
(w), 566 (m), 542 (m), 498 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.35–7.31 (2H, m), 
7.27–7.24 (3H, m), 5.76 (1H, dd, J = 2.0, 0.8 Hz), 5.53 (1H, d, J = 2.0 Hz), 3.43 (1H, t, J 
= 7.6 Hz), 2.02 (1H, dq, J = 20.4, 7.6 Hz), 1.79 (1H, dq, J = 20.8, 7.6 Hz), 0.91 (3H, t, J 
= 7.6 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 141.3, 138.5, 128.5, 128.1, 127.1, 116.9, 57.5, 
26.6, 12.3; HRMS: Calcd for C11H13 [M–Br]
+
: 145.1027; Found: 145.1020; specific 
rotation: [α]D
20 –6.24 (c 1.60, CHCl3) for an enantiomerically enriched sample of 96:4 e.r. 
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Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
53.804 4.16 48.649 53.689 24.10 95.847 
55.451 4.39 51.351 55.468 1.04 4.153 
 
 Representative Procedure for NHC–Cu-Catalyzed Enantioselective Protoboration 
of 1,1-Disubstituted Allenes Followed by Conversion to Carboxylic Acids: An oven-
dried vial equipped with a stir bar was charged with imidazolinium salt A.22 (3.4 mg, 
5.50 µmol), NaOt-Bu (3.8 mg, 0.0400 mmol), CuCl (0.5 mg, 5.00 µmol) and thf (0.3 mL) 
in a N2-filled glove box. The vessel was sealed with a cap (phenolic open top cap with 
red PTFE/white silicone septum) and the solution was allowed to stir at 22 °C for one 
hour. Bis(pinacolato)diboron (27.9 mg, 0.110 mmol) was added to the solution, which 
turned dark brown immediately and the wall of a reaction vial was rinsed with additional 
thf (0.2 mL). The vial was re-sealed with a cap (phenolic open top cap with red 
PTFE/white silicone septum) and removed from the glove box. The mixture was allowed 
to stir at 22 °C for 30 min under a N2 atmosphere. 2-(Buta-2,3-dien-2-yl)-6-
methoxynaphthalene 4.85 (13.1 mg, 0.100 mmol) and t-BuOH (14.3 µL, 0.150 mmol) 
were added through syringes. The resulting solution was allowed to stir at 22 °C for 16 h 
!
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before the reaction was quenched by passing the mixture through a short plug of celite 
and silica gel and eluted with Et2O (3 × 2 mL). The filtrate was concentrated in vacuo to 
provide yellow oil, which was dissolved in mixture of thf (0.5 mL) and pH = 7 buffer 
(0.5 mL). NaIO4 (86.0 mg, 0.400 mmol) and OsO4 (1 drop of 4 wt % H2O solution) was 
added to the mixture and it was allowed to stir at 22 °C for 8 h. The reaction was 
quenched by addition of saturated aqueous solution of Na2SO3 (1 mL) and the mixture 
was allowed to stir for an additional hour to complete quenching OsO4. The water layer 
was washed with Et2O (2 x 2 mL; recovery of remained starting material for 
determination of the conversion of the transformation) and acidified with 3N HCl 
solution until pH<3. Water layer was washed with EtOAc (3 x 2 mL) and the combined 
organic layer was dried over MgSO4, and concentrated under reduced pressure. The 
product (S)-naproxen was isolated by silica gel chromatography (hexanes:Et2O=2:1) as 
colorless oil (17.3 mg, 0.0750 mmol, 75% yield). 
(S)-2-(6-Methoxy-2-naphthyl)propinoic acid, (S)-Naproxen: [Note: The analytical 
data are fully consistent with those reported previously.]
31
 IR (neat): 3097 (br), 2973 (w), 
2938 (w), 1708 (s), 1685 (s), 1629 (w), 1602 (s), 1504 (w), 1480 (w), 1459 (w), 1435 (w), 
1418 (w), 1391 (s), 1345 (w), 1262 (s), 1225 (s), 1191 (s), 1174 (s), 1156 (s), 1120 (w), 
1090 (m), 1070 (m), 1027 (s), 962 (w), 924 (m), 895 (m), 854 (s), 817 (s), 793 (m), 761 
(w), 741 (m), 673 (m), 642 (m), 600 (w), 568 (w), 522 (w), 482 (s), 472 (s) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.72 (1H, s), 7.69 (2H, s), 7.43 (1H, dd, J = 8.4, 2.0 Hz), 
7.15 (1H, dd, J = 8.4, 2.0 Hz), 7.11 (1H, d, J = 2.0 Hz), 3.91 (3H, s), 3.88 (1H, q, J = 7.2 
Hz), 1.60 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 181.0, 157.8, 134.9, 133.9, 
                                                 
(31) (a) Frank, A.; Rüchardt, C. Chem. Lett. 1984, 13, 1431–1434. (b) Boyd E.; Coulbeck E.; Coumbarides 
G. S.; Chavda S.; Dingjan M.; Eames J.; Flinn A.; Motevalli M.; Northen J.; Yohannes Y. Tetrahedron: 
Asymmetry 2007, 18, 2515–2530. 
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129.4, 129.0, 127.3, 126.3, 126.2, 119.1, 105.7, 55.4, 45.4, 18.2; specific rotation: [α]D
21
 
+55.5 (c 1.87, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AD-H column, 95:5 hexanes:i-PrOH, 1.0 mL/min, 220 nm. 
Stereochemistry Proof is based on the optical rotation for the S enantiomer: [α]D
20
 +65.0 
(c 1.00, CHCl3) for a >99:1 e.r.
31 
 
Retention Time Area Area% Retention Time Area Area% 
15.307 4.14 × 10
7
 50.091 15.630 5.46 × 10
5
 5.057 
16.536 4.12 × 10
7
 49.909 17.041 1.02 × 10
7
 94.943 
(S)-2-Phenylpropinoic acid (4.84): [Note: The analytical data are fully consistent with 
those reported previously.]
32
 IR (neat): 3029 (w), 2978 (br), 2936 (w), 1700 (s), 1601 (w), 
1496 (w), 1453 (w), 1412 (w), 1378 (w), 1261 (w), 1227 (m), 1181 (w), 1095 (w), 1065 
(w), 1030 (w), 1006 (w), 992 (w), 911 (w), 858 (w), 759 (w), 726 (m), 695 (s), 658 (w), 
614 (w), 575 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.32–7.30 (4H, m), 7.27–7.25 (1H, 
m), 3.72 (1H, q, J = 7.2 Hz), 1.50 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 
180.8, 139.8, 128.8, 127.7, 127.5, 45.4, 18.2; specific rotation: [α]D
21
 +59.7 (c 0.81, 
CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
                                                 
(32) Shaye, N. A.; Chavda, S.; Coulbeck, E.; Eames, J.; Yohannes, Y. Tetrahedron: Asymmetry 2011, 22, 
439–463. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AD-H column, 95:5 hexanes:i-PrOH, 1.0 mL/min, 220 nm.  
Stereochemistry Proof is based on the optical rotation for the S enantiomer: [α]D
20
 +72.0 
(c 0.61, CHCl3) for a 99:1 e.r.
32 
 
Retention Time Area Area% Retention Time Area Area% 
7.046 1.63 × 10
6
 50.118 6.997 5.16 × 10
5
 5.036 
7.876 1.62 × 10
6
 49.882 7.807 9.73 × 10
6
 94.964 
 
 Representative Procedure for Preparation of Chiral Alkenylboronic Acids:33 An 
oven-dried vial equipped with a stir bar was charged with (R)-4,4,5,5-tetramethyl-2-(3-
phenylbut-1-en-2-yl)-1,3,2-dioxaborolane 4.58a (100 mg, 0.380 mmol), NH4OAc (107.4 
mg, 1.39 mmol), NaIO4 (298 mg, 1.39 mmol) and the mixture of acetone (0.35 mL) and 
water (0.35 mL) in ambient atmosphere. The vial was sealed with a cap and the solution 
was allowed to stir at 22 °C for 12 h. The slurry was filtered by passing it through a short 
plug of celite (4 cm × 1 cm) eluted with acetone and the volatiles were removed from the 
filtrate in vacuo. The aqueous solution was washed with Et2O (3 × 10 mL) and the 
combined organic layer was washed with water, brine and dried over MgSO4, filtered and 
                                                 
(33) Wang, H.-Y.; Anderson, L. L. Org. Lett. 2013, 15, 3362–3365. 
!
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concentrated under vacuum to afford the unpurified product, which was purified by silica 
gel chromatography (hexanes:Et2O=3:1) to afford 55.5 mg of 4.89 as colorless oil (0.315 
mmol, 83% yield). IR (neat): 3215 (br), 3061 (w), 3026 (w), 2966 (w), 2931 (w), 2874 
(w), 1754 (w), 1738 (w), 1602 (w), 1492 (m), 1451 (m), 1409 (s), 1355 (s), 1234 (m), 
1214 (m), 1140 (s), 1068 (s), 1029 (m), 951 (s), 907 (m), 857 (m), 763 (s), 731 (s), 697 
(s), 606 (w), 536 (s), 465 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.29–7.15 (5H, m), 
6.19 (1H, d, J = 2.4 Hz), 5.80 (1H, dd, J = 2.4, 1.2 Hz), 3.77 (1H, q, J = 7.2 Hz), 1.36 (3H, 
d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 131.6, 129.1, 128.3, 127.8, 127.5, 125.9, 
42.6, 20.9; HRMS: Calcd for C10H12B1O2 [M–H]
+
: 175.0930; Found: 175.0958. 
 
 Representative Procedure for NHC–Cu-Catalyzed Diastereoselective Allylic 
Substitution with Alkenylboronic Acids: An oven dried vial equipped with a stir bar 
was charged with chiral imidazolinium salt A.17 (4.7 mg, 5.50 µmol), CuCl (0.5 mg, 
5.00 µmol) and NaOMe (8.1 mg, 0.150 mmol) in a N2 filled glove-box. The vial was 
sealed with a cap (phenolic open top cap with red PTFE/white silicone septum) and 
removed from the glove box. Tetrahydrofuran (0.5 mL) was added to the vial and the 
resulting solution was allowed to stir at 22 °C for one hour. A solution of (E)-diethyl 3-
phenylprop-2-enyl phosphate 4.23 (27 mg, 0.100 mmol) and alkenylboronic acid 4.89 
(26.4 mg, 0.150 mmol) in thf (0.5 mL) was added to the reaction vial through syringe and 
the mixture was allowed to stir at 60 °C for 24 h. The reaction was quenched by passing 
through a short plug of silica gel (4 cm × 1 cm) and eluted with Et2O (10 mL). The 
organic layer was concentrated in vacuo and purified by silica gel chromatography (100% 
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pentane) to afford 15.2 mg of ((2R,4S)-3-methylenehex-5-ene-2,4-diyl)dibenzene 4.86 as 
colorless oil (0.0620 mmol, 62% yield, 96:4 d.r.). 
((2R,4S)-3-Methylenehex-5-ene-2,4-diyl)dibenzene (4.86): IR (neat): 3081 (w), 3060 
(w), 3025 (w), 2966 (w), 2931 (w), 2874 (w), 1634 (w), 1599 (w), 1491 (m), 1450 (m), 
1405 (w), 1370 (w), 1338 (w), 1290 (w), 1254 (w), 1180 (w), 1155 (w), 1071 (w), 1029 
(w), 995 (w), 906 (s), 837 (w), 781 (w), 760 (s), 696 (s), 621 (w), 606 (w), 584 (w), 548 
(w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.30–7.24 (2H, m), 7.22–7.17 (6H, m), 7.04–
7.02 (2H, m), 6.01 (1H, ddd, J = 17.2, 9.8, 7.2 Hz), 5.13 (1H, d, J = 9.8 Hz), 5.09 (1H, s), 
4.97 (1H, d, J = 17.2 Hz), 4.76 (1H, s), 3.91 (1H, d, J = 7.2 Hz), 3.48 (1H, q, J = 7.2 Hz), 
1.35 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 155.2, 145.2, 142.3, 139.9, 
128.7, 128.4, 128.3, 128.0, 126.4, 126.3, 116.0, 112.2, 54.3, 44.6, 21.1; HRMS: Calcd for 
C19H21 [M+H]
+
: 249.1643; Found: 249.1638; specific rotation: [α]D
24
 +102.3 (c 1.30, 
CHCl3). 
((2S,4S)-3-Methylenehex-5-ene-2,4-diyl)dibenzene (4.90): IR (neat): 3081 (w), 3060 
(w), 3025 (w), 2965 (w), 2931 (w), 2874 (w), 1636 (w), 1599 (w), 1490 (m), 1451 (m), 
1406 (w), 1369 (w), 1338 (w), 1295 (w), 1255 (w), 1199 (w), 1155 (w), 1071 (w), 1029 
(w), 995 (w), 906 (s), 836 (w), 761 (s), 697 (s), 611 (w), 548 (w) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.42–7.38 (2H, m), 7.35–7.28 (6H, m), 7.27–7.22 (2H, m), 6.16 (1H, ddd, J 
= 15.6, 10.8, 7.2 Hz), 5.43 (1H, s), 5.34 (1H, d, J = 1.2 Hz), 5.14 (1H, dt, J = 10.8, 1.6 
Hz), 4.77 (1H, dt, J = 15.6, 1,6 Hz), 3.90 (1H, d, J = 6.8 Hz), 3.32 (1H, q, J = 7.2 Hz), 
1.43 (3H, d, J = 7.2 Hz); 
13
C NMR (CDCl3, 100 MHz): δ 154.4, 145.6, 141.8, 140.9, 
128.8, 128.5, 128.4, 128.1, 126.5, 126.3, 115.4, 110.7, 54.3, 44.3, 21.5; HRMS: Calcd for 
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C19H21 [M+H]
+
: 249.1643; Found: 249.1635; specific rotation: [α]D
22
 –182.1 (c 1.70, 
CHCl3). 
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Chapter Five 
NHC–Cu-Catalyzed Chemoselective Boron–
Copper Addition to Monosubstituted Allenes 
followed by Diastereo- and Enantioselective 
Additions to Protecting Group-Free Ketoimines: 
Three-Component, Single-Vessel Catalytic 
Protocol for 2-B(pin)-Substituted Homoallylic 
Tertiary Carbamines 
 
5.1. Introduction 
 Enantiomerically enriched molecules that contain stereogenic carbon center 
bearing a nitrogen atom are useful intermediates in organic synthesis. Therefore, much 
attention has been devoted to the development of catalytic enantioselective C–C bond 
formations by addition of C-based nucleophiles to nitrogen-containing electrophiles.
1
 
Mannich reactions
2
 and allyl addition to imines
3
 are two representative methods for 
                                                 
(1) For reviews, see: (a) Bloch, R. Chem. Rev. 1998, 98, 1407–1438. (b) Kobayashi, S.; Ishitani, H. Chem. 
Rev. 1999, 99, 1069–1094. (c) Shibasaki, M.; Kanai, M. Chem. Rev. 2008, 108, 2853–2873. (d) Kobayashi, 
S.; Mori, Y.; Fossey, J. S.; Salter, M. M. Chem. Rev. 2011, 111, 2626–2704. 
(2) For a review, see: Arend, M.; Westermann, B.; Risch, N. Angew. Chem., Int. Ed. 1998, 37, 1044–1070. 
(3) (a) Vieira, E. M.; Snapper, M. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 3332–3335. For a 
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building of C–C bond by addition of C-based nucleophiles to C=N bonds. However, 
protocols for catalytic enantioselective additions to ketoimines have been rarely 
developed.
4
 The differentiation of two substituents on ketoimine may be more difficult 
(vs aldimines) because of the smaller size difference of them. In addition, since the 
electrophilicity of a ketoimine is low than a ketone, development of catalytic process with 
ketoimines would be challenging. 
One desirable, but underdeveloped set of transformations would be the addition of 
allyl groups to ketoimines, which can afford quaternary carbon stereogenic center-
bearing homoallylic amines. In 2006, Shibasaki, Kanai, and coworkers reported catalytic 
enantioselective allyl additions to benzyl-protected ketoimines promoted by chiral 
bisphosphine–Cu complex.4l Two years later, Shibasaki, Kumagai, and coworkers 
demonstrated Cu-catalyzed additions of allylic cyanides to N-phosphinoyl-ketoimines.
4m
 
Enantioselective additions of functionalized allylic silanes to N-tosyl-ketoimines, 
followed by cyclization, catalyzed by chiral phosphoramidite–Pd catalysts were 
developed by Trost and coworkers in 2010.
4n
 The ketoimines they utilized are protected 
and activated by benzyl, phosphinoyl, or tosyl group, which needs to be detached 
                                                                                                                                                 
review, see: (b) Yus, M.; González-Gómez, J. C.; Foubelo, F. Chem. Rev. 2011, 111, 7774–7854. 
(4) For catalytic enantioselective Mannich-type additions to ketoimines, see: (a) Saaby, S.; Nakama, K.; 
Alstrup Lie, M.; Hazell, R. G.; Jørgensen, K. A. Chem. Eur. J. 2003, 9, 6145–6154. (b) Zhuang, W.; Saaby, 
S.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2004, 43, 4476–4478. (c) Suto, Y.; Kanai, M.; Shibasaki, M. J. 
Am. Chem. Soc. 2007, 129, 500–501. (d) Du, Y.; Xu, L.-W.; Shimizu, Y.; Oisaki, K.; Kanai, M.; Shibasaki, 
M. J. Am. Chem. Soc. 2008, 130, 16146–16147. (e) Wieland, L. C.; Vieira, E. M.; Snapper, M. L.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 570–576. (f) Lu, G.; Yoshino, T.; Morimoto, H.; Matsunaga, 
S.; Shibasaki, M. Angew. Chem., Int. Ed. 2011, 50, 4382–4385. (g) Kano, T.; Song, S.; Kubota, Y.; 
Maruoka, K. Angew. Chem., Int. Ed. 2012, 51, 1191–1194. (h) Hayashi, M.; Sano, M.; Funahashi, Y.; 
Nakamura, S. Angew. Chem., Int. Ed. 2013, 52, 5557–5560. (i) Yin, L.; Takada, H.; Kumagai, N.; 
Shibasaki, M. Angew. Chem., Int. Ed. 2013, 52, 7310–7313. (j) Hayashi, M.; Iwanaga, M.; Shiomi, N.; 
Nakane, D.; Masuda, H.; Nakamura, S. Angew. Chem., Int. Ed. 2014, 53, 8411–8415. (k) Nakamura, S.; 
Yamaji, R.; Hayashi, M. Chem. –Eur. J. 2015, 21, 9615–9618. For catalytic enantioselective allyl addition 
to ketoimines, see: (l) Wada, R.; Shibuguchi, T.; Makino, S.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. 
Chem. Soc. 2006, 128, 7687–7691. (m) Yazaki, R.; Nitabaru, T.; Kumagai, N.; Shibasaki, M. J. Am. Chem. 
Soc. 2008, 130, 14477–14479. (n) Trost, B. M.; Silverman, S. M. J. Am. Chem. Soc. 2010, 132, 8238–8240. 
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afterward. Thus, we are particularly interested in utilization of a protecting group-free 
ketoimine, which was reported by Zhang’s group in their Ir-catalyzed enantioselective 
hydrogenation of “N–H” ketoimines.5 In their study, they introduced a novel class of 
imine, “N–H” ketoimine, which has no protecting group on the nitrogen atom. This type 
of ketoimine is prepared through a simple process, addition of an organolithium or a 
Grignard reagent to a nitrile, followed by treatment of MeOH. The transformation of “N–
H” ketoimine is very useful because the obtained amine has no protecting group, which 
allows us to avoid the deprotection step as well as to be able to choose appropriate 
protecting group for subsequent chemical reactions. For the above reasons, we envisioned 
the sequence shown in Scheme 5.1. Herein, we have disclosed NHC–Cu-catalyzed 
diastereo- and enantioselective additions of 2-B(pin)-substituted allyl groups to 
unprotected ketoimines to afford homoallylic amides containing carbon quaternary 
stereogenic center and alkenylboron moiety. 
 
 
 
                                                 
(5) (a) Hou, G.; Gosselin, F.; Li, W.; McWilliams, J. C.; Sun, Y.; Weisel, M.; O’Shea, P. D.; Chen, C.-y.; 
Davies, I. W.; Zhang, X. J. Am. Chem. Soc. 2009, 131, 9882–9883. (b) Hou, G.; Tao, R.; Sun, Y.; Zhang, 
X.; Gosselin, F. J. Am. Chem. Soc. 2010, 132, 2124–2125. For diastereoselective coupling of unprotected 
ketoimines prepared by the same method and monosubstituted allenes, catalyzed by bisphosphine–Rh 
complexes (one enantioselective example shown with selectivity of 84:16 e.r.), see: (c) Tran, D. N.; 
Cramer, N. Angew. Chem., Int. Ed. 2010, 49, 8181–8184. 
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5.2. Background 
 In this section, we will introduce previously reported catalytic protocols for 
enantioselective additions of allyl unit to acyclic ketoimines. The pioneering work by 
Shibasaki, Kanai, and coworkers was disclosed in 2006, which is catalytic 
enantioselective allyl addition to N-benzyl-ketoimines.
6
 As illustrated in Scheme 5.2, 
reaction of acetophenone-derived ketoimine 5.1 with 3 equiv. of allyl–B(pin) 5.2 in the 
presence of 10 mol % of Cu complex, derived from chiral bisphosphine 5.3 and CuF2 
salt, affords homoallylic amide 5.4 in 92% yield with 94.5:5.5 e.r. The level of 
enantioselectivity for reactions of various aryl-bearing ketoimines is high (92.5:7.5–96:4 
e.r. for 5.5–5.7). However, dialkyl-substituted ketoimine was converted to desired 
homoallylic benzyl amide 5.8 with low enantioselectivity (61.5:38.5 e.r.), mainly due to 
the difficulty of differentiation of methyl and n-alkyl unit on ketoimine. 
 
This is the first catalytic enantioselective allyl addition to ketoimines including 
reasonable substrate scope for methyl ketones bearing various aryl groups with high 
                                                 
(6) Wada, R.; Shibuguchi, T.; Makino, S.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006, 
128, 7687–7691. 
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eanatioselectivity. There are, however, several limitations. First, two-step sequence of 
deprotection of a benzyl group is required to achieve homoallylamines. Oxidation of 5.4 
by use of 2 equiv. of IBX followed by the treatment of HCl afforded the corresponding 
homoallylamine 5.9 in 88% yield (2 steps; eq 5.1). In some cases, the removal of a benzyl 
group might not be effective because a nitrogen atom in 5.4 has actually two different 
benzyl groups, and differentiation of them would be difficult. In addition, only one 
example of dialkyl ketoimine is illustrated with moderate enantioselectivity (61.5:38.5 
e.r. for 5.8). 
 
In 2008, Shibasaki, Kumagai, and coworkers developed enantioselective additions 
of allylic cyanides to N-phosphinoyl-ketoimines promoted by bisphosphine–Cu 
complex.
7
 With 10 mol % of [Cu(CH3CN)4]ClO4, chiral bisphosphine 5.12, Li(OC6H4-p-
OPh) and 10 equiv. of allylcyanide 5.11, phosphinoyl ketoimine 5.10 was converted to 
α,β-unsaturated cyanide bearing quaternary carbon stereogenic center 5.13 in 74% yield 
with 95.5:4.5 e.r. and 91% Z selectivity (Scheme 5.2). A wide range of N-phosphinoyl-
ketoimines were utilized, affording α-addition followed by isomerization products 5.13–
5.20 in up to 95% yield with high enantio- and stereoselectivity (85.5:14.5–96:4 e.r. and 
89–>98% Z). Aryl- and heteroaryl-bearing ketoimines as well as dialkyl ketoimines 
underwent Cu-catalytic transformation to deliver alkenyl cyanides without diminution of 
both efficiency and selectivity. When (E)-methyl-substituted allylcyanide was used, 
                                                 
(7) Yazaki, R.; Nitabaru, T.; Kumagai, N.; Shibasaki, M. J. Am. Chem. Soc. 2008, 130, 14477–14479. 
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desired product 5.20 was afforded in 62% yield with high selectivities (95:5 e.r. and 
>98% Z). Although initial product would be homoallylic amide, subsequent 
isomerization was fast to generate functionalized allylamide (loss of one stereogenic 
center).
 
 
More recently, Trost and coworkers described Pd-catalyzed enantioselective 
additions of functionalized allylsilanes to N-tosyl-ketoimines, followed by cyclization, 
providing pyrrolidines.
8
 As shown in Scheme 5.4, chiral Pd complex derived from 
phosphoramidite 5.23 promotes cycloaddition type reaction of tosyl-protected ketoimine 
5.21 and cyano-trimethylenemethane donor 5.22, delivering highly substituted 
pyrrolidine 5.24 in 91% yield and exclusive selectivities (>99:1 e.r. and >20:1 d.r.). 
                                                 
(8) Trost, B. M.; Silverman, S. M. J. Am. Chem. Soc. 2010, 132, 8238–8240. 
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Reactions of various ketoimines are examined, including aryl- (5.25 and 5.26) and 
heteroaryl- (5.27) bearing methyl ketoimines as well as cyclic- (5.29) and dialkyl- (5.30) 
ketoimines, proceed efficiently (77–99% yield) with high enantioselectivity (90.5:9.5–
>99:1 e.r.). However, for cyclic and dialkyl ketoimine cases, diastereoselectivity for the 
present reaction is moderate (5:1 for 5.29 and 7:1 for 5.30). Moreover, the use of highly 
activated N-tosyl-ketoimine is necessary to achieve high efficiency and selectivity, which 
arises the difficulty for applying the present approach to the synthesis of complex 
molecule (deprotection of tosyl unit needs a harsh condition).  
 
 Herein, we have disclosed efficient and highly selective catalytic process for 
single vessel, multicomponent reaction of monosubstituted allene, unprotected ketoimine, 
and B2(pin)2 promoted by chiral NHC–Cu complex, affording a quaternary carbon 
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stereogenic center-containing homoallylic amine with high diastereo- and 
enantioselectivity. 
 
5.3. Diastereoselective Additions of 2-B(pin)-Substituted Allyl Groups to 
Unprotected Ketoimines 
5.3.1. Search for Optimal Conditions 
 Based on our previous report about the diastereo-, and enantioselective additions 
of 2-B(pin)-substituted allylcopper to carbonyls,
9
 we began our investigation involving a 
monosubstituted allene 5.31, B2(pin)2, and the ketoimine 5.32, which was prepared from 
the reaction of benzonitrile with MeLi followed by the treatment of HCl solution.
5
 As 
illustrated in Scheme 5.5, we have examined various imidazolinium (5.34) and 
imidazolium salts (5.35–5.38) as NHC ligand precursors as well as phosphine ligands 
(5.39–5.41). Interestingly, complete diastereoselectivity was observed regardless of the 
ligand we used (>98:2 d.r.), but diverse level of efficiency was obtained. With N-mesityl-
bearing NHCs, moderate yields are observed (66% for 5.34 and 53% for 5.35), and with 
sterically more demanding imidazolium 5.36 proceeded to similar level of efficiency as 
well (54% yield). Reaction with 5 mol % N-cyclohexyl-containing imidazolium salt 5.37 
as an NHC precursor was performed, leading to the desired product 5.33 most efficiently 
(>98% conversion and 90% yield). Additionally, three representative phosphine ligands 
were evaluated, none of which proceeded with high level of efficiency (49–72% yield for 
5.39–5.41), but with perfect diastereoselectivity (>98:2 d.r.). Based on above 
                                                 
(9) Meng, F.; Jang, H.; Jung, B.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2013, 52, 5046–5051. 
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observations, we chose the imidazolium salt 5.37 as an optimal NHC precursor for 
further study. 
 
 
5.3.2. Substrate Scope of Diastereoselective Cu–B Addition/Allyl Addition to 
Unprotected Ketoimines 
 With an optimal condition (Section 5.3.1) we have evaluated the substrate scope 
of diastereoselective copper–boron addition to monosubstituted allene followed by 
addition to unprotected ketoimine. As illustrated in Scheme 5.6, a wide range of 
ketoimines, prepared through reaction of various nitriles with alkyllithium reagent, are 
examined, affording desired products in up to 94% yield. It is worth to mention that 
exclusive diastereoseletivity was observed for all substrates we investigated (>98:2 d.r.). 
Reactions of 1.5 equiv. of monosubstituted allene 5.31 and aryl-bearing methyl ketoimine 
in the presence of 5–10 mol % of NHC–Cu complex derived from imidazolium salt 5.37 
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and CuCl, proceed to quaternary stereogenic center-containing alkenylboron 5.33 and 
5.42–5.52 with moderate to high efficiently (57–90% yield). Heteroaryl-substituted 
methyl ketoimines are converted to desired products 5.53–5.55 in 41–49% yield, 
probably because of instability of alkenylboron products (see below). When dialkyl 
ketoimines are subjected to the catalytic process, 10 mol % of Cu complex is required for 
high yields of products 5.56 and 5.57 (76% and 56% yield, respectively). In addition, 
monosubstituted allenes bearing a different alkyl group are utilized, delivering 
alkenylboron products 5.59–5.61 efficiently (68–78% yield). 
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5.3.3. Stereochemical Models to Account for Levels in Diastereoselectivity 
 The relative stereochemical identity of alkenylboron product 5.33 (racemic) was 
established by the X-ray crystallography (Figure 5.1). Based on the X-ray structure of 
5.33, it seems that there is an association between the boron and the nitrogen atoms; the 
distance of which in the X-ray structure is 1.692 Å. In addition, we obtained a signal at δ 
22.11 ppm in the 
11
B NMR spectrum of 5.33, relatively upfield signal compare to δ 29.4 
ppm in the 
11
B NMR spectrum of vinyl–B(pin), which supports the aforementioned 
hypothesis of an association between B and N atoms. This association might be caused 
by the coordination of electron lone pair on nitrogen atom to partially empty p orbital on 
boron atom,
10
 which would weaken a carbon–boron bond. For this reason, the latter bond 
is relatively sensitive to hydrolysis during silica gel column chromatography, leading 
relatively low yields of the organoboron products in some cases (e.g., 5.54 and 5.55; 
Scheme 5.6). 
 
Another interesting aspect of the X-ray structure of 5.33 is that the C–N bond and 
the C–(CH2)2OTBS bond are syn relationship to each other. Based on DFT calculation for 
                                                 
(10) For detailed analysis and discussions regarding the impact of coordination of a Lewis basic group to 
the boron atom of a B(pin) moiety, see: Wu, H.; Garcia, J. M.; Haeffner, F.; Radomkit, S.; Zhugralin, A. 
R.; Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 10585–10602. 
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possible stereochemical models (Figure 5.2), the pathway through mode I, which 
provides major syn diastereomer, is 3.7 kcal/mol lower than one through mode II, which 
leads to minor anti isomer. The energy difference between two modes is due to severe 
steric repulsion between a B(pin) and a phenyl groups, both of which are pointing axial 
direction, on mode II. In the favored mode I, a phenyl unit is located on equatorial 
position, which releases the repulsion in mode II. Since the selectivity is controlled by the 
interaction between two units on substrates, not between substrate and ligand, complete 
diastereoselectivity was obtained regardless of the ligand structure (Scheme 5.5). 
 
 
5.4. Diastereo- and Enantioselective Additions of 2-B(pin)-Substituted Allyl 
Groups to Unprotected Ketoimines 
5.4.1. Study of Chiral Cu Complexes 
 To find a chiral Cu complex, promoting reaction of monosubstituted allene, 
B2(pin)2, and unprotected ketoimine to afford diastereo- and enantiomerically enriched 
quaternary carbon stereogenic center bearing a nitrogen atom, several NHC–Cu and 
phosphine–Cu complexes have been screened. As depicted in Scheme 5.7, reaction of 
Chapter 5, Page 351 
 
 
5.31 with phenyl,methyl-ketoimine 5.32 in the presence of monodentate NHC–Cu 
complex derived from A.1 proceeded with low enantioselectivity (40:60 e.r.). With 
sterically more congested monodentate NHC–Cu complex generated from A.13, 
alkenylboron product 5.33 was obtained as almost racemic mixture (54.5:45.5 e.r.). The 
reaction became sluggish when phenol-bearing A.2 was utilized (22% conversion). Then, 
we turned to probe a number of sulfonate-bridged NHC–Cu complexes. N-mesityl-
substituted A.3 promoted multicomponent reaction efficiently, but with minimal 
enantioselectivity (>98% conv and 55:45 e.r.). However, when we altered the mesityl unit 
to 3,5-(t-Bu)2-phenyl group, there was a significant enhancement of enantioselectivity 
(85.5:14.5 e.r. for A.20). For further improvement of selectivity, we replaced 3,5-
substituents from t-Bu group to sterically more demanding, 2,4,6-triisopropylphenyl 
moiety, and obtained 95:5 e.r. (A.17). Several representative bisphosphine–Cu complexes 
were investigated as well. As shown in Scheme 5.7, reasonably high level of 
enantioselectivity was achieved with segphos 5.63 or josiphos 5.64 (18:82 and 19.5:80.5 
e.r., respectively). Remarkable point is that, in all cases, we obtained the product 5.33 as 
a single syn diastereomer (>98:2 d.r.). Based on the screening of chiral Cu complexes, we 
identified the sulfonate-bearing A.17 as an optimal NHC precursor. 
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5.4.2. Substrate Scope of Diastereo- and Enantioselective Cu–B Addition/Allyl 
Addition to Unprotected Ketoimines 
 The catalytic process, promoted by NHC–Cu complex generated from A.17, has a 
considerable substrate scope. We examined various substrates, which were utilized in 
Scheme 5.6 (the catalytic process with achiral Cu complex derived from 5.37). One thing 
we have to mention again is that complete diastereoselectivity was observed for all cases. 
Substantially high enantioselectivity was achieved with ketoimines containing an ortho 
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substituent-bearing phenyl unit (98.5:1.5–99.5:0.5 e.r. for 5.42, 5.43, and 5.45; Scheme 
5.8). However, with 2-F-phenyl-bearing ketoimine, the catalytic reaction was much less 
selective and lower yielding (66:34 e.r. and 30% yield for 5.44), one possible explanation 
of which is that there might be an association between a fluorine atom and the Cu center. 
When the F atom is placed in meta or para position on phenyl ring, the distance of a 
fluorine and the Cu center would be too far to have an association with each other. For 
the above reason, in cases of 5.47 and 5.49, the level of enantioselectivity was much 
higher (93.5:6.5 and 94.5:5.5 e.r., respectively vs 66:34 e.r. for 5.44). Reactions of 
heteroaryl-bearing ketoimine were lower yielding although enantioselectivity was high 
(42–60% yield and 94.5:5.5–96.5:3.5 e.r. for 5.53–5.55). Some of the alkenylboron 
products might be hydrolyzed during the silica gel chromatography due to the possible 
association between N and B atoms, which can facilitate hydrolysis. Dialkyl ketoimines 
were also examined, delivering desired products 5.56 and 5.57 with moderate efficiency 
(38–48% yield). For this class of ketoimines, the enamine formation might become 
competitive. Several different alkyl-bearing allenes were utilized for the multicomponent 
process with B2(pin)2 and acetophenone-derived ketoimine, leading to alkenylboron 
compounds containing a quaternary stereogenic center 5.59–5.61 with high selectivity 
(up to >99:1 e.r.). The level of enantioselectivity was similar with either shorter alkyl 
chain-bearing (5.59) or longer chain-containing allenes, which means that the steric 
interaction between the substituent of allene and NHC ligand might not play an important 
role in the stereochemistry-determining step. 
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 5.4.3. Stereochemical Models to Account for Levels in Enantioselectivity 
 We have tried to build up stereochemical models by DFT calculation, to account 
for high selectivities (Figure 5.3). The relative energy level of the transition state mode 
III, which delivers the major enantiomer, is much lower than that of mode IV (13.2 vs 
24.2 kcal/mol). Based on the proposed stereochemical models, there is a severe steric 
repulsion between the bulky substituent on N-aryl unit of NHC ((i-Pr)3C6H2) and a B(pin) 
moiety in mode IV (Figure 5.3), which makes mode IV less favored. In addition, in both 
modes III and IV, sodium cation-bridge between a sulfonate unit and a nitrogen atom on 
ketoimine is significant for formation of organized, chair-like transition state, which 
might be one of the reasons why sulfonate-bearing NHC–Cu complexes A.20 and A.17 
showed dramatic boost in enantioselectivity (Scheme 5.7). In addition, as we expected 
above, the steric repulsion between N-aryl group and the substituent of allene (R) is not 
severe for both modes III and IV, so it cannot play a significant role to determine the face 
selectivity. This is consistent with the observation above (high enantioselectivities for 
5.59–5.61). 
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5.4.4. Functionalization and Utility in Chemical Synthesis 
 The utility of the aforementioned catalytic method is illustrated by 
transformations to β-amino methyl ketones or allyl addition product, and an application 
toward the synthesis of a medicinally active agent. Simple sodium perborate-mediated 
oxidation of alkenylboron compound 5.33 provided methyl ketone containing β-amine 
unit 5.66, which is identical to Mannich reaction product, in 80% yield without 
diminution of enantiomeric enrichment (Scheme 5.9). Three more β-amino methyl 
ketones 5.67–5.69 are afforded as illustrated in Scheme 5.9, which contain ortho-
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halogen- or meta-methoxy-bearing phenyl unit. Considerable yields of products 5.67–
5.69 are obtained (72–83% yield).  
 
Next, we have made efforts on the determination of the absolute and relative 
configuration of the alkenylboron product. Unfortunately, we failed to obtain pure crystal 
structure of enantiomerically enriched alkenylborons, which lead us to synthesize 
derivatives of them (only X-ray structure of racemic sample of alkenylboron 5.33 was 
obtained; Figure 5.1). Enantiomerically enriched alkenylboron 5.33 (95:5 e.r.) is oxidized 
to 5.66 with sodium perborate efficiently (80% yield) as illustrated in Scheme 5.9. 
Subsequent desilylation by tetra-n-butylammonium fluoride delivers primary alcohol-
bearing methyl ketone 5.70, X-ray structure of which is shown in Figure 5.4. Based on 
this X-ray structure, we confirmed the absolute stereochemistry for two continuative 
stereogenic centers (R configuration for both centers), the relative stereochemistry for 
which matches with that in X-ray structure of from rac-5.33 (syn diastereomer; Figure 
5.1). 
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 As we mentioned above, in some cases, the product of catalytic process, 
alkenylboron compound, might not be stable enough to be purified by silica gel 
chromatography. Especially, when we utilized heteroaryl-substituted ketoimines, 
relatively lower yields were observed (e.g., 42% yield for 5.54 and 60% yield for 5.55; 
Scheme 5.8). To address this issue, as illustrated in eqs 5.2 and 5.3, we performed Cu-
catalyzed multicomponent reaction of allene 5.31 and ketoimine 5.71 or 5.73 in the 
presence of 10 mol % of chiral imidazolinium salt A.17, and directly utilized the 
alkenylboron product without the purification step for the subsequent oxidation with 
sodium perborate. We isolated β-amino methyl ketones 5.72 and 5.74 by silica gel 
column chromatography in 58% and 70% yield, respectively. Noticeably, although we 
performed an additional oxidation reaction, higher yields of methyl ketone products were 
obtained compare to those of alkenylboron products (58% for 5.72 vs 42% for 5.54 and 
70% for 5.74 vs 60% for 5.55). 
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 Cu-catalyzed protodeboration of the alkenylboron 5.33, promoted by 10 mol % 
Cu complex derived from achiral imidazolium salt 5.37, delivers homoallylic amine 5.75 
in 72% yield, which is identical to product of allyl addition to ketoimine (eq 5.4). 
Although protodeboration reaction was performed at 60 °C in six hours, no epimerization 
was observed (>98:2 d.r.). 
 
 Then, we have investigated the synthesis of biologically active molecule to further 
demonstrate the utility of the aforementioned protocol. BMS research group synthesized 
a series of the compounds containing tertiary carbamine, which were related to inhibitors 
of β-amyloid peptide (Αβ) production.11  They obtained an enantiomerically enriched 
product from the racemic mixture by the use of chiral HPLC. We tested to utilize the 
                                                 
(11) Thompson, III, L. A. et al. Compounds for the reduction of beta-amyloid production. United States 
Patent US 2013/0131051 Al 
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single-vessel, multicomponent process for the generation of the core structure of the 
target molecule. To construct the quaternary carbon stereogenic center bearing a nitrogen 
atom, we utilize the present NHC–Cu-catalyzed transformation of monosubstituted allene 
with ortho-chloro-phenyl ketoimine, which affords alkenylboron compound 5.45 in 91% 
yield with >98:2 d.r. and 99.5:0.5 e.r. (Scheme 5.8). As illustrated in Scheme 5.10, Cu-
catalyzed protodeboration of 5.45 is examined in the presence of 10 mol % of NHC–Cu 
complex derived from imidazolium salt 5.37, delivering homoallylic amine 5.76 in 72% 
yield at 60 °C after eight hours. Since the product 5.76 has no protecting group on a 
nitrogen atom, deprotection step is not necessary, and directly used for the next 
transformation. With 2 equiv. of commercially available isothiocyanate 5.77, thiourea 
5.78 is successfully generated in 84% yield from unprotected homoallylic amine 5.76. 
Subsequent desilylation of silyl ether 5.78 is performed with 2 equiv. of tetra-n-
butylammonium fluoride at elevated temperature (60 °C), providing primary alcohol 5.79 
in 85% yield. 
The next step was the challenging transformation to form seven-membered ether 
through an intramolecular cross-coupling of aryl chloride with alcohol moiety on 
compound 5.79. First, we investigated the phoshpine–Pd-catalyzed etherification reaction 
developed by Buchwald and coworkers in 2000.
12
 With 3 mol % Pd complex derived 
from rac-trixiephos 5.84 and Pd(OAc)2, desired aryl ether 5.81 was isolated in 68% yield 
after purification by silica gel chromatography (eq 5.5). The reaction was clean, and we 
did not detect a significant amount of any byproducts. At the same time, we also probed 
Cu-catalyzed Ullmann-type intramolecular coupling, which was reported by Xu, Hu, and 
                                                 
(12) Torraca, K. E.; Kuwabe, S. -I.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 12907–12908. 
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coworkers in 2009.
13
 Cu-catalytic cyclization of 5.79 was performed in the presence of 
10 mol % CuI, 20 mol % 8-hydroxyquinoline 5.80 as a ligand, and 2 equiv. of Cs2CO3, 
furnishing 78% yield of seven-membered ether 5.81 (Scheme 5.10). Since copper (I) salt 
is much more abundant and cheap metal, the strategy for utilizing Ullmann coupling 
seems more attractive method for the medicinally active molecule synthesis. 
 
Conversion of a terminal olefin 5.81 to a primary alcohol 5.82 was proceeded by 
ozonolysis followed by NaBH4-mediated reduction sequence. After careful study of 
aforementioned sequential procedure, we obtain the desired primary alcohol 5.82 in 72% 
yield without decomposition of a thiourea moiety. Then, the target compound 5.83 was 
                                                 
(13) Niu, J.; Guo, P.; Kang, J.; Li, Z.; Xu, J.; Hu, S. J. Org. Chem. 2009, 74, 5075–5078. 
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obtained through cyclization of 5.82 by activation of the primary alcohol with triflic 
anhydride (75% yield).
14
 
 
 
5.5. Conclusions 
 We have described the Cu-catalyzed protocol for multicomponent reaction 
involving a monosubstituted allene, B2(pin)2, and unprotected ketoimine, promoted by 
chiral NHC–Cu complex. The practical and efficient preparation of unprotected 
ketoimine as a bench-stable powder is accomplished through a simple transformation 
with a readily available nitrile and an alkyl–Li or an alkyl–Grignard reagent. Various 
ketoimines are proved to serve as substrate for the present multicomponent reaction, 
affording diastereo- and enantiomerically enriched quaternary carbon stereogenic center-
bearing homoallylic amines, which are not possible to be prepared by other methods. To 
show the utility of the aforementioned transformation, we have demonstrated several 
functionalization methods including oxidation to generate corresponding methyl ketones 
(Mannich reaction product) and Cu-catalyzed protodeboration to achieve allyl addition 
product.  The diastereo- and enantioselective synthesis of biologically active compound 
has been illustrated. The Cu-catalyzed multicomponent reaction delivers the core 
                                                 
(14) Butler, C. R. et al. J. Med. Chem. 2015, 58, 2678–2702. 
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structure of the target molecule with exclusive diastereo- and enantioselectivity (>98:2 
d.r. and 99.5:0.5 e.r.), which allows us to utilize this information for further 
transformations toward the target compound synthesis.  
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5.6. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, max in cm
−1
. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 
1
H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet, app = apparent), and coupling 
constant (Hz). 
13
C NMR spectra were recorded on a Varian Unity INOVA 400 (100 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in 
ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF 
DART (positive mode) at the Mass Spectrometry Facility, Boston College. Unless 
otherwise noted, all reactions were carried out with distilled and degassed solvents under 
an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with standard dry 
box or vacuum-line techniques. Solvents were purified under a positive pressure of dry 
argon by a modified Innovative Technologies purification system: toluene, benzene and 
hexanes were purified through a copper oxide and alumina column; CH2Cl2 and Et2O 
were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific, Inc.) under air atmosphere. Enantiomeric ratios were determined by 
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HPLC analysis (Chiral Technology Chiralcel
®
 OD-H (4.6 x 250 mm)) in comparison 
with authentic racemic materials. Specific rotations were measured on a ATAGO
®
 AP-
300 Automatic Polarimeter. Melting points were measured on a Thomas Hoover capillary 
melting point apparatus and are uncorrected. 
 
5.6.1. Reagents and Ligands 
Allene (5.31): prepared according to previously reported procedures.
15
 
Benzoyl isothiocyanate (5.77): purchased from Alfa Aesar and used as received. 
Bis(pinacolato)diboron [B2(pin)2]: purchased from Frontier Scientific Inc., 
recrystallized from pentane and dried under vacuum prior to use. 
Cesium carbonate: purchased from Aldrich Chemical Co. and used as received. 
Chiral bis-phosphines: purchased from Strem Chemicals Inc. and used as received. 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Copper (I) Iodide: purchased from Strem Chemicals Inc. and used as received. 
8-Hydroxyquinoline (5.80): purchased from Alfa Aesar and used as received. 
Imidazolinium or imidazolium salts (5.34–5.38): purchased from Aldrich Chemical Co. 
and used as received. 
Ketoimines: prepared according to a previously reported procedure.
16
 
Methanol: purchased from Acros and purified by distillation from Na (Aldrich Chemical 
Co.) prior to use. 
                                                 
(15) (a) Crabbé, P.; Fillion, H.; André, D.; Luche, J.-L. J. Chem. Soc., Chem. Commun. 1979, 859–860. (b) 
Searles, S.; Li, Y.; Nassim, B.; Lopes, M.-T. R.; Tran, P. T.; Crabbé, P. J. Chem. Soc., Perkin Trans. 1 
1984, 747–751. (c) Inoue, A. Kondo, J.; Shinokubo, H.; Oshima, K. Chem. Eur. J. 2002, 8, 1730–1740. (d) 
Baird, M. S.; Nizovtsev, A. V.; Bolesov, I. G. Tetrahedron 2002, 58, 1581–1588. 
(16) Hou, G.; Gosselin, F.; Li, W.; McWilliams, J. C.; Sun, Y.; Weisel, M.; O’Shea, P. D.; Chen, C.-y.; 
Davies, I. W.; Zhang, X. J. Am. Chem. Soc. 2009, 131, 9882–9883. 
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2-Methyl-2-propanol (t-BuOH): purchased from Aldrich Chemical Co. and purified by 
distillation from Na (Aldrich Chemical Co.) prior to use. 
Pyridine: purchased from Aldrich Chemical Co. and used as received. 
Palladium (II) acetate: purchased from Strem Chemicals Inc. and used as received. 
Sodium borohydride (NaBH4): purchased from Aldrich Chemical Co. and used as 
received. 
Sodium t-butoxide (NaOt-Bu): purchased from Strem Chemicals Inc. and used as 
received. 
Sodium methoxide (NaOMe): purchased from Strem Chemicals Inc. and used as 
received. 
Sodium perborate tetrahydrate (NaBO3·4H2O): purchased from Aldrich Chemical Co. 
and used as received. 
Tetra-n-butylammonium fluoride solution (1.0 M in thf): purchased from Aldrich 
Chemical Co. and used as received. 
Trifluoromethanesulfonic anhydride: purchased from Aldrich Chemical Co. and used 
as received. 
 
5.6.2. Experimental Procedure and Characterization Data 
 Representative Experimental Procedure for NHC–Cu-Catalyzed Cu–B 
Addition/Addition to Ketoimines: In a N2-filled glove box, an oven-dried vial (4 mL, 
17 × 38 mm) with a magnetic stir bar was charged with imidazolium salt 5.37 (1.6 mg, 
0.00500 mmol, 5.0 mol %), CuCl (0.5 mg, 0.00500 mmol, 5.0 mol %), NaOt-Bu (14.4 
mg, 0.150 mmol, 1.5 equiv.) and thf (0.5 mL). The vessel was sealed with a cap (phenolic 
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open top cap with red PTFE/white silicone septum) and the solution was allowed to stir at 
22 °C for one hour. Bis(pinacolato)diboron (38.1 mg, 0.150 mmol, 1.5 equiv.) was added 
to the solution, causing it to turn dark brown immediately. The vial was re-sealed with a 
cap (phenolic open top cap with red PTFE/white silicone septum) and allowed to stir at 
22 °C for one hour. Allene 5.31 (29.8 mg, 0.150 mmol, 1.5 equiv.) and ketoimine 5.32 
(15.6 mg, 0.100 mmol, 1.0 equiv.) were added to the solution, and the vial was removed 
from the glove box. The resulting solution was allowed to stir at 22 °C for 24 hours 
before the reaction was quenched by passing the mixture through a short plug of Celite 
and silica gel and eluted with Et2O (3 × 2 mL). The filtrate was concentrated in vacuo to 
provide yellow oil, which was purified by silica gel chromatography (hexanes:Et2O=1:1 
to 1:5) to afford 5.33 as a white solid (40.1 mg, 0.0900 mmol, 90% yield). 
 
 Representative Experimental Procedure for Enantioselective NHC–Cu-Catalyzed 
Cu–B Addition/Addition to Ketoimines: In a N2-filled glove box, an oven-dried vial (4 
mL, 17 × 38 mm) with a magnetic stir bar was charged with imidazolinium salt A.17 (6.4 
mg, 0.00750 mmol, 7.5 mol %), CuCl (0.7 mg, 0.00750 mmol, 7.5 mol %), NaOt-Bu 
(14.4 mg, 0.150 mmol, 1.5 equiv.) and thf (0.5 mL). The vessel was sealed with a cap 
(phenolic open top cap with red PTFE/white silicone septum) and the solution was 
allowed to stir at 22 °C for one hour. Bis(pinacolato)diboron (38.1 mg, 0.150 mmol, 1.5 
equiv.) was added to the solution, causing it to turn dark brown immediately. The vial 
was re-sealed with a cap (phenolic open top cap with red PTFE/white silicone septum) 
and allowed to stir at 22 °C for one hour. Allene 5.31 (29.8 mg, 0.150 mmol, 1.5 equiv.) 
and ketoimine 5.32 (15.6 mg, 0.100 mmol, 1.0 equiv.) were added to the solution, and the 
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vial was removed from the glove box. The resulting solution was allowed to stir at 22 °C 
for 24 hours before the reaction was quenched by passing the mixture through a short 
plug of Celite and silica gel and eluted with Et2O (3 × 2 mL). The filtrate was 
concentrated in vacuo. The crude product was purified by silica gel chromatography 
(hexanes:Et2O=1:1 to 1:5) to afford 5.33 as a white solid (33.9 mg, 0.0761 mmol, 76% 
yield). 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-phenyl-4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.33): IR (CH2Cl2): 3237 (w), 3149 (w), 
3043 (w), 2975 (m), 2929 (m), 2857 (w), 1520 (w), 1474 (m), 1457 (m), 1372 (m), 1328 
(m), 1254 (m), 1141 (s), 1095 (s), 1051 (m), 982 (m), 835 (s), 774 (m), 735 (m), 699 (m), 
674 (m), 578 (m) 522 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.35–7.32 (2H, m), 7.28–
7.21 (3H, m), 5.49 (1H, d, J = 2.8 Hz), 5.30 (1H, d, J = 2.8 Hz), 3.58–3.53 (1H, m), 3.49–
3.43 (1H, m), 2.76 (1H, t, J = 6.8 Hz), 1.49 (3H, s), 1.29–1.22 (2H, m), 1.21 (12H, s), 
0.84 (9H, s), –0.03 (3H, s), –0.05 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 144.9, 128.6, 
126.9, 125.2, 119.7, 104.8, 82.7, 80.8, 75.2, 61.9, 61.1, 52.8, 30.7, 26.1, 25.2, 25.1, 24.7, 
24.6, 18.4, –5.2, –5.3; HRMS: Calcd for C25H45B1N1O3Si1 [M+H]
+
: 446.32617; Found: 
446.32608; specific rotation: [α]D
20
 –10.86 (c 1.84, CHCl3) for an enantiomerically 
enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
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Retention Time Area Area% Retention Time Area Area% 
25.521 15007961 49.668 26.143 32409594 95.265 
35.478 15208417 50.332 36.945 1610912 4.735 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-2-(o-tolyl)pent-4-en-2-amine (5.42): IR (CH2Cl2): 3234 (w), 3138 
(w), 2956 (m), 2929 (m), 2857 (w), 1686 (w), 1600 (w), 1471 (m), 1449 (m), 1379 (m), 
1254 (m), 1154 (s), 1096 (s), 1058 (s), 1005 (m), 983 (m), 968 (m), 952 (m), 912 (m), 
876 (m), 834 (s), 775 (s), 760 (s), 735 (s), 702 (s), 677 (m), 448 (m) cm
−1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 7.21–7.17 (3H, m), 7.12–7.09 (1H, m), 5.43 (1H, d, J = 3.2 Hz), 
5.31 (1H, d, J = 2.8 Hz), 3.60–3.55 (2H, m), 3.14 (1H, dd, J = 12.0, 2.4 Hz), 2.50 (3H, s), 
1.52 (3H, s), 1.30–1.26 (2H, m), 1.21 (12H, s), 0.86 (9H, s), 0.01 (3H, s), –0.02 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 142.5, 135.1, 133.4, 127.4, 126.5, 124.2, 118.4, 82.7, 
79.9, 75.2, 64.6, 60.1, 51.6, 27.2, 26.1, 25.4, 25.3, 25.0, 24.8, 22.7, 18.4, –5.2, –5.3; 
HRMS: Calcd for C26H47B1N1O3Si1 [M+H]
+
: 460.34182; Found: 460.34336; specific 
rotation: [α]D
20
 –3.83 (c 2.61, CHCl3) for an enantiomerically enriched sample of 99.5:0.5 
e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
20.814 15448219 49.424 20.759 3771880 99.747 
29.624 15808355 50.576 29.909 9580 0.253 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(2-methoxyphenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.43): IR (CH2Cl2): 3239 (br), 
2975 (m), 2930 (m), 2857 (w), 1600 (w), 1473 (s), 1458 (s), 1372 (m), 1330 (m), 1295 
(m), 1249 (s), 1145 (s), 1094 (s), 1053 (s), 1028 (m), 1007 (m), 982 (m), 967 (m), 951 
(m), 910 (m), 877 (m), 833 (s), 775 (s), 752 (s), 699 (m), 675 (s), 578 (w), 551 (w), 519 
(w), 496 (w), 447 (w), 417 (w), 404 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.25–7.20 
(2H, m), 6.95–6.88 (2H, m), 5.33 (1H, d, J = 3.2 Hz), 5.23 (1H, d, J = 2.8 Hz), 3.83 (3H, 
s), 3.61–3.54 (2H, m), 2.82 (1H, d, J = 10.4 Hz), 1.48 (3H, s), 1.30–1.27 (2H, m), 1.17 
(12H, s), 0.86 (9H, s), –0.01 (3H, s), –0.02 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 157.2, 
131.0, 128.6, 127.9, 121.2, 116.5, 111.8, 82.6, 79.7, 75.2, 62.9, 60.7, 55.4, 52.6, 28.4, 
26.1, 25.3, 25.2, 25.0, 24.6, 18.4, –5.2, –5.3; HRMS: Calcd for C26H47B1N1O4Si1 
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[M+H]
+
: 476.3367; Found: 476.3383; specific rotation: [α]D
20
 –15.54 (c 2.70, CHCl3) for 
an enantiomerically enriched sample of 98.5:1.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
15.408 45883540 51.393 15.437 24661867 98.410 
19.303 43395471 48.607 19.012 398543 1.590 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(2-fluorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.44): IR (CH2Cl2): 3235 (br), 
2976 (m), 2930 (m), 2858 (w), 1474 (s), 1449 (s), 1371 (s), 1331 (m), 1254 (m), 1206 
(m), 1144 (s), 1096 (s), 1067 (m), 1008 (m), 982 (m), 967 (m), 951 (m), 925 (w), 881 (w), 
850 (s), 834 (s), 758 (m), 735 (m), 699 (m), 675 (s), 578 (w), 552 (w), 518 (w), 496 (w), 
452 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.31–7.22 (2H, m), 7.12 (1H, t, J = 8.0 Hz), 
7.03 (1H, dd, J = 12.8, 6.8 Hz), 5.48 (1H, d, J = 2.8 Hz), 5.36 (1H, d, J = 2.8 Hz), 3.64–
3.59 (1H, m), 3.53–3.47 (1H, m), 2.93–2.90 (1H, m), 1.49 (3H, s), 1.28–1.21 (2H, m), 
1.20 (12H, s), 0.85 (9H, s), –0.01 (3H, s), –0.03 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 
160.4 (d, J = 243 Hz), 131.8, 128.9 (d, J = 8.4 Hz), 127.7 (d, J = 4.6 Hz), 124.4 (d, J = 
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3.0 Hz), 120.4, 116.8 (d, J = 23.5 Hz), 82.8, 80.7, 75.2, 61.2, 60.9, 52.3, 29.0, 26.1, 25.2, 
25.1, 25.0, 24.7, 18.4, –5.2, –5.3; HRMS: Calcd for C25H44B1F1N1O3Si1 [M+H]
+
: 
464.31675; Found: 464.31536; specific rotation: [α]D
20
 –4.09 (c 3.42, CHCl3) for an 
enantiomerically enriched sample of 66:34 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
13.193 15306517 50.039 12.349 8958464 34.117 
14.468 15282929 49.961 13.103 17299501 65.883 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(2-chlorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.45): IR (CH2Cl2): 3232 (br), 
2929 (w), 2856 (w), 1661 (w), 1472 (w), 1380 (w), 1362 (w), 1253 (m), 1156 (m), 1139 
(s), 1096 (s), 1038 (s), 1005 (w), 982 (w), 967 (w), 949 (m), 910 (w), 885 (w), 833 (s), 
774 (s), 754 (s), 729 (m), 675 (m), 616 (w), 575 (w), 547 (w), 522 (w), 495 (w), 451 (w), 
430 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.40 (1H, d, J = 8.0 Hz), 7.36 (1H, dd, J = 
8.0, 1.6 Hz), 7.25 (1H, dt, J = 7.6, 1.6 Hz), 7.19 (1H, dt, J = 7.6, 1.6 Hz), 5.44 (1H, d, J = 
3.2 Hz), 5.34 (1H, d, J = 3.2 Hz), 3.67–3.62 (1H, m), 3.59–3.47 (1H, m), 3.22 (1H, d, J = 
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10.4 Hz), 1.56 (3H, s), 1.38–1.32 (2H, m), 1.22 (6H, s), 1.19 (6H, s), 0.86 (9H, s), 0.01 
(3H, s), 0.00 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 141.2, 132.2, 132.1, 128.6, 128.6, 
127.2, 119.1, 82.5, 80.3, 75.1, 63.3, 60.7, 51.7, 27.4, 26.1, 25.2, 25.0, 24.6, 24.5, 18.4, –
5.2, –5.3; HRMS: Calcd for C25H44B1Cl1N1O3Si1 [M+H]
+
: 480.28720; Found: 480.28648; 
specific rotation: [α]D
20
 –6.42 (c 2.49, CHCl3) for an enantiomerically enriched sample of 
99.5:0.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
21.072 21626503 51.870 21.018 45038852 99.374 
24.140 20067467 48.130 24.198 265964 0.626 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(3-methoxyphenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.46): IR (CH2Cl2): 3238 (w), 
3149 (w), 2976 (m), 2930 (m), 2857 (m), 1585 (m), 1474 (s), 1456 (s), 1372 (m), 1328 
(m), 1254 (m), 1141 (s), 1095 (s), 1049 (s), 1008 (m), 982 (s), 951 (m), 834 (s), 775 (s), 
701 (m), 675 (m), 577 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.25 (1H, t, J = 8.0 Hz), 
6.85–6.83 (2H, m), 6.77 (1H, d, J = 9.2 Hz), 5.51 (1H, d, J = 3.2 Hz), 5.32 (1H, d, J = 3.2 
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Hz), 3.80 (3H, s), 3.58–3.53 (1H, m), 3.50–3.42 (1H, m), 2.73 (1H, t, J = 6.8 Hz), 1.47 
(3H, s), 1.32–1.26 (2H, m), 1.21 (6H, s), 1.20 (6H, s), 0.85 (9H, s), –0.03 (3H, s), –0.05 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 159.9, 146.7, 129.6, 120.2, 117.5, 111.9, 111.7, 
82.9, 80.9, 75.2, 61.8, 61.1, 55.4, 52.9, 30.6, 26.1, 25.2, 25.1, 25.0, 24.7, 18.4, –5.2, –5.3; 
HRMS: Calcd for C26H47B1N1O4Si1 [M+H]
+
: 476.33674; Found: 476.33517; specific 
rotation: [α]D
20
 –11.83 (c 1.36, CHCl3) for an enantiomerically enriched sample of 
98.5:1.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(3-fluorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.47): IR (CH2Cl2): 3263 (w), 
3151 (w), 2977 (m), 2930 (m), 2858 (m), 1615 (m), 1590 (m), 1473 (m), 1451 (m), 1372 
(m), 1338 (m), 1254 (m), 1140 (s), 1096 (s), 1061 (s), 1007 (m), 982 (m), 968 (m), 952 
(m), 835 (s), 807 (m), 774 (s), 700 (s), 674 (s), 578 (m), 520 (m) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 7.29 (1H, dt, J = 8.4, 6.0 Hz), 7.12 (1H, d, J = 8.0 Hz), 7.06 (1H, d, J = 10.8 
Hz), 6.92 (1H, d, J = 8.0 Hz), 5.65 (1H, d, J = 3.2 Hz), 5.43 (1H, d, J = 2.8 Hz), 3.55–
3.51 (1H, m), 3.43–3.39 (1H, m), 2.77 (1H, d, J = 10.4 Hz), 1.41 (3H, s), 1.30–1.25 (2H, 
m), 1.23 (12H, s), 0.85 (9H, s), –0.04 (3H, s), –0.06 (3H, s); 13C NMR (CDCl3, 100 
MHz): δ 160.7 (d, J = 235 Hz), 130.0 (d, J = 8.4 Hz), 128.0, 121.3, 121.1, 113.6 (d, J = 
21.2 Hz), 112.8 (d, J = 22.8 Hz), 171.3, 144.1, 128.5, 128.0, 127.7, 125.9, 83.0, 81.7, 
75.2, 61.1, 60.5, 31.5, 30.9, 26.1, 25.1, 25.1, 24.9, 24.7, 18.4, –5.2, –5.3; HRMS: Calcd 
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for C25H44B1F1N1O3Si1 [M+H]
+
: 464.31675; Found: 464.31699; specific rotation: [α]D
20
 
–8.04 (c 1.49, CHCl3) for an enantiomerically enriched sample of 93.5:6.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
24.891 15187285 50.670 24.891 10208352 93.821 
38.709 14785426 49.330 38.935 672282 6.179 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(4-methoxyphenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.48): IR (CH2Cl2): 3242 (w), 
3150 (w), 2975 (m), 2930 (m), 2857 (m), 1605 (m), 1517 (m), 1474 (s), 1457 (s), 1372 
(m), 1327 (m), 1254 (s), 1141 (s), 1094 (s), 1050 (m), 1008 (m), 982 (s), 952 (m), 832 (s), 
774 (s), 675 (s), 622 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.22 (2H, d, J = 8.8 Hz), 
6.86 (2H, d, J = 9.2 Hz), 5.52 (1H, d, J = 3.2 Hz), 5.31 (1H, d, J = 2.8 Hz), 3.79 (3H, s), 
3.59–3.53 (1H, m), 3.47–3.41 (1H, m), 2.72 (1H, dd, J = 8.8, 4.4 Hz), 1.47 (3H, s), 1.33–
1.27 (2H, m), 1.21 (12H, s), 0.85 (9H, s), –0.03 (3H, s), –0.05 (3H, s); 13C NMR (CDCl3, 
100 MHz): δ 172.6, 158.4, 134.8, 126.5, 113.9, 83.0, 80.8, 75.2, 66.0, 61.3, 55.4, 31.7, 
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30.7, 26.1, 25.2, 25.0, 24.7, 24.2, 18.4, –5.1, –5.2; specific rotation: [α]D
20
 –14.60 (c 0.82, 
CHCl3) for an enantiomerically enriched sample of 92.5:7.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
17.860 16897534 50.811 17.255 24088189 92.348 
26.861 16358259 49.189 26.124 1995838 7.652 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(4-fluorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.49): IR (CH2Cl2): 3234 (w), 
2976 (m), 2930 (m), 2858 (m), 1604 (m), 1514 (m), 1474 (s), 1455 (s), 1372 (m), 1329 
(m), 1253 (m), 1141 (s), 1094 (s), 1050 (s), 1008 (m), 982 (s), 968 (m), 951 (m), 924 (m), 
911 (m), 878 (m), 833 (s), 775 (s), 756 (s), 674 (s), 578 (m) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.31 (2H, dd, J = 8.8, 5.6 Hz), 7.00 (2H, dd, J = 8.8, 8.8 Hz), 5.62 (1H, d, J = 
2.8 Hz), 5.38 (1H, d, J = 3.2 Hz), 3.54–3.49 (1H, m), 3.43–3.37 (1H, m), 2.75 (1H, d, J = 
8.4 Hz), 2.10 (3H, s), 1.28–1.24 (2H, m), 1.22 (12H, s), 0.84 (9H, s), –0.04 (3H, s), –0.06 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 161.6 (d, J = 244 Hz), 141.8, 127.1 (d, J = 7.5 
Hz), 122.8, 115.1 (d, J = 21.3 Hz), 81.5, 75.1, 61.3, 60.3, 52.7, 31.5, 26.1, 25.2, 25/1, 
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24.9, 24.7, 18.4, –5.2, –5.3; HRMS: Calcd for C25H44B1F1N1O3Si1 [M+H]
+
: 464.31675; 
Found: 464.31758; specific rotation:  [α]D
20
 –14.16 (c 1.39, CHCl3) for an 
enantiomerically enriched sample of 94.5:5.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(4-chlorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.50): IR (CH2Cl2): 3285 (br), 
2929 (w), 2856 (w), 1686 (w), 1590 (w), 1472 (m), 1448 (s), 1371 (m), 1334 (m), 1302 
(w), 1255 (m), 1217 (w), 1146 (s), 1093 (s), 1010 (m), 982 (m), 952 (m), 924 (w), 883 
(w), 830 (s), 776 (s), 723 (w), 700 (w), 675 (s), 622 (w), 577 (w), 523 (w), 468 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.29 (4H, s), 5.64 (1H, d, J = 2.8 Hz), 5.40 (1H, d, J = 2.8 
Hz), 3.56–3.51 (1H, m), 3.43–3.37 (1H, m), 2.76 (1H, dd, J = 11.2, 2.0 Hz), 1.42 (3H, s), 
1.22 (12H, s), 1.20–1.14 (2H, m), 0.85 (9H, s), –0.03 (3H, s), –0.05 (3H, s); 13C NMR 
(CDCl3, 100 MHz): δ 144.6, 132.6, 128.6, 127.0, 106.2, 83.0, 81.7, 75.2, 61.2, 60.5, 52.6, 
26.1, 25.1, 25.0, 24.7, 24.6, 18.4, –5.2, –5.3; HRMS: Calcd for C25H44B1Cl1N1O3Si1 
[M+H]
+
: 480.28720; Found: 480.28949; specific rotation: [α]D
20
 –18.16 (c 1.32, CHCl3) 
for an enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
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Retention Time Area Area% Retention Time Area Area% 
20.159 21056770 49.513 20.010 35520207 92.308 
22.921 21470574 50.487 22.926 2772334 7.692 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(naphthalen-1-yl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.51): IR (CH2Cl2): 3359 (br), 
2956 (m), 2930 (m), 2858 (w), 1685 (w), 1598 (w), 1471 (s), 1447 (s), 1371 (s), 1336 (m), 
1302 (m), 1253 (m), 1215 (w), 1148 (s), 1095 (s), 1007 (m), 982 (m), 952 (m), 924 (m), 
832 (s), 779 (s), 728 (m), 700 (s), 675 (s), 578 (m), 518 (m), 448 (m), 434 (w) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 8.31 (1H, d, J = 9.2 Hz), 7.89–7.87 (1H, m), 7.79 (1H, d, J = 
7.6 Hz), 7.52–7.49 (2H, m), 7.42 (1H, t, J = 7.6 Hz), 7.32 (1H, d, J = 7.6 Hz), 5.55 (1H, d, 
J = 3.2 Hz), 5.44 (1H, d, J = 2.8 Hz), 3.53 (1H, d, J = 11.6 Hz), 3.48–3.43 (2H, m), 1.78 
(3H, s), 1.26 (6H, s), 1.24 (6H, s), 1.07–1.01 (2H, m), 0.77 (9H, s), –0.12 (3H, s), –0.18 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 140.9, 135.0, 130.3, 129.6, 129.1, 126.2, 125.8, 
125.7, 124.8, 121.9, 119.5, 82.6, 80.2, 75.2, 64.5, 60.4, 53.0, 28.2, 26.1, 25.7, 25.4, 25.0, 
24.7, 18.3, –5.3, –5.4; HRMS: Calcd for C29H47B1N1O3Si1 [M+H]
+
: 496.3418; Found: 
496.3437; specific rotation: [α]D
20
 –2.91 (c 3.43, CHCl3) for an enantiomerically enriched 
sample of 98.5:1.5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 98:2 hexanes/i-
PrOH, 0.4 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
59.235 264275233 49.261 61.353 1488378 1.411 
65.798 272203167 50.739 65.909 104018457 98.589 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(naphthalen-2-yl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.52): IR (CH2Cl2): 3399 (br), 
2976 (m), 2954 (m), 2929 (m), 2857 (w), 1709 (w), 1678 (m), 1628 (w), 1598 (w), 1471 
(s), 1438 (s), 1369 (s), 1301 (m), 1282 (m), 1253 (m), 1228 (w), 1192 (m), 1147 (s), 1103 
(s), 1007 (m), 982 (m), 951 (s), 884 (m), 857 (s), 830 (s), 780 (s), 747 (s), 701 (m), 675 
(s), 617 (w), 577 (m), 553 (m), 520 (m), 476 (s) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 
7.83–7.80 (3H, m), 7.70 (1H, s), 7.50–7.43 (3H, m), 5.61 (1H, d, J = 3.2 Hz), 5.42 (1H, d, 
J = 3.2 Hz), 3.54–3.50 (1H, m), 3.46–3.43 (1H, m), 2.91 (1H, dd, J = 9.2, 2.0 Hz), 1.53 
(3H, s), 1.43–1.35 (2H, m), 1.23 (12H, s), 0.84 (9H, s), –0.04 (3H, s), –0.07 (3H, s); 13C 
NMR (CDCl3, 100 MHz): δ 143.4, 133.2, 132.3, 128.5, 128.0, 127.6, 126.4, 126.0, 124.2, 
123.1, 121.7, 82.7, 81.1, 75.2, 61.5, 61.0, 52.6, 30.9, 26.1, 25.2, 25.1, 25.0, 24.7, 18.4, –
5.2, –5.3; HRMS: Calcd for C29H47B1N1O3Si1 [M+H]
+
: 496.34182; Found: 496.34110; 
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specific rotation: [α]D
20
 –17.08 (c 2.34, CHCl3) for an enantiomerically enriched sample 
of 94:6 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
16.897 37601987 49.602 16.623 78399879 93.093 
28.796 38205533 50.398 27.570 5816862 6.907 
(2R,3S)-2-(Benzo[d][1,3]dioxol-5-yl)-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.54): IR (CH2Cl2): 
3055 (w), 2980 (w), 1505 (m), 1473 (m), 1440 (m), 1370 (m), 1335 (m), 1264 (s), 1143 
(s), 1095 (s), 1040 (s), 1007 (m), 981 (m), 951 (m), 882 (m), 836 (s), 812 (m), 777 (m), 
732 (s), 702 (s), 675 (s), 577 (w), 553 (w), 522 (w), 454 (w), 435 (w) cm
−1
; 
1
H NMR 
(CDCl3, 400 MHz): δ 6.80–6.72 (3H, m), 5.94 (2H, s), 5.52 (1H, d, J = 2.8 Hz), 5.32 (1H, 
d, J = 2.8 Hz), 3.60–3.54 (1H, m), 3.51–3.43 (1H, m), 2.68 (1H, t, J = 6.8 Hz), 1.43 (3H, 
s), 1.38–1.32 (2H, m), 1.23 (12H, s), 0.85 (9H, s), –0.01 (3H, s), –0.03 (3H, s); 13C NMR 
(CDCl3, 100 MHz): δ 148.1, 146.4, 118.8, 118.0, 108.0, 106.8, 106.4, 101.2, 82.9, 81.0, 
75.2, 61.4, 61.3, 31.6, 30.9, 26.1, 25.2, 25.1, 25.0, 24.7, 18.4, –5.1, –5.2; HRMS: Calcd 
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for C26H45B1N1O5Si1 [M+H]
+
: 490.3160; Found: 490.3137; specific rotation: [α]D
20
 +6.99 
(c 1.43, CHCl3) for an enantiomerically enriched sample of 94.5:5.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
19.648 21534978 49.743 19.375 21468166 94.578 
26.862 21757196 50.257 27.557 1230723 5.422 
(2R,3S)-2-(Benzofuran-5-yl)-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.55): IR (CH2Cl2): 3238 (br), 
2974 (m), 2929 (m), 2887 (w), 2856 (w), 1518 (w), 1474 (s), 1458 (s), 1378 (m), 1330 
(m), 1255 (m), 1196 (s), 1144 (s), 1095 (m), 1051 (w), 1007 (m), 982 (m), 968 (m), 952 
(w), 879 (w), 836 (s), 810 (m), 775 (s), 739 (m), 699 (w), 675 (m), 422 (w) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.60 (1H, d, J = 10.0 Hz), 7.51–7.41 (2H, m), 7.22 (1H, d, J 
= 8.4 Hz), 6.74 (1H, s), 5.52 (1H, d, J = 2.8 Hz), 5.33 (1H, d, J = 2.8 Hz), 3.56–3.52 (1H, 
m), 3.39–3.34 (1H, m), 2.82 (1H, t, J = 6.4 Hz), 1.53 (3H, s), 1.32–1.27 (2H, m), 1.23 
(12H, s), 0.85 (9H, s), –0.03 (3H, s), –0.06 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 172.5, 
153.9, 145.7, 145.2, 127.6, 122.0, 117.7, 111.4, 106.8, 82.9, 80.9, 75.2, 61.9, 61.1, 31.7, 
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31.3, 26.1, 25.2, 25.1, 25.0, 24.7, 18.4, –5.2, –5.3; HRMS: Calcd for C27H45B1N1O4Si1 
[M+H]
+
: 486.3211; Found: 486.3220; specific rotation: [α]D
20
 –6.48 (c 1.85, CHCl3) for 
an enantiomerically enriched sample of 94.5:5.5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
16.975 19949090 49.172 16.855 95589785 94.260 
27.678 20621055 50.828 28.152 5821179 5.740 
(2S,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-cyclohexyl-4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.56): IR (CH2Cl2): 3398 (br), 3061 (w), 
3028 (w), 2944 (w), 2827 (w), 1705 (s), 1666 (m), 1625 (w), 1605 (w), 1576 (m), 1494 
(m), 1451 (m), 1415 (w), 1357 (m), 1329 (w), 1256 (m), 1226 (w), 1206 (m), 1169 (m), 
1074 (w), 1025 (s), 976 (m), 912 (w), 843 (w), 752 (s), 698 (s), 558 (m), 547 (m), 517 
(m), 482 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 5.29 (1H, br s), 5.13 (1H, br s), 3.77–
3.72 (1H, m), 3.59–3.53 (1H, m), 2.24 (1H, d, J = 8.4 Hz), 1.84–1.50 (7H, m), 1.47–1.38 
(1H, m), 1.25–1.16 (4H, m), 1.14 (6H, s), 1.11 (6H, s), 1.04 (3H, s), 0.99–0.90 (1H, m), 
0.88 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 82.8, 79.7, 75.2, 
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61.6, 60.9, 51.4, 43.5, 30.0, 27.7, 27.4, 26.6, 26.4, 26.1, 25.3, 25.0, 24.8, 24.7, 20.4, 18.4, 
–5.1, –5.2; HRMS: Calcd for C25H51B1N1O3Si1 [M+H]
+
: 452.37312; Found: 452.37187; 
specific rotation: [α]D
20
 –15.88 (c 1.51, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r. 
Enantiomeric purity was determined by 
1H NMR analysis of derived Mosher’s amide. 
(2S,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-1-cyclohexyl-2-methyl-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine (5.57): IR (CH2Cl2): 3238 (br), 
2976 (w), 2926 (m), 2854 (w), 1707 (w), 1473 (s), 1449 (s), 1370 (s), 1330 (s), 1253 (m), 
1216 (w), 1145 (s), 1095 (s), 982 (m), 951 (s), 924 (s), 883 (w), 833 (s), 775 (s), 732 (w), 
700 (w), 674 (s), 577 (w), 551 (w), 521 (w), 494 (w), 451 (w) cm
−1
; 
1
H NMR (CDCl3, 
400 MHz): δ 5.32 (1H, br s), 5.14 (1H, br s), 3.77–3.73 (1H, m), 3.56–3.52 (1H, m), 
2.29–2.21 (1H, m), 1.80–1.53 (11H, m), 1.40–1.31 (3H, m), 1.21 (6H, s), 1.18 (6H, s), 
1.14 (3H, s), 1.03–0.98 (1H, m), 0.88 (9H, s), 0.03 (6H, s); 13C NMR (CDCl3, 100 MHz): 
δ 107.5, 82.9, 79.9, 75.2, 62.0, 60.2, 42.1, 35.2, 35.1, 33.8, 32.9, 30.9, 30.4, 29.8, 26.1, 
25.2, 25.1, 24.9, 24.7, 18.4, –5.1, –5.2; HRMS: Calcd for C26H53B1N1O3Si1 [M+H]
+
: 
466.38877; Found: 466.39005; specific rotation: [α]D
20
 –8.68 (c 1.61, CHCl3) for an 
enantiomerically enriched sample of 91:9 e.r. 
Enantiomeric purity was determined by 
1H NMR analysis of derived Mosher’s amide. 
(3S,4R)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-4-phenyl-2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)oct-1-en-4-amine (5.58): IR (CH2Cl2): 3238 (br), 2975 (w), 
2929 (w), 2857 (w), 1603 (w), 1506 (w), 1473 (m), 1438 (m), 1371 (m), 1334 (m), 1297 
(w), 1247 (m), 1143 (s), 1093 (s), 1038 (s), 1007 (m), 982 (m), 967 (m), 950 (m), 925 (m), 
881 (m), 833 (s), 807 (m), 774 (s), 727 (m), 698 (m), 674 (s), 645 (w), 618 (m), 577 (w), 
Chapter 5, Page 384 
 
 
555 (w), 521 (w), 496 (w), 428 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.33 (2H, t, J = 
7.6 Hz), 7.23 (1H, t, J = 7.6 Hz), 7.18 (2H, d, J = 7.2 Hz), 5.45 (1H, d, J = 3.2 Hz), 5.29 
(1H, d, J = 2.8 Hz), 3.58–3.52 (1H, m), 3.50–3.44 (1H, m), 2.79 (1H, d, J = 7.6 Hz), 
1.94–1.86 (1H, m), 1.79–1.71 (1H, m), 1.21 (12H, s), 1.19–0.94 (6,m), 0.85 (9H, s), 
0.83–0.78 (3H, m), –0.03 (3H, s), –0.05 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 142.7, 
128.5, 126.8, 125.9, 119.0, 82.6, 80.5, 75.1, 65.2, 60.8, 52.3, 40.7, 31.5, 26.1, 25.4, 25.0, 
24.9, 24.7, 22.7, 18.4, 14.1, –5.2, –5.3; specific rotation: [α]D
20
 –18.29 (c 1.42, CHCl3) 
for an enantiomerically enriched sample of 88:12 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
17.953 16546365 50.460 17.948 17946169 88.016 
19.392 16244594 49.540 19.359 2443568 11.984 
(2R,3S)-3-Methyl-2-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-
2-amine (5.59): IR (CH2Cl2): 3236 (w), 3151 (w), 2976 (m), 2929 (m), 1519 (m), 1474 
(s), 1448 (s), 1371 (s), 1325 (s), 1270 (m), 1217 (m), 1142 (s), 1105 (s), 1069 (m), 1050 
(m), 1008 (m), 981 (s), 968 (m), 951 (m), 850 (s), 762 (m), 737 (m), 700 (s), 674 (s), 578 
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(m), 519 (m) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.45–7.42 (1H, m), 7.37–7.31 (2H, m), 
7.28–7.23 (1H, m), 7.19–7.17 (1H, m), 5.42 (1H, dd, J = 2.0, 2.0 Hz), 5.16 (1H, br s), 
2.79 (1H, q, J = 6.8 Hz), 1.65 (3H, s), 1.18 (12H, s), 0.68 (3H, d, J = 6.8 Hz); 
13
C NMR 
(CDCl3, 100 MHz): δ 146.5, 128.4, 127.2, 125.7, 124.4, 83.0, 80.8, 75.2, 62.0, 30.5, 25.2, 
25.1, 24.9, 24.7, 14.4; HRMS: Calcd for C18H29B1N1O2 [M+H]
+
: 302.22913; Found: 
302.23074; specific rotation: [α]D
20
 –7.99 (c 1.50, CHCl3) for an enantiomerically 
enriched sample of 96:4 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.2 mL/min, 220 nm. 
(2R,3S)-3-Phenethyl-2-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-
en-2-amine (5.60): IR (CH2Cl2): 3370 (br), 3060 (w), 3026 (w), 2976 (m), 2929 (w), 
1685 (w), 1600 (w), 1517 (m), 1473 (s), 1449 (s), 1371 (s), 1330 (s), 1266 (m), 1217 (w), 
1144 (s), 1076 (m), 1029 (w), 1007 (m), 981 (s), 952 (m), 922 (m), 850 (s), 757 (m), 731 
(m), 698 (s), 673 (s), 617 (w), 587 (w), 496 (w), 450 (w) cm
−1
; 
1
H NMR (CDCl3, 400 
MHz): δ 7.33–7.28 (2H, m), 7.25–7.16 (5H, m), 7.13–7.09 (1H, m), 7.05–7.03 (2H, m), 
5.59 (1H, d, J = 3.2 Hz), 5.38 (1H, d, J = 2.8 Hz), 2.73–2.65 (1H, m), 2.56 (1H, dd, J = 
10.8, 2.4 Hz), 2.40–2.32 (1H, m), 1.46 (3H, s), 1.42–1.37 (1H, m), 1.34–1.29 (1H, m), 
1.23 (12H, s); HRMS: Calcd for C25H35B1N1O2 [M+H]
+
: 392.27608; Found: 392.27612; 
specific rotation: [α]D
20
 –6.14 (c 2.60, CHCl3) for an enantiomerically enriched sample of 
97:3 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
18.998 13082825 49.743 18.971 44341680 97.113 
33.619 13218029 50.257 34.080 1318230 2.887 
(2R,3S)-2,6-Diphenyl-3-(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)hexan-
2-amine (5.61): IR (CH2Cl2): 3381 (br), 3029 (w), 2976 (m), 2931 (m), 2860 (w), 1708 
(w), 1685 (w), 1601 (m), 1517 (m), 1474 (s), 1450 (s), 1372 (s), 1266 (m), 1217 (m), 
1146 (s), 1066 (s), 1008 (m), 982 (s), 951 (m), 924 (m), 851 (m), 748 (m), 699 (s), 674 (s), 
578 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.35–7.31 (2H, m), 7.26–7.24 (3H, m), 
7.23–7.18 (2H, m), 7.13–7.09 (1H, m), 7.07–7.05 (2H, m), 5.53 (1H, d, J = 2.8 Hz), 5.31 
(1H, d, J = 2.8 Hz), 2.58 (1H, dd, J = 12.0, 3.2 Hz), 2.47–2.40 (2H, m), 1.72–1.62 (1H, 
m), 1.50 (3H, s), 1.45–1.37 (2H, m), 1.22 (12H, s), 1.07–1.00 (1H, m); 13C NMR (CDCl3, 
100 MHz): δ 144.9, 142.9, 128.6, 128.4, 128.2, 126.9, 125.5, 125.1, 120.3, 82.8, 80.9, 
61.8, 56.5, 35.7, 30.5, 29.6, 28.2, 25.1, 25.0, 24.9, 24.7; specific rotation: [α]D
20
 –10.83 (c 
1.66, CHCl3) for an enantiomerically enriched sample of >99:1 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material derived from acetyl-amine; Chiralcel OD-H column, 90:10 hexanes/i-
PrOH, 0.5 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
24.188 18294690 49.604 25.474 3179514 100.000 
33.936 18586427 50.396    
 
 Representative Procedure for Synthesis of β-Amino Methyl Ketones: (2R,3S)-3-(2-
((tert-Butyldimethylsilyl)oxy)ethyl)-2-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)pent-4-en-2-amine 5.33 (44.6 mg, 0.100 mmol, 1.0 equiv.) was dissolved in a 
mixture of thf (0.5 mL) and H2O (0.5 mL). NaBO3•4H2O (76.9 mg, 0.500 mmol, 5.0 
equiv.) was added to the mixture and it was allowed to stir at 22 °C for three hours. The 
reaction was quenched by addition of H2O (5 mL) and aqueous layer was washed with 
Et2O (3 x 5 mL). The combined organic layer was dried over MgSO4 and concentrated in 
vacuo. The crude product was purified by silica gel chromatography (hexanes:Et2O=1:1) 
to afford (3R,4R)-4-amino-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-phenylpentan-2-
one 5.66 as colorless oil (26.9 mg, 0.0802 mmol, 80% yield). 
(3R,4R)-4-Amino-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4-phenylpentan-2-one 
(5.66). IR (CH2Cl2): 2954 (w), 2928 (w), 2884 (w), 2856 (w), 1703 (m), 1600 (w), 1494 
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(w), 1471 (w), 1462 (w), 1445 (w), 1358 (w), 1254 (m), 1166 (w), 1093 (s), 1042 (w), 
1006 (w), 938 (w), 832 (s), 812 (m), 775 (s), 700 (s), 661 (w), 645 (w), 568 (w), 535 (w) 
cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 7.49 (2H, d, J = 7.2 Hz), 7.33 (2H, t, J = 7.6 Hz), 
7.22 (1H, t, J = 7.6 Hz), 3.40 (2H, t, J = 5.6 Hz), 3.25 (1H, d, J = 10.4 Hz), 2.17 (3H, s), 
1.90–1.80 (1H, m), 1.43–1.36 (1H, m), 1.26 (3H, s), 0.85 (9H, s), –0.04 (3H, s), –0.07 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 214.0, 147.5, 128.4, 126.7, 125.5, 61.8, 58.9, 
57.1, 34.4, 31.8, 30.3, 26.0, 18.4, –5.3, –5.4; HRMS: Calcd for C19H34N1O2Si1 [M+H]
+
: 
336.23588; Found: 336.23634. 
 
 Pepresentative Experimental Procedure for Cu-Catalyzed Protodeboration of 
Alkenylboron: In a N2-filled glove box, an oven-dried vial with a magnetic stir bar was 
charged with imidazolium salt 5.37 (16.0 mg, 0.0501 mmol, 10.0 mol %), CuCl (5.0 mg, 
0.0501 mmol, 10.0 mol %), NaOMe (32.5 mg, 0.601 mmol, 1.2 equiv.) and thf (2.0 mL). 
The vessel was sealed with a cap and the solution was allowed to stir at 22 °C for one 
hour. (2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(2-chlorophenyl)-4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-2-amine 5.45 (240.5 mg, 0.501 mmol, 1.0 
equiv.) and MeOH (101.4 μL, 2.51 mmol, 5.0 equiv.) were added to the solution, and the 
vial was re-sealed and removed from the glove box. The resulting solution was allowed 
to stir at 60 °C for eight hours before the reaction was quenched by passing the mixture 
through a short plug of Celite and silica gel and eluted with Et2O (3 × 5 mL). The filtrate 
was concentrated in vacuo. The crude product was purified by silica gel chromatography 
(hexanes:Et2O=2:1 to 1:5) to afford (2R,3S)-3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-
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(2-chlorophenyl)pent-4-en-2-amine 5.76 as colorless oil (127.7 mg, 0.361 mmol, 72% 
yield). 
(2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-phenylpent-4-en-2-amine (5.75). 
IR (CH2Cl2): 3354 (br), 2928 (m), 2856 (m), 1664 (m), 1599 (w), 1551 (w), 1462 (m), 
1446 (m), 1377 (m), 1252 (m), 1143 (m), 1094 (s), 1030 (m), 1005 (m), 949 (m), 917 (m), 
881 (m), 833 (s), 773 (s), 700 (s), 665 (m), 566 (w), 496 (w), 475 (w), 451 (w) cm
−1
; 
1
H 
NMR (CDCl3, 400 MHz): δ 7.43–7.41 (2H, m), 7.35–7.29 (2H, m), 7.20 (1H, t, J = 6.8 
Hz), 5.61 (1H, dt, J = 17.2, 10.4 Hz), 5.18 (1H, dd, J = 10.4, 2.0 Hz), 5.08 (1H, dd, J = 
17.6, 2.0 Hz), 3.53–3.47 (1H, m), 3.40–3.34 (1H, m), 2.47 (1H, t, J = 10.0 Hz), 2.27 (3H, 
s), 1.48–1.45 (1H, m), 1.35–1.32 (1H, m), 0.84 (9H, s), –0.05 (3H, s), –0.07 (3H, s); 13C 
NMR (CDCl3, 100 MHz): δ 144.6, 141.5, 141.0, 131.9, 128.1, 107.0, 56.8, 51.8, 46.1, 
32.9, 31.8, 30.5, 25.7, –5.3; HRMS: Calcd for C19H34N1O1Si1 [M+H]
+
: 320.24097; 
Found: 320.24125. 
 
 Synthesis of Medicinally Active Molecule 
Experimental Procedure for Synthesis of Thiourea 5.78 from 5.76: To a solution of 
5.76 (522 mg, 1.48 mmol, 1.0 equiv.) in thf (10 mL) was added benzoyl isothiocyanate 
5.77 (298 μL, 2.21 mmol, 1.5 equiv.) in one portion. The solution was allowed to stir at 
22 °C for two hours. Water (10 mL) was added to quench the reaction. The organic layer 
was separated and the aqueous layer was extracted by EtOAc (3 × 5 mL). The combined 
organic layer was dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
crude product was purified by silica gel chromatography (hexanes:Et2O=10:1 to 5:1) to 
afford the desired product 5.78 as pale yellow oil (643 mg, 1.243 mmol, 84% yield). 
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N-(((2R,3S)-3-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-(2-chlorophenyl)pent-4-en-2-
yl)carbamothioyl)benzamide (5.78). IR (CH2Cl2): 3258 (br), 3066 (w), 2952 (m), 2925 
(m), 2854 (m), 2262 (w), 1724 (m), 1694 (s), 1599 (m), 1544 (s), 1504 (m), 1469 (s), 
1430 (m), 1376 (m), 1362 (m), 1250 (s), 1095 (s), 1034 (s), 1002 (m), 922 (m), 881 (m), 
834 (s), 807 (m), 773 (s), 757 (s), 708 (s), 675 (m), 666 (m), 617 (m), 574 (m), 459 (w), 
441 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 11.74 (1H, br s), 8.80 (1H, br s),  7.84 (2H, 
d, J = 7.6 Hz), 7.60 (1H, t, J = 7.6 Hz), 7.50 (2H, t, J = 7.6 Hz), 7.32 (2H, dd, J = 21.2, 
8.0 Hz), 7.17 (2H, dt, J = 21.2, 7.6 Hz), 5.44–5.35 (1H, m), 4.90 (1H, d, J = 10.0 Hz), 
4.80 (1H, d, J = 16.8 Hz), 3.76–3.71 (1H, m), 3.64–3.57 (1H, m), 3.49 (1H, t, J = 10.0 
Hz), 2.13 (3H, s), 0.93 (9H, s), 0.90–0.80 (2H, m), 0.09 (3H, s), 0.07 (3H, s); 13C NMR 
(CDCl3, 100 MHz): δ 177.8, 166.6, 139.4, 135.8, 133.4, 132.1, 131.5, 131.4, 130.7, 129.1, 
128.3, 127.6, 126.2, 119.0, 64.7, 46.9, 32.1, 32.0, 29.8, 26.1, 18.4, –5.3; HRMS: Calcd 
for C27H38Cl1N2O2S1Si1 [M+H]
+
: 517.21118; Found: 517.21210. 
 
Experimental Procedure for TBS-Deprotection of 5.78: To a solution of N-(((2R,3S)-
3-(2-((tert-butyldimethylsilyl)oxy)ethyl)-2-(2-chlorophenyl)pent-4-en-2-
yl)carbamothioyl)benzamide 5.78 (611 mg, 1.18 mmol, 1.0 equiv.) in thf (10 mL) was 
added 1.0 M solution of tetra-n-butylammonium fluoride in thf (2.23 mL, 2.23 mmol, 2.0 
equiv.) slowly through a syringe. The solution was allowed to stir at 60 °C for 18 hours. 
The reaction was quenched by the addition of H2O (50 mL) and the organic layer was 
extracted with EtOAc (3 × 50 mL) and washed with brine. The organic layer was dried 
over Na2SO4, concentrated in vacuo and the crude product was purified by silica gel 
column chromatography (hexanes:Et2O=2:1 to 1:5) to afford N-(((2R,3S)-2-(2-
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chlorophenyl)-3-(2-hydroxyethyl)pent-4-en-2-yl)carbamothioyl)benzamide 5.79 as 
colorless oil (404.4 mg, 1.00 mmol, 85% yield). 
N-(((2R,3S)-2-(2-Chlorophenyl)-3-(2-hydroxyethyl)pent-4-en-2-
yl)carbamothioyl)benzamide (5.79). IR (CH2Cl2): 3234 (w), 3067 (w), 2925 (w), 1671 
(w), 1588 (s), 1567 (s), 1504 (w), 1471 (m), 1446 (m), 1428 (s), 1348 (s), 1292 (m), 1268 
(m), 1140 (s), 1110 (w), 1059 (m), 1034 (s), 1017 (s), 994 (m), 915 (w), 826 (w), 757 (m), 
714 (s), 689 (m), 617 (w), 574 (w), 461 (w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 11.4 
(1H, br s), 8.21 (2H, d, J = 8.0 Hz), 7.50–7.38 (5H, m), 7.27–7.25 (2H, m), 5.74–5.65 
(1H, m), 5.06 (1H, d, J = 11.2 Hz), 5.05 (1H, d, J = 16.4 Hz), 4.46–4.41 (1H, m), 4.35–
4.29 (1H, m), 3.96 (1H, dd, J = 10.0, 7.6 Hz), 2.17–2.10 (1H, m), 2.03–1.99 (1H, m), 
1.78 (3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 168.6, 166.8, 150.1, 140.7, 137.0, 132.9, 
132.1, 131.8, 129.5, 129.4, 128.9, 128.1, 127.3, 118.7, 69.9, 64.9, 45.1, 31.4, 24.3; 
HRMS: Calcd for C21H24Cl1N2O2S1 [M+H]
+
: 403.12470; Found: 403.12444. 
 
Experimental Procedure for Cu-Catalyzed Intramolecular Ullmann Coupling of 
5.79: To a vial were added CuI (9.5 mg, 0.0496 mmol, 10 mol %), 8-hydroxyquinoline 
5.80 (14.4 mg, 0.0993 mmol, 20 mol %), and Cs2CO3 (323.4 mg, 0.993 mmol, 2.0 equv.) 
under N2 atm. The vial was then evacuated and backfilled with N2 atm. N-(((2R,3S)-2-(2-
Chlorophenyl)-3-(2-hydroxyethyl)pent-4-en-2-yl)carbamothioyl)benzamide 5.79 (200 mg, 
0.496 mmol, 1.0 equiv.) and toluene (10 mL) were added by syringe at 22 °C. The 
solution was allowed to stir at 110 °C for 24 hour. The solution was allowed to reach 
22 °C and then diluted with CH2Cl2 (50 mL). The slurry was filtered and washed with 
CH2Cl2 (3 × 50 mL). The solvent was removed in vacuo, and the residue was purified by 
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silica gel column chromatography to afford N-(((4S,5R)-5-methyl-4-vinyl-2,3,4,5-
tetrahydrobenzo[b]oxepin-5-yl)carbamothioyl)benzamide 5.81 (141.8 mg, 0.387 mmol, 
78% yield). 
N-(((4S,5R)-5-Methyl-4-vinyl-2,3,4,5-tetrahydrobenzo[b]oxepin-5-
yl)carbamothioyl)benzamide (5.81). IR (CH2Cl2): 3241 (w), 3066 (w), 2923 (m), 2852 
(w), 1695 (m), 1666 (m), 1591 (s), 1568 (s), 1504 (w), 1468 (s), 1447 (m), 1429 (s), 1350 
(s), 1291 (w), 1266 (s), 1204 (m), 1140 (s), 1059 (s), 1034 (s), 1017 (s), 994 (s), 913 (s), 
802 (m), 756 (s), 712 (s), 689 (s), 646 (m), 617 (w), 574 (w), 497 (w), 460 (w), 434 (w), 
418 (w) cm
−1
; 
1
H NMR (CDCl3, 600 MHz): δ 11.46 (1H, br s), 8.22 (2H, d, J = 7.2 Hz), 
7.49–7.44 (2H, m), 7.43–7.39 (3H, m), 7.28–7.25 (2H, m), 5.71–5.67 (1H, m), 5.06 (1H, 
d, J = 10.2 Hz), 5.05 (1H, d, J = 17.4 Hz), 4.45–4.42 (1H, m), 4.32 (1H, ddd, J = 12.0, 
9.0, 3.0 Hz), 3.97 (1H, dd, J = 12.6, 7.8 Hz), 2.18–2.12 (1H, m), 2.07–2.02 (1H, m), 1.78 
(3H, s); 
13
C NMR (CDCl3, 100 MHz): δ 188.3, 166.9, 140.7, 137.1, 137.0, 134.4, 132.9, 
132.1, 129.5, 129.4, 128.9, 128.1, 127.3, 118.7, 69.9, 64.9, 45.1, 37.3, 31.4. 
 
Experimental Procedure for Ozonolysis/Reduction of 5.81: N-(((4S,5R)-5-Methyl-4-
vinyl-2,3,4,5-tetrahydrobenzo[b]oxepin-5-yl)carbamothioyl)benzamide 5.81 (47.5 mg, 
0.130 mmol, 1.0 equiv.) was dissolved in a 5:1 mixture of CH2Cl2 (2 mL) and MeOH 
(0.4 mL) and NaHCO3 (87.1 mg, 1.04 mmol, 8.0 equiv.) was added. The solution was 
allowed to cool to –78 °C, then ozone was bubbled through the solution until it turned to 
blue for about five minutes. To the solution was added NaBH4 (24.5 mg, 0.648 mmol, 5.0 
equiv.) and it was allowed to warm to 4 °C slowly for 18 hours. The reaction was 
quenched by the addition of H2O (5 mL) and the organic layer was extracted with CH2Cl2 
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(3 × 5 mL) and washed with brine. The organic layer was dried over Na2SO4, 
concentrated in vacuo and the crude product was purified by silica gel column 
chromatography (hexanes:EtOAc=1:1 to EtOAc 100%) to afford N-(((4R,5R)-4-
(hydroxymethyl)-5-methyl-2,3,4,5-tetrahydrobenzo[b]oxepin-5-
yl)carbamothioyl)benzamide 5.82 as white solid (34.7 mg, 0.0937 mmol, 72% yield). 
N-(((4R,5R)-4-(Hydroxymethyl)-5-methyl-2,3,4,5-tetrahydrobenzo[b]oxepin-5-
yl)carbamothioyl)benzamide (5.82). IR (CH2Cl2): 3406 (w), 3067 (w), 2928 (w), 1597 
(s), 1586 (s), 1565 (s), 1490 (m), 1460 (m), 1445 (m), 1356 (s), 1271 (w), 1191 (m), 1136 
(m), 1097 (w), 1046 (m), 1035 (m), 1007 (m), 947 (w), 826 (w), 758 (m), 715 (m), 687 
(w) cm
−1
; 
1
H NMR (CDCl3, 400 MHz): δ 12.0 (1H, br s), 8.3 (2H, d, J = 8.0 Hz), 7.70 
(1H, dd, J = 8.0, 1.6 Hz), 7.49 (1H, tt, J = 7.2, 1.6 Hz), 7.44–7.39 (3H, m), 7.36 (1H, dd, 
J = 8.0, 1.6 Hz), 7.28 (1H, td, J = 7.6, 1.6 Hz), 4.65 (1H, dd, J = 12.4, 1.2 Hz), 4.55 (1H, 
dd, J = 12.4, 1.6 Hz), 3.65 (2H, dd, J = 7.2, 4.4 Hz), 3.25–3.20 (1H, m), 2.00 (3H, s), 
1.39–1.29 (1H, m), 1.26–1.16 (1H, m); 13C NMR (CDCl3, 100 MHz): δ 179.5, 162.3, 
139.0, 137.2, 132.5, 132.0, 131.3, 129.4, 129.3, 128.2, 128.1, 127.3, 64.8, 60.8, 59.9, 34.7, 
29.3; HRMS: Calcd for C20H23N2O3S1 [M+H]
+
: 371.14239; Found: 371.13653. 
 
Experimental Procedure for Cyclization of 5.81: To a solution of N-(((4R,5R)-4-
(hydroxymethyl)-5-methyl-2,3,4,5-tetrahydrobenzo[b]oxepin-5-
yl)carbamothioyl)benzamide 5.82 (11.3 mg, 0.0305 mmol, 1.0 equiv.) in CH2Cl2 (1 mL) 
at –20 °C was added pyridine (7.4 μL, 0.0915 mmol, 3.0 equiv.), followed by dropwise 
addition of trifluoromethanesulfonic anhydride (7.7 μL, 0.0458 mmol, 1.5 equiv.). After 
the addition, the solution was allowed to stir at –20 °C for two hours. The reaction was 
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quenched by the addition of saturated aq. Solution of NaHCO3 (5 mL) and the organic 
layer was extracted with CH2Cl2 (3 × 5 mL) and washed with brine. The organic layer 
was dried over Na2SO4 and concentrated in vacuo to afford N-((4aR,11bR)-11b-methyl-
4a,5,6,11b-tetrahydro-4H-benzo[2,3]oxepino[4,5-d][1,3]thiazin-2-yl)benzamide 5.83 as 
yellow solid (8.1 mg, 0.0230 mmol, 75% yield). 
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 X-Ray Crystal Structure of rac-5.33 
 
Table 1. Crystal data and structure refinement for rac-5.33. 
Identification code  C25H44BNO3Si(C6H13BO3) 
Empirical formula  C31 H57 B2 N O6 Si 
Formula weight  589.48 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.7751(10) Å = 100.057(2)°. 
 b = 10.8228(15) Å = 95.125(3)°. 
 c = 24.618(4) Å  = 100.679(2)°. 
Volume 1732.7(4) Å3 
Z 2 
Density (calculated) 1.130 Mg/m3 
Absorption coefficient 0.107 mm-1 
F(000) 644 
Crystal size 0.380 x 0.220 x 0.100 mm3 
Theta range for data collection 1.952 to 28.424°. 
Index ranges -9<=h<=9, -14<=k<=14, -32<=l<=32 
Reflections collected 60094 
Independent reflections 8614 [R(int) = 0.1048] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.7033 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8614 / 0 / 393 
Goodness-of-fit on F2 1.002 
Final R indices [I>2sigma(I)] R1 = 0.0502, wR2 = 0.0921 
R indices (all data) R1 = 0.1046, wR2 = 0.1113 
Extinction coefficient na 
Largest diff. peak and hole 0.329 and -0.279 e.Å-3 
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Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for rac-5.33. U(eq) is defined as one third of  the trace of the orthogonalized 
Uij tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________   
Si(1) 1074(1) 2844(1) 5976(1) 24(1) 
O(1) 6496(2) 5783(1) 8586(1) 19(1) 
O(2) 9852(2) 6364(1) 8433(1) 18(1) 
O(3) 3015(2) 3300(1) 6467(1) 26(1) 
O(4) 14484(2) 10081(1) 8432(1) 21(1) 
O(5) 13183(2) 7832(1) 8227(1) 21(1) 
O(6) 11060(2) 9377(1) 8424(1) 21(1) 
N(1) 7236(2) 7249(1) 7887(1) 17(1) 
B(1) 7759(3) 5994(2) 8157(1) 18(1) 
B(2) 12909(3) 9040(2) 8353(1) 18(1) 
C(1) 7045(3) 6879(2) 7263(1) 18(1) 
C(2) 6070(3) 5426(2) 7156(1) 20(1) 
C(3) 7253(3) 4929(2) 7593(1) 20(1) 
C(4) 9194(3) 7074(2) 7098(1) 22(1) 
C(5) 5870(3) 7687(2) 6967(1) 21(1) 
C(6) 5645(3) 8890(2) 7219(1) 25(1) 
C(7) 4686(3) 9640(2) 6922(1) 34(1) 
C(8) 3922(3) 9182(2) 6370(1) 41(1) 
C(9) 4130(3) 7983(2) 6116(1) 40(1) 
C(10) 5107(3) 7244(2) 6407(1) 31(1) 
C(11) 3807(3) 5157(2) 7222(1) 23(1) 
C(12) 2833(3) 3746(2) 7039(1) 26(1) 
C(13) -396(3) 4132(2) 5977(1) 39(1) 
C(14) -618(3) 1368(2) 6091(1) 34(1) 
C(15) 2251(3) 2556(2) 5315(1) 26(1) 
C(16) 3666(3) 3794(2) 5258(1) 35(1) 
C(17) 3484(3) 1504(2) 5321(1) 36(1) 
C(18) 619(4) 2166(2) 4808(1) 44(1) 
C(19) 7736(3) 3782(2) 7501(1) 26(1) 
C(20) 7665(3) 6376(2) 9114(1) 20(1) 
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C(21) 9829(3) 6201(2) 9004(1) 21(1) 
C(22) 7542(3) 7792(2) 9250(1) 22(1) 
C(23) 6795(3) 5694(2) 9555(1) 25(1) 
C(24) 10159(3) 4851(2) 9024(1) 27(1) 
C(25) 11520(3) 7177(2) 9380(1) 28(1) 
C(26) 13719(3) 11191(2) 8691(1) 23(1) 
C(27) 11399(3) 10779(2) 8499(1) 24(1) 
C(28) 14277(3) 11344(2) 9313(1) 33(1) 
C(29) 14765(3) 12353(2) 8486(1) 34(1) 
C(30) 10784(3) 11086(2) 7937(1) 36(1) 
C(31) 10076(3) 11239(2) 8925(1) 36(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for rac-5.33. 
_____________________________________________________  
Si(1)-O(3)  1.6433(14) 
Si(1)-C(13)  1.857(2) 
Si(1)-C(14)  1.866(2) 
Si(1)-C(15)  1.879(2) 
O(1)-C(20)  1.435(2) 
O(1)-B(1)  1.441(2) 
O(2)-C(21)  1.448(2) 
O(2)-B(1)  1.468(2) 
O(3)-C(12)  1.430(2) 
O(4)-B(2)  1.373(2) 
O(4)-C(26)  1.464(2) 
O(5)-B(2)  1.342(2) 
O(5)-H(5O)  0.83(2) 
O(6)-B(2)  1.385(2) 
O(6)-C(27)  1.468(2) 
N(1)-C(1)  1.505(2) 
N(1)-B(1)  1.692(2) 
N(1)-H(1NA)  0.884(19) 
N(1)-H(1NB)  0.901(19) 
B(1)-C(3)  1.607(3) 
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C(1)-C(5)  1.519(2) 
C(1)-C(4)  1.533(2) 
C(1)-C(2)  1.555(2) 
C(2)-C(3)  1.516(2) 
C(2)-C(11)  1.536(2) 
C(2)-H(3)  1.0000 
C(3)-C(19)  1.329(2) 
C(4)-H(5A)  0.9800 
C(4)-H(5B)  0.9800 
C(4)-H(5C)  0.9800 
C(5)-C(6)  1.383(3) 
C(5)-C(10)  1.395(3) 
C(6)-C(7)  1.392(3) 
C(6)-H(7)  0.9500 
C(7)-C(8)  1.379(3) 
C(7)-H(8)  0.9500 
C(8)-C(9)  1.376(3) 
C(8)-H(9)  0.9500 
C(9)-C(10)  1.380(3) 
C(9)-H(10)  0.9500 
C(10)-H(11)  0.9500 
C(11)-C(12)  1.517(2) 
C(11)-H(12A)  0.9900 
C(11)-H(12B)  0.9900 
C(12)-H(13A)  0.9900 
C(12)-H(13B)  0.9900 
C(13)-H(14A)  0.9800 
C(13)-H(14B)  0.9800 
C(13)-H(14C)  0.9800 
C(14)-H(15A)  0.9800 
C(14)-H(15B)  0.9800 
C(14)-H(15C)  0.9800 
C(15)-C(16)  1.532(3) 
C(15)-C(17)  1.534(3) 
C(15)-C(18)  1.535(3) 
C(16)-H(17A)  0.9800 
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C(16)-H(17B)  0.9800 
C(16)-H(17C)  0.9800 
C(17)-H(18A)  0.9800 
C(17)-H(18B)  0.9800 
C(17)-H(18C)  0.9800 
C(18)-H(19A)  0.9800 
C(18)-H(19B)  0.9800 
C(18)-H(19C)  0.9800 
C(19)-H(20A)  0.9500 
C(19)-H(20B)  0.9500 
C(20)-C(23)  1.520(2) 
C(20)-C(22)  1.531(2) 
C(20)-C(21)  1.553(2) 
C(21)-C(25)  1.518(2) 
C(21)-C(24)  1.527(2) 
C(22)-H(23A)  0.9800 
C(22)-H(23B)  0.9800 
C(22)-H(23C)  0.9800 
C(23)-H(24A)  0.9800 
C(23)-H(24B)  0.9800 
C(23)-H(24C)  0.9800 
C(24)-H(25A)  0.9800 
C(24)-H(25B)  0.9800 
C(24)-H(25C)  0.9800 
C(25)-H(26A)  0.9800 
C(25)-H(26B)  0.9800 
C(25)-H(26C)  0.9800 
C(26)-C(29)  1.515(3) 
C(26)-C(28)  1.516(3) 
C(26)-C(27)  1.558(3) 
C(27)-C(30)  1.518(3) 
C(27)-C(31)  1.518(3) 
C(28)-H(29A)  0.9800 
C(28)-H(29B)  0.9800 
C(28)-H(29C)  0.9800 
C(29)-H(30A)  0.9800 
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C(29)-H(30B)  0.9800 
C(29)-H(30C)  0.9800 
C(30)-H(31A)  0.9800 
C(30)-H(31B)  0.9800 
C(30)-H(31C)  0.9800 
C(31)-H(32A)  0.9800 
C(31)-H(32B)  0.9800 
C(31)-H(32C)  0.9800 
 
O(3)-Si(1)-C(13) 110.22(9) 
O(3)-Si(1)-C(14) 110.18(9) 
C(13)-Si(1)-C(14) 108.97(10) 
O(3)-Si(1)-C(15) 104.21(8) 
C(13)-Si(1)-C(15) 110.86(10) 
C(14)-Si(1)-C(15) 112.34(9) 
C(20)-O(1)-B(1) 108.01(13) 
C(21)-O(2)-B(1) 107.99(13) 
C(12)-O(3)-Si(1) 123.46(11) 
B(2)-O(4)-C(26) 106.65(13) 
B(2)-O(5)-H(5O) 110.9(14) 
B(2)-O(6)-C(27) 106.96(13) 
C(1)-N(1)-B(1) 108.13(13) 
C(1)-N(1)-H(1NA) 110.5(12) 
B(1)-N(1)-H(1NA) 107.5(12) 
C(1)-N(1)-H(1NB) 112.1(12) 
B(1)-N(1)-H(1NB) 111.7(12) 
H(1NA)-N(1)-H(1NB) 106.8(17) 
O(1)-B(1)-O(2) 106.24(15) 
O(1)-B(1)-C(3) 116.23(14) 
O(2)-B(1)-C(3) 118.66(15) 
O(1)-B(1)-N(1) 109.31(14) 
O(2)-B(1)-N(1) 107.62(13) 
C(3)-B(1)-N(1) 97.99(14) 
O(5)-B(2)-O(4) 122.29(17) 
O(5)-B(2)-O(6) 124.65(16) 
O(4)-B(2)-O(6) 113.06(16) 
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N(1)-C(1)-C(5) 113.20(14) 
N(1)-C(1)-C(4) 107.26(14) 
C(5)-C(1)-C(4) 108.26(14) 
N(1)-C(1)-C(2) 102.33(13) 
C(5)-C(1)-C(2) 115.16(14) 
C(4)-C(1)-C(2) 110.30(14) 
C(3)-C(2)-C(11) 110.09(14) 
C(3)-C(2)-C(1) 103.58(14) 
C(11)-C(2)-C(1) 113.44(14) 
C(3)-C(2)-H(3) 109.9 
C(11)-C(2)-H(3) 109.9 
C(1)-C(2)-H(3) 109.9 
C(19)-C(3)-C(2) 123.06(17) 
C(19)-C(3)-B(1) 127.92(17) 
C(2)-C(3)-B(1) 109.02(14) 
C(1)-C(4)-H(5A) 109.5 
C(1)-C(4)-H(5B) 109.5 
H(5A)-C(4)-H(5B) 109.5 
C(1)-C(4)-H(5C) 109.5 
H(5A)-C(4)-H(5C) 109.5 
H(5B)-C(4)-H(5C) 109.5 
C(6)-C(5)-C(10) 118.35(18) 
C(6)-C(5)-C(1) 122.49(17) 
C(10)-C(5)-C(1) 119.01(17) 
C(5)-C(6)-C(7) 120.79(19) 
C(5)-C(6)-H(7) 119.6 
C(7)-C(6)-H(7) 119.6 
C(8)-C(7)-C(6) 120.1(2) 
C(8)-C(7)-H(8) 120.0 
C(6)-C(7)-H(8) 120.0 
C(9)-C(8)-C(7) 119.6(2) 
C(9)-C(8)-H(9) 120.2 
C(7)-C(8)-H(9) 120.2 
C(8)-C(9)-C(10) 120.5(2) 
C(8)-C(9)-H(10) 119.7 
C(10)-C(9)-H(10) 119.7 
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C(9)-C(10)-C(5) 120.7(2) 
C(9)-C(10)-H(11) 119.7 
C(5)-C(10)-H(11) 119.7 
C(12)-C(11)-C(2) 112.25(15) 
C(12)-C(11)-H(12A) 109.2 
C(2)-C(11)-H(12A) 109.2 
C(12)-C(11)-H(12B) 109.2 
C(2)-C(11)-H(12B) 109.2 
H(12A)-C(11)-H(12B) 107.9 
O(3)-C(12)-C(11) 110.90(15) 
O(3)-C(12)-H(13A) 109.5 
C(11)-C(12)-H(13A) 109.5 
O(3)-C(12)-H(13B) 109.5 
C(11)-C(12)-H(13B) 109.5 
H(13A)-C(12)-H(13B) 108.0 
Si(1)-C(13)-H(14A) 109.5 
Si(1)-C(13)-H(14B) 109.5 
H(14A)-C(13)-H(14B) 109.5 
Si(1)-C(13)-H(14C) 109.5 
H(14A)-C(13)-H(14C) 109.5 
H(14B)-C(13)-H(14C) 109.5 
Si(1)-C(14)-H(15A) 109.5 
Si(1)-C(14)-H(15B) 109.5 
H(15A)-C(14)-H(15B) 109.5 
Si(1)-C(14)-H(15C) 109.5 
H(15A)-C(14)-H(15C) 109.5 
H(15B)-C(14)-H(15C) 109.5 
C(16)-C(15)-C(17) 108.72(17) 
C(16)-C(15)-C(18) 108.02(17) 
C(17)-C(15)-C(18) 109.38(17) 
C(16)-C(15)-Si(1) 109.37(13) 
C(17)-C(15)-Si(1) 110.53(13) 
C(18)-C(15)-Si(1) 110.76(15) 
C(15)-C(16)-H(17A) 109.5 
C(15)-C(16)-H(17B) 109.5 
H(17A)-C(16)-H(17B) 109.5 
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C(15)-C(16)-H(17C) 109.5 
H(17A)-C(16)-H(17C) 109.5 
H(17B)-C(16)-H(17C) 109.5 
C(15)-C(17)-H(18A) 109.5 
C(15)-C(17)-H(18B) 109.5 
H(18A)-C(17)-H(18B) 109.5 
C(15)-C(17)-H(18C) 109.5 
H(18A)-C(17)-H(18C) 109.5 
H(18B)-C(17)-H(18C) 109.5 
C(15)-C(18)-H(19A) 109.5 
C(15)-C(18)-H(19B) 109.5 
H(19A)-C(18)-H(19B) 109.5 
C(15)-C(18)-H(19C) 109.5 
H(19A)-C(18)-H(19C) 109.5 
H(19B)-C(18)-H(19C) 109.5 
C(3)-C(19)-H(20A) 120.0 
C(3)-C(19)-H(20B) 120.0 
H(20A)-C(19)-H(20B) 120.0 
O(1)-C(20)-C(23) 108.31(14) 
O(1)-C(20)-C(22) 109.68(14) 
C(23)-C(20)-C(22) 109.63(15) 
O(1)-C(20)-C(21) 102.11(14) 
C(23)-C(20)-C(21) 114.89(15) 
C(22)-C(20)-C(21) 111.86(14) 
O(2)-C(21)-C(25) 110.34(14) 
O(2)-C(21)-C(24) 107.26(14) 
C(25)-C(21)-C(24) 109.46(15) 
O(2)-C(21)-C(20) 101.97(13) 
C(25)-C(21)-C(20) 114.34(15) 
C(24)-C(21)-C(20) 113.01(14) 
C(20)-C(22)-H(23A) 109.5 
C(20)-C(22)-H(23B) 109.5 
H(23A)-C(22)-H(23B) 109.5 
C(20)-C(22)-H(23C) 109.5 
H(23A)-C(22)-H(23C) 109.5 
H(23B)-C(22)-H(23C) 109.5 
Chapter 5, Page 404 
 
 
C(20)-C(23)-H(24A) 109.5 
C(20)-C(23)-H(24B) 109.5 
H(24A)-C(23)-H(24B) 109.5 
C(20)-C(23)-H(24C) 109.5 
H(24A)-C(23)-H(24C) 109.5 
H(24B)-C(23)-H(24C) 109.5 
C(21)-C(24)-H(25A) 109.5 
C(21)-C(24)-H(25B) 109.5 
H(25A)-C(24)-H(25B) 109.5 
C(21)-C(24)-H(25C) 109.5 
H(25A)-C(24)-H(25C) 109.5 
H(25B)-C(24)-H(25C) 109.5 
C(21)-C(25)-H(26A) 109.5 
C(21)-C(25)-H(26B) 109.5 
H(26A)-C(25)-H(26B) 109.5 
C(21)-C(25)-H(26C) 109.5 
H(26A)-C(25)-H(26C) 109.5 
H(26B)-C(25)-H(26C) 109.5 
O(4)-C(26)-C(29) 108.00(15) 
O(4)-C(26)-C(28) 106.31(15) 
C(29)-C(26)-C(28) 110.59(16) 
O(4)-C(26)-C(27) 102.67(13) 
C(29)-C(26)-C(27) 114.71(16) 
C(28)-C(26)-C(27) 113.74(16) 
O(6)-C(27)-C(30) 106.90(15) 
O(6)-C(27)-C(31) 107.60(14) 
C(30)-C(27)-C(31) 111.12(17) 
O(6)-C(27)-C(26) 102.32(13) 
C(30)-C(27)-C(26) 113.25(16) 
C(31)-C(27)-C(26) 114.80(16) 
C(26)-C(28)-H(29A) 109.5 
C(26)-C(28)-H(29B) 109.5 
H(29A)-C(28)-H(29B) 109.5 
C(26)-C(28)-H(29C) 109.5 
H(29A)-C(28)-H(29C) 109.5 
H(29B)-C(28)-H(29C) 109.5 
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C(26)-C(29)-H(30A) 109.5 
C(26)-C(29)-H(30B) 109.5 
H(30A)-C(29)-H(30B) 109.5 
C(26)-C(29)-H(30C) 109.5 
H(30A)-C(29)-H(30C) 109.5 
H(30B)-C(29)-H(30C) 109.5 
C(27)-C(30)-H(31A) 109.5 
C(27)-C(30)-H(31B) 109.5 
H(31A)-C(30)-H(31B) 109.5 
C(27)-C(30)-H(31C) 109.5 
H(31A)-C(30)-H(31C) 109.5 
H(31B)-C(30)-H(31C) 109.5 
C(27)-C(31)-H(32A) 109.5 
C(27)-C(31)-H(32B) 109.5 
H(32A)-C(31)-H(32B) 109.5 
C(27)-C(31)-H(32C) 109.5 
H(32A)-C(31)-H(32C) 109.5 
H(32B)-C(31)-H(32C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
 
Table 4. Anisotropic displacement parameters (Å2x 103) for rac-5.33. The anisotropic 
displacement factor exponent takes the form: -22[h2 a*2U11 + ...  + 2 h k a* b* U12] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
Si(1) 21(1)  21(1) 27(1)  -1(1) 0(1)  1(1) 
O(1) 16(1)  20(1) 18(1)  4(1) -1(1)  -1(1) 
O(2) 15(1)  19(1) 21(1)  7(1) 0(1)  2(1) 
O(3) 22(1)  31(1) 22(1)  -4(1) 2(1)  1(1) 
O(4) 18(1)  17(1) 27(1)  2(1) 4(1)  1(1) 
O(5) 16(1)  17(1) 29(1)  4(1) 5(1)  2(1) 
O(6) 17(1)  14(1) 32(1)  5(1) 4(1)  2(1) 
N(1) 16(1)  18(1) 18(1)  2(1) 2(1)  3(1) 
B(1) 16(1)  16(1) 22(1)  6(1) 2(1)  5(1) 
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B(2) 18(1)  19(1) 17(1)  4(1) 1(1)  2(1) 
C(1) 18(1)  21(1) 15(1)  1(1) 3(1)  4(1) 
C(2) 18(1)  20(1) 19(1)  -1(1) 3(1)  2(1) 
C(3) 16(1)  19(1) 24(1)  6(1) 6(1)  1(1) 
C(4) 21(1)  24(1) 21(1)  3(1) 5(1)  5(1) 
C(5) 17(1)  29(1) 21(1)  8(1) 4(1)  6(1) 
C(6) 23(1)  30(1) 24(1)  11(1) 6(1)  7(1) 
C(7) 37(1)  38(1) 38(1)  19(1) 12(1)  18(1) 
C(8) 38(1)  61(2) 37(1)  29(1) 9(1)  24(1) 
C(9) 38(1)  64(2) 24(1)  15(1) 1(1)  19(1) 
C(10) 32(1)  43(1) 21(1)  6(1) 2(1)  14(1) 
C(11) 18(1)  27(1) 21(1)  0(1) 3(1)  2(1) 
C(12) 21(1)  31(1) 22(1)  3(1) 4(1)  -2(1) 
C(13) 35(1)  38(1) 45(1)  3(1) 3(1)  13(1) 
C(14) 29(1)  29(1) 38(1)  0(1) 6(1)  -2(1) 
C(15) 29(1)  22(1) 24(1)  2(1) -1(1)  2(1) 
C(16) 41(1)  27(1) 34(1)  5(1) 9(1)  0(1) 
C(17) 47(1)  30(1) 37(1)  9(1) 17(1)  13(1) 
C(18) 47(1)  45(1) 30(1)  2(1) -5(1)  -4(1) 
C(19) 26(1)  24(1) 29(1)  5(1) 6(1)  4(1) 
C(20) 18(1)  21(1) 18(1)  6(1) -1(1)  0(1) 
C(21) 18(1)  21(1) 22(1)  7(1) -1(1)  1(1) 
C(22) 22(1)  24(1) 22(1)  5(1) 4(1)  4(1) 
C(23) 24(1)  26(1) 25(1)  10(1) 2(1)  2(1) 
C(24) 24(1)  27(1) 33(1)  12(1) 1(1)  7(1) 
C(25) 22(1)  32(1) 27(1)  8(1) -3(1)  1(1) 
C(26) 21(1)  17(1) 32(1)  1(1) 4(1)  4(1) 
C(27) 21(1)  14(1) 37(1)  7(1) 4(1)  3(1) 
C(28) 30(1)  32(1) 33(1)  -3(1) 4(1)  4(1) 
C(29) 25(1)  20(1) 55(2)  6(1) 7(1)  -1(1) 
C(30) 29(1)  27(1) 53(2)  17(1) -5(1)  1(1) 
C(31) 26(1)  21(1) 59(2)  1(1) 12(1)  6(1) 
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Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
for rac-5.33. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(5O) 12150(30) 7311(19) 8258(8) 31 
H(1NA) 6080(30) 7400(17) 7994(8) 21 
H(1NB) 8180(30) 7969(18) 8020(8) 21 
H(3) 6278 5004 6776 24 
H(5A) 9859 7979 7216 33 
H(5B) 9128 6821 6694 33 
H(5C) 9969 6546 7280 33 
H(7) 6152 9208 7601 30 
H(8) 4557 10470 7099 41 
H(9) 3256 9689 6167 49 
H(10) 3597 7663 5737 48 
H(11) 5261 6424 6224 37 
H(12A) 3640 5442 7617 28 
H(12B) 3103 5660 6998 28 
H(13A) 3495 3243 7272 31 
H(13B) 1384 3617 7093 31 
H(14A) -945 4292 6332 59 
H(14B) -1510 3865 5672 59 
H(14C) 493 4918 5928 59 
H(15A) 149 685 6093 50 
H(15B) -1752 1093 5791 50 
H(15C) -1140 1552 6449 50 
H(17A) 4284 3645 4914 52 
H(17B) 4729 4058 5577 52 
H(17C) 2890 4470 5248 52 
H(18A) 4137 1393 4981 54 
H(18B) 2582 696 5340 54 
H(18C) 4521 1749 5646 54 
H(19A) -136 2852 4795 66 
H(19B) -311 1377 4836 66 
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H(19C) 1263 2019 4468 66 
H(20A) 7336 3231 7148 32 
H(20B) 8479 3512 7788 32 
H(23A) 8256 8252 8993 34 
H(23B) 8170 8163 9632 34 
H(23C) 6119 7869 9214 34 
H(24A) 5427 5844 9594 37 
H(24B) 7658 6026 9911 37 
H(24C) 6737 4771 9446 37 
H(25A) 9017 4220 8803 41 
H(25B) 10256 4730 9410 41 
H(25C) 11415 4736 8872 41 
H(26A) 12832 7013 9282 42 
H(26B) 11416 7105 9768 42 
H(26C) 11406 8042 9332 42 
H(29A) 13570 10591 9440 50 
H(29B) 13880 12114 9506 50 
H(29C) 15742 11425 9397 50 
H(30A) 16208 12554 8630 51 
H(30B) 14156 13086 8617 51 
H(30C) 14609 12170 8079 51 
H(31A) 11610 10738 7665 54 
H(31B) 10993 12018 7969 54 
H(31C) 9351 10700 7815 54 
H(32A) 8647 10914 8776 53 
H(32B) 10356 12179 9008 53 
H(32C) 10371 10923 9267 53 
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Table 6. Torsion angles [°] for rac-5.33. 
________________________________________________________________  
C(13)-Si(1)-O(3)-C(12) 54.51(16) 
C(14)-Si(1)-O(3)-C(12) -65.79(16) 
C(15)-Si(1)-O(3)-C(12) 173.50(14) 
C(20)-O(1)-B(1)-O(2) 17.23(17) 
C(20)-O(1)-B(1)-C(3) 151.68(15) 
C(20)-O(1)-B(1)-N(1) -98.63(15) 
C(21)-O(2)-B(1)-O(1) 7.49(17) 
C(21)-O(2)-B(1)-C(3) -125.65(16) 
C(21)-O(2)-B(1)-N(1) 124.48(14) 
C(1)-N(1)-B(1)-O(1) -134.31(14) 
C(1)-N(1)-B(1)-O(2) 110.72(15) 
C(1)-N(1)-B(1)-C(3) -12.84(16) 
C(26)-O(4)-B(2)-O(5) -166.39(17) 
C(26)-O(4)-B(2)-O(6) 12.9(2) 
C(27)-O(6)-B(2)-O(5) -174.23(18) 
C(27)-O(6)-B(2)-O(4) 6.5(2) 
B(1)-N(1)-C(1)-C(5) 159.38(14) 
B(1)-N(1)-C(1)-C(4) -81.27(16) 
B(1)-N(1)-C(1)-C(2) 34.82(16) 
N(1)-C(1)-C(2)-C(3) -44.07(16) 
C(5)-C(1)-C(2)-C(3) -167.31(14) 
C(4)-C(1)-C(2)-C(3) 69.80(17) 
N(1)-C(1)-C(2)-C(11) 75.26(17) 
C(5)-C(1)-C(2)-C(11) -48.0(2) 
C(4)-C(1)-C(2)-C(11) -170.87(15) 
C(11)-C(2)-C(3)-C(19) 95.0(2) 
C(1)-C(2)-C(3)-C(19) -143.36(17) 
C(11)-C(2)-C(3)-B(1) -84.50(17) 
C(1)-C(2)-C(3)-B(1) 37.11(17) 
O(1)-B(1)-C(3)-C(19) -78.3(2) 
O(2)-B(1)-C(3)-C(19) 50.3(3) 
N(1)-B(1)-C(3)-C(19) 165.48(17) 
O(1)-B(1)-C(3)-C(2) 101.17(17) 
O(2)-B(1)-C(3)-C(2) -130.18(16) 
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N(1)-B(1)-C(3)-C(2) -15.02(16) 
N(1)-C(1)-C(5)-C(6) 21.8(2) 
C(4)-C(1)-C(5)-C(6) -96.9(2) 
C(2)-C(1)-C(5)-C(6) 139.10(17) 
N(1)-C(1)-C(5)-C(10) -162.77(16) 
C(4)-C(1)-C(5)-C(10) 78.5(2) 
C(2)-C(1)-C(5)-C(10) -45.5(2) 
C(10)-C(5)-C(6)-C(7) -0.2(3) 
C(1)-C(5)-C(6)-C(7) 175.25(17) 
C(5)-C(6)-C(7)-C(8) 0.8(3) 
C(6)-C(7)-C(8)-C(9) -0.5(3) 
C(7)-C(8)-C(9)-C(10) -0.4(3) 
C(8)-C(9)-C(10)-C(5) 1.1(3) 
C(6)-C(5)-C(10)-C(9) -0.8(3) 
C(1)-C(5)-C(10)-C(9) -176.36(18) 
C(3)-C(2)-C(11)-C(12) -72.29(19) 
C(1)-C(2)-C(11)-C(12) 172.18(15) 
Si(1)-O(3)-C(12)-C(11) -112.93(15) 
C(2)-C(11)-C(12)-O(3) -59.7(2) 
O(3)-Si(1)-C(15)-C(16) -58.95(15) 
C(13)-Si(1)-C(15)-C(16) 59.60(16) 
C(14)-Si(1)-C(15)-C(16) -178.22(14) 
O(3)-Si(1)-C(15)-C(17) 60.72(14) 
C(13)-Si(1)-C(15)-C(17) 179.27(14) 
C(14)-Si(1)-C(15)-C(17) -58.54(16) 
O(3)-Si(1)-C(15)-C(18) -177.89(13) 
C(13)-Si(1)-C(15)-C(18) -59.34(16) 
C(14)-Si(1)-C(15)-C(18) 62.85(16) 
B(1)-O(1)-C(20)-C(23) -154.74(14) 
B(1)-O(1)-C(20)-C(22) 85.66(16) 
B(1)-O(1)-C(20)-C(21) -33.10(16) 
B(1)-O(2)-C(21)-C(25) -148.64(15) 
B(1)-O(2)-C(21)-C(24) 92.20(16) 
B(1)-O(2)-C(21)-C(20) -26.77(16) 
O(1)-C(20)-C(21)-O(2) 36.32(15) 
C(23)-C(20)-C(21)-O(2) 153.31(14) 
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C(22)-C(20)-C(21)-O(2) -80.88(16) 
O(1)-C(20)-C(21)-C(25) 155.40(14) 
C(23)-C(20)-C(21)-C(25) -87.61(19) 
C(22)-C(20)-C(21)-C(25) 38.2(2) 
O(1)-C(20)-C(21)-C(24) -78.49(17) 
C(23)-C(20)-C(21)-C(24) 38.5(2) 
C(22)-C(20)-C(21)-C(24) 164.31(15) 
B(2)-O(4)-C(26)-C(29) -146.86(16) 
B(2)-O(4)-C(26)-C(28) 94.43(16) 
B(2)-O(4)-C(26)-C(27) -25.29(18) 
B(2)-O(6)-C(27)-C(30) 97.74(17) 
B(2)-O(6)-C(27)-C(31) -142.82(16) 
B(2)-O(6)-C(27)-C(26) -21.51(18) 
O(4)-C(26)-C(27)-O(6) 28.25(17) 
C(29)-C(26)-C(27)-O(6) 145.12(16) 
C(28)-C(26)-C(27)-O(6) -86.17(17) 
O(4)-C(26)-C(27)-C(30) -86.44(17) 
C(29)-C(26)-C(27)-C(30) 30.4(2) 
C(28)-C(26)-C(27)-C(30) 159.15(17) 
O(4)-C(26)-C(27)-C(31) 144.47(15) 
C(29)-C(26)-C(27)-C(31) -98.6(2) 
C(28)-C(26)-C(27)-C(31) 30.1(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 
 
Table 7. Hydrogen bonds for rac-5.33 [Å and °]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 O(5)-H(5O)...O(2) 0.83(2) 1.83(2) 2.6516(17) 170(2) 
 N(1)-H(1NA)...O(5)#1 0.884(19) 2.20(2) 3.084(2) 177.1(17) 
 N(1)-H(1NB)...O(6) 0.901(19) 2.268(19) 3.1425(19) 163.8(16) 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z       
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 X-Ray Crystal Structure of 5.70 
 
Table 1. Crystal data and structure refinement for 5.70. 
Identification code  C13H19NO2 
Empirical formula  C13 H19 N O2 
Formula weight  221.29 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.8093(10) Å = 90°. 
 b = 11.0945(15) Å = 90°. 
 c = 14.1156(19) Å  = 90°. 
Volume 1223.0(3) Å3 
Z 4 
Density (calculated) 1.202 Mg/m3 
Absorption coefficient 0.642 mm-1 
F(000) 480 
Crystal size 0.440 x 0.320 x 0.250 mm3 
Theta range for data collection 5.070 to 66.891°. 
Index ranges -9<=h<=9, -13<=k<=13, -16<=l<=16 
Reflections collected 8468 
Independent reflections 2150 [R(int) = 0.0326] 
Completeness to theta = 66.891° 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.6456 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2150 / 2 / 159 
Goodness-of-fit on F2 1.097 
Final R indices [I>2sigma(I)] R1 = 0.0301, wR2 = 0.0792 
R indices (all data) R1 = 0.0301, wR2 = 0.0793 
Absolute structure parameter -0.01(6) 
Extinction coefficient na 
Largest diff. peak and hole 0.233 and -0.130 e.Å-3 
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Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for 5.70. U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________   
O(1) 8740(2) 2934(2) 735(1) 31(1) 
O(2) 5599(2) 5512(1) 2495(1) 31(1) 
N(1) 2229(2) 2562(2) 1210(1) 20(1) 
C(1) 7642(2) 2978(2) 1534(1) 25(1) 
C(2) 5929(2) 3488(2) 1245(1) 20(1) 
C(3) 4684(2) 3520(2) 2082(1) 16(1) 
C(4) 2742(2) 3625(2) 1775(1) 17(1) 
C(5) 1650(2) 3627(2) 2675(1) 16(1) 
C(6) 1429(2) 2560(2) 3185(1) 20(1) 
C(7) 504(2) 2538(2) 4020(1) 25(1) 
C(8) -218(2) 3589(2) 4375(1) 27(1) 
C(9) -21(3) 4652(2) 3877(1) 26(1) 
C(10) 899(2) 4676(2) 3033(1) 21(1) 
C(11) 5190(2) 4517(2) 2776(1) 19(1) 
C(12) 5216(3) 4223(2) 3808(1) 30(1) 
C(13) 2437(2) 4732(2) 1156(1) 24(1) 
 
 
Table 3. Bond lengths [Å] and angles [°] for 5.70. 
_____________________________________________________  
O(1)-C(1)  1.418(2) 
O(1)-H(3N)  0.80(3) 
O(2)-C(11)  1.215(2) 
N(1)-C(4)  1.479(2) 
N(1)-H(1N)  0.87(2) 
N(1)-H(2N)  0.873(19) 
C(1)-C(2)  1.509(2) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
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C(2)-C(3)  1.530(2) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(11)  1.530(2) 
C(3)-C(4)  1.582(2) 
C(3)-H(3)  1.0000 
C(4)-C(13)  1.527(2) 
C(4)-C(5)  1.529(2) 
C(5)-C(6)  1.397(2) 
C(5)-C(10)  1.398(2) 
C(6)-C(7)  1.383(3) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.389(3) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.381(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.392(3) 
C(9)-H(9)  0.9500 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.492(3) 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
 
C(1)-O(1)-H(3N) 112(2) 
C(4)-N(1)-H(1N) 111.7(17) 
C(4)-N(1)-H(2N) 110.5(16) 
H(1N)-N(1)-H(2N) 105(2) 
O(1)-C(1)-C(2) 109.52(15) 
O(1)-C(1)-H(1A) 109.8 
C(2)-C(1)-H(1A) 109.8 
O(1)-C(1)-H(1B) 109.8 
C(2)-C(1)-H(1B) 109.8 
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H(1A)-C(1)-H(1B) 108.2 
C(1)-C(2)-C(3) 111.31(14) 
C(1)-C(2)-H(2A) 109.4 
C(3)-C(2)-H(2A) 109.4 
C(1)-C(2)-H(2B) 109.4 
C(3)-C(2)-H(2B) 109.4 
H(2A)-C(2)-H(2B) 108.0 
C(2)-C(3)-C(11) 110.35(13) 
C(2)-C(3)-C(4) 113.57(13) 
C(11)-C(3)-C(4) 111.70(13) 
C(2)-C(3)-H(3) 106.9 
C(11)-C(3)-H(3) 106.9 
C(4)-C(3)-H(3) 106.9 
N(1)-C(4)-C(13) 106.92(14) 
N(1)-C(4)-C(5) 107.34(13) 
C(13)-C(4)-C(5) 112.81(15) 
N(1)-C(4)-C(3) 110.37(14) 
C(13)-C(4)-C(3) 111.42(14) 
C(5)-C(4)-C(3) 107.91(13) 
C(6)-C(5)-C(10) 117.88(15) 
C(6)-C(5)-C(4) 119.70(15) 
C(10)-C(5)-C(4) 122.39(15) 
C(7)-C(6)-C(5) 121.22(16) 
C(7)-C(6)-H(6) 119.4 
C(5)-C(6)-H(6) 119.4 
C(6)-C(7)-C(8) 120.38(18) 
C(6)-C(7)-H(7) 119.8 
C(8)-C(7)-H(7) 119.8 
C(9)-C(8)-C(7) 119.18(17) 
C(9)-C(8)-H(8) 120.4 
C(7)-C(8)-H(8) 120.4 
C(8)-C(9)-C(10) 120.65(17) 
C(8)-C(9)-H(9) 119.7 
C(10)-C(9)-H(9) 119.7 
C(9)-C(10)-C(5) 120.69(17) 
C(9)-C(10)-H(10) 119.7 
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C(5)-C(10)-H(10) 119.7 
O(2)-C(11)-C(12) 120.87(17) 
O(2)-C(11)-C(3) 120.99(16) 
C(12)-C(11)-C(3) 118.12(16) 
C(11)-C(12)-H(12A) 109.5 
C(11)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
C(11)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
C(4)-C(13)-H(13A) 109.5 
C(4)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
C(4)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms: 
 
 
Table 4. Anisotropic displacement parameters (Å2x 103) for 5.70. The anisotropic 
displacement factor exponent takes the form: -22[h2 a*2U11 + ...  + 2 h k a* b* U12] 
________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 9(1)  58(1) 25(1)  -11(1) 0(1)  4(1) 
O(2) 30(1)  20(1) 42(1)  -2(1) 2(1)  -6(1) 
N(1) 14(1)  27(1) 20(1)  -4(1) 1(1)  -1(1) 
C(1) 14(1)  38(1) 23(1)  -3(1) 0(1)  4(1) 
C(2) 11(1)  27(1) 20(1)  -1(1) 0(1)  0(1) 
C(3) 11(1)  15(1) 21(1)  2(1) 0(1)  0(1) 
C(4) 12(1)  18(1) 20(1)  2(1) 0(1)  0(1) 
C(5) 9(1)  18(1) 21(1)  -1(1) -3(1)  0(1) 
C(6) 17(1)  18(1) 25(1)  -1(1) 0(1)  -1(1) 
C(7) 23(1)  27(1) 24(1)  3(1) 1(1)  -8(1) 
C(8) 18(1)  41(1) 21(1)  -5(1) 3(1)  -2(1) 
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C(9) 19(1)  30(1) 28(1)  -10(1) -2(1)  7(1) 
C(10) 17(1)  18(1) 26(1)  -2(1) -5(1)  2(1) 
C(11) 10(1)  20(1) 28(1)  -3(1) 1(1)  0(1) 
C(12) 22(1)  41(1) 26(1)  -5(1) -3(1)  -6(1) 
C(13) 17(1)  28(1) 29(1)  9(1) 2(1)  5(1) 
 
 
Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
for 5.70. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(3N) 9690(40) 2750(30) 880(20) 46(8) 
H(1N) 2730(30) 2550(20) 661(15) 30(6) 
H(2N) 2550(30) 1898(19) 1491(16) 29(6) 
H(1A) 8158 3491 2032 30 
H(1B) 7489 2157 1796 30 
H(2A) 5437 2987 732 23 
H(2B) 6088 4315 996 23 
H(3) 4811 2737 2425 19 
H(6) 1923 1835 2953 24 
H(7) 361 1801 4352 30 
H(8) -840 3577 4953 32 
H(9) -519 5373 4113 31 
H(10) 1018 5413 2697 25 
H(12A) 6104 3619 3932 45 
H(12B) 4098 3903 3997 45 
H(12C) 5464 4955 4172 45 
H(13A) 3038 4633 551 37 
H(13B) 2871 5451 1480 37 
H(13C) 1207 4824 1038 37 
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Table 6. Torsion angles [°] for 5.70. 
________________________________________________________________  
O(1)-C(1)-C(2)-C(3) 178.48(15) 
C(1)-C(2)-C(3)-C(11) 72.82(19) 
C(1)-C(2)-C(3)-C(4) -160.87(15) 
C(2)-C(3)-C(4)-N(1) 62.09(19) 
C(11)-C(3)-C(4)-N(1) -172.31(14) 
C(2)-C(3)-C(4)-C(13) -56.5(2) 
C(11)-C(3)-C(4)-C(13) 69.06(19) 
C(2)-C(3)-C(4)-C(5) 179.10(14) 
C(11)-C(3)-C(4)-C(5) -55.30(18) 
N(1)-C(4)-C(5)-C(6) 45.61(19) 
C(13)-C(4)-C(5)-C(6) 163.13(15) 
C(3)-C(4)-C(5)-C(6) -73.35(18) 
N(1)-C(4)-C(5)-C(10) -136.63(16) 
C(13)-C(4)-C(5)-C(10) -19.1(2) 
C(3)-C(4)-C(5)-C(10) 104.42(17) 
C(10)-C(5)-C(6)-C(7) -0.3(2) 
C(4)-C(5)-C(6)-C(7) 177.56(16) 
C(5)-C(6)-C(7)-C(8) -0.5(3) 
C(6)-C(7)-C(8)-C(9) 0.9(3) 
C(7)-C(8)-C(9)-C(10) -0.5(3) 
C(8)-C(9)-C(10)-C(5) -0.3(3) 
C(6)-C(5)-C(10)-C(9) 0.7(3) 
C(4)-C(5)-C(10)-C(9) -177.08(16) 
C(2)-C(3)-C(11)-O(2) 44.2(2) 
C(4)-C(3)-C(11)-O(2) -83.17(19) 
C(2)-C(3)-C(11)-C(12) -134.11(17) 
C(4)-C(3)-C(11)-C(12) 98.54(18) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 7. Hydrogen bonds for 5.70 [Å and °]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 O(1)-H(3N)...N(1)#1 0.80(3) 2.05(3) 2.837(2) 171(3) 
 N(1)-H(1N)...O(1)#2 0.87(2) 2.19(2) 3.039(2) 166(2) 
 N(1)-H(2N)...O(2)#3 0.873(19) 2.55(2) 3.374(2) 158(2) 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z    #2 x-1/2,-y+1/2,-z    #3 -x+1,y-1/2,-z+1/2 
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